data_2k2t_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k2t _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.408 ' H ' ' CD ' ' A' ' 29' ' ' GLU . 52.9 t . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 109.99 -0.374 . . . . 3.3700000000000001 109.99 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.465 ' HA ' ' HB3' ' A' ' 11' ' ' PRO . 29.4 tt0 -78.54 104.1 8.92 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.107 0.479 . . . . 7.2400000000000002 110.527 -178.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.446 ' H ' ' HA ' ' A' ' 11' ' ' PRO . 86.8 mt -69.21 -65.27 0.73 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.459 -0.792 . . . . 2.8199999999999998 111.017 -178.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.3 p -162.62 -72.05 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.482 -0.326 . . . . 3.8999999999999999 110.928 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -88.04 -65.06 1.06 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.675 -0.491 . . . . 4.5899999999999999 109.675 178.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.445 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 24.3 p -108.27 125.73 31.27 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-O 121.085 0.469 . . . . 3.0 109.994 172.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.465 ' HB3' ' HA ' ' A' ' 6' ' ' GLN . 34.9 Cg_exo -62.91 -17.11 58.14 Favored 'Trans proline' 0 CA--C 1.528 0.196 0 C-N-CA 122.958 2.439 . . . . 2.0299999999999998 112.818 178.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 68.09 123.78 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.778 0.674 . . . . 1.5 110.947 -176.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.469 ' HB1' ' HB3' ' A' ' 34' ' ' TYR . . . 69.57 -56.67 0.56 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.41 0.684 . . . . 1.3100000000000001 110.866 -176.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.486 ' HA ' ' CD ' ' A' ' 18' ' ' PRO . 87.8 m -77.02 -0.34 24.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.072 0.463 . . . . 1.47 110.221 175.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.409 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 25.2 t -69.51 -18.55 63.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.887 -0.597 . . . . 1.3799999999999999 111.185 -176.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.8 m -105.94 8.86 32.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.626 0.251 . . . . 2.2999999999999998 111.544 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.5 m120 53.81 66.46 4.45 Favored Pre-proline 0 N--CA 1.467 0.41 0 CA-C-N 115.901 -0.59 . . . . 2.3500000000000001 110.96 -173.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.486 ' CD ' ' HA ' ' A' ' 14' ' ' CYS . 11.1 Cg_endo -54.88 -53.05 6.62 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.822 2.348 . . . . 0.91000000000000003 112.035 -177.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.577 ' SG ' ' HB3' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -91.21 18.9 6.38 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.941 -0.572 . . . . 0.55000000000000004 110.876 -177.327 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.431 ' HA3' ' HD3' ' A' ' 21' ' ' PRO . . . 72.93 -128.2 11.84 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.838 -0.619 . . . . 0.70999999999999996 111.867 -176.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.514 ' HD2' ' CB ' ' A' ' 24' ' ' ALA . 2.8 Cg_endo -87.05 169.88 7.34 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.462 2.774 . . . . 1.04 112.044 178.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -66.53 -35.45 80.27 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.048 0.452 . . . . 3.4199999999999999 110.693 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.91 -28.98 70.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.83 -0.623 . . . . 1.23 110.869 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.514 ' CB ' ' HD2' ' A' ' 21' ' ' PRO . . . -78.54 -63.53 1.38 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 1.0700000000000001 110.141 177.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -160.83 148.1 15.71 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.436 -0.887 . . . . 0.60999999999999999 112.259 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.8 m -94.0 140.31 29.87 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.122 -0.325 . . . . 1.4299999999999999 110.122 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.577 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 19.6 p -102.86 140.75 36.73 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.015 0.436 . . . . 1.4199999999999999 110.939 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -130.59 125.27 33.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.787 -0.642 . . . . 2.52 109.997 176.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.408 ' CD ' ' H ' ' A' ' 5' ' ' VAL . 3.0 mp0 -66.84 122.73 18.33 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.192 0.52 . . . . 1.6599999999999999 110.326 176.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.576 ' HG1' HG22 ' A' ' 35' ' ' ILE . 49.3 p -122.76 -173.9 2.8 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.413 -0.812 . . . . 1.29 110.796 -178.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -55.35 -41.38 72.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.968 0.413 . . . . 3.1600000000000001 110.907 177.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.6 m -80.18 -5.18 55.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 1.8100000000000001 111.439 -177.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 29' ' ' GLU . . . 126.89 -68.77 0.53 Allowed Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.37 -0.692 . . . . 0.46999999999999997 111.37 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.469 ' HB3' ' HB1' ' A' ' 13' ' ' ALA . 54.5 p90 -155.55 156.6 35.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.832 0.348 . . . . 0.88 110.391 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.576 HG22 ' HG1' ' A' ' 30' ' ' THR . 44.2 pt -129.58 164.98 30.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.81 -0.632 . . . . 1.3400000000000001 109.462 170.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.9 m -123.4 128.8 50.36 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.171 0.51 . . . . 0.33000000000000002 111.39 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -112.92 100.9 9.0 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.071 -0.715 . . . . 5.1799999999999997 109.071 177.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 85.1 m -76.02 143.78 41.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.135 0.493 . . . . 0.27000000000000002 110.981 -177.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -77.06 167.96 20.9 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.198 -0.91 . . . . 0.97999999999999998 110.088 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -60.74 106.59 0.58 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.935 -0.575 . . . . 3.5499999999999998 110.685 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 122.05 -5.59 10.36 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 121.01 -0.614 . . . . 0.93999999999999995 111.714 -175.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -124.7 163.51 21.89 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 122.35 0.26 . . . . 1.1399999999999999 110.59 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.465 ' HG3' HG13 ' A' ' 55' ' ' ILE . 24.5 ptt180 -144.37 158.71 43.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.932 0.396 . . . . 3.46 111.189 -174.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.425 HD11 ' HA ' ' A' ' 44' ' ' ILE . 15.1 mm -85.06 136.96 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.907 -0.588 . . . . 1.0900000000000001 110.485 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 37.9 t -143.84 145.02 32.03 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.935 -0.575 . . . . 0.87 109.987 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.473 ' HB3' ' HA2' ' A' ' 50' ' ' GLY . 81.6 mt -95.08 112.99 24.64 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.466 -0.938 . . . . 1.5700000000000001 108.466 172.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -85.66 75.49 10.1 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.949 0.404 . . . . 2.52 112.014 -170.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.53 -59.0 3.74 Favored Glycine 0 CA--C 1.518 0.253 0 CA-C-N 115.859 -0.609 . . . . 1.4199999999999999 113.375 173.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.3 p -91.24 5.74 47.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.779 0.323 . . . . 1.79 111.793 -174.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.473 ' HA2' ' HB3' ' A' ' 46' ' ' LEU . . . 86.58 4.45 83.01 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.57 -0.824 . . . . 0.85999999999999999 112.681 177.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -66.05 134.52 53.04 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.685 -0.487 . . . . 1.6799999999999999 109.685 175.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.7 t -79.4 109.89 14.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.185 -0.672 . . . . 1.2 109.185 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 18' ' ' PRO . 12.7 t -128.3 169.67 13.95 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 116.009 -0.541 . . . . 1.72 109.825 -179.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 35.5 t -116.39 130.18 56.63 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.521 -0.548 . . . . 0.31 109.521 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.465 HG13 ' HG3' ' A' ' 43' ' ' ARG . 32.2 pt -127.52 166.72 23.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.954 -0.566 . . . . 1.1499999999999999 109.503 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.4 p -73.13 136.64 25.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 121.233 0.539 . . . . 1.3600000000000001 110.37 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -76.23 -33.48 59.21 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.227 -0.657 . . . . 5.4800000000000004 109.227 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 . . . . . 0 C--N 1.327 -0.405 0 CA-C-N 114.648 -1.16 . . . . 3.3199999999999998 108.473 174.523 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 27' ' ' CYS . 10.7 p . . . . . 0 N--CA 1.481 1.115 0 CA-C-O 121.806 0.812 . . . . 3.3700000000000001 110.695 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.517 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 21.8 tp60 -78.8 -42.99 26.36 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.187 -0.671 . . . . 7.2400000000000002 109.187 177.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.679 ' H ' HD21 ' A' ' 7' ' ' LEU . 1.3 pt? -106.33 164.26 12.17 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.664 -0.698 . . . . 2.8199999999999998 109.628 172.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.8 m -99.06 -12.56 20.44 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.83 0.678 . . . . 3.8999999999999999 112.83 -169.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -81.74 -92.49 0.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.875 -0.417 . . . . 4.5899999999999999 109.875 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 23.3 p -122.18 113.37 31.13 Favored Pre-proline 0 CA--C 1.507 -0.708 0 N-CA-C 109.218 -0.66 . . . . 3.0 109.218 168.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.798 ' HB2' ' HB2' ' A' ' 14' ' ' CYS . 26.4 Cg_exo -62.62 101.48 0.26 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.523 2.149 . . . . 2.0299999999999998 109.668 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.07 -34.97 46.13 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.611 0.597 . . . . 1.5 112.611 -170.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.886 ' HB1' ' HG2' ' A' ' 29' ' ' GLU . . . -84.22 -36.9 22.43 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.967 0.413 . . . . 1.3100000000000001 110.931 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.798 ' HB2' ' HB2' ' A' ' 11' ' ' PRO . 33.5 m -83.09 -18.5 39.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.314 -0.403 . . . . 1.47 111.45 -176.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 34.5 t -68.41 -8.99 45.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.127 0.489 . . . . 1.3799999999999999 109.81 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.0 m -88.81 -0.08 57.01 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.97 -0.559 . . . . 2.2999999999999998 110.882 175.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 59.43 68.71 1.48 Allowed Pre-proline 0 N--CA 1.467 0.422 0 CA-C-N 115.107 -0.951 . . . . 2.3500000000000001 111.852 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.432 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 3.5 Cg_exo -78.85 -75.08 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.91 2.407 . . . . 0.91000000000000003 112.44 -177.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.45 24.05 0.28 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.469 -0.332 . . . . 0.55000000000000004 111.81 -177.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.48 -123.14 15.98 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.118 -0.563 . . . . 0.70999999999999996 111.837 -178.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -87.11 154.44 8.29 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.836 2.357 . . . . 1.04 111.494 175.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -70.02 -7.25 39.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.114 0.483 . . . . 3.4199999999999999 110.364 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.84 -34.51 51.82 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.0 -0.545 . . . . 1.23 110.127 173.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.448 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . . . -71.86 -52.41 17.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.753 -0.658 . . . . 1.0700000000000001 109.492 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.401 ' CA ' ' HA ' ' A' ' 38' ' ' CYS . . . -156.86 159.39 29.55 Favored Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 120.57 -0.824 . . . . 0.60999999999999999 111.79 177.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.8 m -83.44 138.08 33.62 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.985 -0.746 . . . . 1.4299999999999999 108.985 176.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.416 ' O ' HG12 ' A' ' 5' ' ' VAL . 41.7 t -98.7 112.94 24.85 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.394 0.616 . . . . 1.4199999999999999 109.535 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.421 ' HB3' HG13 ' A' ' 35' ' ' ILE . 1.7 tmtp? -110.31 102.76 11.38 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.549 -0.75 . . . . 2.52 109.18 -175.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.886 ' HG2' ' HB1' ' A' ' 13' ' ' ALA . 28.6 mt-10 -73.7 122.66 22.69 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.705 -0.68 . . . . 1.6599999999999999 110.401 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 35.8 p -102.42 -175.07 2.72 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.468 -0.787 . . . . 1.29 110.228 -177.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -74.61 -26.17 59.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.514 0.673 . . . . 3.1600000000000001 109.296 176.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.6 m -84.56 -8.44 58.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.312 -0.858 . . . . 1.8100000000000001 111.092 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 142.07 -93.41 0.18 Allowed Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.392 -0.683 . . . . 0.46999999999999997 111.392 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 50.2 p90 -153.46 154.69 34.88 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.314 0.578 . . . . 0.88 111.178 177.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.421 HG13 ' HB3' ' A' ' 28' ' ' LYS . 44.7 pt -129.42 160.2 40.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 108.186 -1.042 . . . . 1.3400000000000001 108.186 168.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 99.4 m -120.83 134.8 55.28 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.041 0.448 . . . . 0.33000000000000002 110.743 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.564 ' HA ' ' NE ' ' A' ' 37' ' ' ARG . 1.5 tpm_? -117.13 99.98 7.41 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.74 -0.664 . . . . 5.1799999999999997 109.358 177.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 42' ' ' TYR . 81.1 m -73.47 141.66 46.83 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.049 0.452 . . . . 0.27000000000000002 110.855 -176.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -73.88 168.67 18.97 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.86 -0.609 . . . . 0.97999999999999998 109.763 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -59.0 118.7 6.11 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.989 0.424 . . . . 3.5499999999999998 110.245 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 116.18 -14.26 16.14 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.715 -0.755 . . . . 0.93999999999999995 112.017 -175.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.466 ' HB2' ' HB3' ' A' ' 38' ' ' CYS . 84.1 m-85 -120.59 162.8 19.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.654 0.264 . . . . 1.1399999999999999 110.657 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -143.78 157.65 44.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.423 -0.353 . . . . 3.46 110.709 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.9 mm -77.27 136.04 25.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.014 -0.539 . . . . 1.0900000000000001 111.282 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 36.3 t -138.48 152.62 48.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.509 -0.768 . . . . 0.87 109.333 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.471 HD12 ' HA2' ' A' ' 50' ' ' GLY . 75.9 mt -107.1 145.31 32.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.173 0.511 . . . . 1.5700000000000001 109.869 175.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -65.86 -21.66 66.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.524 -0.762 . . . . 2.52 111.476 -176.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 127.81 -28.69 4.36 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 111.261 -0.735 . . . . 1.4199999999999999 111.261 -176.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.5 p -100.5 -7.28 24.35 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.449 0.642 . . . . 1.79 109.951 176.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.471 ' HA2' HD12 ' A' ' 46' ' ' LEU . . . 109.78 13.75 15.56 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.438 -0.801 . . . . 0.85999999999999999 113.09 172.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -76.34 133.9 39.85 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.477 -0.564 . . . . 1.6799999999999999 109.477 174.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.1 t -79.61 111.71 16.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.047 0.451 . . . . 1.2 110.683 -175.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.4 p -121.38 177.04 5.35 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.81 -0.632 . . . . 1.72 110.085 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 45.4 t -133.98 130.7 38.02 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.037 0.446 . . . . 0.31 110.552 -176.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 32.9 pt -132.09 172.07 16.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.7 -0.682 . . . . 1.1499999999999999 109.443 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.9 p -65.66 141.42 18.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.84 0.352 . . . . 1.3600000000000001 110.243 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -76.49 -75.8 0.18 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.112 -0.699 . . . . 5.4800000000000004 109.112 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 . . . . . 0 C--N 1.319 -0.719 0 N-CA-C 108.778 -0.823 . . . . 3.3199999999999998 108.778 168.857 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.59 ' H ' ' CD ' ' A' ' 29' ' ' GLU . 15.6 t . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 121.115 0.483 . . . . 3.3700000000000001 110.434 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.476 ' HG2' ' CD ' ' A' ' 29' ' ' GLU . 54.4 mm-40 -97.68 -177.58 3.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.419 . . . . 7.2400000000000002 109.978 176.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.6 mp 62.33 -177.64 0.13 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.634 0.584 . . . . 2.8199999999999998 111.66 177.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.2 m -121.56 -3.86 9.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.162 -0.472 . . . . 3.8999999999999999 111.517 -175.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -115.22 -69.32 0.86 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.954 -0.387 . . . . 4.5899999999999999 109.954 174.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.514 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 18.8 p -126.54 128.71 24.28 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.363 -0.38 . . . . 3.0 110.609 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.524 ' CB ' ' HA ' ' A' ' 5' ' ' VAL . 58.9 Cg_endo -75.85 53.43 3.69 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 123.16 2.573 . . . . 2.0299999999999998 114.15 -172.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.501 ' O ' ' HB3' ' A' ' 15' ' ' SER . . . 43.56 -93.04 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.318 1.229 . . . . 1.5 114.318 173.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.533 ' HB1' ' HG3' ' A' ' 29' ' ' GLU . . . -73.71 -35.14 65.09 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.105 0.478 . . . . 1.3100000000000001 110.659 -177.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.404 ' HB2' ' HB2' ' A' ' 11' ' ' PRO . 68.5 m -84.9 3.3 38.72 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.711 -0.677 . . . . 1.47 110.117 178.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.514 ' OG ' ' HB ' ' A' ' 10' ' ' THR . 30.5 t -70.3 -15.35 62.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.657 -0.701 . . . . 1.3799999999999999 111.218 -176.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.2 p -89.53 -0.26 57.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.924 0.393 . . . . 2.2999999999999998 110.871 177.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.6 m120 58.93 63.9 3.54 Favored Pre-proline 0 N--CA 1.467 0.409 0 CA-C-N 115.064 -0.971 . . . . 2.3500000000000001 111.43 -175.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.5 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 20.2 Cg_exo -65.26 -50.41 2.03 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.723 2.282 . . . . 0.91000000000000003 111.782 -177.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.527 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 0.7 OUTLIER -87.44 8.01 26.64 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.861 -0.608 . . . . 0.55000000000000004 110.252 -179.266 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.404 ' HA3' ' HD3' ' A' ' 21' ' ' PRO . . . 76.72 -122.95 6.47 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.743 -0.662 . . . . 0.70999999999999996 112.783 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.404 ' HD3' ' HA3' ' A' ' 20' ' ' GLY . 4.5 Cg_endo -83.29 162.41 15.15 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.617 2.878 . . . . 1.04 112.554 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -67.61 -18.78 65.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.356 -0.838 . . . . 3.4199999999999999 111.85 -177.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.51 -16.63 47.98 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.82 0.343 . . . . 1.23 111.111 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.43 -60.73 2.25 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.266 -0.424 . . . . 1.0700000000000001 110.88 -177.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -161.14 164.56 34.94 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.009 -1.091 . . . . 0.60999999999999999 113.224 -177.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.25 134.75 34.93 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.995 -0.372 . . . . 1.4299999999999999 109.995 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.527 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 49.4 t -117.5 119.79 36.11 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.843 0.354 . . . . 1.4199999999999999 110.905 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -118.48 126.24 51.6 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.786 -0.643 . . . . 2.52 110.246 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.59 ' CD ' ' H ' ' A' ' 5' ' ' VAL . 49.4 mp0 -70.71 123.78 22.71 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.116 -0.493 . . . . 1.6599999999999999 109.857 175.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 73.3 p -115.3 -174.72 2.56 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.244 -0.435 . . . . 1.29 110.763 -178.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -77.78 -26.37 49.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.299 0.571 . . . . 3.1600000000000001 109.868 175.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.85 -25.86 60.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.709 -0.678 . . . . 1.8100000000000001 109.588 175.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 147.93 -82.69 0.19 Allowed Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.525 -1.03 . . . . 0.46999999999999997 110.525 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.441 ' HD2' ' HB3' ' A' ' 13' ' ' ALA . 28.0 p90 -154.83 163.64 39.98 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 110.111 -0.329 . . . . 0.88 110.111 175.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.1 pt -128.59 151.5 35.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 116.182 -0.463 . . . . 1.3400000000000001 110.369 175.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.5 ' SG ' ' HB2' ' A' ' 18' ' ' PRO . 20.9 m -121.23 118.81 30.54 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.191 0.519 . . . . 0.33000000000000002 110.306 178.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -108.78 100.55 9.76 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.514 -0.766 . . . . 5.1799999999999997 110.075 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 98.6 m -75.72 139.65 42.01 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.078 0.466 . . . . 0.27000000000000002 111.469 -175.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -84.54 175.99 8.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.55 -0.75 . . . . 0.97999999999999998 110.486 177.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -54.77 119.31 5.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.052 -0.522 . . . . 3.5499999999999998 110.765 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.82 2.22 46.07 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.577 -0.82 . . . . 0.93999999999999995 112.327 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -127.79 162.16 27.28 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.145 -0.317 . . . . 1.1399999999999999 110.145 177.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.404 ' HD3' ' HG3' ' A' ' 57' ' ' ARG . 21.6 ptt180 -145.96 154.47 41.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.858 0.361 . . . . 3.46 110.978 -178.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.45 HD12 ' O ' ' A' ' 36' ' ' CYS . 20.9 mm -78.33 133.49 30.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.797 -0.638 . . . . 1.0900000000000001 110.346 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.4 t -140.01 151.37 45.41 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.137 -0.69 . . . . 0.87 109.137 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 55.8 mt -102.85 145.35 29.92 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.519 -0.549 . . . . 1.5700000000000001 109.519 173.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -84.43 -160.24 0.46 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.705 -0.68 . . . . 2.52 109.776 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -65.67 -28.07 73.26 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.647 -0.787 . . . . 1.4199999999999999 112.938 177.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 82.6 p -90.76 -30.38 17.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 117.261 0.53 . . . . 1.79 111.407 -176.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.82 18.49 7.85 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.681 -0.771 . . . . 0.85999999999999999 111.403 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 -74.73 141.97 44.41 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.401 -0.4 . . . . 1.6799999999999999 109.961 177.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.9 t -78.3 110.84 14.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.103 0.477 . . . . 1.2 109.933 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.0 p -124.99 169.79 11.76 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.818 -0.628 . . . . 1.72 110.464 -177.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 25.2 t -121.81 129.93 53.01 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.084 -0.71 . . . . 0.31 109.084 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 33.9 pt -128.49 157.21 41.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.527 -0.306 . . . . 1.1499999999999999 110.383 -177.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.91 123.85 22.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.422 0.629 . . . . 1.3600000000000001 110.369 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.404 ' HG3' ' HD3' ' A' ' 43' ' ' ARG . 74.7 ttt180 -88.49 142.09 28.0 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.668 -0.696 . . . . 5.4800000000000004 109.866 -177.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.019 -0.537 . . . . 3.3199999999999998 111.083 178.097 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.637 HG22 ' HG3' ' A' ' 11' ' ' PRO . 11.8 t . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 121.162 0.506 . . . . 3.3700000000000001 110.159 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.463 ' OE1' ' HB2' ' A' ' 29' ' ' GLU . 55.4 mt-30 -94.4 -10.77 31.48 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.267 0.469 . . . . 7.2400000000000002 112.267 -178.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 62.1 mt -81.99 -87.53 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.674 -0.41 . . . . 2.8199999999999998 110.935 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.7 m -147.11 -67.07 0.26 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.022 0.439 . . . . 3.8999999999999999 110.05 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.416 ' HG3' HG22 ' A' ' 10' ' ' THR . 10.8 pt-20 -118.12 -30.05 5.42 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.205 -0.452 . . . . 4.5899999999999999 110.126 177.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.494 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 37.8 p -100.35 132.03 23.12 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.054 -0.521 . . . . 3.0 110.686 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.926 ' HB2' ' HB2' ' A' ' 14' ' ' CYS . 4.1 Cg_exo -78.0 29.39 0.45 Allowed 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 123.489 2.793 . . . . 2.0299999999999998 113.458 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 50.98 -99.72 0.08 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.879 0.696 . . . . 1.5 112.879 176.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.435 ' HB2' ' HB3' ' A' ' 34' ' ' TYR . . . -66.66 -27.34 67.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.457 0.646 . . . . 1.3100000000000001 110.334 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.926 ' HB2' ' HB2' ' A' ' 11' ' ' PRO . 69.0 m -93.85 3.35 55.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.4 -0.818 . . . . 1.47 110.78 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.754 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 20.7 t -69.96 -22.3 63.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.366 -0.379 . . . . 1.3799999999999999 110.97 -176.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.6 m -89.09 7.1 36.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.492 -0.322 . . . . 2.2999999999999998 111.357 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 54.03 72.59 1.08 Allowed Pre-proline 0 N--CA 1.466 0.369 0 CA-C-N 115.693 -0.685 . . . . 2.3500000000000001 111.183 -176.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.417 ' HG2' ' SG ' ' A' ' 27' ' ' CYS . 14.4 Cg_exo -66.29 -42.22 10.78 Favored 'Trans proline' 0 CA--C 1.52 -0.213 0 C-N-CA 123.13 2.554 . . . . 0.91000000000000003 111.803 -175.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.507 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -82.02 -3.11 53.82 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.542 -0.753 . . . . 0.55000000000000004 110.337 -178.189 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.16 -137.59 13.52 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.433 -0.803 . . . . 0.70999999999999996 111.324 -176.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.524 ' HD2' ' HB2' ' A' ' 24' ' ' ALA . 6.2 Cg_exo -77.72 171.34 17.57 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.593 2.195 . . . . 1.04 111.769 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.34 -39.53 94.79 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.905 0.383 . . . . 3.4199999999999999 110.318 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.47 -23.62 66.01 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.512 -0.767 . . . . 1.23 111.397 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.524 ' HB2' ' HD2' ' A' ' 21' ' ' PRO . . . -81.36 -56.57 3.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.908 0.385 . . . . 1.0700000000000001 110.363 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -171.39 161.1 33.46 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.619 -0.801 . . . . 0.60999999999999999 111.965 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.6 m -102.33 140.74 36.21 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.548 -0.538 . . . . 1.4299999999999999 109.548 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.507 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 38.2 t -105.35 143.28 33.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.189 0.518 . . . . 1.4199999999999999 110.752 -177.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.745 ' HE2' ' HA ' ' A' ' 28' ' ' LYS . 0.5 OUTLIER -131.88 122.07 25.08 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.725 -0.67 . . . . 2.52 110.139 -177.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.463 ' HB2' ' OE1' ' A' ' 6' ' ' GLN . 5.0 mp0 -66.99 125.79 27.09 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.356 -0.609 . . . . 1.6599999999999999 109.356 175.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 31.8 p -106.98 173.71 6.2 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.851 -0.613 . . . . 1.29 110.494 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -79.82 46.83 0.81 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 122.027 0.918 . . . . 3.1600000000000001 109.974 175.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.5 t -162.9 -41.43 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.816 -1.083 . . . . 1.8100000000000001 108.325 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -179.52 -100.08 0.13 Allowed Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.298 -0.864 . . . . 0.46999999999999997 111.276 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.435 ' HB3' ' HB2' ' A' ' 13' ' ' ALA . 36.9 p90 -148.93 151.23 34.27 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.748 -0.464 . . . . 0.88 109.748 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.8 pt -129.87 161.88 38.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.936 -0.394 . . . . 1.3400000000000001 109.936 172.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 33.3 m -121.22 130.95 53.95 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.239 -0.437 . . . . 0.33000000000000002 110.821 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -111.02 101.52 10.07 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.946 -0.761 . . . . 5.1799999999999997 108.946 175.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.502 ' HB3' ' HB2' ' A' ' 42' ' ' TYR . 88.9 m -73.56 145.31 45.6 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.911 -0.586 . . . . 0.27000000000000002 110.876 -177.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -77.69 170.88 15.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.537 -0.756 . . . . 0.97999999999999998 109.772 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -66.2 103.23 0.95 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.049 0.452 . . . . 3.5499999999999998 110.335 -178.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 128.6 -1.03 6.41 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.529 -0.76 . . . . 0.93999999999999995 111.456 -175.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.502 ' HB2' ' HB3' ' A' ' 38' ' ' CYS . 80.2 m-85 -130.23 162.44 28.94 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.673 -0.491 . . . . 1.1399999999999999 109.673 177.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.798 ' HG2' ' HB2' ' A' ' 57' ' ' ARG . 2.7 ptp180 -143.55 161.47 38.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.612 0.244 . . . . 3.46 110.72 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.433 HD12 ' HA ' ' A' ' 44' ' ' ILE . 12.5 mm -81.3 140.03 17.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 121.059 0.457 . . . . 1.0900000000000001 111.38 -176.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.4 t -147.12 154.68 41.41 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.693 -0.685 . . . . 0.87 109.36 177.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 80.9 mt -96.79 145.99 25.32 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.435 -0.58 . . . . 1.5700000000000001 109.435 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -64.79 -15.04 61.15 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.546 -0.752 . . . . 2.52 111.901 -177.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.49 -30.26 4.76 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.353 -0.699 . . . . 1.4199999999999999 111.353 -176.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.5 p -102.84 -24.43 13.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.103 0.478 . . . . 1.79 110.219 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 131.04 20.85 1.13 Allowed Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.543 -0.753 . . . . 0.85999999999999999 112.897 174.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -83.82 133.08 34.77 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.618 -0.512 . . . . 1.6799999999999999 109.618 174.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.6 t -80.02 111.8 17.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.023 0.439 . . . . 1.2 110.333 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.7 t -127.45 173.85 9.49 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.909 -0.587 . . . . 1.72 109.582 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 19' ' ' CYS . 48.5 t -122.83 131.19 53.65 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.555 -0.535 . . . . 0.31 109.555 -176.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 20.9 pt -123.54 142.15 41.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.14 0.495 . . . . 1.1499999999999999 110.945 -176.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.1 p -66.55 126.77 26.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.424 -0.807 . . . . 1.3600000000000001 110.514 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.798 ' HB2' ' HG2' ' A' ' 43' ' ' ARG . 4.2 tpm_? -123.34 131.89 53.81 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.979 -0.748 . . . . 5.4800000000000004 108.979 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 . . . . . 0 C--O 1.239 0.5 0 CA-C-O 121.062 0.458 . . . . 3.3199999999999998 111.265 -176.137 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.436 HG13 ' SG ' ' A' ' 27' ' ' CYS . 16.9 m . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.933 0.397 . . . . 3.3700000000000001 111.436 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.88 -32.85 15.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.955 0.407 . . . . 7.2400000000000002 110.34 178.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.535 HD13 ' HA ' ' A' ' 11' ' ' PRO . 95.7 mt -85.67 -175.57 5.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.989 -0.551 . . . . 2.8199999999999998 110.939 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.4 t -69.51 -72.52 0.19 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.394 -0.366 . . . . 3.8999999999999999 111.804 -173.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.402 ' HB2' ' H ' ' A' ' 10' ' ' THR . 13.0 mm-40 -98.92 -88.92 0.32 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.095 0.474 . . . . 4.5899999999999999 110.759 -171.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.528 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 0.7 OUTLIER -102.47 108.1 56.23 Favored Pre-proline 0 N--CA 1.446 -0.642 0 CA-C-N 115.754 -0.657 . . . . 3.0 109.499 175.118 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.535 ' HA ' HD13 ' A' ' 7' ' ' LEU . 0.9 OUTLIER -81.9 64.8 8.51 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.581 2.854 . . . . 2.0299999999999998 113.568 -169.869 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.426 ' O ' ' HB3' ' A' ' 15' ' ' SER . . . 43.65 -87.44 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 O-C-N 124.339 1.024 . . . . 1.5 113.712 174.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.442 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . . . -62.55 -41.59 98.99 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.301 -0.409 . . . . 1.3100000000000001 111.532 -177.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.576 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 52.5 t -85.37 -3.15 58.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.143 0.497 . . . . 1.47 110.774 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.426 ' HB3' ' O ' ' A' ' 12' ' ' ALA . 36.6 t -65.59 -17.52 64.64 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.283 -0.417 . . . . 1.3799999999999999 111.463 -177.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 36.5 m -108.1 14.89 24.74 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.925 0.393 . . . . 2.2999999999999998 111.49 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 55.95 73.29 0.86 Allowed Pre-proline 0 N--CA 1.47 0.544 0 CA-C-N 115.313 -0.858 . . . . 2.3500000000000001 112.283 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.576 ' HD3' ' HA ' ' A' ' 14' ' ' CYS . 24.6 Cg_endo -62.19 -43.56 23.28 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.829 2.353 . . . . 0.91000000000000003 112.191 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 2.6 m -90.56 17.9 6.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.266 -0.425 . . . . 0.55000000000000004 111.109 -176.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.443 ' HA3' ' HD3' ' A' ' 21' ' ' PRO . . . 70.98 -123.74 10.95 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 116.102 -0.499 . . . . 0.70999999999999996 112.553 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.443 ' HD3' ' HA3' ' A' ' 20' ' ' GLY . 1.6 Cg_endo -78.76 157.87 27.92 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 123.287 2.658 . . . . 1.04 112.063 178.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -67.42 -27.9 67.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.664 -0.698 . . . . 3.4199999999999999 110.565 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.04 -15.04 61.09 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.61 -0.723 . . . . 1.23 111.288 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.91 -52.37 6.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.341 -0.39 . . . . 1.0700000000000001 110.351 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -169.76 174.31 43.99 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.3 -0.952 . . . . 0.60999999999999999 113.083 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.5 m -101.38 140.89 35.06 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 122.46 0.304 . . . . 1.4299999999999999 110.86 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.436 ' SG ' HG13 ' A' ' 5' ' ' VAL . 27.9 p -102.55 130.09 49.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.899 0.381 . . . . 1.4199999999999999 110.517 177.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -124.5 117.06 23.54 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.203 -0.666 . . . . 2.52 109.203 176.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -71.95 119.1 15.65 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.192 0.52 . . . . 1.6599999999999999 109.973 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.9 p -112.17 -175.68 2.74 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.876 -0.602 . . . . 1.29 110.683 -176.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -68.19 -24.01 64.9 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.395 0.617 . . . . 3.1600000000000001 109.728 174.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.9 m -78.77 -19.32 52.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.614 -0.721 . . . . 1.8100000000000001 110.038 177.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 133.2 -71.77 0.49 Allowed Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.985 -0.846 . . . . 0.46999999999999997 110.985 -177.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.442 ' CD1' ' HB2' ' A' ' 13' ' ' ALA . 50.2 p90 -155.98 158.93 38.71 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.306 -0.257 . . . . 0.88 110.306 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.2 pt -131.74 157.07 43.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.272 -0.64 . . . . 1.3400000000000001 109.272 170.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.0 m -121.06 119.22 31.84 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.634 0.73 . . . . 0.33000000000000002 111.06 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -105.72 99.46 9.06 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.992 -1.003 . . . . 5.1799999999999997 109.975 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 77.8 m -77.88 146.2 35.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.979 0.418 . . . . 0.27000000000000002 110.845 -176.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -84.06 179.02 7.61 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.833 -0.622 . . . . 0.97999999999999998 109.996 176.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -58.77 132.44 53.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.674 0.273 . . . . 3.5499999999999998 110.544 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.85 5.65 80.84 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.477 -0.868 . . . . 0.93999999999999995 112.398 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -125.54 154.5 42.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.025 0.441 . . . . 1.1399999999999999 110.624 177.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.516 ' HG3' HG13 ' A' ' 55' ' ' ILE . 24.7 ptt180 -140.43 160.85 39.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.779 -0.646 . . . . 3.46 111.172 -171.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.4 mm -87.51 134.36 27.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.798 -0.637 . . . . 1.0900000000000001 110.65 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.0 t -143.53 173.54 11.55 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.442 -0.799 . . . . 0.87 109.217 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 78.8 mt -107.69 145.02 33.97 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.247 0.546 . . . . 1.5700000000000001 109.998 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -61.85 -23.91 66.57 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.027 -0.988 . . . . 2.52 111.509 -177.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 133.61 -22.56 3.89 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 111.223 -0.751 . . . . 1.4199999999999999 111.223 -175.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 37.4 p -111.71 -27.09 8.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.042 0.449 . . . . 1.79 110.393 177.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 133.57 24.02 0.7 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.766 -0.73 . . . . 0.85999999999999999 112.901 175.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -87.26 145.9 26.18 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.417 -0.586 . . . . 1.6799999999999999 109.417 174.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.1 t -79.4 111.16 15.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.953 0.406 . . . . 1.2 110.087 -176.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 18' ' ' PRO . 65.7 p -124.78 169.13 12.31 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.989 -0.55 . . . . 1.72 110.472 -178.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 34.0 t -121.81 131.23 53.95 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.023 -0.535 . . . . 0.31 109.656 -178.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.516 HG13 ' HG3' ' A' ' 43' ' ' ARG . 34.5 pt -131.73 167.13 27.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.249 -0.432 . . . . 1.1499999999999999 110.115 -177.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.9 p -76.91 137.35 22.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.474 0.654 . . . . 1.3600000000000001 111.28 -175.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.413 ' HD3' ' HD3' ' A' ' 43' ' ' ARG . 19.1 tpt180 -101.14 106.72 17.99 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.17 -1.048 . . . . 5.4800000000000004 108.17 173.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.469 0.489 0 N-CA-C 112.209 0.448 . . . . 3.3199999999999998 112.209 -171.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.478 0.934 0 CA-C-O 122.146 0.974 . . . . 3.3700000000000001 109.93 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -81.65 -38.49 25.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.822 -0.626 . . . . 7.2400000000000002 110.718 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.686 ' HB2' ' HA ' ' A' ' 11' ' ' PRO . 85.3 mt -88.11 155.18 19.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.182 -0.463 . . . . 2.8199999999999998 110.039 178.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.3 t -85.68 -33.67 21.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.445 -0.798 . . . . 3.8999999999999999 111.823 -167.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -93.71 -79.7 0.4 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.316 -0.624 . . . . 4.5899999999999999 109.316 177.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.5 p -124.04 129.61 24.69 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 115.849 -0.614 . . . . 3.0 109.905 172.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.686 ' HA ' ' HB2' ' A' ' 7' ' ' LEU . 62.6 Cg_endo -76.78 -163.05 0.18 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.604 2.203 . . . . 2.0299999999999998 111.84 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -103.89 -65.43 1.02 Allowed 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.469 -0.492 . . . . 1.5 110.23 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.735 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . . . -71.78 -48.22 48.1 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.122 -0.49 . . . . 1.3100000000000001 110.59 -177.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.504 ' HB2' ' CG ' ' A' ' 11' ' ' PRO . 65.7 m -66.63 -23.16 66.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.366 -0.379 . . . . 1.47 111.048 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.7 t -67.94 -28.11 67.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.022 0.439 . . . . 1.3799999999999999 110.402 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.0 t -82.72 -0.89 49.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.262 0.553 . . . . 2.2999999999999998 110.291 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 62.29 73.04 0.57 Allowed Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 115.056 -0.975 . . . . 2.3500000000000001 111.146 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.519 ' O ' ' HA ' ' A' ' 53' ' ' THR . 5.7 Cg_exo -74.69 -64.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.499 2.133 . . . . 0.91000000000000003 111.162 -177.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -84.13 27.36 0.68 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.851 -0.613 . . . . 0.55000000000000004 110.869 -178.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.94 -125.5 22.24 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.142 -0.551 . . . . 0.70999999999999996 112.071 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.594 ' HG2' ' HB1' ' A' ' 24' ' ' ALA . 90.6 Cg_endo -78.51 156.78 28.65 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.778 2.319 . . . . 1.04 112.379 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -68.43 -11.95 60.45 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.249 -0.887 . . . . 3.4199999999999999 110.39 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.81 -14.5 34.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.698 -0.683 . . . . 1.23 111.526 177.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.594 ' HB1' ' HG2' ' A' ' 21' ' ' PRO . . . -78.27 -35.89 47.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.412 0.625 . . . . 1.0700000000000001 110.453 -177.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -177.92 -171.73 41.63 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.632 -0.794 . . . . 0.60999999999999999 112.093 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.9 m -92.12 134.1 35.16 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 110.083 -0.34 . . . . 1.4299999999999999 110.083 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.428 ' SG ' ' HG2' ' A' ' 18' ' ' PRO . 43.0 t -106.1 112.67 25.81 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.375 -0.602 . . . . 1.4199999999999999 109.375 177.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.46 ' HB3' ' CG1' ' A' ' 35' ' ' ILE . 17.8 tppt? -116.05 107.66 15.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.122 -0.49 . . . . 2.52 110.108 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.735 ' HG2' ' HB2' ' A' ' 13' ' ' ALA . 36.2 mt-10 -74.38 118.74 17.68 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.073 -0.512 . . . . 1.6599999999999999 109.973 178.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 70.9 p -109.98 -175.11 2.65 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.775 -0.648 . . . . 1.29 110.372 -175.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -76.1 -17.61 59.54 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.319 0.581 . . . . 3.1600000000000001 109.755 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.8 t -88.94 -1.2 57.99 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.664 -0.698 . . . . 1.8100000000000001 109.937 175.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 124.52 -79.89 0.36 Allowed Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 111.064 -0.814 . . . . 0.46999999999999997 111.064 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.465 ' HB3' ' CB ' ' A' ' 13' ' ' ALA . 54.8 p90 -156.2 154.46 30.82 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.149 -0.315 . . . . 0.88 110.149 178.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.46 ' CG1' ' HB3' ' A' ' 28' ' ' LYS . 44.2 pt -122.68 148.92 26.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 108.794 -0.817 . . . . 1.3400000000000001 108.794 166.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.403 ' SG ' ' HB2' ' A' ' 18' ' ' PRO . 50.3 m -120.63 123.03 41.81 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.279 0.561 . . . . 0.33000000000000002 110.791 -177.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 48.6 ttp85 -116.08 100.73 8.16 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.354 -0.839 . . . . 5.1799999999999997 109.885 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 81.8 m -77.39 155.13 32.08 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.256 0.551 . . . . 0.27000000000000002 111.86 -175.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -79.07 -179.63 6.8 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.061 -0.972 . . . . 0.97999999999999998 109.684 174.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -64.42 -39.15 93.28 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.981 0.419 . . . . 3.5499999999999998 111.588 -172.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.29 6.79 59.27 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.545 -0.836 . . . . 0.93999999999999995 112.743 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.46 ' HB3' ' SG ' ' A' ' 54' ' ' CYS . 96.1 m-85 -128.78 161.43 29.77 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 122.583 -0.363 . . . . 1.1399999999999999 110.938 -176.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -142.73 162.43 35.49 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.883 0.373 . . . . 3.46 110.639 -176.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.0 mm -84.91 128.94 38.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.898 -0.592 . . . . 1.0900000000000001 110.891 -178.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.7 t -133.98 151.98 51.67 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.322 -0.854 . . . . 0.87 109.235 178.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 86.5 mt -101.82 142.54 32.97 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.122 0.487 . . . . 1.5700000000000001 109.786 176.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -64.35 -22.02 66.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.312 -0.858 . . . . 2.52 111.959 -174.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 129.38 -23.62 4.82 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.904 -0.665 . . . . 1.4199999999999999 111.508 -175.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.6 p -106.55 -25.5 11.79 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.005 0.431 . . . . 1.79 109.85 175.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 131.47 15.56 1.6 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.928 -0.654 . . . . 0.85999999999999999 112.952 174.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -74.53 134.53 42.2 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.446 -0.576 . . . . 1.6799999999999999 109.446 174.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.8 t -79.71 110.27 15.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.668 -0.493 . . . . 1.2 109.668 -178.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 18' ' ' PRO . 65.9 p -121.4 171.13 8.99 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.962 -0.563 . . . . 1.72 109.846 -178.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . 0.46 ' SG ' ' HB3' ' A' ' 42' ' ' TYR . 15.6 t -126.72 130.68 50.82 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.328 -0.396 . . . . 0.31 110.046 -176.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 41.2 pt -133.68 165.32 32.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.06 -0.518 . . . . 1.1499999999999999 109.937 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.0 p -65.11 127.83 26.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.336 0.588 . . . . 1.3600000000000001 110.726 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -82.64 -40.82 20.22 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.498 -0.774 . . . . 5.4800000000000004 110.249 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 . . . . . 0 C--N 1.324 -0.515 0 CA-C-N 115.419 -0.81 . . . . 3.3199999999999998 109.631 -178.371 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.704 HG13 ' H ' ' A' ' 6' ' ' GLN . 2.8 p . . . . . 0 N--CA 1.474 0.745 0 CA-C-O 119.491 -0.29 . . . . 3.3700000000000001 111.077 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.704 ' H ' HG13 ' A' ' 5' ' ' VAL . 25.0 tp60 -177.59 -48.07 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.952 0.406 . . . . 7.2400000000000002 110.148 -176.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.4 mt 69.88 -95.69 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.297 -0.865 . . . . 2.8199999999999998 112.021 173.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.3 m -154.51 -82.05 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.493 0.187 . . . . 3.8999999999999999 110.893 -176.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -67.68 -64.68 0.81 Allowed 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.52 -0.548 . . . . 4.5899999999999999 109.52 177.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.6 p -141.35 143.41 30.2 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 115.449 -0.796 . . . . 3.0 109.85 176.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.465 ' HB3' ' HA ' ' A' ' 6' ' ' GLN . 48.8 Cg_endo -75.33 90.43 1.11 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 121.599 1.533 . . . . 2.0299999999999998 109.098 171.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -46.97 -33.01 4.27 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.591 0.96 . . . . 1.5 113.591 -166.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.801 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . . . -94.95 -29.89 14.42 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.218 0.451 . . . . 1.3100000000000001 112.218 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.447 ' HB2' ' HB2' ' A' ' 11' ' ' PRO . 35.7 m -97.1 2.55 51.38 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 122.039 -0.413 . . . . 1.47 111.164 -178.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.5 t -66.31 -17.88 65.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.09 -0.504 . . . . 1.3799999999999999 111.25 -173.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.7 m -97.47 4.19 50.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.605 -0.27 . . . . 2.2999999999999998 111.543 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 57.5 76.37 0.48 Allowed Pre-proline 0 N--CA 1.469 0.525 0 CA-C-N 115.616 -0.72 . . . . 2.3500000000000001 111.394 -175.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -73.23 -73.02 0.01 OUTLIER 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 122.902 2.401 . . . . 0.91000000000000003 112.784 -177.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -71.1 -28.39 64.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.191 0.519 . . . . 0.55000000000000004 111.158 -176.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.41 ' HA3' ' HD3' ' A' ' 21' ' ' PRO . . . 105.67 -122.86 7.32 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.611 -0.722 . . . . 0.70999999999999996 112.312 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 24' ' ' ALA . 10.2 Cg_endo -86.3 156.12 9.51 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.302 2.668 . . . . 1.04 112.49 -177.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -62.62 -23.29 66.98 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 114.984 -1.007 . . . . 3.4199999999999999 111.003 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.12 -34.58 76.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.288 -0.415 . . . . 1.23 110.8 175.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.474 ' HB3' ' HD2' ' A' ' 21' ' ' PRO . . . -83.74 -57.89 3.03 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.032 -0.531 . . . . 1.0700000000000001 110.578 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -168.39 143.61 8.24 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.276 -0.964 . . . . 0.60999999999999999 112.452 -177.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.8 m -83.73 145.02 28.96 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.201 -0.296 . . . . 1.4299999999999999 110.201 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 53.4 t -100.24 113.53 26.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.202 0.525 . . . . 1.4199999999999999 110.304 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -109.99 114.35 27.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.658 -0.701 . . . . 2.52 109.902 -176.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.801 ' HG2' ' HB2' ' A' ' 13' ' ' ALA . 45.5 mt-10 -78.2 119.71 21.97 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.114 0.483 . . . . 1.6599999999999999 110.143 -177.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 78.7 p -119.01 -173.31 2.47 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.417 -0.81 . . . . 1.29 110.946 -173.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -64.51 -32.71 74.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.014 0.435 . . . . 3.1600000000000001 110.176 175.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.0 m -73.93 -2.67 24.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.946 -0.57 . . . . 1.8100000000000001 110.437 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.06 -74.94 0.24 Allowed Glycine 0 N--CA 1.44 -1.058 0 N-CA-C 110.496 -1.042 . . . . 0.46999999999999997 110.496 -177.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.571 ' HB3' ' HB1' ' A' ' 13' ' ' ALA . 51.9 p90 -153.45 151.45 29.88 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.068 0.461 . . . . 0.88 110.174 176.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 47.2 pt -128.5 162.07 35.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 108.384 -0.969 . . . . 1.3400000000000001 108.384 169.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 68.3 m -120.85 129.85 53.7 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.153 0.501 . . . . 0.33000000000000002 110.319 -178.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.743 ' HA ' ' HE ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -105.93 99.97 9.54 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.885 -0.598 . . . . 5.1799999999999997 109.627 178.674 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.429 ' HB3' ' HB2' ' A' ' 42' ' ' TYR . 84.3 m -83.86 133.8 34.72 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.694 -0.684 . . . . 0.27000000000000002 110.932 -176.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -68.88 151.69 46.24 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.995 -1.002 . . . . 0.97999999999999998 109.038 175.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -59.46 120.53 9.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.479 0.657 . . . . 3.5499999999999998 110.678 -176.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.25 -8.14 14.09 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 110.513 -1.035 . . . . 0.93999999999999995 110.513 -171.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.442 ' CD2' ' HA ' ' A' ' 56' ' ' VAL . 71.6 m-85 -128.02 162.8 25.96 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.915 -0.772 . . . . 1.1399999999999999 108.915 176.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.782 ' HG2' ' HB2' ' A' ' 57' ' ' ARG . 9.2 ptp180 -152.39 165.15 35.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.075 0.464 . . . . 3.46 111.587 174.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.3 mm -70.29 137.64 23.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.207 -0.906 . . . . 1.0900000000000001 110.895 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.416 ' HB2' HG12 ' A' ' 55' ' ' ILE . 23.0 t -145.72 165.75 27.87 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.985 -0.746 . . . . 0.87 108.985 178.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 87.8 mt -104.72 138.03 41.64 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.671 -0.492 . . . . 1.5700000000000001 109.671 178.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -60.6 -24.18 65.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.068 -0.969 . . . . 2.52 111.911 -174.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 131.76 -26.5 3.82 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 111.015 -0.834 . . . . 1.4199999999999999 111.015 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.2 p -100.57 -30.38 11.81 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.707 -0.479 . . . . 1.79 109.707 175.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 131.77 22.55 0.93 Allowed Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.597 -0.729 . . . . 0.85999999999999999 112.447 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -85.41 142.83 28.99 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.662 -0.496 . . . . 1.6799999999999999 109.662 176.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.7 t -79.71 110.81 15.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.187 0.518 . . . . 1.2 110.138 -176.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.1 p -125.6 171.67 10.37 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.924 -0.58 . . . . 1.72 110.188 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 44.3 t -124.65 129.94 51.48 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.498 -0.556 . . . . 0.31 109.498 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.416 HG12 ' HB2' ' A' ' 45' ' ' SER . 26.0 pt -131.27 148.02 32.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.03 0.443 . . . . 1.1499999999999999 110.723 -176.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.442 ' HA ' ' CD2' ' A' ' 42' ' ' TYR . 7.6 p -62.48 123.92 16.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.635 -0.711 . . . . 1.3600000000000001 110.442 177.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.782 ' HB2' ' HG2' ' A' ' 43' ' ' ARG . 21.5 tpt180 -125.59 114.11 18.3 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.263 -0.426 . . . . 5.4800000000000004 110.536 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 . . . . . 0 C--N 1.326 -0.452 0 CA-C-N 115.739 -0.664 . . . . 3.3199999999999998 111.182 178.812 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.0 t . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 120.928 0.394 . . . . 3.3700000000000001 110.422 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.634 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 60.9 tt0 -72.03 132.8 44.76 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.094 -0.503 . . . . 7.2400000000000002 110.513 176.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -137.19 9.78 2.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.054 -0.521 . . . . 2.8199999999999998 110.153 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.7 p -169.55 -174.94 2.02 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.681 -0.691 . . . . 3.8999999999999999 110.265 -172.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -45.17 -56.93 4.29 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.41 0.624 . . . . 4.5899999999999999 110.285 175.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.0 p -97.72 128.15 35.17 Favored Pre-proline 0 N--CA 1.441 -0.91 0 CA-C-N 115.268 -0.878 . . . . 3.0 109.796 173.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.634 ' HA ' ' HA ' ' A' ' 6' ' ' GLN . 51.1 Cg_exo -57.95 -19.08 38.3 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.05 2.5 . . . . 2.0299999999999998 112.759 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.621 ' H ' ' HB3' ' A' ' 15' ' ' SER . . . 66.9 121.19 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.89 0.744 . . . . 1.5 111.602 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.609 ' HB1' ' CD1' ' A' ' 34' ' ' TYR . . . 70.68 -58.37 0.56 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.655 -0.702 . . . . 1.3100000000000001 110.978 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.9 t -83.18 7.62 15.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.755 0.788 . . . . 1.47 109.447 174.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.621 ' HB3' ' H ' ' A' ' 12' ' ' ALA . 6.3 p -70.15 -25.24 63.37 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.299 -0.864 . . . . 1.3799999999999999 112.317 -175.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.9 t -93.6 11.37 29.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.975 0.417 . . . . 2.2999999999999998 110.745 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 55.71 63.57 6.14 Favored Pre-proline 0 N--CA 1.468 0.451 0 CA-C-N 115.396 -0.82 . . . . 2.3500000000000001 111.041 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.518 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 23.6 Cg_exo -63.95 -56.01 0.55 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.994 2.463 . . . . 0.91000000000000003 112.512 -174.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.463 ' SG ' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -96.56 7.61 46.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.91 -0.587 . . . . 0.55000000000000004 111.212 -178.692 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.406 ' HA3' ' HD3' ' A' ' 21' ' ' PRO . . . 73.22 -130.5 13.76 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.009 -0.615 . . . . 0.70999999999999996 112.789 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 24' ' ' ALA . 10.6 Cg_endo -91.24 170.89 3.14 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 123.709 2.94 . . . . 1.04 112.555 -178.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -63.75 -21.0 66.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.633 -0.712 . . . . 3.4199999999999999 110.588 176.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.58 -32.78 74.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.941 0.4 . . . . 1.23 110.56 175.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.503 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . . . -94.61 -63.61 1.16 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.96 -0.564 . . . . 1.0700000000000001 110.952 -177.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -162.25 142.05 7.67 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.69 -0.767 . . . . 0.60999999999999999 112.277 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.2 m -84.38 141.18 31.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.786 0.327 . . . . 1.4299999999999999 110.215 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.463 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 6.9 p -100.17 129.35 46.18 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.215 -0.448 . . . . 1.4199999999999999 110.068 177.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -128.31 111.48 13.42 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.399 -0.593 . . . . 2.52 109.399 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.454 ' HG3' ' HB2' ' A' ' 13' ' ' ALA . 2.9 mp0 -68.33 119.71 13.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.127 0.489 . . . . 1.6599999999999999 110.93 -178.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 60.7 p -102.66 -175.69 2.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.581 -0.736 . . . . 1.29 110.403 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -64.78 -44.84 88.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.693 0.283 . . . . 3.1600000000000001 110.258 175.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.5 m -62.75 -41.09 99.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.091 0.472 . . . . 1.8100000000000001 110.667 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 172.64 -82.19 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.81 -0.709 . . . . 0.46999999999999997 111.657 177.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.609 ' CD1' ' HB1' ' A' ' 13' ' ' ALA . 42.4 p90 -155.5 156.01 34.45 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.91 0.385 . . . . 0.88 110.886 176.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 46.3 pt -125.06 159.69 31.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.716 -0.675 . . . . 1.3400000000000001 109.485 172.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.518 ' SG ' ' HB2' ' A' ' 18' ' ' PRO . 36.4 m -123.57 121.1 34.75 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.108 0.48 . . . . 0.33000000000000002 110.539 178.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -101.92 100.18 10.45 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.048 -0.723 . . . . 5.1799999999999997 109.048 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 75.1 m -80.72 136.63 36.2 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.967 -0.56 . . . . 0.27000000000000002 111.108 -175.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -71.83 155.07 40.83 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.254 -0.885 . . . . 0.97999999999999998 109.327 175.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -60.49 121.2 11.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.154 0.502 . . . . 3.5499999999999998 110.105 -178.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.48 -10.42 11.53 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.721 -0.952 . . . . 0.93999999999999995 110.721 -170.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.503 ' CE2' ' HA ' ' A' ' 24' ' ' ALA . 92.9 m-85 -123.91 162.62 22.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.96 -0.62 . . . . 1.1399999999999999 110.099 176.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.443 ' HG3' HG13 ' A' ' 55' ' ' ILE . 31.6 ptt180 -139.04 156.51 47.14 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.906 0.384 . . . . 3.46 110.665 -177.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.432 HD11 ' HA ' ' A' ' 44' ' ' ILE . 14.1 mm -83.08 130.31 35.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.949 -0.569 . . . . 1.0900000000000001 110.705 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 44.1 t -132.21 155.99 47.25 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.579 -0.737 . . . . 0.87 109.809 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 84.3 mt -105.34 136.84 44.14 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.331 -0.618 . . . . 1.5700000000000001 109.331 175.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -59.22 -28.13 66.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.059 -0.973 . . . . 2.52 111.832 -176.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 137.07 -34.69 2.17 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.804 -0.918 . . . . 1.4199999999999999 110.804 -174.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 56.2 p -87.26 -29.72 21.44 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.368 0.604 . . . . 1.79 109.398 175.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 127.78 14.73 2.5 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.314 -0.857 . . . . 0.85999999999999999 112.333 176.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -82.02 142.34 32.44 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.845 0.355 . . . . 1.6799999999999999 110.248 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.3 t -79.21 111.64 16.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.898 -0.592 . . . . 1.2 111.163 -172.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.9 p -120.64 169.95 9.89 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.983 -0.553 . . . . 1.72 110.263 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 17.3 t -125.0 131.85 53.35 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 110.04 -0.356 . . . . 0.31 110.04 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.443 HG13 ' HG3' ' A' ' 43' ' ' ARG . 29.0 pt -133.02 169.99 20.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.053 -0.521 . . . . 1.1499999999999999 110.204 -179.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.0 p -72.85 140.74 17.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.995 0.426 . . . . 1.3600000000000001 110.801 -177.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -76.75 -37.79 55.32 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.82 -0.627 . . . . 5.4800000000000004 110.409 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 . . . . . 0 C--N 1.324 -0.543 0 N-CA-C 109.155 -0.683 . . . . 3.3199999999999998 109.155 172.841 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.9 m . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 120.892 0.377 . . . . 3.3700000000000001 110.557 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.61 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 7.6 tt0 -93.84 94.42 8.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.879 0.371 . . . . 7.2400000000000002 110.092 -177.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.0 mt -85.74 99.71 11.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.959 -0.564 . . . . 2.8199999999999998 111.595 -175.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.7 m 72.11 -62.52 0.46 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.513 -0.767 . . . . 3.8999999999999999 112.368 173.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -132.44 -63.95 0.78 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.888 0.375 . . . . 4.5899999999999999 110.484 -176.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.518 ' C ' ' H ' ' A' ' 12' ' ' ALA . 14.7 p -90.26 142.18 28.24 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.92 -0.582 . . . . 3.0 110.868 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.61 ' HA ' ' HA ' ' A' ' 6' ' ' GLN . 11.4 Cg_exo -72.47 29.04 0.27 Allowed 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 123.009 2.473 . . . . 2.0299999999999998 112.144 171.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.554 ' HB3' ' OE2' ' A' ' 29' ' ' GLU . . . 43.63 -96.01 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.633 1.346 . . . . 1.5 114.633 175.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.679 ' HB1' ' HG2' ' A' ' 29' ' ' GLU . . . -86.23 -18.09 33.04 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.261 0.553 . . . . 1.3100000000000001 110.802 -174.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 41.9 t -104.15 11.81 34.63 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.773 -0.825 . . . . 1.47 108.773 175.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 39.3 t -65.94 -28.53 68.99 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.073 -0.967 . . . . 1.3799999999999999 111.151 -174.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.1 m -101.45 13.21 35.69 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.968 0.413 . . . . 2.2999999999999998 111.472 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.6 m120 55.79 84.54 0.21 Allowed Pre-proline 0 N--CA 1.469 0.509 0 CA-C-N 115.389 -0.823 . . . . 2.3500000000000001 112.103 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.412 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 2.9 Cg_exo -73.13 -58.26 0.07 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.998 2.465 . . . . 0.91000000000000003 112.36 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.432 ' SG ' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -86.39 17.52 3.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.069 -0.514 . . . . 0.55000000000000004 111.796 -175.048 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.466 ' HA3' ' HD3' ' A' ' 21' ' ' PRO . . . 76.01 -124.82 7.54 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.036 -0.602 . . . . 0.70999999999999996 112.938 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.466 ' HD3' ' HA3' ' A' ' 20' ' ' GLY . 9.2 Cg_endo -90.52 160.73 4.4 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.725 2.95 . . . . 1.04 112.362 -178.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -64.31 -21.31 66.56 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.642 -0.708 . . . . 3.4199999999999999 111.325 -178.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.69 -31.96 67.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.324 -0.398 . . . . 1.23 110.78 177.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.432 ' CB ' ' HD2' ' A' ' 21' ' ' PRO . . . -76.92 -50.16 13.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.812 -0.631 . . . . 1.0700000000000001 110.59 -177.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -172.82 166.6 39.26 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.23 -0.986 . . . . 0.60999999999999999 112.866 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.5 m -93.41 139.37 30.77 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.997 -0.372 . . . . 1.4299999999999999 109.997 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.432 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 6.0 p -100.52 115.63 30.56 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.258 0.551 . . . . 1.4199999999999999 110.39 177.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -114.6 119.78 37.94 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.911 -0.586 . . . . 2.52 109.696 -176.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.679 ' HG2' ' HB1' ' A' ' 13' ' ' ALA . 31.6 mt-10 -79.8 130.14 35.07 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.01 -0.541 . . . . 1.6599999999999999 110.568 -175.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.3 p -121.54 -174.86 2.95 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.854 -0.612 . . . . 1.29 111.43 -173.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -68.67 -29.3 67.74 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.961 0.41 . . . . 3.1600000000000001 110.904 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.6 t -85.85 -4.76 59.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.178 0.513 . . . . 1.8100000000000001 110.165 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 133.08 -83.12 0.3 Allowed Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 111.144 -0.782 . . . . 0.46999999999999997 111.144 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.412 ' CE1' ' HB3' ' A' ' 18' ' ' PRO . 46.3 p90 -156.62 153.48 28.63 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.072 0.463 . . . . 0.88 110.593 178.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 47.6 pt -125.7 165.19 23.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 108.764 -0.828 . . . . 1.3400000000000001 108.764 169.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.41 ' O ' HD12 ' A' ' 44' ' ' ILE . 62.6 m -121.38 131.25 54.07 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.225 0.536 . . . . 0.33000000000000002 110.443 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -107.73 98.07 7.71 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.302 -0.863 . . . . 5.1799999999999997 108.775 177.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 90.6 m -79.85 133.25 36.25 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.192 0.52 . . . . 0.27000000000000002 110.865 -176.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -64.9 143.99 57.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.17 -0.923 . . . . 0.97999999999999998 109.439 177.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -44.69 111.13 0.28 Allowed 'General case' 0 C--O 1.234 0.271 0 O-C-N 123.864 0.728 . . . . 3.5499999999999998 111.268 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 125.96 -20.49 6.35 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.375 -0.829 . . . . 0.93999999999999995 111.124 -174.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -112.91 162.43 15.84 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.126 -0.537 . . . . 1.1399999999999999 109.682 174.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -140.72 157.25 45.69 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.976 0.417 . . . . 3.46 110.882 -176.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 44' ' ' ILE . 21.1 mm -82.11 128.12 39.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.463 -0.789 . . . . 1.0900000000000001 111.223 -178.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.4 t -129.59 150.47 50.9 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.633 -0.712 . . . . 0.87 109.083 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.445 HD21 ' HA ' ' A' ' 52' ' ' VAL . 64.5 mt -115.53 124.17 50.37 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.033 -0.729 . . . . 1.5700000000000001 109.033 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.43 56.61 1.41 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.023 -0.535 . . . . 2.52 112.228 -175.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.75 -56.88 4.24 Favored Glycine 0 N--CA 1.453 -0.195 0 CA-C-N 116.225 -0.443 . . . . 1.4199999999999999 113.298 174.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.1 p -78.92 7.56 7.0 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.161 0.43 . . . . 1.79 112.161 -176.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.85 10.75 84.69 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.983 -0.627 . . . . 0.85999999999999999 112.552 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.417 ' O ' ' HA ' ' A' ' 46' ' ' LEU . 12.9 m120 -72.41 128.08 34.53 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.122 -0.696 . . . . 1.6799999999999999 109.122 176.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.445 ' HA ' HD21 ' A' ' 46' ' ' LEU . 31.5 t -79.69 111.49 16.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.024 -0.534 . . . . 1.2 110.631 -174.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.9 p -122.34 177.79 5.23 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.593 -0.521 . . . . 1.72 109.593 177.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . 0.43 ' HB2' ' HB3' ' A' ' 19' ' ' CYS . 25.4 t -129.19 129.85 45.58 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.928 0.394 . . . . 0.31 110.051 -176.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 26.3 pt -131.59 164.94 33.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.081 -0.509 . . . . 1.1499999999999999 110.35 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.8 p -69.35 138.44 22.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.271 0.558 . . . . 1.3600000000000001 110.911 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.2 ttp180 -85.02 -53.81 5.05 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.076 -0.712 . . . . 5.4800000000000004 109.076 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 . . . . . 0 C--O 1.232 0.151 0 CA-C-N 115.433 -0.803 . . . . 3.3199999999999998 110.33 173.1 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.494 ' HA ' ' HB3' ' A' ' 11' ' ' PRO . 47.5 t . . . . . 0 N--CA 1.479 1.018 0 CA-C-O 120.747 0.308 . . . . 3.3700000000000001 110.404 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.654 ' NE2' ' HB2' ' A' ' 29' ' ' GLU . 44.0 mt-30 -139.44 179.14 6.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.273 -0.422 . . . . 7.2400000000000002 110.166 177.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.1 mt 69.53 167.26 0.28 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.838 0.827 . . . . 2.8199999999999998 112.195 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.0 m -109.9 30.21 6.91 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.079 -0.964 . . . . 3.8999999999999999 110.836 -176.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -142.12 -76.42 0.28 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.953 -0.758 . . . . 4.5899999999999999 108.953 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.453 ' C ' ' H ' ' A' ' 12' ' ' ALA . 8.9 p -137.65 146.94 55.26 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 108.546 -0.909 . . . . 3.0 108.546 173.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.735 ' HB2' ' HB3' ' A' ' 14' ' ' CYS . 44.4 Cg_endo -71.5 20.39 0.25 Allowed 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 122.558 2.172 . . . . 2.0299999999999998 113.32 -177.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.453 ' H ' ' C ' ' A' ' 10' ' ' THR . . . 48.73 -94.52 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.877 0.871 . . . . 1.5 112.879 175.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.519 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . . . -65.33 -27.46 68.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.272 -0.422 . . . . 1.3100000000000001 111.309 -177.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.735 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 33.4 t -95.87 -2.86 46.5 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.063 -0.517 . . . . 1.47 110.559 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.425 ' HA ' ' HG2' ' A' ' 11' ' ' PRO . 9.7 t -70.72 -9.6 57.61 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.89 0.376 . . . . 1.3799999999999999 111.504 -174.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.5 m -90.45 4.85 49.84 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.034 0.445 . . . . 2.2999999999999998 111.275 177.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.441 ' N ' ' HD3' ' A' ' 18' ' ' PRO . 4.1 m-20 54.14 59.94 11.4 Favored Pre-proline 0 N--CA 1.467 0.423 0 CA-C-N 115.219 -0.9 . . . . 2.3500000000000001 110.984 -174.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.441 ' HD3' ' N ' ' A' ' 17' ' ' ASN . 11.5 Cg_exo -70.22 -52.62 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.952 2.434 . . . . 0.91000000000000003 112.131 -174.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.523 ' SG ' ' HB3' ' A' ' 27' ' ' CYS . 1.8 m -82.3 -7.3 59.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.757 -0.656 . . . . 0.55000000000000004 110.754 -177.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.34 -144.83 17.42 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.779 -0.724 . . . . 0.70999999999999996 112.389 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.44 ' HD2' ' CB ' ' A' ' 24' ' ' ALA . 9.6 Cg_endo -88.64 175.04 3.89 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.377 2.718 . . . . 1.04 112.761 -177.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -53.04 -46.02 68.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.401 -0.363 . . . . 3.4199999999999999 111.193 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.1 -24.09 66.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.476 0.547 . . . . 1.23 112.476 -176.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.44 ' CB ' ' HD2' ' A' ' 21' ' ' PRO . . . -85.96 -65.85 0.97 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.751 0.31 . . . . 1.0700000000000001 110.853 -177.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -168.56 155.97 27.0 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 119.971 -1.109 . . . . 0.60999999999999999 112.901 -177.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.2 m -90.29 142.58 27.58 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.772 0.32 . . . . 1.4299999999999999 110.526 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.523 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 14.9 p -100.55 129.08 46.44 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.079 0.466 . . . . 1.4199999999999999 110.5 178.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.416 ' HB3' HG13 ' A' ' 35' ' ' ILE . 29.4 tptp -117.43 106.56 13.33 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.638 -0.71 . . . . 2.52 110.046 -178.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.654 ' HB2' ' NE2' ' A' ' 6' ' ' GLN . 57.4 mp0 -67.4 119.48 12.31 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.315 -0.624 . . . . 1.6599999999999999 109.315 176.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 48.1 p -102.13 -173.42 2.34 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.849 -0.614 . . . . 1.29 111.037 -174.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -71.41 -37.99 71.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.18 0.514 . . . . 3.1600000000000001 110.164 177.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.7 m -83.3 -28.17 29.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.76 -0.654 . . . . 1.8100000000000001 111.277 -177.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 174.3 -94.56 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.878 -0.677 . . . . 0.46999999999999997 111.658 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.553 ' OH ' ' HB2' ' A' ' 51' ' ' ASN . 38.1 p90 -156.1 154.21 30.57 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.628 0.252 . . . . 0.88 110.556 177.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.416 HG13 ' HB3' ' A' ' 28' ' ' LYS . 40.1 pt -129.38 165.99 28.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.876 -0.602 . . . . 1.3400000000000001 109.412 171.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.458 ' O ' HD12 ' A' ' 44' ' ' ILE . 55.9 m -121.49 131.45 54.16 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.261 -0.427 . . . . 0.33000000000000002 110.404 -179.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 -114.86 101.56 9.16 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.05 -0.523 . . . . 5.1799999999999997 109.811 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 42' ' ' TYR . 85.0 m -81.58 151.12 27.84 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.686 -0.688 . . . . 0.27000000000000002 111.375 -174.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -84.73 159.71 20.45 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.431 -0.804 . . . . 0.97999999999999998 109.325 175.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -51.19 122.68 8.07 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 120.991 0.424 . . . . 3.5499999999999998 111.276 -178.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 112.45 -16.22 24.39 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.601 -0.727 . . . . 0.93999999999999995 111.421 -175.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.466 ' HB2' ' HB3' ' A' ' 38' ' ' CYS . 89.6 m-85 -114.74 162.62 16.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.937 0.398 . . . . 1.1399999999999999 110.597 179.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.525 ' HG3' HG13 ' A' ' 55' ' ' ILE . 21.9 ptt180 -140.86 158.16 44.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.141 -0.481 . . . . 3.46 111.181 -174.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.458 HD12 ' O ' ' A' ' 36' ' ' CYS . 16.0 mm -84.41 132.39 31.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.785 -0.643 . . . . 1.0900000000000001 110.708 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.47 ' HB2' HG12 ' A' ' 55' ' ' ILE . 33.8 t -133.02 164.37 27.16 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.753 -0.658 . . . . 0.87 109.545 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 77.5 mt -124.1 121.8 36.15 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.295 -0.631 . . . . 1.5700000000000001 109.295 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.98 69.31 10.52 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.361 -0.382 . . . . 2.52 111.96 -176.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.44 -72.32 2.83 Favored Glycine 0 CA--C 1.517 0.216 0 CA-C-N 115.957 -0.565 . . . . 1.4199999999999999 113.472 173.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.8 p -73.42 -0.41 14.77 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.397 0.517 . . . . 1.79 112.397 -173.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.35 20.3 52.52 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.32 -0.943 . . . . 0.85999999999999999 111.657 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.553 ' HB2' ' OH ' ' A' ' 34' ' ' TYR . 9.5 p30 -81.76 135.91 35.45 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.116 -0.698 . . . . 1.6799999999999999 109.116 175.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 39.4 t -79.98 118.57 27.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.061 -0.518 . . . . 1.2 111.271 -172.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 81.1 p -128.01 172.44 10.93 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.082 -0.508 . . . . 1.72 110.619 177.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . 0.462 ' HB3' ' O ' ' A' ' 19' ' ' CYS . 40.0 t -122.79 131.64 53.86 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.961 -0.563 . . . . 0.31 109.551 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.525 HG13 ' HG3' ' A' ' 43' ' ' ARG . 23.9 pt -134.59 164.56 33.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.974 -0.557 . . . . 1.1499999999999999 109.835 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.3 p -71.75 136.22 26.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.418 0.628 . . . . 1.3600000000000001 110.952 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -87.93 -65.14 1.05 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.13 -1.063 . . . . 5.4800000000000004 108.13 171.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 114.461 -1.245 . . . . 3.3199999999999998 108.383 179.585 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.408 ' H ' ' CD ' ' A' ' 29' ' ' GLU . 52.9 t . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 109.99 -0.374 . . . . 3.3700000000000001 109.99 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.465 ' HA ' ' HB3' ' A' ' 11' ' ' PRO . 29.4 tt0 -78.54 104.1 8.92 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.107 0.479 . . . . 7.2400000000000002 110.527 -178.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.446 ' H ' ' HA ' ' A' ' 11' ' ' PRO . 86.8 mt -69.21 -65.27 0.73 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.459 -0.792 . . . . 2.8199999999999998 111.017 -178.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.3 p -162.62 -72.05 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.482 -0.326 . . . . 3.8999999999999999 110.928 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -88.04 -65.06 1.06 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.675 -0.491 . . . . 4.5899999999999999 109.675 178.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.445 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 24.3 p -108.27 125.73 31.27 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-O 121.085 0.469 . . . . 3.0 109.994 172.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.465 ' HB3' ' HA ' ' A' ' 6' ' ' GLN . 34.9 Cg_exo -62.91 -17.11 58.14 Favored 'Trans proline' 0 CA--C 1.528 0.196 0 C-N-CA 122.958 2.439 . . . . 2.0299999999999998 112.818 178.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 68.09 123.78 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.778 0.674 . . . . 1.5 110.947 -176.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.469 ' HB1' ' HB3' ' A' ' 34' ' ' TYR . . . 69.57 -56.67 0.56 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.41 0.684 . . . . 1.3100000000000001 110.866 -176.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.486 ' HA ' ' CD ' ' A' ' 18' ' ' PRO . 87.8 m -77.02 -0.34 24.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.072 0.463 . . . . 1.47 110.221 175.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.409 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 25.2 t -69.51 -18.55 63.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.887 -0.597 . . . . 1.3799999999999999 111.185 -176.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.8 m -105.94 8.86 32.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.626 0.251 . . . . 2.2999999999999998 111.544 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.5 m120 53.81 66.46 4.45 Favored Pre-proline 0 N--CA 1.467 0.41 0 CA-C-N 115.901 -0.59 . . . . 2.3500000000000001 110.96 -173.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.486 ' CD ' ' HA ' ' A' ' 14' ' ' CYS . 11.1 Cg_endo -54.88 -53.05 6.62 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.822 2.348 . . . . 0.91000000000000003 112.035 -177.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.577 ' SG ' ' HB3' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -91.21 18.9 6.38 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.941 -0.572 . . . . 0.55000000000000004 110.876 -177.327 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.431 ' HA3' ' HD3' ' A' ' 21' ' ' PRO . . . 72.93 -128.2 11.84 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.838 -0.619 . . . . 0.70999999999999996 111.867 -176.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.514 ' HD2' ' CB ' ' A' ' 24' ' ' ALA . 2.8 Cg_endo -87.05 169.88 7.34 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.462 2.774 . . . . 1.04 112.044 178.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -66.53 -35.45 80.27 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.048 0.452 . . . . 3.4199999999999999 110.693 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.91 -28.98 70.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.83 -0.623 . . . . 1.23 110.869 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.514 ' CB ' ' HD2' ' A' ' 21' ' ' PRO . . . -78.54 -63.53 1.38 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 1.0700000000000001 110.141 177.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -160.83 148.1 15.71 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.436 -0.887 . . . . 0.60999999999999999 112.259 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.8 m -94.0 140.31 29.87 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.122 -0.325 . . . . 1.4299999999999999 110.122 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.577 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 19.6 p -102.86 140.75 36.73 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.015 0.436 . . . . 1.4199999999999999 110.939 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -130.59 125.27 33.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.787 -0.642 . . . . 2.52 109.997 176.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.408 ' CD ' ' H ' ' A' ' 5' ' ' VAL . 3.0 mp0 -66.84 122.73 18.33 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.192 0.52 . . . . 1.6599999999999999 110.326 176.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.576 ' HG1' HG22 ' A' ' 35' ' ' ILE . 49.3 p -122.76 -173.9 2.8 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.413 -0.812 . . . . 1.29 110.796 -178.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -55.35 -41.38 72.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.968 0.413 . . . . 3.1600000000000001 110.907 177.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.6 m -80.18 -5.18 55.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 1.8100000000000001 111.439 -177.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 29' ' ' GLU . . . 126.89 -68.77 0.53 Allowed Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.37 -0.692 . . . . 0.46999999999999997 111.37 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.469 ' HB3' ' HB1' ' A' ' 13' ' ' ALA . 54.5 p90 -155.55 156.6 35.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.832 0.348 . . . . 0.88 110.391 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.576 HG22 ' HG1' ' A' ' 30' ' ' THR . 44.2 pt -129.58 164.98 30.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.81 -0.632 . . . . 1.3400000000000001 109.462 170.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.9 m -123.4 128.8 50.36 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.171 0.51 . . . . 0.33000000000000002 111.39 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -112.92 100.9 9.0 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.071 -0.715 . . . . 5.1799999999999997 109.071 177.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 85.1 m -76.02 143.78 41.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.135 0.493 . . . . 0.27000000000000002 110.981 -177.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -77.06 167.96 20.9 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.198 -0.91 . . . . 0.97999999999999998 110.088 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -60.74 106.59 0.58 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.935 -0.575 . . . . 3.5499999999999998 110.685 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 122.05 -5.59 10.36 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 121.01 -0.614 . . . . 0.93999999999999995 111.714 -175.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -124.7 163.51 21.89 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 122.35 0.26 . . . . 1.1399999999999999 110.59 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.465 ' HG3' HG13 ' A' ' 55' ' ' ILE . 24.5 ptt180 -144.37 158.71 43.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.932 0.396 . . . . 3.46 111.189 -174.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.425 HD11 ' HA ' ' A' ' 44' ' ' ILE . 15.1 mm -85.06 136.96 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.907 -0.588 . . . . 1.0900000000000001 110.485 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 37.9 t -143.84 145.02 32.03 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.935 -0.575 . . . . 0.87 109.987 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.473 ' HB3' ' HA2' ' A' ' 50' ' ' GLY . 81.6 mt -95.08 112.99 24.64 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.466 -0.938 . . . . 1.5700000000000001 108.466 172.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -85.66 75.49 10.1 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.949 0.404 . . . . 2.52 112.014 -170.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.53 -59.0 3.74 Favored Glycine 0 CA--C 1.518 0.253 0 CA-C-N 115.859 -0.609 . . . . 1.4199999999999999 113.375 173.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.3 p -91.24 5.74 47.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.779 0.323 . . . . 1.79 111.793 -174.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.473 ' HA2' ' HB3' ' A' ' 46' ' ' LEU . . . 86.58 4.45 83.01 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.57 -0.824 . . . . 0.85999999999999999 112.681 177.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -66.05 134.52 53.04 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.685 -0.487 . . . . 1.6799999999999999 109.685 175.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.7 t -79.4 109.89 14.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.185 -0.672 . . . . 1.2 109.185 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 18' ' ' PRO . 12.7 t -128.3 169.67 13.95 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 116.009 -0.541 . . . . 1.72 109.825 -179.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 35.5 t -116.39 130.18 56.63 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.521 -0.548 . . . . 0.31 109.521 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.465 HG13 ' HG3' ' A' ' 43' ' ' ARG . 32.2 pt -127.52 166.72 23.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.954 -0.566 . . . . 1.1499999999999999 109.503 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.4 p -73.13 136.64 25.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 121.233 0.539 . . . . 1.3600000000000001 110.37 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -76.23 -33.48 59.21 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.227 -0.657 . . . . 5.4800000000000004 109.227 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.41 ' HB3' ' O ' ' A' ' 61' ' ' GLY . 6.2 tp-100 -177.79 -71.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.648 -1.16 . . . . 3.3199999999999998 108.473 174.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -138.72 -73.83 0.39 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.38 -0.827 . . . . 5.9900000000000002 109.448 174.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 45.6 m -131.35 42.17 3.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.597 0.713 . . . . 4.9100000000000001 109.273 173.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 58' ' ' GLN . . . . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.076 -1.402 . . . . 4.7400000000000002 111.241 -176.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 27' ' ' CYS . 10.7 p . . . . . 0 N--CA 1.481 1.115 0 CA-C-O 121.806 0.812 . . . . 3.3700000000000001 110.695 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.517 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 21.8 tp60 -78.8 -42.99 26.36 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.187 -0.671 . . . . 7.2400000000000002 109.187 177.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.679 ' H ' HD21 ' A' ' 7' ' ' LEU . 1.3 pt? -106.33 164.26 12.17 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.664 -0.698 . . . . 2.8199999999999998 109.628 172.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.8 m -99.06 -12.56 20.44 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.83 0.678 . . . . 3.8999999999999999 112.83 -169.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -81.74 -92.49 0.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.875 -0.417 . . . . 4.5899999999999999 109.875 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 23.3 p -122.18 113.37 31.13 Favored Pre-proline 0 CA--C 1.507 -0.708 0 N-CA-C 109.218 -0.66 . . . . 3.0 109.218 168.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.798 ' HB2' ' HB2' ' A' ' 14' ' ' CYS . 26.4 Cg_exo -62.62 101.48 0.26 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.523 2.149 . . . . 2.0299999999999998 109.668 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.07 -34.97 46.13 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.611 0.597 . . . . 1.5 112.611 -170.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.886 ' HB1' ' HG2' ' A' ' 29' ' ' GLU . . . -84.22 -36.9 22.43 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.967 0.413 . . . . 1.3100000000000001 110.931 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.798 ' HB2' ' HB2' ' A' ' 11' ' ' PRO . 33.5 m -83.09 -18.5 39.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.314 -0.403 . . . . 1.47 111.45 -176.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 34.5 t -68.41 -8.99 45.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.127 0.489 . . . . 1.3799999999999999 109.81 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.0 m -88.81 -0.08 57.01 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.97 -0.559 . . . . 2.2999999999999998 110.882 175.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 59.43 68.71 1.48 Allowed Pre-proline 0 N--CA 1.467 0.422 0 CA-C-N 115.107 -0.951 . . . . 2.3500000000000001 111.852 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.432 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 3.5 Cg_exo -78.85 -75.08 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.91 2.407 . . . . 0.91000000000000003 112.44 -177.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.45 24.05 0.28 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.469 -0.332 . . . . 0.55000000000000004 111.81 -177.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.48 -123.14 15.98 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.118 -0.563 . . . . 0.70999999999999996 111.837 -178.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -87.11 154.44 8.29 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.836 2.357 . . . . 1.04 111.494 175.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -70.02 -7.25 39.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.114 0.483 . . . . 3.4199999999999999 110.364 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.84 -34.51 51.82 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.0 -0.545 . . . . 1.23 110.127 173.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.448 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . . . -71.86 -52.41 17.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.753 -0.658 . . . . 1.0700000000000001 109.492 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.401 ' CA ' ' HA ' ' A' ' 38' ' ' CYS . . . -156.86 159.39 29.55 Favored Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 120.57 -0.824 . . . . 0.60999999999999999 111.79 177.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.8 m -83.44 138.08 33.62 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.985 -0.746 . . . . 1.4299999999999999 108.985 176.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.416 ' O ' HG12 ' A' ' 5' ' ' VAL . 41.7 t -98.7 112.94 24.85 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.394 0.616 . . . . 1.4199999999999999 109.535 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.421 ' HB3' HG13 ' A' ' 35' ' ' ILE . 1.7 tmtp? -110.31 102.76 11.38 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.549 -0.75 . . . . 2.52 109.18 -175.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.886 ' HG2' ' HB1' ' A' ' 13' ' ' ALA . 28.6 mt-10 -73.7 122.66 22.69 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.705 -0.68 . . . . 1.6599999999999999 110.401 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 35.8 p -102.42 -175.07 2.72 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.468 -0.787 . . . . 1.29 110.228 -177.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -74.61 -26.17 59.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.514 0.673 . . . . 3.1600000000000001 109.296 176.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.6 m -84.56 -8.44 58.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.312 -0.858 . . . . 1.8100000000000001 111.092 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 142.07 -93.41 0.18 Allowed Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.392 -0.683 . . . . 0.46999999999999997 111.392 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 50.2 p90 -153.46 154.69 34.88 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.314 0.578 . . . . 0.88 111.178 177.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.421 HG13 ' HB3' ' A' ' 28' ' ' LYS . 44.7 pt -129.42 160.2 40.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 108.186 -1.042 . . . . 1.3400000000000001 108.186 168.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 99.4 m -120.83 134.8 55.28 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.041 0.448 . . . . 0.33000000000000002 110.743 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.564 ' HA ' ' NE ' ' A' ' 37' ' ' ARG . 1.5 tpm_? -117.13 99.98 7.41 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.74 -0.664 . . . . 5.1799999999999997 109.358 177.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 42' ' ' TYR . 81.1 m -73.47 141.66 46.83 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.049 0.452 . . . . 0.27000000000000002 110.855 -176.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -73.88 168.67 18.97 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.86 -0.609 . . . . 0.97999999999999998 109.763 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -59.0 118.7 6.11 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.989 0.424 . . . . 3.5499999999999998 110.245 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.469 ' HA2' ' N ' ' A' ' 61' ' ' GLY . . . 116.18 -14.26 16.14 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.715 -0.755 . . . . 0.93999999999999995 112.017 -175.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.466 ' HB2' ' HB3' ' A' ' 38' ' ' CYS . 84.1 m-85 -120.59 162.8 19.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.654 0.264 . . . . 1.1399999999999999 110.657 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -143.78 157.65 44.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.423 -0.353 . . . . 3.46 110.709 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.9 mm -77.27 136.04 25.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.014 -0.539 . . . . 1.0900000000000001 111.282 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 36.3 t -138.48 152.62 48.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.509 -0.768 . . . . 0.87 109.333 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.471 HD12 ' HA2' ' A' ' 50' ' ' GLY . 75.9 mt -107.1 145.31 32.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.173 0.511 . . . . 1.5700000000000001 109.869 175.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -65.86 -21.66 66.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.524 -0.762 . . . . 2.52 111.476 -176.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 127.81 -28.69 4.36 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 111.261 -0.735 . . . . 1.4199999999999999 111.261 -176.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.5 p -100.5 -7.28 24.35 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.449 0.642 . . . . 1.79 109.951 176.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.471 ' HA2' HD12 ' A' ' 46' ' ' LEU . . . 109.78 13.75 15.56 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.438 -0.801 . . . . 0.85999999999999999 113.09 172.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -76.34 133.9 39.85 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.477 -0.564 . . . . 1.6799999999999999 109.477 174.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.1 t -79.61 111.71 16.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.047 0.451 . . . . 1.2 110.683 -175.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.4 p -121.38 177.04 5.35 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.81 -0.632 . . . . 1.72 110.085 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 45.4 t -133.98 130.7 38.02 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.037 0.446 . . . . 0.31 110.552 -176.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 32.9 pt -132.09 172.07 16.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.7 -0.682 . . . . 1.1499999999999999 109.443 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.9 p -65.66 141.42 18.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.84 0.352 . . . . 1.3600000000000001 110.243 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -76.49 -75.8 0.18 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.112 -0.699 . . . . 5.4800000000000004 109.112 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -114.88 -62.03 1.66 Allowed 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.778 -0.823 . . . . 3.3199999999999998 108.778 168.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 178.38 86.23 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.323 -0.853 . . . . 5.9900000000000002 109.023 176.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.9 m 57.18 33.4 23.26 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.987 0.899 . . . . 4.9100000000000001 109.938 -171.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.469 ' N ' ' HA2' ' A' ' 41' ' ' GLY . . . . . . . . 0 N--CA 1.438 -1.217 0 N-CA-C 109.415 -1.474 . . . . 4.7400000000000002 109.415 -177.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.59 ' H ' ' CD ' ' A' ' 29' ' ' GLU . 15.6 t . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 121.115 0.483 . . . . 3.3700000000000001 110.434 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.476 ' HG2' ' CD ' ' A' ' 29' ' ' GLU . 54.4 mm-40 -97.68 -177.58 3.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.419 . . . . 7.2400000000000002 109.978 176.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.6 mp 62.33 -177.64 0.13 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.634 0.584 . . . . 2.8199999999999998 111.66 177.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.2 m -121.56 -3.86 9.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.162 -0.472 . . . . 3.8999999999999999 111.517 -175.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -115.22 -69.32 0.86 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.954 -0.387 . . . . 4.5899999999999999 109.954 174.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.514 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 18.8 p -126.54 128.71 24.28 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.363 -0.38 . . . . 3.0 110.609 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.524 ' CB ' ' HA ' ' A' ' 5' ' ' VAL . 58.9 Cg_endo -75.85 53.43 3.69 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 123.16 2.573 . . . . 2.0299999999999998 114.15 -172.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.501 ' O ' ' HB3' ' A' ' 15' ' ' SER . . . 43.56 -93.04 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.318 1.229 . . . . 1.5 114.318 173.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.533 ' HB1' ' HG3' ' A' ' 29' ' ' GLU . . . -73.71 -35.14 65.09 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.105 0.478 . . . . 1.3100000000000001 110.659 -177.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.404 ' HB2' ' HB2' ' A' ' 11' ' ' PRO . 68.5 m -84.9 3.3 38.72 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.711 -0.677 . . . . 1.47 110.117 178.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.514 ' OG ' ' HB ' ' A' ' 10' ' ' THR . 30.5 t -70.3 -15.35 62.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.657 -0.701 . . . . 1.3799999999999999 111.218 -176.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.2 p -89.53 -0.26 57.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.924 0.393 . . . . 2.2999999999999998 110.871 177.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.6 m120 58.93 63.9 3.54 Favored Pre-proline 0 N--CA 1.467 0.409 0 CA-C-N 115.064 -0.971 . . . . 2.3500000000000001 111.43 -175.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.5 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 20.2 Cg_exo -65.26 -50.41 2.03 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.723 2.282 . . . . 0.91000000000000003 111.782 -177.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.527 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 0.7 OUTLIER -87.44 8.01 26.64 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.861 -0.608 . . . . 0.55000000000000004 110.252 -179.266 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.404 ' HA3' ' HD3' ' A' ' 21' ' ' PRO . . . 76.72 -122.95 6.47 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.743 -0.662 . . . . 0.70999999999999996 112.783 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.404 ' HD3' ' HA3' ' A' ' 20' ' ' GLY . 4.5 Cg_endo -83.29 162.41 15.15 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.617 2.878 . . . . 1.04 112.554 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -67.61 -18.78 65.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.356 -0.838 . . . . 3.4199999999999999 111.85 -177.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.51 -16.63 47.98 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.82 0.343 . . . . 1.23 111.111 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.43 -60.73 2.25 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.266 -0.424 . . . . 1.0700000000000001 110.88 -177.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -161.14 164.56 34.94 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.009 -1.091 . . . . 0.60999999999999999 113.224 -177.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.25 134.75 34.93 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.995 -0.372 . . . . 1.4299999999999999 109.995 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.527 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 49.4 t -117.5 119.79 36.11 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.843 0.354 . . . . 1.4199999999999999 110.905 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -118.48 126.24 51.6 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.786 -0.643 . . . . 2.52 110.246 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.59 ' CD ' ' H ' ' A' ' 5' ' ' VAL . 49.4 mp0 -70.71 123.78 22.71 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.116 -0.493 . . . . 1.6599999999999999 109.857 175.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 73.3 p -115.3 -174.72 2.56 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.244 -0.435 . . . . 1.29 110.763 -178.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -77.78 -26.37 49.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.299 0.571 . . . . 3.1600000000000001 109.868 175.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.85 -25.86 60.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.709 -0.678 . . . . 1.8100000000000001 109.588 175.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 147.93 -82.69 0.19 Allowed Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.525 -1.03 . . . . 0.46999999999999997 110.525 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.441 ' HD2' ' HB3' ' A' ' 13' ' ' ALA . 28.0 p90 -154.83 163.64 39.98 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 110.111 -0.329 . . . . 0.88 110.111 175.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.1 pt -128.59 151.5 35.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 116.182 -0.463 . . . . 1.3400000000000001 110.369 175.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.5 ' SG ' ' HB2' ' A' ' 18' ' ' PRO . 20.9 m -121.23 118.81 30.54 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.191 0.519 . . . . 0.33000000000000002 110.306 178.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -108.78 100.55 9.76 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.514 -0.766 . . . . 5.1799999999999997 110.075 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 98.6 m -75.72 139.65 42.01 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.078 0.466 . . . . 0.27000000000000002 111.469 -175.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -84.54 175.99 8.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.55 -0.75 . . . . 0.97999999999999998 110.486 177.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.766 ' HG3' ' HA2' ' A' ' 61' ' ' GLY . 48.6 tt0 -54.77 119.31 5.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.052 -0.522 . . . . 3.5499999999999998 110.765 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.82 2.22 46.07 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.577 -0.82 . . . . 0.93999999999999995 112.327 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -127.79 162.16 27.28 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.145 -0.317 . . . . 1.1399999999999999 110.145 177.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.404 ' HD3' ' HG3' ' A' ' 57' ' ' ARG . 21.6 ptt180 -145.96 154.47 41.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.858 0.361 . . . . 3.46 110.978 -178.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.45 HD12 ' O ' ' A' ' 36' ' ' CYS . 20.9 mm -78.33 133.49 30.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.797 -0.638 . . . . 1.0900000000000001 110.346 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.4 t -140.01 151.37 45.41 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.137 -0.69 . . . . 0.87 109.137 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 55.8 mt -102.85 145.35 29.92 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.519 -0.549 . . . . 1.5700000000000001 109.519 173.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -84.43 -160.24 0.46 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.705 -0.68 . . . . 2.52 109.776 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -65.67 -28.07 73.26 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.647 -0.787 . . . . 1.4199999999999999 112.938 177.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 82.6 p -90.76 -30.38 17.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 117.261 0.53 . . . . 1.79 111.407 -176.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.82 18.49 7.85 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.681 -0.771 . . . . 0.85999999999999999 111.403 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 -74.73 141.97 44.41 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.401 -0.4 . . . . 1.6799999999999999 109.961 177.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.9 t -78.3 110.84 14.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.103 0.477 . . . . 1.2 109.933 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.0 p -124.99 169.79 11.76 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.818 -0.628 . . . . 1.72 110.464 -177.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 25.2 t -121.81 129.93 53.01 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.084 -0.71 . . . . 0.31 109.084 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 33.9 pt -128.49 157.21 41.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.527 -0.306 . . . . 1.1499999999999999 110.383 -177.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.91 123.85 22.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.422 0.629 . . . . 1.3600000000000001 110.369 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.519 ' HG2' ' H ' ' A' ' 59' ' ' GLU . 74.7 ttt180 -88.49 142.09 28.0 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.668 -0.696 . . . . 5.4800000000000004 109.866 -177.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -72.49 4.03 4.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.019 -0.537 . . . . 3.3199999999999998 111.083 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.519 ' H ' ' HG2' ' A' ' 57' ' ' ARG . 9.6 tp10 -127.43 123.85 37.07 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.587 -0.894 . . . . 5.9900000000000002 108.587 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.1 p -79.62 65.98 4.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.558 0.694 . . . . 4.9100000000000001 110.849 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.766 ' HA2' ' HG3' ' A' ' 40' ' ' GLN . . . . . . . . 0 N--CA 1.441 -1.016 0 CA-C-O 118.718 -1.045 . . . . 4.7400000000000002 110.944 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.637 HG22 ' HG3' ' A' ' 11' ' ' PRO . 11.8 t . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 121.162 0.506 . . . . 3.3700000000000001 110.159 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.463 ' OE1' ' HB2' ' A' ' 29' ' ' GLU . 55.4 mt-30 -94.4 -10.77 31.48 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.267 0.469 . . . . 7.2400000000000002 112.267 -178.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 62.1 mt -81.99 -87.53 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.674 -0.41 . . . . 2.8199999999999998 110.935 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.7 m -147.11 -67.07 0.26 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.022 0.439 . . . . 3.8999999999999999 110.05 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.416 ' HG3' HG22 ' A' ' 10' ' ' THR . 10.8 pt-20 -118.12 -30.05 5.42 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.205 -0.452 . . . . 4.5899999999999999 110.126 177.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.494 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 37.8 p -100.35 132.03 23.12 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.054 -0.521 . . . . 3.0 110.686 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.926 ' HB2' ' HB2' ' A' ' 14' ' ' CYS . 4.1 Cg_exo -78.0 29.39 0.45 Allowed 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 123.489 2.793 . . . . 2.0299999999999998 113.458 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 50.98 -99.72 0.08 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.879 0.696 . . . . 1.5 112.879 176.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.435 ' HB2' ' HB3' ' A' ' 34' ' ' TYR . . . -66.66 -27.34 67.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.457 0.646 . . . . 1.3100000000000001 110.334 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.926 ' HB2' ' HB2' ' A' ' 11' ' ' PRO . 69.0 m -93.85 3.35 55.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.4 -0.818 . . . . 1.47 110.78 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.754 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 20.7 t -69.96 -22.3 63.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.366 -0.379 . . . . 1.3799999999999999 110.97 -176.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.6 m -89.09 7.1 36.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.492 -0.322 . . . . 2.2999999999999998 111.357 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 54.03 72.59 1.08 Allowed Pre-proline 0 N--CA 1.466 0.369 0 CA-C-N 115.693 -0.685 . . . . 2.3500000000000001 111.183 -176.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.417 ' HG2' ' SG ' ' A' ' 27' ' ' CYS . 14.4 Cg_exo -66.29 -42.22 10.78 Favored 'Trans proline' 0 CA--C 1.52 -0.213 0 C-N-CA 123.13 2.554 . . . . 0.91000000000000003 111.803 -175.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.507 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -82.02 -3.11 53.82 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.542 -0.753 . . . . 0.55000000000000004 110.337 -178.189 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.16 -137.59 13.52 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.433 -0.803 . . . . 0.70999999999999996 111.324 -176.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.524 ' HD2' ' HB2' ' A' ' 24' ' ' ALA . 6.2 Cg_exo -77.72 171.34 17.57 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.593 2.195 . . . . 1.04 111.769 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.34 -39.53 94.79 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.905 0.383 . . . . 3.4199999999999999 110.318 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.47 -23.62 66.01 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.512 -0.767 . . . . 1.23 111.397 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.524 ' HB2' ' HD2' ' A' ' 21' ' ' PRO . . . -81.36 -56.57 3.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.908 0.385 . . . . 1.0700000000000001 110.363 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -171.39 161.1 33.46 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.619 -0.801 . . . . 0.60999999999999999 111.965 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.6 m -102.33 140.74 36.21 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.548 -0.538 . . . . 1.4299999999999999 109.548 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.507 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 38.2 t -105.35 143.28 33.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.189 0.518 . . . . 1.4199999999999999 110.752 -177.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.745 ' HE2' ' HA ' ' A' ' 28' ' ' LYS . 0.5 OUTLIER -131.88 122.07 25.08 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.725 -0.67 . . . . 2.52 110.139 -177.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.463 ' HB2' ' OE1' ' A' ' 6' ' ' GLN . 5.0 mp0 -66.99 125.79 27.09 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.356 -0.609 . . . . 1.6599999999999999 109.356 175.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 31.8 p -106.98 173.71 6.2 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.851 -0.613 . . . . 1.29 110.494 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -79.82 46.83 0.81 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 122.027 0.918 . . . . 3.1600000000000001 109.974 175.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.5 t -162.9 -41.43 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.816 -1.083 . . . . 1.8100000000000001 108.325 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -179.52 -100.08 0.13 Allowed Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.298 -0.864 . . . . 0.46999999999999997 111.276 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.435 ' HB3' ' HB2' ' A' ' 13' ' ' ALA . 36.9 p90 -148.93 151.23 34.27 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.748 -0.464 . . . . 0.88 109.748 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.8 pt -129.87 161.88 38.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.936 -0.394 . . . . 1.3400000000000001 109.936 172.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 33.3 m -121.22 130.95 53.95 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.239 -0.437 . . . . 0.33000000000000002 110.821 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -111.02 101.52 10.07 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.946 -0.761 . . . . 5.1799999999999997 108.946 175.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.502 ' HB3' ' HB2' ' A' ' 42' ' ' TYR . 88.9 m -73.56 145.31 45.6 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.911 -0.586 . . . . 0.27000000000000002 110.876 -177.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -77.69 170.88 15.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.537 -0.756 . . . . 0.97999999999999998 109.772 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.419 ' HG3' ' HB3' ' A' ' 60' ' ' SER . 62.3 tt0 -66.2 103.23 0.95 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.049 0.452 . . . . 3.5499999999999998 110.335 -178.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 128.6 -1.03 6.41 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.529 -0.76 . . . . 0.93999999999999995 111.456 -175.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.502 ' HB2' ' HB3' ' A' ' 38' ' ' CYS . 80.2 m-85 -130.23 162.44 28.94 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.673 -0.491 . . . . 1.1399999999999999 109.673 177.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.798 ' HG2' ' HB2' ' A' ' 57' ' ' ARG . 2.7 ptp180 -143.55 161.47 38.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.612 0.244 . . . . 3.46 110.72 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.433 HD12 ' HA ' ' A' ' 44' ' ' ILE . 12.5 mm -81.3 140.03 17.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 121.059 0.457 . . . . 1.0900000000000001 111.38 -176.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.4 t -147.12 154.68 41.41 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.693 -0.685 . . . . 0.87 109.36 177.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 80.9 mt -96.79 145.99 25.32 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.435 -0.58 . . . . 1.5700000000000001 109.435 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -64.79 -15.04 61.15 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.546 -0.752 . . . . 2.52 111.901 -177.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.49 -30.26 4.76 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.353 -0.699 . . . . 1.4199999999999999 111.353 -176.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.5 p -102.84 -24.43 13.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.103 0.478 . . . . 1.79 110.219 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 131.04 20.85 1.13 Allowed Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.543 -0.753 . . . . 0.85999999999999999 112.897 174.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -83.82 133.08 34.77 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.618 -0.512 . . . . 1.6799999999999999 109.618 174.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.6 t -80.02 111.8 17.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.023 0.439 . . . . 1.2 110.333 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.7 t -127.45 173.85 9.49 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.909 -0.587 . . . . 1.72 109.582 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 19' ' ' CYS . 48.5 t -122.83 131.19 53.65 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.555 -0.535 . . . . 0.31 109.555 -176.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 20.9 pt -123.54 142.15 41.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.14 0.495 . . . . 1.1499999999999999 110.945 -176.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.1 p -66.55 126.77 26.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.424 -0.807 . . . . 1.3600000000000001 110.514 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.798 ' HB2' ' HG2' ' A' ' 43' ' ' ARG . 4.2 tpm_? -123.34 131.89 53.81 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.979 -0.748 . . . . 5.4800000000000004 108.979 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -45.67 -54.21 8.13 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-O 121.062 0.458 . . . . 3.3199999999999998 111.265 -176.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -94.72 147.71 23.03 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.361 -0.836 . . . . 5.9900000000000002 108.969 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.419 ' HB3' ' HG3' ' A' ' 40' ' ' GLN . 22.2 m -75.01 64.13 1.3 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.506 0.67 . . . . 4.9100000000000001 110.761 -178.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.082 0 CA-C-O 118.681 -1.066 . . . . 4.7400000000000002 110.903 179.338 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.436 HG13 ' SG ' ' A' ' 27' ' ' CYS . 16.9 m . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.933 0.397 . . . . 3.3700000000000001 111.436 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.88 -32.85 15.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.955 0.407 . . . . 7.2400000000000002 110.34 178.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.535 HD13 ' HA ' ' A' ' 11' ' ' PRO . 95.7 mt -85.67 -175.57 5.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.989 -0.551 . . . . 2.8199999999999998 110.939 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.4 t -69.51 -72.52 0.19 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.394 -0.366 . . . . 3.8999999999999999 111.804 -173.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.402 ' HB2' ' H ' ' A' ' 10' ' ' THR . 13.0 mm-40 -98.92 -88.92 0.32 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.095 0.474 . . . . 4.5899999999999999 110.759 -171.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.528 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 0.7 OUTLIER -102.47 108.1 56.23 Favored Pre-proline 0 N--CA 1.446 -0.642 0 CA-C-N 115.754 -0.657 . . . . 3.0 109.499 175.118 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.535 ' HA ' HD13 ' A' ' 7' ' ' LEU . 0.9 OUTLIER -81.9 64.8 8.51 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.581 2.854 . . . . 2.0299999999999998 113.568 -169.869 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.426 ' O ' ' HB3' ' A' ' 15' ' ' SER . . . 43.65 -87.44 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 O-C-N 124.339 1.024 . . . . 1.5 113.712 174.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.442 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . . . -62.55 -41.59 98.99 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.301 -0.409 . . . . 1.3100000000000001 111.532 -177.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.576 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 52.5 t -85.37 -3.15 58.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.143 0.497 . . . . 1.47 110.774 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.426 ' HB3' ' O ' ' A' ' 12' ' ' ALA . 36.6 t -65.59 -17.52 64.64 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.283 -0.417 . . . . 1.3799999999999999 111.463 -177.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 36.5 m -108.1 14.89 24.74 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.925 0.393 . . . . 2.2999999999999998 111.49 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 55.95 73.29 0.86 Allowed Pre-proline 0 N--CA 1.47 0.544 0 CA-C-N 115.313 -0.858 . . . . 2.3500000000000001 112.283 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.576 ' HD3' ' HA ' ' A' ' 14' ' ' CYS . 24.6 Cg_endo -62.19 -43.56 23.28 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.829 2.353 . . . . 0.91000000000000003 112.191 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 2.6 m -90.56 17.9 6.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.266 -0.425 . . . . 0.55000000000000004 111.109 -176.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.443 ' HA3' ' HD3' ' A' ' 21' ' ' PRO . . . 70.98 -123.74 10.95 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 116.102 -0.499 . . . . 0.70999999999999996 112.553 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.443 ' HD3' ' HA3' ' A' ' 20' ' ' GLY . 1.6 Cg_endo -78.76 157.87 27.92 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 123.287 2.658 . . . . 1.04 112.063 178.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -67.42 -27.9 67.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.664 -0.698 . . . . 3.4199999999999999 110.565 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.04 -15.04 61.09 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.61 -0.723 . . . . 1.23 111.288 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.91 -52.37 6.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.341 -0.39 . . . . 1.0700000000000001 110.351 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -169.76 174.31 43.99 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.3 -0.952 . . . . 0.60999999999999999 113.083 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.5 m -101.38 140.89 35.06 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 122.46 0.304 . . . . 1.4299999999999999 110.86 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.436 ' SG ' HG13 ' A' ' 5' ' ' VAL . 27.9 p -102.55 130.09 49.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.899 0.381 . . . . 1.4199999999999999 110.517 177.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -124.5 117.06 23.54 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.203 -0.666 . . . . 2.52 109.203 176.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -71.95 119.1 15.65 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.192 0.52 . . . . 1.6599999999999999 109.973 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.9 p -112.17 -175.68 2.74 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.876 -0.602 . . . . 1.29 110.683 -176.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -68.19 -24.01 64.9 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.395 0.617 . . . . 3.1600000000000001 109.728 174.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.9 m -78.77 -19.32 52.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.614 -0.721 . . . . 1.8100000000000001 110.038 177.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 133.2 -71.77 0.49 Allowed Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.985 -0.846 . . . . 0.46999999999999997 110.985 -177.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.442 ' CD1' ' HB2' ' A' ' 13' ' ' ALA . 50.2 p90 -155.98 158.93 38.71 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.306 -0.257 . . . . 0.88 110.306 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.2 pt -131.74 157.07 43.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.272 -0.64 . . . . 1.3400000000000001 109.272 170.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.0 m -121.06 119.22 31.84 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.634 0.73 . . . . 0.33000000000000002 111.06 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -105.72 99.46 9.06 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.992 -1.003 . . . . 5.1799999999999997 109.975 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 77.8 m -77.88 146.2 35.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.979 0.418 . . . . 0.27000000000000002 110.845 -176.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -84.06 179.02 7.61 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.833 -0.622 . . . . 0.97999999999999998 109.996 176.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -58.77 132.44 53.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.674 0.273 . . . . 3.5499999999999998 110.544 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.85 5.65 80.84 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.477 -0.868 . . . . 0.93999999999999995 112.398 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -125.54 154.5 42.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.025 0.441 . . . . 1.1399999999999999 110.624 177.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.516 ' HG3' HG13 ' A' ' 55' ' ' ILE . 24.7 ptt180 -140.43 160.85 39.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.779 -0.646 . . . . 3.46 111.172 -171.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.4 mm -87.51 134.36 27.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.798 -0.637 . . . . 1.0900000000000001 110.65 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.0 t -143.53 173.54 11.55 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.442 -0.799 . . . . 0.87 109.217 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 78.8 mt -107.69 145.02 33.97 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.247 0.546 . . . . 1.5700000000000001 109.998 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -61.85 -23.91 66.57 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.027 -0.988 . . . . 2.52 111.509 -177.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 133.61 -22.56 3.89 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 111.223 -0.751 . . . . 1.4199999999999999 111.223 -175.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 37.4 p -111.71 -27.09 8.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.042 0.449 . . . . 1.79 110.393 177.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 133.57 24.02 0.7 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.766 -0.73 . . . . 0.85999999999999999 112.901 175.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -87.26 145.9 26.18 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.417 -0.586 . . . . 1.6799999999999999 109.417 174.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.1 t -79.4 111.16 15.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.953 0.406 . . . . 1.2 110.087 -176.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 18' ' ' PRO . 65.7 p -124.78 169.13 12.31 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.989 -0.55 . . . . 1.72 110.472 -178.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 34.0 t -121.81 131.23 53.95 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.023 -0.535 . . . . 0.31 109.656 -178.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.516 HG13 ' HG3' ' A' ' 43' ' ' ARG . 34.5 pt -131.73 167.13 27.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.249 -0.432 . . . . 1.1499999999999999 110.115 -177.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.9 p -76.91 137.35 22.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.474 0.654 . . . . 1.3600000000000001 111.28 -175.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' A' ' 59' ' ' GLU . 19.1 tpt180 -101.14 106.72 17.99 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.17 -1.048 . . . . 5.4800000000000004 108.17 173.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.51 -4.08 13.83 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.209 0.448 . . . . 3.3199999999999998 112.209 -171.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.443 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 10.1 tp10 -126.11 115.86 20.48 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.286 -1.005 . . . . 5.9900000000000002 108.286 175.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.4 p -48.42 122.95 5.9 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.604 0.565 . . . . 4.9100000000000001 111.984 -171.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.747 -1.029 . . . . 4.7400000000000002 111.168 -178.024 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.478 0.934 0 CA-C-O 122.146 0.974 . . . . 3.3700000000000001 109.93 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -81.65 -38.49 25.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.822 -0.626 . . . . 7.2400000000000002 110.718 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.686 ' HB2' ' HA ' ' A' ' 11' ' ' PRO . 85.3 mt -88.11 155.18 19.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.182 -0.463 . . . . 2.8199999999999998 110.039 178.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.3 t -85.68 -33.67 21.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.445 -0.798 . . . . 3.8999999999999999 111.823 -167.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -93.71 -79.7 0.4 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.316 -0.624 . . . . 4.5899999999999999 109.316 177.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.5 p -124.04 129.61 24.69 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 115.849 -0.614 . . . . 3.0 109.905 172.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.686 ' HA ' ' HB2' ' A' ' 7' ' ' LEU . 62.6 Cg_endo -76.78 -163.05 0.18 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.604 2.203 . . . . 2.0299999999999998 111.84 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -103.89 -65.43 1.02 Allowed 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.469 -0.492 . . . . 1.5 110.23 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.735 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . . . -71.78 -48.22 48.1 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.122 -0.49 . . . . 1.3100000000000001 110.59 -177.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.504 ' HB2' ' CG ' ' A' ' 11' ' ' PRO . 65.7 m -66.63 -23.16 66.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.366 -0.379 . . . . 1.47 111.048 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.7 t -67.94 -28.11 67.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.022 0.439 . . . . 1.3799999999999999 110.402 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.0 t -82.72 -0.89 49.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.262 0.553 . . . . 2.2999999999999998 110.291 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 62.29 73.04 0.57 Allowed Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 115.056 -0.975 . . . . 2.3500000000000001 111.146 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.519 ' O ' ' HA ' ' A' ' 53' ' ' THR . 5.7 Cg_exo -74.69 -64.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.499 2.133 . . . . 0.91000000000000003 111.162 -177.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -84.13 27.36 0.68 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.851 -0.613 . . . . 0.55000000000000004 110.869 -178.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.94 -125.5 22.24 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.142 -0.551 . . . . 0.70999999999999996 112.071 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.594 ' HG2' ' HB1' ' A' ' 24' ' ' ALA . 90.6 Cg_endo -78.51 156.78 28.65 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.778 2.319 . . . . 1.04 112.379 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -68.43 -11.95 60.45 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.249 -0.887 . . . . 3.4199999999999999 110.39 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.81 -14.5 34.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.698 -0.683 . . . . 1.23 111.526 177.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.594 ' HB1' ' HG2' ' A' ' 21' ' ' PRO . . . -78.27 -35.89 47.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.412 0.625 . . . . 1.0700000000000001 110.453 -177.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -177.92 -171.73 41.63 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.632 -0.794 . . . . 0.60999999999999999 112.093 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.9 m -92.12 134.1 35.16 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 110.083 -0.34 . . . . 1.4299999999999999 110.083 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.428 ' SG ' ' HG2' ' A' ' 18' ' ' PRO . 43.0 t -106.1 112.67 25.81 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.375 -0.602 . . . . 1.4199999999999999 109.375 177.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.46 ' HB3' ' CG1' ' A' ' 35' ' ' ILE . 17.8 tppt? -116.05 107.66 15.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.122 -0.49 . . . . 2.52 110.108 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.735 ' HG2' ' HB2' ' A' ' 13' ' ' ALA . 36.2 mt-10 -74.38 118.74 17.68 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.073 -0.512 . . . . 1.6599999999999999 109.973 178.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 70.9 p -109.98 -175.11 2.65 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.775 -0.648 . . . . 1.29 110.372 -175.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -76.1 -17.61 59.54 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.319 0.581 . . . . 3.1600000000000001 109.755 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.8 t -88.94 -1.2 57.99 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.664 -0.698 . . . . 1.8100000000000001 109.937 175.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 124.52 -79.89 0.36 Allowed Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 111.064 -0.814 . . . . 0.46999999999999997 111.064 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.465 ' HB3' ' CB ' ' A' ' 13' ' ' ALA . 54.8 p90 -156.2 154.46 30.82 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.149 -0.315 . . . . 0.88 110.149 178.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.46 ' CG1' ' HB3' ' A' ' 28' ' ' LYS . 44.2 pt -122.68 148.92 26.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 108.794 -0.817 . . . . 1.3400000000000001 108.794 166.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.403 ' SG ' ' HB2' ' A' ' 18' ' ' PRO . 50.3 m -120.63 123.03 41.81 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.279 0.561 . . . . 0.33000000000000002 110.791 -177.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 48.6 ttp85 -116.08 100.73 8.16 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.354 -0.839 . . . . 5.1799999999999997 109.885 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 81.8 m -77.39 155.13 32.08 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.256 0.551 . . . . 0.27000000000000002 111.86 -175.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -79.07 -179.63 6.8 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.061 -0.972 . . . . 0.97999999999999998 109.684 174.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -64.42 -39.15 93.28 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.981 0.419 . . . . 3.5499999999999998 111.588 -172.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.457 ' HA3' ' H ' ' A' ' 61' ' ' GLY . . . -80.29 6.79 59.27 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.545 -0.836 . . . . 0.93999999999999995 112.743 -178.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.46 ' HB3' ' SG ' ' A' ' 54' ' ' CYS . 96.1 m-85 -128.78 161.43 29.77 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 122.583 -0.363 . . . . 1.1399999999999999 110.938 -176.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -142.73 162.43 35.49 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.883 0.373 . . . . 3.46 110.639 -176.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.0 mm -84.91 128.94 38.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.898 -0.592 . . . . 1.0900000000000001 110.891 -178.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.7 t -133.98 151.98 51.67 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.322 -0.854 . . . . 0.87 109.235 178.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 86.5 mt -101.82 142.54 32.97 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.122 0.487 . . . . 1.5700000000000001 109.786 176.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -64.35 -22.02 66.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.312 -0.858 . . . . 2.52 111.959 -174.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 129.38 -23.62 4.82 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.904 -0.665 . . . . 1.4199999999999999 111.508 -175.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.6 p -106.55 -25.5 11.79 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.005 0.431 . . . . 1.79 109.85 175.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 131.47 15.56 1.6 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.928 -0.654 . . . . 0.85999999999999999 112.952 174.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -74.53 134.53 42.2 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.446 -0.576 . . . . 1.6799999999999999 109.446 174.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.8 t -79.71 110.27 15.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.668 -0.493 . . . . 1.2 109.668 -178.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 18' ' ' PRO . 65.9 p -121.4 171.13 8.99 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.962 -0.563 . . . . 1.72 109.846 -178.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.46 ' SG ' ' HB3' ' A' ' 42' ' ' TYR . 15.6 t -126.72 130.68 50.82 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.328 -0.396 . . . . 0.31 110.046 -176.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 41.2 pt -133.68 165.32 32.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.06 -0.518 . . . . 1.1499999999999999 109.937 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.0 p -65.11 127.83 26.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.336 0.588 . . . . 1.3600000000000001 110.726 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -82.64 -40.82 20.22 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.498 -0.774 . . . . 5.4800000000000004 110.249 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -165.77 -72.73 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.419 -0.81 . . . . 3.3199999999999998 109.631 -178.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -128.71 121.98 29.68 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.282 -0.872 . . . . 5.9900000000000002 109.318 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.9 m -56.85 116.11 2.98 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.233 0.54 . . . . 4.9100000000000001 112.251 -173.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.457 ' H ' ' HA3' ' A' ' 41' ' ' GLY . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.013 -1.437 . . . . 4.7400000000000002 111.018 178.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.704 HG13 ' H ' ' A' ' 6' ' ' GLN . 2.8 p . . . . . 0 N--CA 1.474 0.745 0 CA-C-O 119.491 -0.29 . . . . 3.3700000000000001 111.077 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.704 ' H ' HG13 ' A' ' 5' ' ' VAL . 25.0 tp60 -177.59 -48.07 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.952 0.406 . . . . 7.2400000000000002 110.148 -176.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.4 mt 69.88 -95.69 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.297 -0.865 . . . . 2.8199999999999998 112.021 173.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.3 m -154.51 -82.05 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.493 0.187 . . . . 3.8999999999999999 110.893 -176.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -67.68 -64.68 0.81 Allowed 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.52 -0.548 . . . . 4.5899999999999999 109.52 177.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.6 p -141.35 143.41 30.2 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 115.449 -0.796 . . . . 3.0 109.85 176.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.465 ' HB3' ' HA ' ' A' ' 6' ' ' GLN . 48.8 Cg_endo -75.33 90.43 1.11 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 121.599 1.533 . . . . 2.0299999999999998 109.098 171.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -46.97 -33.01 4.27 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.591 0.96 . . . . 1.5 113.591 -166.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.801 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . . . -94.95 -29.89 14.42 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.218 0.451 . . . . 1.3100000000000001 112.218 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.447 ' HB2' ' HB2' ' A' ' 11' ' ' PRO . 35.7 m -97.1 2.55 51.38 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 122.039 -0.413 . . . . 1.47 111.164 -178.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.5 t -66.31 -17.88 65.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.09 -0.504 . . . . 1.3799999999999999 111.25 -173.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.7 m -97.47 4.19 50.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.605 -0.27 . . . . 2.2999999999999998 111.543 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 57.5 76.37 0.48 Allowed Pre-proline 0 N--CA 1.469 0.525 0 CA-C-N 115.616 -0.72 . . . . 2.3500000000000001 111.394 -175.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -73.23 -73.02 0.01 OUTLIER 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 122.902 2.401 . . . . 0.91000000000000003 112.784 -177.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -71.1 -28.39 64.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.191 0.519 . . . . 0.55000000000000004 111.158 -176.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.41 ' HA3' ' HD3' ' A' ' 21' ' ' PRO . . . 105.67 -122.86 7.32 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.611 -0.722 . . . . 0.70999999999999996 112.312 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 24' ' ' ALA . 10.2 Cg_endo -86.3 156.12 9.51 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.302 2.668 . . . . 1.04 112.49 -177.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -62.62 -23.29 66.98 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 114.984 -1.007 . . . . 3.4199999999999999 111.003 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.12 -34.58 76.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.288 -0.415 . . . . 1.23 110.8 175.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.474 ' HB3' ' HD2' ' A' ' 21' ' ' PRO . . . -83.74 -57.89 3.03 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.032 -0.531 . . . . 1.0700000000000001 110.578 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -168.39 143.61 8.24 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.276 -0.964 . . . . 0.60999999999999999 112.452 -177.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.8 m -83.73 145.02 28.96 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.201 -0.296 . . . . 1.4299999999999999 110.201 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 53.4 t -100.24 113.53 26.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.202 0.525 . . . . 1.4199999999999999 110.304 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -109.99 114.35 27.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.658 -0.701 . . . . 2.52 109.902 -176.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.801 ' HG2' ' HB2' ' A' ' 13' ' ' ALA . 45.5 mt-10 -78.2 119.71 21.97 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.114 0.483 . . . . 1.6599999999999999 110.143 -177.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 78.7 p -119.01 -173.31 2.47 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.417 -0.81 . . . . 1.29 110.946 -173.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -64.51 -32.71 74.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.014 0.435 . . . . 3.1600000000000001 110.176 175.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.0 m -73.93 -2.67 24.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.946 -0.57 . . . . 1.8100000000000001 110.437 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.06 -74.94 0.24 Allowed Glycine 0 N--CA 1.44 -1.058 0 N-CA-C 110.496 -1.042 . . . . 0.46999999999999997 110.496 -177.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.571 ' HB3' ' HB1' ' A' ' 13' ' ' ALA . 51.9 p90 -153.45 151.45 29.88 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.068 0.461 . . . . 0.88 110.174 176.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 47.2 pt -128.5 162.07 35.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 108.384 -0.969 . . . . 1.3400000000000001 108.384 169.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 68.3 m -120.85 129.85 53.7 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.153 0.501 . . . . 0.33000000000000002 110.319 -178.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.743 ' HA ' ' HE ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -105.93 99.97 9.54 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.885 -0.598 . . . . 5.1799999999999997 109.627 178.674 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.429 ' HB3' ' HB2' ' A' ' 42' ' ' TYR . 84.3 m -83.86 133.8 34.72 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.694 -0.684 . . . . 0.27000000000000002 110.932 -176.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -68.88 151.69 46.24 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.995 -1.002 . . . . 0.97999999999999998 109.038 175.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.421 ' HB2' ' O ' ' A' ' 61' ' ' GLY . 3.8 pt20 -59.46 120.53 9.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.479 0.657 . . . . 3.5499999999999998 110.678 -176.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.25 -8.14 14.09 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 110.513 -1.035 . . . . 0.93999999999999995 110.513 -171.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.442 ' CD2' ' HA ' ' A' ' 56' ' ' VAL . 71.6 m-85 -128.02 162.8 25.96 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.915 -0.772 . . . . 1.1399999999999999 108.915 176.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.782 ' HG2' ' HB2' ' A' ' 57' ' ' ARG . 9.2 ptp180 -152.39 165.15 35.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.075 0.464 . . . . 3.46 111.587 174.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.3 mm -70.29 137.64 23.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.207 -0.906 . . . . 1.0900000000000001 110.895 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.416 ' HB2' HG12 ' A' ' 55' ' ' ILE . 23.0 t -145.72 165.75 27.87 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.985 -0.746 . . . . 0.87 108.985 178.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 87.8 mt -104.72 138.03 41.64 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.671 -0.492 . . . . 1.5700000000000001 109.671 178.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -60.6 -24.18 65.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.068 -0.969 . . . . 2.52 111.911 -174.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 131.76 -26.5 3.82 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 111.015 -0.834 . . . . 1.4199999999999999 111.015 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.2 p -100.57 -30.38 11.81 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.707 -0.479 . . . . 1.79 109.707 175.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 131.77 22.55 0.93 Allowed Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.597 -0.729 . . . . 0.85999999999999999 112.447 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -85.41 142.83 28.99 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.662 -0.496 . . . . 1.6799999999999999 109.662 176.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.7 t -79.71 110.81 15.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.187 0.518 . . . . 1.2 110.138 -176.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.1 p -125.6 171.67 10.37 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.924 -0.58 . . . . 1.72 110.188 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 44.3 t -124.65 129.94 51.48 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.498 -0.556 . . . . 0.31 109.498 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.416 HG12 ' HB2' ' A' ' 45' ' ' SER . 26.0 pt -131.27 148.02 32.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.03 0.443 . . . . 1.1499999999999999 110.723 -176.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.442 ' HA ' ' CD2' ' A' ' 42' ' ' TYR . 7.6 p -62.48 123.92 16.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.635 -0.711 . . . . 1.3600000000000001 110.442 177.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.782 ' HB2' ' HG2' ' A' ' 43' ' ' ARG . 21.5 tpt180 -125.59 114.11 18.3 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.263 -0.426 . . . . 5.4800000000000004 110.536 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.437 ' HG3' ' HG3' ' A' ' 59' ' ' GLU . 3.9 pt20 -58.19 -33.17 68.96 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.739 -0.664 . . . . 3.3199999999999998 111.182 178.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.437 ' HG3' ' HG3' ' A' ' 58' ' ' GLN . 38.7 mt-10 -105.19 67.29 0.78 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.909 -0.587 . . . . 5.9900000000000002 111.742 -176.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 62.7 m -127.03 -52.41 1.42 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.625 -0.716 . . . . 4.9100000000000001 109.921 172.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' A' ' 40' ' ' GLN . . . . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.544 -1.142 . . . . 4.7400000000000002 111.674 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.0 t . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 120.928 0.394 . . . . 3.3700000000000001 110.422 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.634 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 60.9 tt0 -72.03 132.8 44.76 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.094 -0.503 . . . . 7.2400000000000002 110.513 176.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -137.19 9.78 2.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.054 -0.521 . . . . 2.8199999999999998 110.153 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.7 p -169.55 -174.94 2.02 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.681 -0.691 . . . . 3.8999999999999999 110.265 -172.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -45.17 -56.93 4.29 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.41 0.624 . . . . 4.5899999999999999 110.285 175.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.0 p -97.72 128.15 35.17 Favored Pre-proline 0 N--CA 1.441 -0.91 0 CA-C-N 115.268 -0.878 . . . . 3.0 109.796 173.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.634 ' HA ' ' HA ' ' A' ' 6' ' ' GLN . 51.1 Cg_exo -57.95 -19.08 38.3 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.05 2.5 . . . . 2.0299999999999998 112.759 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.621 ' H ' ' HB3' ' A' ' 15' ' ' SER . . . 66.9 121.19 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.89 0.744 . . . . 1.5 111.602 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.609 ' HB1' ' CD1' ' A' ' 34' ' ' TYR . . . 70.68 -58.37 0.56 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.655 -0.702 . . . . 1.3100000000000001 110.978 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.9 t -83.18 7.62 15.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.755 0.788 . . . . 1.47 109.447 174.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.621 ' HB3' ' H ' ' A' ' 12' ' ' ALA . 6.3 p -70.15 -25.24 63.37 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.299 -0.864 . . . . 1.3799999999999999 112.317 -175.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.9 t -93.6 11.37 29.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.975 0.417 . . . . 2.2999999999999998 110.745 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 55.71 63.57 6.14 Favored Pre-proline 0 N--CA 1.468 0.451 0 CA-C-N 115.396 -0.82 . . . . 2.3500000000000001 111.041 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.518 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 23.6 Cg_exo -63.95 -56.01 0.55 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.994 2.463 . . . . 0.91000000000000003 112.512 -174.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.463 ' SG ' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -96.56 7.61 46.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.91 -0.587 . . . . 0.55000000000000004 111.212 -178.692 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.406 ' HA3' ' HD3' ' A' ' 21' ' ' PRO . . . 73.22 -130.5 13.76 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.009 -0.615 . . . . 0.70999999999999996 112.789 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 24' ' ' ALA . 10.6 Cg_endo -91.24 170.89 3.14 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 123.709 2.94 . . . . 1.04 112.555 -178.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -63.75 -21.0 66.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.633 -0.712 . . . . 3.4199999999999999 110.588 176.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.58 -32.78 74.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.941 0.4 . . . . 1.23 110.56 175.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.503 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . . . -94.61 -63.61 1.16 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.96 -0.564 . . . . 1.0700000000000001 110.952 -177.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -162.25 142.05 7.67 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.69 -0.767 . . . . 0.60999999999999999 112.277 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.2 m -84.38 141.18 31.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.786 0.327 . . . . 1.4299999999999999 110.215 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.463 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 6.9 p -100.17 129.35 46.18 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.215 -0.448 . . . . 1.4199999999999999 110.068 177.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -128.31 111.48 13.42 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.399 -0.593 . . . . 2.52 109.399 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.454 ' HG3' ' HB2' ' A' ' 13' ' ' ALA . 2.9 mp0 -68.33 119.71 13.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.127 0.489 . . . . 1.6599999999999999 110.93 -178.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 60.7 p -102.66 -175.69 2.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.581 -0.736 . . . . 1.29 110.403 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -64.78 -44.84 88.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.693 0.283 . . . . 3.1600000000000001 110.258 175.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.5 m -62.75 -41.09 99.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.091 0.472 . . . . 1.8100000000000001 110.667 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 172.64 -82.19 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.81 -0.709 . . . . 0.46999999999999997 111.657 177.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.609 ' CD1' ' HB1' ' A' ' 13' ' ' ALA . 42.4 p90 -155.5 156.01 34.45 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.91 0.385 . . . . 0.88 110.886 176.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 46.3 pt -125.06 159.69 31.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.716 -0.675 . . . . 1.3400000000000001 109.485 172.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.518 ' SG ' ' HB2' ' A' ' 18' ' ' PRO . 36.4 m -123.57 121.1 34.75 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.108 0.48 . . . . 0.33000000000000002 110.539 178.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -101.92 100.18 10.45 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.048 -0.723 . . . . 5.1799999999999997 109.048 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 75.1 m -80.72 136.63 36.2 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.967 -0.56 . . . . 0.27000000000000002 111.108 -175.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -71.83 155.07 40.83 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.254 -0.885 . . . . 0.97999999999999998 109.327 175.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -60.49 121.2 11.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.154 0.502 . . . . 3.5499999999999998 110.105 -178.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.48 -10.42 11.53 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.721 -0.952 . . . . 0.93999999999999995 110.721 -170.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.503 ' CE2' ' HA ' ' A' ' 24' ' ' ALA . 92.9 m-85 -123.91 162.62 22.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.96 -0.62 . . . . 1.1399999999999999 110.099 176.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.443 ' HG3' HG13 ' A' ' 55' ' ' ILE . 31.6 ptt180 -139.04 156.51 47.14 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.906 0.384 . . . . 3.46 110.665 -177.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.432 HD11 ' HA ' ' A' ' 44' ' ' ILE . 14.1 mm -83.08 130.31 35.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.949 -0.569 . . . . 1.0900000000000001 110.705 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 44.1 t -132.21 155.99 47.25 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.579 -0.737 . . . . 0.87 109.809 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 84.3 mt -105.34 136.84 44.14 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.331 -0.618 . . . . 1.5700000000000001 109.331 175.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -59.22 -28.13 66.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.059 -0.973 . . . . 2.52 111.832 -176.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 137.07 -34.69 2.17 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.804 -0.918 . . . . 1.4199999999999999 110.804 -174.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 56.2 p -87.26 -29.72 21.44 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.368 0.604 . . . . 1.79 109.398 175.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 127.78 14.73 2.5 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.314 -0.857 . . . . 0.85999999999999999 112.333 176.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -82.02 142.34 32.44 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.845 0.355 . . . . 1.6799999999999999 110.248 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.3 t -79.21 111.64 16.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.898 -0.592 . . . . 1.2 111.163 -172.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.9 p -120.64 169.95 9.89 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.983 -0.553 . . . . 1.72 110.263 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 17.3 t -125.0 131.85 53.35 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 110.04 -0.356 . . . . 0.31 110.04 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.443 HG13 ' HG3' ' A' ' 43' ' ' ARG . 29.0 pt -133.02 169.99 20.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.053 -0.521 . . . . 1.1499999999999999 110.204 -179.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.422 HG23 ' HA ' ' A' ' 59' ' ' GLU . 11.0 p -72.85 140.74 17.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.995 0.426 . . . . 1.3600000000000001 110.801 -177.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -76.75 -37.79 55.32 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.82 -0.627 . . . . 5.4800000000000004 110.409 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -150.44 -65.45 0.2 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.155 -0.683 . . . . 3.3199999999999998 109.155 172.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.422 ' HA ' HG23 ' A' ' 56' ' ' VAL . 9.8 tp10 -174.96 100.56 0.08 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.306 -0.861 . . . . 5.9900000000000002 109.378 177.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.9 t 52.59 38.87 27.01 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 121.546 0.689 . . . . 4.9100000000000001 109.813 -174.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.948 0 CA-C-O 117.761 -1.577 . . . . 4.7400000000000002 110.132 -173.429 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.9 m . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 120.892 0.377 . . . . 3.3700000000000001 110.557 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.61 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 7.6 tt0 -93.84 94.42 8.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.879 0.371 . . . . 7.2400000000000002 110.092 -177.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.0 mt -85.74 99.71 11.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.959 -0.564 . . . . 2.8199999999999998 111.595 -175.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.7 m 72.11 -62.52 0.46 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.513 -0.767 . . . . 3.8999999999999999 112.368 173.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -132.44 -63.95 0.78 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.888 0.375 . . . . 4.5899999999999999 110.484 -176.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.518 ' C ' ' H ' ' A' ' 12' ' ' ALA . 14.7 p -90.26 142.18 28.24 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.92 -0.582 . . . . 3.0 110.868 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.61 ' HA ' ' HA ' ' A' ' 6' ' ' GLN . 11.4 Cg_exo -72.47 29.04 0.27 Allowed 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 123.009 2.473 . . . . 2.0299999999999998 112.144 171.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.554 ' HB3' ' OE2' ' A' ' 29' ' ' GLU . . . 43.63 -96.01 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.633 1.346 . . . . 1.5 114.633 175.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.679 ' HB1' ' HG2' ' A' ' 29' ' ' GLU . . . -86.23 -18.09 33.04 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.261 0.553 . . . . 1.3100000000000001 110.802 -174.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 41.9 t -104.15 11.81 34.63 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.773 -0.825 . . . . 1.47 108.773 175.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 39.3 t -65.94 -28.53 68.99 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.073 -0.967 . . . . 1.3799999999999999 111.151 -174.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.1 m -101.45 13.21 35.69 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.968 0.413 . . . . 2.2999999999999998 111.472 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.6 m120 55.79 84.54 0.21 Allowed Pre-proline 0 N--CA 1.469 0.509 0 CA-C-N 115.389 -0.823 . . . . 2.3500000000000001 112.103 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.412 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 2.9 Cg_exo -73.13 -58.26 0.07 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.998 2.465 . . . . 0.91000000000000003 112.36 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.432 ' SG ' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -86.39 17.52 3.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.069 -0.514 . . . . 0.55000000000000004 111.796 -175.048 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.466 ' HA3' ' HD3' ' A' ' 21' ' ' PRO . . . 76.01 -124.82 7.54 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.036 -0.602 . . . . 0.70999999999999996 112.938 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.466 ' HD3' ' HA3' ' A' ' 20' ' ' GLY . 9.2 Cg_endo -90.52 160.73 4.4 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.725 2.95 . . . . 1.04 112.362 -178.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -64.31 -21.31 66.56 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.642 -0.708 . . . . 3.4199999999999999 111.325 -178.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.69 -31.96 67.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.324 -0.398 . . . . 1.23 110.78 177.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.432 ' CB ' ' HD2' ' A' ' 21' ' ' PRO . . . -76.92 -50.16 13.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.812 -0.631 . . . . 1.0700000000000001 110.59 -177.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -172.82 166.6 39.26 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.23 -0.986 . . . . 0.60999999999999999 112.866 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.5 m -93.41 139.37 30.77 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.997 -0.372 . . . . 1.4299999999999999 109.997 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.432 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 6.0 p -100.52 115.63 30.56 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.258 0.551 . . . . 1.4199999999999999 110.39 177.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -114.6 119.78 37.94 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.911 -0.586 . . . . 2.52 109.696 -176.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.679 ' HG2' ' HB1' ' A' ' 13' ' ' ALA . 31.6 mt-10 -79.8 130.14 35.07 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.01 -0.541 . . . . 1.6599999999999999 110.568 -175.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.3 p -121.54 -174.86 2.95 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.854 -0.612 . . . . 1.29 111.43 -173.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -68.67 -29.3 67.74 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.961 0.41 . . . . 3.1600000000000001 110.904 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.6 t -85.85 -4.76 59.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.178 0.513 . . . . 1.8100000000000001 110.165 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 133.08 -83.12 0.3 Allowed Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 111.144 -0.782 . . . . 0.46999999999999997 111.144 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.412 ' CE1' ' HB3' ' A' ' 18' ' ' PRO . 46.3 p90 -156.62 153.48 28.63 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.072 0.463 . . . . 0.88 110.593 178.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 47.6 pt -125.7 165.19 23.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 108.764 -0.828 . . . . 1.3400000000000001 108.764 169.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.41 ' O ' HD12 ' A' ' 44' ' ' ILE . 62.6 m -121.38 131.25 54.07 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.225 0.536 . . . . 0.33000000000000002 110.443 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -107.73 98.07 7.71 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.302 -0.863 . . . . 5.1799999999999997 108.775 177.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 90.6 m -79.85 133.25 36.25 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.192 0.52 . . . . 0.27000000000000002 110.865 -176.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -64.9 143.99 57.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.17 -0.923 . . . . 0.97999999999999998 109.439 177.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -44.69 111.13 0.28 Allowed 'General case' 0 C--O 1.234 0.271 0 O-C-N 123.864 0.728 . . . . 3.5499999999999998 111.268 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.656 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 125.96 -20.49 6.35 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.375 -0.829 . . . . 0.93999999999999995 111.124 -174.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -112.91 162.43 15.84 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.126 -0.537 . . . . 1.1399999999999999 109.682 174.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -140.72 157.25 45.69 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.976 0.417 . . . . 3.46 110.882 -176.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 44' ' ' ILE . 21.1 mm -82.11 128.12 39.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.463 -0.789 . . . . 1.0900000000000001 111.223 -178.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.4 t -129.59 150.47 50.9 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.633 -0.712 . . . . 0.87 109.083 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.445 HD21 ' HA ' ' A' ' 52' ' ' VAL . 64.5 mt -115.53 124.17 50.37 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.033 -0.729 . . . . 1.5700000000000001 109.033 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.43 56.61 1.41 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.023 -0.535 . . . . 2.52 112.228 -175.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.75 -56.88 4.24 Favored Glycine 0 N--CA 1.453 -0.195 0 CA-C-N 116.225 -0.443 . . . . 1.4199999999999999 113.298 174.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.1 p -78.92 7.56 7.0 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.161 0.43 . . . . 1.79 112.161 -176.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.85 10.75 84.69 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.983 -0.627 . . . . 0.85999999999999999 112.552 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.417 ' O ' ' HA ' ' A' ' 46' ' ' LEU . 12.9 m120 -72.41 128.08 34.53 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.122 -0.696 . . . . 1.6799999999999999 109.122 176.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.445 ' HA ' HD21 ' A' ' 46' ' ' LEU . 31.5 t -79.69 111.49 16.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.024 -0.534 . . . . 1.2 110.631 -174.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.9 p -122.34 177.79 5.23 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.593 -0.521 . . . . 1.72 109.593 177.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.43 ' HB2' ' HB3' ' A' ' 19' ' ' CYS . 25.4 t -129.19 129.85 45.58 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.928 0.394 . . . . 0.31 110.051 -176.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 26.3 pt -131.59 164.94 33.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.081 -0.509 . . . . 1.1499999999999999 110.35 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.8 p -69.35 138.44 22.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.271 0.558 . . . . 1.3600000000000001 110.911 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.2 ttp180 -85.02 -53.81 5.05 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.076 -0.712 . . . . 5.4800000000000004 109.076 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -177.74 89.59 0.03 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.433 -0.803 . . . . 3.3199999999999998 110.33 173.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 60.13 23.7 12.98 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.216 0.821 . . . . 5.9900000000000002 113.216 173.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.656 ' HA ' ' HA3' ' A' ' 41' ' ' GLY . 23.1 t 68.53 161.09 0.19 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.256 0.551 . . . . 4.9100000000000001 111.515 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.928 0 CA-C-O 118.752 -1.027 . . . . 4.7400000000000002 111.772 -178.842 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.494 ' HA ' ' HB3' ' A' ' 11' ' ' PRO . 47.5 t . . . . . 0 N--CA 1.479 1.018 0 CA-C-O 120.747 0.308 . . . . 3.3700000000000001 110.404 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.654 ' NE2' ' HB2' ' A' ' 29' ' ' GLU . 44.0 mt-30 -139.44 179.14 6.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.273 -0.422 . . . . 7.2400000000000002 110.166 177.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.1 mt 69.53 167.26 0.28 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.838 0.827 . . . . 2.8199999999999998 112.195 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.0 m -109.9 30.21 6.91 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.079 -0.964 . . . . 3.8999999999999999 110.836 -176.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -142.12 -76.42 0.28 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.953 -0.758 . . . . 4.5899999999999999 108.953 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.453 ' C ' ' H ' ' A' ' 12' ' ' ALA . 8.9 p -137.65 146.94 55.26 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 108.546 -0.909 . . . . 3.0 108.546 173.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.735 ' HB2' ' HB3' ' A' ' 14' ' ' CYS . 44.4 Cg_endo -71.5 20.39 0.25 Allowed 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 122.558 2.172 . . . . 2.0299999999999998 113.32 -177.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.453 ' H ' ' C ' ' A' ' 10' ' ' THR . . . 48.73 -94.52 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.877 0.871 . . . . 1.5 112.879 175.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.519 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . . . -65.33 -27.46 68.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.272 -0.422 . . . . 1.3100000000000001 111.309 -177.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.735 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 33.4 t -95.87 -2.86 46.5 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.063 -0.517 . . . . 1.47 110.559 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.425 ' HA ' ' HG2' ' A' ' 11' ' ' PRO . 9.7 t -70.72 -9.6 57.61 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.89 0.376 . . . . 1.3799999999999999 111.504 -174.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.5 m -90.45 4.85 49.84 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.034 0.445 . . . . 2.2999999999999998 111.275 177.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.441 ' N ' ' HD3' ' A' ' 18' ' ' PRO . 4.1 m-20 54.14 59.94 11.4 Favored Pre-proline 0 N--CA 1.467 0.423 0 CA-C-N 115.219 -0.9 . . . . 2.3500000000000001 110.984 -174.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.441 ' HD3' ' N ' ' A' ' 17' ' ' ASN . 11.5 Cg_exo -70.22 -52.62 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.952 2.434 . . . . 0.91000000000000003 112.131 -174.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.523 ' SG ' ' HB3' ' A' ' 27' ' ' CYS . 1.8 m -82.3 -7.3 59.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.757 -0.656 . . . . 0.55000000000000004 110.754 -177.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.34 -144.83 17.42 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.779 -0.724 . . . . 0.70999999999999996 112.389 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.44 ' HD2' ' CB ' ' A' ' 24' ' ' ALA . 9.6 Cg_endo -88.64 175.04 3.89 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.377 2.718 . . . . 1.04 112.761 -177.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -53.04 -46.02 68.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.401 -0.363 . . . . 3.4199999999999999 111.193 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.1 -24.09 66.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.476 0.547 . . . . 1.23 112.476 -176.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.44 ' CB ' ' HD2' ' A' ' 21' ' ' PRO . . . -85.96 -65.85 0.97 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.751 0.31 . . . . 1.0700000000000001 110.853 -177.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -168.56 155.97 27.0 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 119.971 -1.109 . . . . 0.60999999999999999 112.901 -177.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.2 m -90.29 142.58 27.58 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.772 0.32 . . . . 1.4299999999999999 110.526 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.523 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 14.9 p -100.55 129.08 46.44 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.079 0.466 . . . . 1.4199999999999999 110.5 178.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.416 ' HB3' HG13 ' A' ' 35' ' ' ILE . 29.4 tptp -117.43 106.56 13.33 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.638 -0.71 . . . . 2.52 110.046 -178.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.654 ' HB2' ' NE2' ' A' ' 6' ' ' GLN . 57.4 mp0 -67.4 119.48 12.31 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.315 -0.624 . . . . 1.6599999999999999 109.315 176.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 48.1 p -102.13 -173.42 2.34 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.849 -0.614 . . . . 1.29 111.037 -174.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -71.41 -37.99 71.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.18 0.514 . . . . 3.1600000000000001 110.164 177.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.7 m -83.3 -28.17 29.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.76 -0.654 . . . . 1.8100000000000001 111.277 -177.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 174.3 -94.56 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.878 -0.677 . . . . 0.46999999999999997 111.658 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.553 ' OH ' ' HB2' ' A' ' 51' ' ' ASN . 38.1 p90 -156.1 154.21 30.57 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.628 0.252 . . . . 0.88 110.556 177.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.416 HG13 ' HB3' ' A' ' 28' ' ' LYS . 40.1 pt -129.38 165.99 28.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.876 -0.602 . . . . 1.3400000000000001 109.412 171.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.458 ' O ' HD12 ' A' ' 44' ' ' ILE . 55.9 m -121.49 131.45 54.16 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.261 -0.427 . . . . 0.33000000000000002 110.404 -179.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 -114.86 101.56 9.16 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.05 -0.523 . . . . 5.1799999999999997 109.811 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 42' ' ' TYR . 85.0 m -81.58 151.12 27.84 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.686 -0.688 . . . . 0.27000000000000002 111.375 -174.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -84.73 159.71 20.45 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.431 -0.804 . . . . 0.97999999999999998 109.325 175.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -51.19 122.68 8.07 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 120.991 0.424 . . . . 3.5499999999999998 111.276 -178.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 112.45 -16.22 24.39 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.601 -0.727 . . . . 0.93999999999999995 111.421 -175.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.466 ' HB2' ' HB3' ' A' ' 38' ' ' CYS . 89.6 m-85 -114.74 162.62 16.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.937 0.398 . . . . 1.1399999999999999 110.597 179.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.525 ' HG3' HG13 ' A' ' 55' ' ' ILE . 21.9 ptt180 -140.86 158.16 44.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.141 -0.481 . . . . 3.46 111.181 -174.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.458 HD12 ' O ' ' A' ' 36' ' ' CYS . 16.0 mm -84.41 132.39 31.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.785 -0.643 . . . . 1.0900000000000001 110.708 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.47 ' HB2' HG12 ' A' ' 55' ' ' ILE . 33.8 t -133.02 164.37 27.16 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.753 -0.658 . . . . 0.87 109.545 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 77.5 mt -124.1 121.8 36.15 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.295 -0.631 . . . . 1.5700000000000001 109.295 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.98 69.31 10.52 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.361 -0.382 . . . . 2.52 111.96 -176.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.44 -72.32 2.83 Favored Glycine 0 CA--C 1.517 0.216 0 CA-C-N 115.957 -0.565 . . . . 1.4199999999999999 113.472 173.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.8 p -73.42 -0.41 14.77 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.397 0.517 . . . . 1.79 112.397 -173.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.35 20.3 52.52 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.32 -0.943 . . . . 0.85999999999999999 111.657 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.553 ' HB2' ' OH ' ' A' ' 34' ' ' TYR . 9.5 p30 -81.76 135.91 35.45 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.116 -0.698 . . . . 1.6799999999999999 109.116 175.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 39.4 t -79.98 118.57 27.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.061 -0.518 . . . . 1.2 111.271 -172.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 81.1 p -128.01 172.44 10.93 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.082 -0.508 . . . . 1.72 110.619 177.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.462 ' HB3' ' O ' ' A' ' 19' ' ' CYS . 40.0 t -122.79 131.64 53.86 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.961 -0.563 . . . . 0.31 109.551 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.525 HG13 ' HG3' ' A' ' 43' ' ' ARG . 23.9 pt -134.59 164.56 33.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.974 -0.557 . . . . 1.1499999999999999 109.835 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.3 p -71.75 136.22 26.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.418 0.628 . . . . 1.3600000000000001 110.952 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -87.93 -65.14 1.05 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.13 -1.063 . . . . 5.4800000000000004 108.13 171.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 172.53 127.82 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.461 -1.245 . . . . 3.3199999999999998 108.383 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 65.66 -175.43 0.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 O-C-N 123.503 0.502 . . . . 5.9900000000000002 110.323 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 42.1 m -141.08 130.16 23.33 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.929 0.395 . . . . 4.9100000000000001 110.641 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.91 0 CA-C-O 118.713 -1.048 . . . . 4.7400000000000002 111.992 -179.323 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 52.9 t . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 109.99 -0.374 . . . . 2.8 109.99 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.437 ' HA ' ' HB3' ' A' ' 11' ' ' PRO . 29.4 tt0 -78.54 104.1 8.92 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.107 0.479 . . . . 6.69 110.527 -178.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.47 ' H ' ' HA ' ' A' ' 11' ' ' PRO . 86.8 mt -69.21 -65.27 0.73 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.459 -0.792 . . . . 2.82 111.017 -178.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.3 p -162.62 -72.05 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.482 -0.326 . . . . 3.77 110.928 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -88.04 -65.06 1.06 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.675 -0.491 . . . . 4.59 109.675 178.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.45 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 24.3 p -108.27 125.73 31.27 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-O 121.085 0.469 . . . . 2.42 109.994 172.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.47 ' HA ' ' H ' ' A' ' 7' ' ' LEU . 34.9 Cg_exo -62.91 -17.11 58.14 Favored 'Trans proline' 0 CA--C 1.528 0.196 0 C-N-CA 122.958 2.439 . . . . 1.69 112.818 178.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 68.09 123.78 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.778 0.674 . . . . 1.42 110.947 -176.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.516 ' HB1' ' HB3' ' A' ' 34' ' ' TYR . . . 69.57 -56.67 0.56 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.41 0.684 . . . . 0.64 110.866 -176.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.496 ' HA ' ' CD ' ' A' ' 18' ' ' PRO . 87.8 m -77.02 -0.34 24.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.072 0.463 . . . . 1.47 110.221 175.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.401 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 25.2 t -69.51 -18.55 63.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.887 -0.597 . . . . 1.36 111.185 -176.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.8 m -105.94 8.86 32.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.626 0.251 . . . . 1.64 111.544 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.5 m120 53.81 66.46 4.45 Favored Pre-proline 0 N--CA 1.467 0.41 0 CA-C-N 115.901 -0.59 . . . . 1.69 110.96 -173.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.496 ' CD ' ' HA ' ' A' ' 14' ' ' CYS . 11.1 Cg_endo -54.88 -53.05 6.62 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.822 2.348 . . . . 0.54 112.035 -177.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.593 ' SG ' ' HB3' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -91.21 18.9 6.38 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.941 -0.572 . . . . 0.55 110.876 -177.327 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.443 ' HA3' ' HD3' ' A' ' 21' ' ' PRO . . . 72.93 -128.2 11.84 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.838 -0.619 . . . . 0.69 111.867 -176.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.539 ' HD2' ' HB3' ' A' ' 24' ' ' ALA . 2.8 Cg_endo -87.05 169.88 7.34 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.462 2.774 . . . . 0.83 112.044 178.064 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -66.53 -35.45 80.27 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.048 0.452 . . . . 3.42 110.693 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.91 -28.98 70.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.83 -0.623 . . . . 0.65 110.869 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.539 ' HB3' ' HD2' ' A' ' 21' ' ' PRO . . . -78.54 -63.53 1.38 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.41 110.141 177.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -160.83 148.1 15.71 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.436 -0.887 . . . . 0.61 112.259 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.8 m -94.0 140.31 29.87 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.122 -0.325 . . . . 0.87 110.122 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.593 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 19.6 p -102.86 140.75 36.73 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.015 0.436 . . . . 1.42 110.939 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -130.59 125.27 33.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.787 -0.642 . . . . 1.92 109.997 176.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 3.0 mp0 -66.84 122.73 18.33 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.192 0.52 . . . . 1.66 110.326 176.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 49.3 p -122.76 -173.9 2.8 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.413 -0.812 . . . . 0.62 110.796 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -55.35 -41.38 72.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.968 0.413 . . . . 2.43 110.907 177.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.6 m -80.18 -5.18 55.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 1.44 111.439 -177.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 29' ' ' GLU . . . 126.89 -68.77 0.53 Allowed Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.37 -0.692 . . . . 0.37 111.37 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.516 ' HB3' ' HB1' ' A' ' 13' ' ' ALA . 54.5 p90 -155.55 156.6 35.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.832 0.348 . . . . 0.57 110.391 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.2 pt -129.58 164.98 30.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.81 -0.632 . . . . 0.64 109.462 170.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.9 m -123.4 128.8 50.36 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.171 0.51 . . . . 0.29 111.39 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -112.92 100.9 9.0 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.071 -0.715 . . . . 4.43 109.071 177.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 85.1 m -76.02 143.78 41.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.135 0.493 . . . . 0.27 110.981 -177.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -77.06 167.96 20.9 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.198 -0.91 . . . . 0.71 110.088 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -60.74 106.59 0.58 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.935 -0.575 . . . . 2.9 110.685 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 122.05 -5.59 10.36 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 121.01 -0.614 . . . . 0.48 111.714 -175.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -124.7 163.51 21.89 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 122.35 0.26 . . . . 0.54 110.59 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.495 ' HG3' HG13 ' A' ' 55' ' ' ILE . 24.5 ptt180 -144.37 158.71 43.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.932 0.396 . . . . 3.05 111.189 -174.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.435 HD13 ' HA ' ' A' ' 44' ' ' ILE . 15.1 mm -85.06 136.96 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.907 -0.588 . . . . 0.34 110.485 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 37.9 t -143.84 145.02 32.03 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.935 -0.575 . . . . 0.49 109.987 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.476 ' HB3' ' HA2' ' A' ' 50' ' ' GLY . 81.6 mt -95.08 112.99 24.64 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.466 -0.938 . . . . 0.95 108.466 172.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -85.66 75.49 10.1 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.949 0.404 . . . . 2.52 112.014 -170.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.53 -59.0 3.74 Favored Glycine 0 CA--C 1.518 0.253 0 CA-C-N 115.859 -0.609 . . . . 1.42 113.375 173.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.3 p -91.24 5.74 47.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.779 0.323 . . . . 1.27 111.793 -174.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.476 ' HA2' ' HB3' ' A' ' 46' ' ' LEU . . . 86.58 4.45 83.01 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.57 -0.824 . . . . 0.79 112.681 177.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -66.05 134.52 53.04 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.685 -0.487 . . . . 1.5 109.685 175.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.7 t -79.4 109.89 14.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.185 -0.672 . . . . 0.5 109.185 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 18' ' ' PRO . 12.7 t -128.3 169.67 13.95 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 116.009 -0.541 . . . . 1.05 109.825 -179.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 35.5 t -116.39 130.18 56.63 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.521 -0.548 . . . . 0.29 109.521 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.495 HG13 ' HG3' ' A' ' 43' ' ' ARG . 32.2 pt -127.52 166.72 23.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.954 -0.566 . . . . 0.47 109.503 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.4 p -73.13 136.64 25.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 121.233 0.539 . . . . 0.74 110.37 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -76.23 -33.48 59.21 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.227 -0.657 . . . . 4.7 109.227 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 . . . . . 0 C--N 1.327 -0.405 0 CA-C-N 114.648 -1.16 . . . . 3.32 108.473 174.523 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 27' ' ' CYS . 10.7 p . . . . . 0 N--CA 1.481 1.115 0 CA-C-O 121.806 0.812 . . . . 2.8 110.695 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.546 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 21.8 tp60 -78.8 -42.99 26.36 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.187 -0.671 . . . . 6.69 109.187 177.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.723 ' H ' HD23 ' A' ' 7' ' ' LEU . 1.3 pt? -106.33 164.26 12.17 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.664 -0.698 . . . . 2.82 109.628 172.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.8 m -99.06 -12.56 20.44 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.83 0.678 . . . . 3.77 112.83 -169.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -81.74 -92.49 0.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.875 -0.417 . . . . 4.59 109.875 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.3 p -122.18 113.37 31.13 Favored Pre-proline 0 CA--C 1.507 -0.708 0 N-CA-C 109.218 -0.66 . . . . 2.42 109.218 168.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.823 ' HB2' ' HB2' ' A' ' 14' ' ' CYS . 26.4 Cg_exo -62.62 101.48 0.26 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.523 2.149 . . . . 1.69 109.668 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.07 -34.97 46.13 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.611 0.597 . . . . 1.42 112.611 -170.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.907 ' HB3' ' HG2' ' A' ' 29' ' ' GLU . . . -84.22 -36.9 22.43 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.967 0.413 . . . . 0.64 110.931 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.823 ' HB2' ' HB2' ' A' ' 11' ' ' PRO . 33.5 m -83.09 -18.5 39.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.314 -0.403 . . . . 1.47 111.45 -176.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 34.5 t -68.41 -8.99 45.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.127 0.489 . . . . 1.36 109.81 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.0 m -88.81 -0.08 57.01 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.97 -0.559 . . . . 1.64 110.882 175.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 59.43 68.71 1.48 Allowed Pre-proline 0 N--CA 1.467 0.422 0 CA-C-N 115.107 -0.951 . . . . 1.69 111.852 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.46 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 3.5 Cg_exo -78.85 -75.08 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.91 2.407 . . . . 0.54 112.44 -177.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.45 24.05 0.28 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.469 -0.332 . . . . 0.55 111.81 -177.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.48 -123.14 15.98 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.118 -0.563 . . . . 0.69 111.837 -178.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -87.11 154.44 8.29 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.836 2.357 . . . . 0.83 111.494 175.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -70.02 -7.25 39.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.114 0.483 . . . . 3.42 110.364 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.84 -34.51 51.82 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.0 -0.545 . . . . 0.65 110.127 173.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.457 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . . . -71.86 -52.41 17.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.753 -0.658 . . . . 0.41 109.492 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.411 ' CA ' ' HA ' ' A' ' 38' ' ' CYS . . . -156.86 159.39 29.55 Favored Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 120.57 -0.824 . . . . 0.61 111.79 177.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.8 m -83.44 138.08 33.62 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.985 -0.746 . . . . 0.87 108.985 176.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.42 ' O ' HG12 ' A' ' 5' ' ' VAL . 41.7 t -98.7 112.94 24.85 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.394 0.616 . . . . 1.42 109.535 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.453 ' HB3' HG13 ' A' ' 35' ' ' ILE . 1.7 tmtp? -110.31 102.76 11.38 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.549 -0.75 . . . . 1.92 109.18 -175.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.907 ' HG2' ' HB3' ' A' ' 13' ' ' ALA . 28.6 mt-10 -73.7 122.66 22.69 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.705 -0.68 . . . . 1.66 110.401 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 35.8 p -102.42 -175.07 2.72 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.468 -0.787 . . . . 0.62 110.228 -177.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -74.61 -26.17 59.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.514 0.673 . . . . 2.43 109.296 176.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.6 m -84.56 -8.44 58.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.312 -0.858 . . . . 1.44 111.092 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 142.07 -93.41 0.18 Allowed Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.392 -0.683 . . . . 0.37 111.392 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.544 ' HB3' ' HB1' ' A' ' 13' ' ' ALA . 50.2 p90 -153.46 154.69 34.88 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.314 0.578 . . . . 0.57 111.178 177.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.453 HG13 ' HB3' ' A' ' 28' ' ' LYS . 44.7 pt -129.42 160.2 40.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 108.186 -1.042 . . . . 0.64 108.186 168.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 99.4 m -120.83 134.8 55.28 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.041 0.448 . . . . 0.29 110.743 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.586 ' NE ' ' HA ' ' A' ' 37' ' ' ARG . 1.5 tpm_? -117.13 99.98 7.41 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.74 -0.664 . . . . 4.43 109.358 177.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.505 ' HB3' ' HB2' ' A' ' 42' ' ' TYR . 81.1 m -73.47 141.66 46.83 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.049 0.452 . . . . 0.27 110.855 -176.147 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -73.88 168.67 18.97 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.86 -0.609 . . . . 0.71 109.763 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -59.0 118.7 6.11 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.989 0.424 . . . . 2.9 110.245 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 116.18 -14.26 16.14 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.715 -0.755 . . . . 0.48 112.017 -175.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.505 ' HB2' ' HB3' ' A' ' 38' ' ' CYS . 84.1 m-85 -120.59 162.8 19.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.654 0.264 . . . . 0.54 110.657 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -143.78 157.65 44.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.423 -0.353 . . . . 3.05 110.709 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.9 mm -77.27 136.04 25.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.014 -0.539 . . . . 0.34 111.282 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 36.3 t -138.48 152.62 48.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.509 -0.768 . . . . 0.49 109.333 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.493 HD13 ' HA2' ' A' ' 50' ' ' GLY . 75.9 mt -107.1 145.31 32.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.173 0.511 . . . . 0.95 109.869 175.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -65.86 -21.66 66.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.524 -0.762 . . . . 2.52 111.476 -176.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 127.81 -28.69 4.36 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 111.261 -0.735 . . . . 1.42 111.261 -176.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.5 p -100.5 -7.28 24.35 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.449 0.642 . . . . 1.27 109.951 176.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.493 ' HA2' HD13 ' A' ' 46' ' ' LEU . . . 109.78 13.75 15.56 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.438 -0.801 . . . . 0.79 113.09 172.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -76.34 133.9 39.85 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.477 -0.564 . . . . 1.5 109.477 174.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.1 t -79.61 111.71 16.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.047 0.451 . . . . 0.5 110.683 -175.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.4 p -121.38 177.04 5.35 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.81 -0.632 . . . . 1.05 110.085 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 45.4 t -133.98 130.7 38.02 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.037 0.446 . . . . 0.29 110.552 -176.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 32.9 pt -132.09 172.07 16.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.7 -0.682 . . . . 0.47 109.443 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.9 p -65.66 141.42 18.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.84 0.352 . . . . 0.74 110.243 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -76.49 -75.8 0.18 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.112 -0.699 . . . . 4.7 109.112 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 . . . . . 0 C--N 1.319 -0.719 0 N-CA-C 108.778 -0.823 . . . . 3.32 108.778 168.857 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.527 ' HA ' ' CB ' ' A' ' 11' ' ' PRO . 15.6 t . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 121.115 0.483 . . . . 2.8 110.434 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.49 ' HG2' ' CD ' ' A' ' 29' ' ' GLU . 54.4 mm-40 -97.68 -177.58 3.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.419 . . . . 6.69 109.978 176.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.6 mp 62.33 -177.64 0.13 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.634 0.584 . . . . 2.82 111.66 177.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.2 m -121.56 -3.86 9.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.162 -0.472 . . . . 3.77 111.517 -175.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -115.22 -69.32 0.86 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.954 -0.387 . . . . 4.59 109.954 174.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.52 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 18.8 p -126.54 128.71 24.28 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.363 -0.38 . . . . 2.42 110.609 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.527 ' CB ' ' HA ' ' A' ' 5' ' ' VAL . 58.9 Cg_endo -75.85 53.43 3.69 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 123.16 2.573 . . . . 1.69 114.15 -172.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.518 ' O ' ' HB3' ' A' ' 15' ' ' SER . . . 43.56 -93.04 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.318 1.229 . . . . 1.42 114.318 173.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.567 ' HB3' ' HG3' ' A' ' 29' ' ' GLU . . . -73.71 -35.14 65.09 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.105 0.478 . . . . 0.64 110.659 -177.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.416 ' HB2' ' HB2' ' A' ' 11' ' ' PRO . 68.5 m -84.9 3.3 38.72 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.711 -0.677 . . . . 1.47 110.117 178.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.52 ' OG ' ' HB ' ' A' ' 10' ' ' THR . 30.5 t -70.3 -15.35 62.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.657 -0.701 . . . . 1.36 111.218 -176.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.2 p -89.53 -0.26 57.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.924 0.393 . . . . 1.64 110.871 177.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.6 m120 58.93 63.9 3.54 Favored Pre-proline 0 N--CA 1.467 0.409 0 CA-C-N 115.064 -0.971 . . . . 1.69 111.43 -175.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.509 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 20.2 Cg_exo -65.26 -50.41 2.03 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.723 2.282 . . . . 0.54 111.782 -177.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.517 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 0.7 OUTLIER -87.44 8.01 26.64 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.861 -0.608 . . . . 0.55 110.252 -179.266 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.433 ' HA3' ' HD3' ' A' ' 21' ' ' PRO . . . 76.72 -122.95 6.47 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.743 -0.662 . . . . 0.69 112.783 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.433 ' HD3' ' HA3' ' A' ' 20' ' ' GLY . 4.5 Cg_endo -83.29 162.41 15.15 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.617 2.878 . . . . 0.83 112.554 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -67.61 -18.78 65.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.356 -0.838 . . . . 3.42 111.85 -177.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.51 -16.63 47.98 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.82 0.343 . . . . 0.65 111.111 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.43 -60.73 2.25 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.266 -0.424 . . . . 0.41 110.88 -177.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -161.14 164.56 34.94 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.009 -1.091 . . . . 0.61 113.224 -177.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.25 134.75 34.93 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.995 -0.372 . . . . 0.87 109.995 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.517 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 49.4 t -117.5 119.79 36.11 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.843 0.354 . . . . 1.42 110.905 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -118.48 126.24 51.6 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.786 -0.643 . . . . 1.92 110.246 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.567 ' HG3' ' HB3' ' A' ' 13' ' ' ALA . 49.4 mp0 -70.71 123.78 22.71 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.116 -0.493 . . . . 1.66 109.857 175.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 73.3 p -115.3 -174.72 2.56 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.244 -0.435 . . . . 0.62 110.763 -178.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -77.78 -26.37 49.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.299 0.571 . . . . 2.43 109.868 175.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.85 -25.86 60.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.709 -0.678 . . . . 1.44 109.588 175.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 147.93 -82.69 0.19 Allowed Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.525 -1.03 . . . . 0.37 110.525 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.447 ' HD2' ' HB1' ' A' ' 13' ' ' ALA . 28.0 p90 -154.83 163.64 39.98 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 110.111 -0.329 . . . . 0.57 110.111 175.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.1 pt -128.59 151.5 35.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 116.182 -0.463 . . . . 0.64 110.369 175.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.509 ' SG ' ' HB2' ' A' ' 18' ' ' PRO . 20.9 m -121.23 118.81 30.54 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.191 0.519 . . . . 0.29 110.306 178.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -108.78 100.55 9.76 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.514 -0.766 . . . . 4.43 110.075 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 98.6 m -75.72 139.65 42.01 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.078 0.466 . . . . 0.27 111.469 -175.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -84.54 175.99 8.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.55 -0.75 . . . . 0.71 110.486 177.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -54.77 119.31 5.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.052 -0.522 . . . . 2.9 110.765 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.82 2.22 46.07 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.577 -0.82 . . . . 0.48 112.327 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -127.79 162.16 27.28 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.145 -0.317 . . . . 0.54 110.145 177.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -145.96 154.47 41.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.858 0.361 . . . . 3.05 110.978 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.48 HD11 ' O ' ' A' ' 36' ' ' CYS . 20.9 mm -78.33 133.49 30.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.797 -0.638 . . . . 0.34 110.346 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.4 t -140.01 151.37 45.41 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.137 -0.69 . . . . 0.49 109.137 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.406 ' HB3' ' HA2' ' A' ' 50' ' ' GLY . 55.8 mt -102.85 145.35 29.92 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.519 -0.549 . . . . 0.95 109.519 173.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -84.43 -160.24 0.46 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.705 -0.68 . . . . 2.52 109.776 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -65.67 -28.07 73.26 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.647 -0.787 . . . . 1.42 112.938 177.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 82.6 p -90.76 -30.38 17.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 117.261 0.53 . . . . 1.27 111.407 -176.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.406 ' HA2' ' HB3' ' A' ' 46' ' ' LEU . . . 111.82 18.49 7.85 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.681 -0.771 . . . . 0.79 111.403 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 -74.73 141.97 44.41 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.401 -0.4 . . . . 1.5 109.961 177.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.9 t -78.3 110.84 14.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.103 0.477 . . . . 0.5 109.933 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.0 p -124.99 169.79 11.76 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.818 -0.628 . . . . 1.05 110.464 -177.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 25.2 t -121.81 129.93 53.01 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.084 -0.71 . . . . 0.29 109.084 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 33.9 pt -128.49 157.21 41.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.527 -0.306 . . . . 0.47 110.383 -177.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.91 123.85 22.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.422 0.629 . . . . 0.74 110.369 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -88.49 142.09 28.0 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.668 -0.696 . . . . 4.7 109.866 -177.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.019 -0.537 . . . . 3.32 111.083 178.097 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.634 HG22 ' HG3' ' A' ' 11' ' ' PRO . 11.8 t . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 121.162 0.506 . . . . 2.8 110.159 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.476 ' OE1' ' HB2' ' A' ' 29' ' ' GLU . 55.4 mt-30 -94.4 -10.77 31.48 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.267 0.469 . . . . 6.69 112.267 -178.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.407 HD11 ' HB2' ' A' ' 12' ' ' ALA . 62.1 mt -81.99 -87.53 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.674 -0.41 . . . . 2.82 110.935 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.7 m -147.11 -67.07 0.26 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.022 0.439 . . . . 3.77 110.05 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.432 ' HG3' HG23 ' A' ' 10' ' ' THR . 10.8 pt-20 -118.12 -30.05 5.42 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.205 -0.452 . . . . 4.59 110.126 177.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.5 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 37.8 p -100.35 132.03 23.12 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.054 -0.521 . . . . 2.42 110.686 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.963 ' HB2' ' HB2' ' A' ' 14' ' ' CYS . 4.1 Cg_exo -78.0 29.39 0.45 Allowed 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 123.489 2.793 . . . . 1.69 113.458 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.407 ' HB2' HD11 ' A' ' 7' ' ' LEU . . . 50.98 -99.72 0.08 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.879 0.696 . . . . 1.42 112.879 176.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . . . -66.66 -27.34 67.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.457 0.646 . . . . 0.64 110.334 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.963 ' HB2' ' HB2' ' A' ' 11' ' ' PRO . 69.0 m -93.85 3.35 55.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.4 -0.818 . . . . 1.47 110.78 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.756 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 20.7 t -69.96 -22.3 63.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.366 -0.379 . . . . 1.36 110.97 -176.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.6 m -89.09 7.1 36.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.492 -0.322 . . . . 1.64 111.357 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 54.03 72.59 1.08 Allowed Pre-proline 0 N--CA 1.466 0.369 0 CA-C-N 115.693 -0.685 . . . . 1.69 111.183 -176.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.417 ' HG2' ' SG ' ' A' ' 27' ' ' CYS . 14.4 Cg_exo -66.29 -42.22 10.78 Favored 'Trans proline' 0 CA--C 1.52 -0.213 0 C-N-CA 123.13 2.554 . . . . 0.54 111.803 -175.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.504 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -82.02 -3.11 53.82 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.542 -0.753 . . . . 0.55 110.337 -178.189 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.16 -137.59 13.52 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.433 -0.803 . . . . 0.69 111.324 -176.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.489 ' HD2' ' CB ' ' A' ' 24' ' ' ALA . 6.2 Cg_exo -77.72 171.34 17.57 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.593 2.195 . . . . 0.83 111.769 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.34 -39.53 94.79 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.905 0.383 . . . . 3.42 110.318 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.47 -23.62 66.01 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.512 -0.767 . . . . 0.65 111.397 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.489 ' CB ' ' HD2' ' A' ' 21' ' ' PRO . . . -81.36 -56.57 3.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.908 0.385 . . . . 0.41 110.363 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -171.39 161.1 33.46 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.619 -0.801 . . . . 0.61 111.965 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.6 m -102.33 140.74 36.21 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.548 -0.538 . . . . 0.87 109.548 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.504 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 38.2 t -105.35 143.28 33.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.189 0.518 . . . . 1.42 110.752 -177.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.761 ' HA ' ' HE2' ' A' ' 28' ' ' LYS . 0.5 OUTLIER -131.88 122.07 25.08 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.725 -0.67 . . . . 1.92 110.139 -177.917 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.476 ' HB2' ' OE1' ' A' ' 6' ' ' GLN . 5.0 mp0 -66.99 125.79 27.09 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.356 -0.609 . . . . 1.66 109.356 175.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 31.8 p -106.98 173.71 6.2 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.851 -0.613 . . . . 0.62 110.494 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -79.82 46.83 0.81 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 122.027 0.918 . . . . 2.43 109.974 175.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.5 t -162.9 -41.43 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.816 -1.083 . . . . 1.44 108.325 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -179.52 -100.08 0.13 Allowed Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.298 -0.864 . . . . 0.37 111.276 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.422 ' HB3' ' HB3' ' A' ' 13' ' ' ALA . 36.9 p90 -148.93 151.23 34.27 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.748 -0.464 . . . . 0.57 109.748 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.8 pt -129.87 161.88 38.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.936 -0.394 . . . . 0.64 109.936 172.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 33.3 m -121.22 130.95 53.95 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.239 -0.437 . . . . 0.29 110.821 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.403 ' HD2' ' HA ' ' A' ' 37' ' ' ARG . 27.0 tpt180 -111.02 101.52 10.07 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.946 -0.761 . . . . 4.43 108.946 175.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 42' ' ' TYR . 88.9 m -73.56 145.31 45.6 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.911 -0.586 . . . . 0.27 110.876 -177.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -77.69 170.88 15.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.537 -0.756 . . . . 0.71 109.772 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -66.2 103.23 0.95 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.049 0.452 . . . . 2.9 110.335 -178.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 128.6 -1.03 6.41 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.529 -0.76 . . . . 0.48 111.456 -175.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.53 ' HB2' ' HB3' ' A' ' 38' ' ' CYS . 80.2 m-85 -130.23 162.44 28.94 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.673 -0.491 . . . . 0.54 109.673 177.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.811 ' HG2' ' HB2' ' A' ' 57' ' ' ARG . 2.7 ptp180 -143.55 161.47 38.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.612 0.244 . . . . 3.05 110.72 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 44' ' ' ILE . 12.5 mm -81.3 140.03 17.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 121.059 0.457 . . . . 0.34 111.38 -176.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.4 t -147.12 154.68 41.41 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.693 -0.685 . . . . 0.49 109.36 177.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.404 HD13 ' HA2' ' A' ' 50' ' ' GLY . 80.9 mt -96.79 145.99 25.32 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.435 -0.58 . . . . 0.95 109.435 174.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -64.79 -15.04 61.15 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.546 -0.752 . . . . 2.52 111.901 -177.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.49 -30.26 4.76 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.353 -0.699 . . . . 1.42 111.353 -176.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.5 p -102.84 -24.43 13.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.103 0.478 . . . . 1.27 110.219 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.404 ' HA2' HD13 ' A' ' 46' ' ' LEU . . . 131.04 20.85 1.13 Allowed Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.543 -0.753 . . . . 0.79 112.897 174.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -83.82 133.08 34.77 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.618 -0.512 . . . . 1.5 109.618 174.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.6 t -80.02 111.8 17.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.023 0.439 . . . . 0.5 110.333 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.7 t -127.45 173.85 9.49 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.909 -0.587 . . . . 1.05 109.582 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.501 ' HB3' ' O ' ' A' ' 19' ' ' CYS . 48.5 t -122.83 131.19 53.65 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.555 -0.535 . . . . 0.29 109.555 -176.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 20.9 pt -123.54 142.15 41.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.14 0.495 . . . . 0.47 110.945 -176.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.1 p -66.55 126.77 26.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.424 -0.807 . . . . 0.74 110.514 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.811 ' HB2' ' HG2' ' A' ' 43' ' ' ARG . 4.2 tpm_? -123.34 131.89 53.81 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.979 -0.748 . . . . 4.7 108.979 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 . . . . . 0 C--O 1.239 0.5 0 CA-C-O 121.062 0.458 . . . . 3.32 111.265 -176.137 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.445 HG13 ' SG ' ' A' ' 27' ' ' CYS . 16.9 m . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.933 0.397 . . . . 2.8 111.436 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -90.88 -32.85 15.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.955 0.407 . . . . 6.69 110.34 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.575 HD12 ' HA ' ' A' ' 11' ' ' PRO . 95.7 mt -85.67 -175.57 5.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.989 -0.551 . . . . 2.82 110.939 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.4 t -69.51 -72.52 0.19 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.394 -0.366 . . . . 3.77 111.804 -173.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.415 ' HB2' ' H ' ' A' ' 10' ' ' THR . 13.0 mm-40 -98.92 -88.92 0.32 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.095 0.474 . . . . 4.59 110.759 -171.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.52 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 0.7 OUTLIER -102.47 108.1 56.23 Favored Pre-proline 0 N--CA 1.446 -0.642 0 CA-C-N 115.754 -0.657 . . . . 2.42 109.499 175.118 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.575 ' HA ' HD12 ' A' ' 7' ' ' LEU . 0.9 OUTLIER -81.9 64.8 8.51 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.581 2.854 . . . . 1.69 113.568 -169.869 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.444 ' O ' ' HB3' ' A' ' 15' ' ' SER . . . 43.65 -87.44 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 O-C-N 124.339 1.024 . . . . 1.42 113.712 174.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.449 ' HB1' ' CD1' ' A' ' 34' ' ' TYR . . . -62.55 -41.59 98.99 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.301 -0.409 . . . . 0.64 111.532 -177.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.598 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 52.5 t -85.37 -3.15 58.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.143 0.497 . . . . 1.47 110.774 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.444 ' HB3' ' O ' ' A' ' 12' ' ' ALA . 36.6 t -65.59 -17.52 64.64 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.283 -0.417 . . . . 1.36 111.463 -177.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 36.5 m -108.1 14.89 24.74 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.925 0.393 . . . . 1.64 111.49 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 55.95 73.29 0.86 Allowed Pre-proline 0 N--CA 1.47 0.544 0 CA-C-N 115.313 -0.858 . . . . 1.69 112.283 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.598 ' HD3' ' HA ' ' A' ' 14' ' ' CYS . 24.6 Cg_endo -62.19 -43.56 23.28 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.829 2.353 . . . . 0.54 112.191 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 2.6 m -90.56 17.9 6.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.266 -0.425 . . . . 0.55 111.109 -176.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.463 ' HA3' ' HD3' ' A' ' 21' ' ' PRO . . . 70.98 -123.74 10.95 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 116.102 -0.499 . . . . 0.69 112.553 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.463 ' HD3' ' HA3' ' A' ' 20' ' ' GLY . 1.6 Cg_endo -78.76 157.87 27.92 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 123.287 2.658 . . . . 0.83 112.063 178.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -67.42 -27.9 67.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.664 -0.698 . . . . 3.42 110.565 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.04 -15.04 61.09 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.61 -0.723 . . . . 0.65 111.288 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.91 -52.37 6.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.341 -0.39 . . . . 0.41 110.351 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -169.76 174.31 43.99 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.3 -0.952 . . . . 0.61 113.083 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.5 m -101.38 140.89 35.06 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 122.46 0.304 . . . . 0.87 110.86 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.445 ' SG ' HG13 ' A' ' 5' ' ' VAL . 27.9 p -102.55 130.09 49.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.899 0.381 . . . . 1.42 110.517 177.006 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -124.5 117.06 23.54 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.203 -0.666 . . . . 1.92 109.203 176.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -71.95 119.1 15.65 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.192 0.52 . . . . 1.66 109.973 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.9 p -112.17 -175.68 2.74 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.876 -0.602 . . . . 0.62 110.683 -176.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -68.19 -24.01 64.9 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.395 0.617 . . . . 2.43 109.728 174.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.9 m -78.77 -19.32 52.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.614 -0.721 . . . . 1.44 110.038 177.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 133.2 -71.77 0.49 Allowed Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.985 -0.846 . . . . 0.37 110.985 -177.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.449 ' CD1' ' HB1' ' A' ' 13' ' ' ALA . 50.2 p90 -155.98 158.93 38.71 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.306 -0.257 . . . . 0.57 110.306 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.2 pt -131.74 157.07 43.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.272 -0.64 . . . . 0.64 109.272 170.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.0 m -121.06 119.22 31.84 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.634 0.73 . . . . 0.29 111.06 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -105.72 99.46 9.06 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.992 -1.003 . . . . 4.43 109.975 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 77.8 m -77.88 146.2 35.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.979 0.418 . . . . 0.27 110.845 -176.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -84.06 179.02 7.61 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.833 -0.622 . . . . 0.71 109.996 176.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -58.77 132.44 53.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.674 0.273 . . . . 2.9 110.544 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.85 5.65 80.84 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.477 -0.868 . . . . 0.48 112.398 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -125.54 154.5 42.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.025 0.441 . . . . 0.54 110.624 177.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.549 ' HG3' HG13 ' A' ' 55' ' ' ILE . 24.7 ptt180 -140.43 160.85 39.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.779 -0.646 . . . . 3.05 111.172 -171.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.405 ' HA ' HD13 ' A' ' 44' ' ' ILE . 20.4 mm -87.51 134.36 27.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.798 -0.637 . . . . 0.34 110.65 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.0 t -143.53 173.54 11.55 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.442 -0.799 . . . . 0.49 109.217 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.409 ' HA ' ' O ' ' A' ' 51' ' ' ASN . 78.8 mt -107.69 145.02 33.97 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.247 0.546 . . . . 0.95 109.998 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -61.85 -23.91 66.57 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.027 -0.988 . . . . 2.52 111.509 -177.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 133.61 -22.56 3.89 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 111.223 -0.751 . . . . 1.42 111.223 -175.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 37.4 p -111.71 -27.09 8.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.042 0.449 . . . . 1.27 110.393 177.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 133.57 24.02 0.7 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.766 -0.73 . . . . 0.79 112.901 175.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.409 ' O ' ' HA ' ' A' ' 46' ' ' LEU . 20.7 m120 -87.26 145.9 26.18 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.417 -0.586 . . . . 1.5 109.417 174.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.1 t -79.4 111.16 15.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.953 0.406 . . . . 0.5 110.087 -176.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 18' ' ' PRO . 65.7 p -124.78 169.13 12.31 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.989 -0.55 . . . . 1.05 110.472 -178.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 34.0 t -121.81 131.23 53.95 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.023 -0.535 . . . . 0.29 109.656 -178.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.549 HG13 ' HG3' ' A' ' 43' ' ' ARG . 34.5 pt -131.73 167.13 27.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.249 -0.432 . . . . 0.47 110.115 -177.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.9 p -76.91 137.35 22.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.474 0.654 . . . . 0.74 111.28 -175.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.446 ' HD3' ' HD3' ' A' ' 43' ' ' ARG . 19.1 tpt180 -101.14 106.72 17.99 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.17 -1.048 . . . . 4.7 108.17 173.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.469 0.489 0 N-CA-C 112.209 0.448 . . . . 3.32 112.209 -171.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.478 0.934 0 CA-C-O 122.146 0.974 . . . . 2.8 109.93 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -81.65 -38.49 25.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.822 -0.626 . . . . 6.69 110.718 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.662 ' HB2' ' HA ' ' A' ' 11' ' ' PRO . 85.3 mt -88.11 155.18 19.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.182 -0.463 . . . . 2.82 110.039 178.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.3 t -85.68 -33.67 21.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.445 -0.798 . . . . 3.77 111.823 -167.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -93.71 -79.7 0.4 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.316 -0.624 . . . . 4.59 109.316 177.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.5 p -124.04 129.61 24.69 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 115.849 -0.614 . . . . 2.42 109.905 172.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.662 ' HA ' ' HB2' ' A' ' 7' ' ' LEU . 62.6 Cg_endo -76.78 -163.05 0.18 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.604 2.203 . . . . 1.69 111.84 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -103.89 -65.43 1.02 Allowed 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.469 -0.492 . . . . 1.42 110.23 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.756 ' HB3' ' HG2' ' A' ' 29' ' ' GLU . . . -71.78 -48.22 48.1 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.122 -0.49 . . . . 0.64 110.59 -177.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.52 ' HB2' ' CG ' ' A' ' 11' ' ' PRO . 65.7 m -66.63 -23.16 66.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.366 -0.379 . . . . 1.47 111.048 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.7 t -67.94 -28.11 67.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.022 0.439 . . . . 1.36 110.402 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.0 t -82.72 -0.89 49.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.262 0.553 . . . . 1.64 110.291 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 62.29 73.04 0.57 Allowed Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 115.056 -0.975 . . . . 1.69 111.146 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.534 ' O ' ' HA ' ' A' ' 53' ' ' THR . 5.7 Cg_exo -74.69 -64.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.499 2.133 . . . . 0.54 111.162 -177.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -84.13 27.36 0.68 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.851 -0.613 . . . . 0.55 110.869 -178.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.94 -125.5 22.24 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.142 -0.551 . . . . 0.69 112.071 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.562 ' HG2' ' HB2' ' A' ' 24' ' ' ALA . 90.6 Cg_endo -78.51 156.78 28.65 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.778 2.319 . . . . 0.83 112.379 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -68.43 -11.95 60.45 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.249 -0.887 . . . . 3.42 110.39 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.81 -14.5 34.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.698 -0.683 . . . . 0.65 111.526 177.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.562 ' HB2' ' HG2' ' A' ' 21' ' ' PRO . . . -78.27 -35.89 47.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.412 0.625 . . . . 0.41 110.453 -177.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -177.92 -171.73 41.63 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.632 -0.794 . . . . 0.61 112.093 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.9 m -92.12 134.1 35.16 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 110.083 -0.34 . . . . 0.87 110.083 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.44 ' SG ' ' HG2' ' A' ' 18' ' ' PRO . 43.0 t -106.1 112.67 25.81 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.375 -0.602 . . . . 1.42 109.375 177.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.459 ' HB3' ' CG1' ' A' ' 35' ' ' ILE . 17.8 tppt? -116.05 107.66 15.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.122 -0.49 . . . . 1.92 110.108 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.756 ' HG2' ' HB3' ' A' ' 13' ' ' ALA . 36.2 mt-10 -74.38 118.74 17.68 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.073 -0.512 . . . . 1.66 109.973 178.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 70.9 p -109.98 -175.11 2.65 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.775 -0.648 . . . . 0.62 110.372 -175.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -76.1 -17.61 59.54 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.319 0.581 . . . . 2.43 109.755 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.8 t -88.94 -1.2 57.99 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.664 -0.698 . . . . 1.44 109.937 175.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 124.52 -79.89 0.36 Allowed Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 111.064 -0.814 . . . . 0.37 111.064 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.469 ' HB3' ' CB ' ' A' ' 13' ' ' ALA . 54.8 p90 -156.2 154.46 30.82 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.149 -0.315 . . . . 0.57 110.149 178.067 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.459 ' CG1' ' HB3' ' A' ' 28' ' ' LYS . 44.2 pt -122.68 148.92 26.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 108.794 -0.817 . . . . 0.64 108.794 166.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.413 ' SG ' ' HB2' ' A' ' 18' ' ' PRO . 50.3 m -120.63 123.03 41.81 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.279 0.561 . . . . 0.29 110.791 -177.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 48.6 ttp85 -116.08 100.73 8.16 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.354 -0.839 . . . . 4.43 109.885 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 81.8 m -77.39 155.13 32.08 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.256 0.551 . . . . 0.27 111.86 -175.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -79.07 -179.63 6.8 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.061 -0.972 . . . . 0.71 109.684 174.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -64.42 -39.15 93.28 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.981 0.419 . . . . 2.9 111.588 -172.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.29 6.79 59.27 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.545 -0.836 . . . . 0.48 112.743 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.478 ' HB3' ' SG ' ' A' ' 54' ' ' CYS . 96.1 m-85 -128.78 161.43 29.77 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 122.583 -0.363 . . . . 0.54 110.938 -176.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -142.73 162.43 35.49 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.883 0.373 . . . . 3.05 110.639 -176.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.0 mm -84.91 128.94 38.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.898 -0.592 . . . . 0.34 110.891 -178.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.7 t -133.98 151.98 51.67 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.322 -0.854 . . . . 0.49 109.235 178.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 86.5 mt -101.82 142.54 32.97 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.122 0.487 . . . . 0.95 109.786 176.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -64.35 -22.02 66.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.312 -0.858 . . . . 2.52 111.959 -174.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 129.38 -23.62 4.82 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.904 -0.665 . . . . 1.42 111.508 -175.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.6 p -106.55 -25.5 11.79 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.005 0.431 . . . . 1.27 109.85 175.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 131.47 15.56 1.6 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.928 -0.654 . . . . 0.79 112.952 174.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -74.53 134.53 42.2 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.446 -0.576 . . . . 1.5 109.446 174.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.8 t -79.71 110.27 15.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.668 -0.493 . . . . 0.5 109.668 -178.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 18' ' ' PRO . 65.9 p -121.4 171.13 8.99 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.962 -0.563 . . . . 1.05 109.846 -178.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.478 ' SG ' ' HB3' ' A' ' 42' ' ' TYR . 15.6 t -126.72 130.68 50.82 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.328 -0.396 . . . . 0.29 110.046 -176.243 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 41.2 pt -133.68 165.32 32.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.06 -0.518 . . . . 0.47 109.937 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.0 p -65.11 127.83 26.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.336 0.588 . . . . 0.74 110.726 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 57' ' ' ARG . 13.2 ttm180 -82.64 -40.82 20.22 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.498 -0.774 . . . . 4.7 110.249 -178.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 . . . . . 0 C--N 1.324 -0.515 0 CA-C-N 115.419 -0.81 . . . . 3.32 109.631 -178.371 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.659 HG13 ' H ' ' A' ' 6' ' ' GLN . 2.8 p . . . . . 0 N--CA 1.474 0.745 0 CA-C-O 119.491 -0.29 . . . . 2.8 111.077 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.659 ' H ' HG13 ' A' ' 5' ' ' VAL . 25.0 tp60 -177.59 -48.07 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.952 0.406 . . . . 6.69 110.148 -176.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.4 mt 69.88 -95.69 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.297 -0.865 . . . . 2.82 112.021 173.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.3 m -154.51 -82.05 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.493 0.187 . . . . 3.77 110.893 -176.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -67.68 -64.68 0.81 Allowed 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.52 -0.548 . . . . 4.59 109.52 177.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.6 p -141.35 143.41 30.2 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 115.449 -0.796 . . . . 2.42 109.85 176.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.467 ' HB2' ' HB2' ' A' ' 14' ' ' CYS . 48.8 Cg_endo -75.33 90.43 1.11 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 121.599 1.533 . . . . 1.69 109.098 171.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -46.97 -33.01 4.27 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.591 0.96 . . . . 1.42 113.591 -166.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.86 ' HB3' ' HG2' ' A' ' 29' ' ' GLU . . . -94.95 -29.89 14.42 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.218 0.451 . . . . 0.64 112.218 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.467 ' HB2' ' HB2' ' A' ' 11' ' ' PRO . 35.7 m -97.1 2.55 51.38 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 122.039 -0.413 . . . . 1.47 111.164 -178.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.5 t -66.31 -17.88 65.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.09 -0.504 . . . . 1.36 111.25 -173.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.7 m -97.47 4.19 50.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.605 -0.27 . . . . 1.64 111.543 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 57.5 76.37 0.48 Allowed Pre-proline 0 N--CA 1.469 0.525 0 CA-C-N 115.616 -0.72 . . . . 1.69 111.394 -175.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -73.23 -73.02 0.01 OUTLIER 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 122.902 2.401 . . . . 0.54 112.784 -177.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -71.1 -28.39 64.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.191 0.519 . . . . 0.55 111.158 -176.003 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.412 ' HA3' ' HD3' ' A' ' 21' ' ' PRO . . . 105.67 -122.86 7.32 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.611 -0.722 . . . . 0.69 112.312 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.506 ' HD2' ' HB3' ' A' ' 24' ' ' ALA . 10.2 Cg_endo -86.3 156.12 9.51 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.302 2.668 . . . . 0.83 112.49 -177.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -62.62 -23.29 66.98 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 114.984 -1.007 . . . . 3.42 111.003 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.12 -34.58 76.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.288 -0.415 . . . . 0.65 110.8 175.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.506 ' HB3' ' HD2' ' A' ' 21' ' ' PRO . . . -83.74 -57.89 3.03 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.032 -0.531 . . . . 0.41 110.578 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -168.39 143.61 8.24 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.276 -0.964 . . . . 0.61 112.452 -177.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.8 m -83.73 145.02 28.96 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.201 -0.296 . . . . 0.87 110.201 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 53.4 t -100.24 113.53 26.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.202 0.525 . . . . 1.42 110.304 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -109.99 114.35 27.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.658 -0.701 . . . . 1.92 109.902 -176.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.86 ' HG2' ' HB3' ' A' ' 13' ' ' ALA . 45.5 mt-10 -78.2 119.71 21.97 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.114 0.483 . . . . 1.66 110.143 -177.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 78.7 p -119.01 -173.31 2.47 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.417 -0.81 . . . . 0.62 110.946 -173.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -64.51 -32.71 74.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.014 0.435 . . . . 2.43 110.176 175.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.0 m -73.93 -2.67 24.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.946 -0.57 . . . . 1.44 110.437 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.06 -74.94 0.24 Allowed Glycine 0 N--CA 1.44 -1.058 0 N-CA-C 110.496 -1.042 . . . . 0.37 110.496 -177.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.715 ' HB3' ' HB1' ' A' ' 13' ' ' ALA . 51.9 p90 -153.45 151.45 29.88 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.068 0.461 . . . . 0.57 110.174 176.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 47.2 pt -128.5 162.07 35.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 108.384 -0.969 . . . . 0.64 108.384 169.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.414 ' HB2' ' CD1' ' A' ' 44' ' ' ILE . 68.3 m -120.85 129.85 53.7 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.153 0.501 . . . . 0.29 110.319 -178.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.792 ' HA ' ' HE ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -105.93 99.97 9.54 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.885 -0.598 . . . . 4.43 109.627 178.674 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.463 ' HB3' ' HB2' ' A' ' 42' ' ' TYR . 84.3 m -83.86 133.8 34.72 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.694 -0.684 . . . . 0.27 110.932 -176.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -68.88 151.69 46.24 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.995 -1.002 . . . . 0.71 109.038 175.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -59.46 120.53 9.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.479 0.657 . . . . 2.9 110.678 -176.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.25 -8.14 14.09 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 110.513 -1.035 . . . . 0.48 110.513 -171.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.463 ' HB2' ' HB3' ' A' ' 38' ' ' CYS . 71.6 m-85 -128.02 162.8 25.96 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.915 -0.772 . . . . 0.54 108.915 176.128 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.803 ' HG2' ' HB2' ' A' ' 57' ' ' ARG . 9.2 ptp180 -152.39 165.15 35.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.075 0.464 . . . . 3.05 111.587 174.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.414 ' CD1' ' HB2' ' A' ' 36' ' ' CYS . 38.3 mm -70.29 137.64 23.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.207 -0.906 . . . . 0.34 110.895 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.44 ' HB2' HG12 ' A' ' 55' ' ' ILE . 23.0 t -145.72 165.75 27.87 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.985 -0.746 . . . . 0.49 108.985 178.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 87.8 mt -104.72 138.03 41.64 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.671 -0.492 . . . . 0.95 109.671 178.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -60.6 -24.18 65.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.068 -0.969 . . . . 2.52 111.911 -174.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 131.76 -26.5 3.82 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 111.015 -0.834 . . . . 1.42 111.015 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.2 p -100.57 -30.38 11.81 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.707 -0.479 . . . . 1.27 109.707 175.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 131.77 22.55 0.93 Allowed Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.597 -0.729 . . . . 0.79 112.447 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -85.41 142.83 28.99 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.662 -0.496 . . . . 1.5 109.662 176.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.7 t -79.71 110.81 15.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.187 0.518 . . . . 0.5 110.138 -176.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.1 p -125.6 171.67 10.37 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.924 -0.58 . . . . 1.05 110.188 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 44.3 t -124.65 129.94 51.48 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.498 -0.556 . . . . 0.29 109.498 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.44 HG12 ' HB2' ' A' ' 45' ' ' SER . 26.0 pt -131.27 148.02 32.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.03 0.443 . . . . 0.47 110.723 -176.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.449 ' HA ' ' CD2' ' A' ' 42' ' ' TYR . 7.6 p -62.48 123.92 16.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.635 -0.711 . . . . 0.74 110.442 177.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.803 ' HB2' ' HG2' ' A' ' 43' ' ' ARG . 21.5 tpt180 -125.59 114.11 18.3 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.263 -0.426 . . . . 4.7 110.536 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 . . . . . 0 C--N 1.326 -0.452 0 CA-C-N 115.739 -0.664 . . . . 3.32 111.182 178.812 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.0 t . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 120.928 0.394 . . . . 2.8 110.422 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.622 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 60.9 tt0 -72.03 132.8 44.76 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.094 -0.503 . . . . 6.69 110.513 176.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.403 ' H ' HD23 ' A' ' 7' ' ' LEU . 2.5 pt? -137.19 9.78 2.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.054 -0.521 . . . . 2.82 110.153 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.7 p -169.55 -174.94 2.02 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.681 -0.691 . . . . 3.77 110.265 -172.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -45.17 -56.93 4.29 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.41 0.624 . . . . 4.59 110.285 175.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.0 p -97.72 128.15 35.17 Favored Pre-proline 0 N--CA 1.441 -0.91 0 CA-C-N 115.268 -0.878 . . . . 2.42 109.796 173.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.622 ' HA ' ' HA ' ' A' ' 6' ' ' GLN . 51.1 Cg_exo -57.95 -19.08 38.3 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.05 2.5 . . . . 1.69 112.759 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.673 ' H ' ' HB3' ' A' ' 15' ' ' SER . . . 66.9 121.19 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.89 0.744 . . . . 1.42 111.602 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.59 ' HB1' ' CD1' ' A' ' 34' ' ' TYR . . . 70.68 -58.37 0.56 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.655 -0.702 . . . . 0.64 110.978 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.9 t -83.18 7.62 15.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.755 0.788 . . . . 1.47 109.447 174.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.673 ' HB3' ' H ' ' A' ' 12' ' ' ALA . 6.3 p -70.15 -25.24 63.37 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.299 -0.864 . . . . 1.36 112.317 -175.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.9 t -93.6 11.37 29.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.975 0.417 . . . . 1.64 110.745 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 55.71 63.57 6.14 Favored Pre-proline 0 N--CA 1.468 0.451 0 CA-C-N 115.396 -0.82 . . . . 1.69 111.041 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.532 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 23.6 Cg_exo -63.95 -56.01 0.55 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.994 2.463 . . . . 0.54 112.512 -174.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.476 ' SG ' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -96.56 7.61 46.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.91 -0.587 . . . . 0.55 111.212 -178.692 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.417 ' HA3' ' HD3' ' A' ' 21' ' ' PRO . . . 73.22 -130.5 13.76 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.009 -0.615 . . . . 0.69 112.789 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 24' ' ' ALA . 10.6 Cg_endo -91.24 170.89 3.14 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 123.709 2.94 . . . . 0.83 112.555 -178.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -63.75 -21.0 66.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.633 -0.712 . . . . 3.42 110.588 176.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.58 -32.78 74.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.941 0.4 . . . . 0.65 110.56 175.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.509 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . . . -94.61 -63.61 1.16 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.96 -0.564 . . . . 0.41 110.952 -177.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -162.25 142.05 7.67 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.69 -0.767 . . . . 0.61 112.277 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.2 m -84.38 141.18 31.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.786 0.327 . . . . 0.87 110.215 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.476 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 6.9 p -100.17 129.35 46.18 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.215 -0.448 . . . . 1.42 110.068 177.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -128.31 111.48 13.42 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.399 -0.593 . . . . 1.92 109.399 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.45 ' HG3' ' HB3' ' A' ' 13' ' ' ALA . 2.9 mp0 -68.33 119.71 13.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.127 0.489 . . . . 1.66 110.93 -178.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 60.7 p -102.66 -175.69 2.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.581 -0.736 . . . . 0.62 110.403 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -64.78 -44.84 88.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.693 0.283 . . . . 2.43 110.258 175.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.5 m -62.75 -41.09 99.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.091 0.472 . . . . 1.44 110.667 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 172.64 -82.19 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.81 -0.709 . . . . 0.37 111.657 177.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.59 ' CD1' ' HB1' ' A' ' 13' ' ' ALA . 42.4 p90 -155.5 156.01 34.45 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.91 0.385 . . . . 0.57 110.886 176.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 46.3 pt -125.06 159.69 31.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.716 -0.675 . . . . 0.64 109.485 172.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.532 ' SG ' ' HB2' ' A' ' 18' ' ' PRO . 36.4 m -123.57 121.1 34.75 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.108 0.48 . . . . 0.29 110.539 178.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -101.92 100.18 10.45 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.048 -0.723 . . . . 4.43 109.048 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 75.1 m -80.72 136.63 36.2 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.967 -0.56 . . . . 0.27 111.108 -175.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -71.83 155.07 40.83 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.254 -0.885 . . . . 0.71 109.327 175.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -60.49 121.2 11.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.154 0.502 . . . . 2.9 110.105 -178.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.48 -10.42 11.53 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.721 -0.952 . . . . 0.48 110.721 -170.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.509 ' CE2' ' HA ' ' A' ' 24' ' ' ALA . 92.9 m-85 -123.91 162.62 22.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.96 -0.62 . . . . 0.54 110.099 176.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.476 ' HG3' HG13 ' A' ' 55' ' ' ILE . 31.6 ptt180 -139.04 156.51 47.14 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.906 0.384 . . . . 3.05 110.665 -177.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.437 HD13 ' HA ' ' A' ' 44' ' ' ILE . 14.1 mm -83.08 130.31 35.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.949 -0.569 . . . . 0.34 110.705 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 44.1 t -132.21 155.99 47.25 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.579 -0.737 . . . . 0.49 109.809 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 84.3 mt -105.34 136.84 44.14 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.331 -0.618 . . . . 0.95 109.331 175.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -59.22 -28.13 66.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.059 -0.973 . . . . 2.52 111.832 -176.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 137.07 -34.69 2.17 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.804 -0.918 . . . . 1.42 110.804 -174.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 56.2 p -87.26 -29.72 21.44 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.368 0.604 . . . . 1.27 109.398 175.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 127.78 14.73 2.5 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.314 -0.857 . . . . 0.79 112.333 176.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -82.02 142.34 32.44 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.845 0.355 . . . . 1.5 110.248 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.3 t -79.21 111.64 16.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.898 -0.592 . . . . 0.5 111.163 -172.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.9 p -120.64 169.95 9.89 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.983 -0.553 . . . . 1.05 110.263 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.416 ' HB2' ' HB3' ' A' ' 19' ' ' CYS . 17.3 t -125.0 131.85 53.35 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 110.04 -0.356 . . . . 0.29 110.04 -178.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.476 HG13 ' HG3' ' A' ' 43' ' ' ARG . 29.0 pt -133.02 169.99 20.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.053 -0.521 . . . . 0.47 110.204 -179.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.0 p -72.85 140.74 17.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.995 0.426 . . . . 0.74 110.801 -177.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -76.75 -37.79 55.32 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.82 -0.627 . . . . 4.7 110.409 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 . . . . . 0 C--N 1.324 -0.543 0 N-CA-C 109.155 -0.683 . . . . 3.32 109.155 172.841 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.9 m . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 120.892 0.377 . . . . 2.8 110.557 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.579 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 52.9 tt0 -93.84 94.42 8.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.879 0.371 . . . . 6.69 110.092 -177.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.0 mt -85.74 99.71 11.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.959 -0.564 . . . . 2.82 111.595 -175.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.7 m 72.11 -62.52 0.46 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.513 -0.767 . . . . 3.77 112.368 173.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -132.44 -63.95 0.78 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.888 0.375 . . . . 4.59 110.484 -176.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.485 ' C ' ' H ' ' A' ' 12' ' ' ALA . 14.7 p -90.26 142.18 28.24 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.92 -0.582 . . . . 2.42 110.868 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.579 ' HA ' ' HA ' ' A' ' 6' ' ' GLN . 11.4 Cg_exo -72.47 29.04 0.27 Allowed 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 123.009 2.473 . . . . 1.69 112.144 171.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.518 ' HB3' ' OE2' ' A' ' 29' ' ' GLU . . . 43.63 -96.01 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.633 1.346 . . . . 1.42 114.633 175.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.707 ' HB3' ' HG2' ' A' ' 29' ' ' GLU . . . -86.23 -18.09 33.04 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.261 0.553 . . . . 0.64 110.802 -174.074 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 41.9 t -104.15 11.81 34.63 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.773 -0.825 . . . . 1.47 108.773 175.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 39.3 t -65.94 -28.53 68.99 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.073 -0.967 . . . . 1.36 111.151 -174.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.1 m -101.45 13.21 35.69 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.968 0.413 . . . . 1.64 111.472 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.6 m120 55.79 84.54 0.21 Allowed Pre-proline 0 N--CA 1.469 0.509 0 CA-C-N 115.389 -0.823 . . . . 1.69 112.103 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.441 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 2.9 Cg_exo -73.13 -58.26 0.07 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.998 2.465 . . . . 0.54 112.36 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.463 ' HB3' ' HB2' ' A' ' 54' ' ' CYS . 0.0 OUTLIER -86.39 17.52 3.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.069 -0.514 . . . . 0.55 111.796 -175.048 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.477 ' HA3' ' HD3' ' A' ' 21' ' ' PRO . . . 76.01 -124.82 7.54 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.036 -0.602 . . . . 0.69 112.938 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.477 ' HD3' ' HA3' ' A' ' 20' ' ' GLY . 9.2 Cg_endo -90.52 160.73 4.4 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.725 2.95 . . . . 0.83 112.362 -178.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -64.31 -21.31 66.56 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.642 -0.708 . . . . 3.42 111.325 -178.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.69 -31.96 67.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.324 -0.398 . . . . 0.65 110.78 177.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.448 ' HB3' ' HD2' ' A' ' 21' ' ' PRO . . . -76.92 -50.16 13.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.812 -0.631 . . . . 0.41 110.59 -177.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -172.82 166.6 39.26 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.23 -0.986 . . . . 0.61 112.866 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.5 m -93.41 139.37 30.77 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.997 -0.372 . . . . 0.87 109.997 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.45 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 6.0 p -100.52 115.63 30.56 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.258 0.551 . . . . 1.42 110.39 177.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -114.6 119.78 37.94 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.911 -0.586 . . . . 1.92 109.696 -176.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.707 ' HG2' ' HB3' ' A' ' 13' ' ' ALA . 31.6 mt-10 -79.8 130.14 35.07 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.01 -0.541 . . . . 1.66 110.568 -175.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.3 p -121.54 -174.86 2.95 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.854 -0.612 . . . . 0.62 111.43 -173.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -68.67 -29.3 67.74 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.961 0.41 . . . . 2.43 110.904 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.6 t -85.85 -4.76 59.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.178 0.513 . . . . 1.44 110.165 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 133.08 -83.12 0.3 Allowed Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 111.144 -0.782 . . . . 0.37 111.144 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.441 ' CE1' ' HB3' ' A' ' 18' ' ' PRO . 46.3 p90 -156.62 153.48 28.63 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.072 0.463 . . . . 0.57 110.593 178.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 47.6 pt -125.7 165.19 23.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 108.764 -0.828 . . . . 0.64 108.764 169.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.417 ' O ' HD11 ' A' ' 44' ' ' ILE . 62.6 m -121.38 131.25 54.07 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.225 0.536 . . . . 0.29 110.443 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -107.73 98.07 7.71 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.302 -0.863 . . . . 4.43 108.775 177.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 90.6 m -79.85 133.25 36.25 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.192 0.52 . . . . 0.27 110.865 -176.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -64.9 143.99 57.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.17 -0.923 . . . . 0.71 109.439 177.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.46 ' CD ' ' H ' ' A' ' 40' ' ' GLN . 2.7 pm0 -44.69 111.13 0.28 Allowed 'General case' 0 C--O 1.234 0.271 0 O-C-N 123.864 0.728 . . . . 2.9 111.268 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 125.96 -20.49 6.35 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.375 -0.829 . . . . 0.48 111.124 -174.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -112.91 162.43 15.84 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.126 -0.537 . . . . 0.54 109.682 174.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.428 ' HG3' HG13 ' A' ' 55' ' ' ILE . 30.3 ptt180 -140.72 157.25 45.69 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.976 0.417 . . . . 3.05 110.882 -176.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.449 HD13 ' HA ' ' A' ' 44' ' ' ILE . 21.1 mm -82.11 128.12 39.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.463 -0.789 . . . . 0.34 111.223 -178.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.406 ' HB2' HG12 ' A' ' 55' ' ' ILE . 33.4 t -129.59 150.47 50.9 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.633 -0.712 . . . . 0.49 109.083 176.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 52' ' ' VAL . 64.5 mt -115.53 124.17 50.37 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.033 -0.729 . . . . 0.95 109.033 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.43 56.61 1.41 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.023 -0.535 . . . . 2.52 112.228 -175.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.75 -56.88 4.24 Favored Glycine 0 N--CA 1.453 -0.195 0 CA-C-N 116.225 -0.443 . . . . 1.42 113.298 174.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.1 p -78.92 7.56 7.0 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.161 0.43 . . . . 1.27 112.161 -176.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.85 10.75 84.69 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.983 -0.627 . . . . 0.79 112.552 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.427 ' O ' ' HA ' ' A' ' 46' ' ' LEU . 12.9 m120 -72.41 128.08 34.53 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.122 -0.696 . . . . 1.5 109.122 176.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.468 ' HA ' HD23 ' A' ' 46' ' ' LEU . 31.5 t -79.69 111.49 16.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.024 -0.534 . . . . 0.5 110.631 -174.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.9 p -122.34 177.79 5.23 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.593 -0.521 . . . . 1.05 109.593 177.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.463 ' HB2' ' HB3' ' A' ' 19' ' ' CYS . 25.4 t -129.19 129.85 45.58 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.928 0.394 . . . . 0.29 110.051 -176.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.428 HG13 ' HG3' ' A' ' 43' ' ' ARG . 26.3 pt -131.59 164.94 33.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.081 -0.509 . . . . 0.47 110.35 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.8 p -69.35 138.44 22.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.271 0.558 . . . . 0.74 110.911 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.2 ttp180 -85.02 -53.81 5.05 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.076 -0.712 . . . . 4.7 109.076 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 . . . . . 0 C--O 1.232 0.151 0 CA-C-N 115.433 -0.803 . . . . 3.32 110.33 173.1 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.526 ' HA ' ' HB3' ' A' ' 11' ' ' PRO . 47.5 t . . . . . 0 N--CA 1.479 1.018 0 CA-C-O 120.747 0.308 . . . . 2.8 110.404 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.661 ' NE2' ' HB2' ' A' ' 29' ' ' GLU . 44.0 mt-30 -139.44 179.14 6.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.273 -0.422 . . . . 6.69 110.166 177.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.1 mt 69.53 167.26 0.28 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.838 0.827 . . . . 2.82 112.195 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.0 m -109.9 30.21 6.91 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.079 -0.964 . . . . 3.77 110.836 -176.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -142.12 -76.42 0.28 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.953 -0.758 . . . . 4.59 108.953 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.424 ' C ' ' H ' ' A' ' 12' ' ' ALA . 8.9 p -137.65 146.94 55.26 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 108.546 -0.909 . . . . 2.42 108.546 173.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.758 ' HB2' ' HB3' ' A' ' 14' ' ' CYS . 44.4 Cg_endo -71.5 20.39 0.25 Allowed 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 122.558 2.172 . . . . 1.69 113.32 -177.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.424 ' H ' ' C ' ' A' ' 10' ' ' THR . . . 48.73 -94.52 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.877 0.871 . . . . 1.42 112.879 175.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.536 ' HB1' ' CD1' ' A' ' 34' ' ' TYR . . . -65.33 -27.46 68.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.272 -0.422 . . . . 0.64 111.309 -177.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.758 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 33.4 t -95.87 -2.86 46.5 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.063 -0.517 . . . . 1.47 110.559 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.42 ' HA ' ' HG2' ' A' ' 11' ' ' PRO . 9.7 t -70.72 -9.6 57.61 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.89 0.376 . . . . 1.36 111.504 -174.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.5 m -90.45 4.85 49.84 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.034 0.445 . . . . 1.64 111.275 177.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.436 ' N ' ' HD3' ' A' ' 18' ' ' PRO . 4.1 m-20 54.14 59.94 11.4 Favored Pre-proline 0 N--CA 1.467 0.423 0 CA-C-N 115.219 -0.9 . . . . 1.69 110.984 -174.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.436 ' HD3' ' N ' ' A' ' 17' ' ' ASN . 11.5 Cg_exo -70.22 -52.62 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.952 2.434 . . . . 0.54 112.131 -174.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.542 ' SG ' ' HB3' ' A' ' 27' ' ' CYS . 1.8 m -82.3 -7.3 59.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.757 -0.656 . . . . 0.55 110.754 -177.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.34 -144.83 17.42 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.779 -0.724 . . . . 0.69 112.389 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.452 ' HD2' ' CB ' ' A' ' 24' ' ' ALA . 9.6 Cg_endo -88.64 175.04 3.89 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.377 2.718 . . . . 0.83 112.761 -177.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -53.04 -46.02 68.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.401 -0.363 . . . . 3.42 111.193 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.1 -24.09 66.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.476 0.547 . . . . 0.65 112.476 -176.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.452 ' CB ' ' HD2' ' A' ' 21' ' ' PRO . . . -85.96 -65.85 0.97 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.751 0.31 . . . . 0.41 110.853 -177.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -168.56 155.97 27.0 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 119.971 -1.109 . . . . 0.61 112.901 -177.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.2 m -90.29 142.58 27.58 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.772 0.32 . . . . 0.87 110.526 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.542 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 14.9 p -100.55 129.08 46.44 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.079 0.466 . . . . 1.42 110.5 178.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.443 ' HB3' HG13 ' A' ' 35' ' ' ILE . 29.4 tptp -117.43 106.56 13.33 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.638 -0.71 . . . . 1.92 110.046 -178.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.661 ' HB2' ' NE2' ' A' ' 6' ' ' GLN . 57.4 mp0 -67.4 119.48 12.31 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.315 -0.624 . . . . 1.66 109.315 176.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 48.1 p -102.13 -173.42 2.34 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.849 -0.614 . . . . 0.62 111.037 -174.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -71.41 -37.99 71.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.18 0.514 . . . . 2.43 110.164 177.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.7 m -83.3 -28.17 29.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.76 -0.654 . . . . 1.44 111.277 -177.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 174.3 -94.56 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.878 -0.677 . . . . 0.37 111.658 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.564 ' OH ' ' HB2' ' A' ' 51' ' ' ASN . 38.1 p90 -156.1 154.21 30.57 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.628 0.252 . . . . 0.57 110.556 177.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.443 HG13 ' HB3' ' A' ' 28' ' ' LYS . 40.1 pt -129.38 165.99 28.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.876 -0.602 . . . . 0.64 109.412 171.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.45 ' O ' HD11 ' A' ' 44' ' ' ILE . 55.9 m -121.49 131.45 54.16 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.261 -0.427 . . . . 0.29 110.404 -179.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 -114.86 101.56 9.16 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.05 -0.523 . . . . 4.43 109.811 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.507 ' HB3' ' HB2' ' A' ' 42' ' ' TYR . 85.0 m -81.58 151.12 27.84 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.686 -0.688 . . . . 0.27 111.375 -174.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -84.73 159.71 20.45 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.431 -0.804 . . . . 0.71 109.325 175.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -51.19 122.68 8.07 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 120.991 0.424 . . . . 2.9 111.276 -178.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 112.45 -16.22 24.39 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.601 -0.727 . . . . 0.48 111.421 -175.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.507 ' HB2' ' HB3' ' A' ' 38' ' ' CYS . 89.6 m-85 -114.74 162.62 16.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.937 0.398 . . . . 0.54 110.597 179.04 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.554 ' HG3' HG13 ' A' ' 55' ' ' ILE . 21.9 ptt180 -140.86 158.16 44.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.141 -0.481 . . . . 3.05 111.181 -174.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.45 HD11 ' O ' ' A' ' 36' ' ' CYS . 16.0 mm -84.41 132.39 31.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.785 -0.643 . . . . 0.34 110.708 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.491 ' HB2' HG12 ' A' ' 55' ' ' ILE . 33.8 t -133.02 164.37 27.16 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.753 -0.658 . . . . 0.49 109.545 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.404 ' HA ' ' O ' ' A' ' 51' ' ' ASN . 77.5 mt -124.1 121.8 36.15 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.295 -0.631 . . . . 0.95 109.295 178.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.98 69.31 10.52 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.361 -0.382 . . . . 2.52 111.96 -176.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.44 -72.32 2.83 Favored Glycine 0 CA--C 1.517 0.216 0 CA-C-N 115.957 -0.565 . . . . 1.42 113.472 173.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.8 p -73.42 -0.41 14.77 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.397 0.517 . . . . 1.27 112.397 -173.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.35 20.3 52.52 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.32 -0.943 . . . . 0.79 111.657 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.564 ' HB2' ' OH ' ' A' ' 34' ' ' TYR . 9.5 p30 -81.76 135.91 35.45 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.116 -0.698 . . . . 1.5 109.116 175.137 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.402 ' HA ' HD23 ' A' ' 46' ' ' LEU . 39.4 t -79.98 118.57 27.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.061 -0.518 . . . . 0.5 111.271 -172.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 81.1 p -128.01 172.44 10.93 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.082 -0.508 . . . . 1.05 110.619 177.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 19' ' ' CYS . 40.0 t -122.79 131.64 53.86 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.961 -0.563 . . . . 0.29 109.551 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.554 HG13 ' HG3' ' A' ' 43' ' ' ARG . 23.9 pt -134.59 164.56 33.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.974 -0.557 . . . . 0.47 109.835 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.3 p -71.75 136.22 26.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.418 0.628 . . . . 0.74 110.952 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -87.93 -65.14 1.05 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.13 -1.063 . . . . 4.7 108.13 171.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 114.461 -1.245 . . . . 3.32 108.383 179.585 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 52.9 t . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 109.99 -0.374 . . . . 2.8 109.99 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.437 ' HA ' ' HB3' ' A' ' 11' ' ' PRO . 29.4 tt0 -78.54 104.1 8.92 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.107 0.479 . . . . 6.69 110.527 -178.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.47 ' H ' ' HA ' ' A' ' 11' ' ' PRO . 86.8 mt -69.21 -65.27 0.73 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.459 -0.792 . . . . 2.82 111.017 -178.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.3 p -162.62 -72.05 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.482 -0.326 . . . . 3.77 110.928 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -88.04 -65.06 1.06 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.675 -0.491 . . . . 4.59 109.675 178.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.45 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 24.3 p -108.27 125.73 31.27 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-O 121.085 0.469 . . . . 2.42 109.994 172.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.47 ' HA ' ' H ' ' A' ' 7' ' ' LEU . 34.9 Cg_exo -62.91 -17.11 58.14 Favored 'Trans proline' 0 CA--C 1.528 0.196 0 C-N-CA 122.958 2.439 . . . . 1.69 112.818 178.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 68.09 123.78 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.778 0.674 . . . . 1.42 110.947 -176.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.516 ' HB1' ' HB3' ' A' ' 34' ' ' TYR . . . 69.57 -56.67 0.56 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.41 0.684 . . . . 0.64 110.866 -176.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.496 ' HA ' ' CD ' ' A' ' 18' ' ' PRO . 87.8 m -77.02 -0.34 24.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.072 0.463 . . . . 1.47 110.221 175.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.401 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 25.2 t -69.51 -18.55 63.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.887 -0.597 . . . . 1.36 111.185 -176.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.8 m -105.94 8.86 32.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.626 0.251 . . . . 1.64 111.544 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.5 m120 53.81 66.46 4.45 Favored Pre-proline 0 N--CA 1.467 0.41 0 CA-C-N 115.901 -0.59 . . . . 1.69 110.96 -173.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.496 ' CD ' ' HA ' ' A' ' 14' ' ' CYS . 11.1 Cg_endo -54.88 -53.05 6.62 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.822 2.348 . . . . 0.54 112.035 -177.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.593 ' SG ' ' HB3' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -91.21 18.9 6.38 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.941 -0.572 . . . . 0.55 110.876 -177.327 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.443 ' HA3' ' HD3' ' A' ' 21' ' ' PRO . . . 72.93 -128.2 11.84 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.838 -0.619 . . . . 0.69 111.867 -176.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.539 ' HD2' ' HB3' ' A' ' 24' ' ' ALA . 2.8 Cg_endo -87.05 169.88 7.34 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.462 2.774 . . . . 0.83 112.044 178.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -66.53 -35.45 80.27 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.048 0.452 . . . . 3.42 110.693 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.91 -28.98 70.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.83 -0.623 . . . . 0.65 110.869 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.539 ' HB3' ' HD2' ' A' ' 21' ' ' PRO . . . -78.54 -63.53 1.38 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.41 110.141 177.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -160.83 148.1 15.71 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.436 -0.887 . . . . 0.61 112.259 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.8 m -94.0 140.31 29.87 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.122 -0.325 . . . . 0.87 110.122 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.593 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 19.6 p -102.86 140.75 36.73 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.015 0.436 . . . . 1.42 110.939 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -130.59 125.27 33.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.787 -0.642 . . . . 1.92 109.997 176.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 3.0 mp0 -66.84 122.73 18.33 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.192 0.52 . . . . 1.66 110.326 176.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 49.3 p -122.76 -173.9 2.8 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.413 -0.812 . . . . 0.62 110.796 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -55.35 -41.38 72.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.968 0.413 . . . . 2.43 110.907 177.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.6 m -80.18 -5.18 55.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 1.44 111.439 -177.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 29' ' ' GLU . . . 126.89 -68.77 0.53 Allowed Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.37 -0.692 . . . . 0.37 111.37 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.516 ' HB3' ' HB1' ' A' ' 13' ' ' ALA . 54.5 p90 -155.55 156.6 35.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.832 0.348 . . . . 0.57 110.391 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.2 pt -129.58 164.98 30.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.81 -0.632 . . . . 0.64 109.462 170.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.9 m -123.4 128.8 50.36 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.171 0.51 . . . . 0.29 111.39 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -112.92 100.9 9.0 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.071 -0.715 . . . . 4.43 109.071 177.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 85.1 m -76.02 143.78 41.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.135 0.493 . . . . 0.27 110.981 -177.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -77.06 167.96 20.9 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.198 -0.91 . . . . 0.71 110.088 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -60.74 106.59 0.58 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.935 -0.575 . . . . 2.9 110.685 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 122.05 -5.59 10.36 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 121.01 -0.614 . . . . 0.48 111.714 -175.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -124.7 163.51 21.89 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 122.35 0.26 . . . . 0.54 110.59 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.495 ' HG3' HG13 ' A' ' 55' ' ' ILE . 24.5 ptt180 -144.37 158.71 43.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.932 0.396 . . . . 3.05 111.189 -174.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.435 HD13 ' HA ' ' A' ' 44' ' ' ILE . 15.1 mm -85.06 136.96 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.907 -0.588 . . . . 0.34 110.485 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 37.9 t -143.84 145.02 32.03 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.935 -0.575 . . . . 0.49 109.987 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.476 ' HB3' ' HA2' ' A' ' 50' ' ' GLY . 81.6 mt -95.08 112.99 24.64 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.466 -0.938 . . . . 0.95 108.466 172.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -85.66 75.49 10.1 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.949 0.404 . . . . 2.52 112.014 -170.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.53 -59.0 3.74 Favored Glycine 0 CA--C 1.518 0.253 0 CA-C-N 115.859 -0.609 . . . . 1.42 113.375 173.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.3 p -91.24 5.74 47.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.779 0.323 . . . . 1.27 111.793 -174.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.476 ' HA2' ' HB3' ' A' ' 46' ' ' LEU . . . 86.58 4.45 83.01 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.57 -0.824 . . . . 0.79 112.681 177.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -66.05 134.52 53.04 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.685 -0.487 . . . . 1.5 109.685 175.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.7 t -79.4 109.89 14.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.185 -0.672 . . . . 0.5 109.185 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 18' ' ' PRO . 12.7 t -128.3 169.67 13.95 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 116.009 -0.541 . . . . 1.05 109.825 -179.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 35.5 t -116.39 130.18 56.63 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.521 -0.548 . . . . 0.29 109.521 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.495 HG13 ' HG3' ' A' ' 43' ' ' ARG . 32.2 pt -127.52 166.72 23.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.954 -0.566 . . . . 0.47 109.503 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.4 p -73.13 136.64 25.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 121.233 0.539 . . . . 0.74 110.37 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -76.23 -33.48 59.21 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.227 -0.657 . . . . 4.7 109.227 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.425 ' HB3' ' O ' ' A' ' 61' ' ' GLY . 6.2 tp-100 -177.79 -71.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.648 -1.16 . . . . 3.32 108.473 174.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -138.72 -73.83 0.39 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.38 -0.827 . . . . 5.99 109.448 174.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 45.6 m -131.35 42.17 3.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.597 0.713 . . . . 4.66 109.273 173.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.425 ' O ' ' HB3' ' A' ' 58' ' ' GLN . . . . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.076 -1.402 . . . . 4.74 111.241 -176.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 27' ' ' CYS . 10.7 p . . . . . 0 N--CA 1.481 1.115 0 CA-C-O 121.806 0.812 . . . . 2.8 110.695 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.546 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 21.8 tp60 -78.8 -42.99 26.36 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.187 -0.671 . . . . 6.69 109.187 177.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.723 ' H ' HD23 ' A' ' 7' ' ' LEU . 1.3 pt? -106.33 164.26 12.17 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.664 -0.698 . . . . 2.82 109.628 172.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.8 m -99.06 -12.56 20.44 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.83 0.678 . . . . 3.77 112.83 -169.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -81.74 -92.49 0.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.875 -0.417 . . . . 4.59 109.875 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.3 p -122.18 113.37 31.13 Favored Pre-proline 0 CA--C 1.507 -0.708 0 N-CA-C 109.218 -0.66 . . . . 2.42 109.218 168.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.823 ' HB2' ' HB2' ' A' ' 14' ' ' CYS . 26.4 Cg_exo -62.62 101.48 0.26 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.523 2.149 . . . . 1.69 109.668 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.07 -34.97 46.13 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.611 0.597 . . . . 1.42 112.611 -170.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.907 ' HB3' ' HG2' ' A' ' 29' ' ' GLU . . . -84.22 -36.9 22.43 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.967 0.413 . . . . 0.64 110.931 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.823 ' HB2' ' HB2' ' A' ' 11' ' ' PRO . 33.5 m -83.09 -18.5 39.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.314 -0.403 . . . . 1.47 111.45 -176.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 34.5 t -68.41 -8.99 45.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.127 0.489 . . . . 1.36 109.81 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.0 m -88.81 -0.08 57.01 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.97 -0.559 . . . . 1.64 110.882 175.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 59.43 68.71 1.48 Allowed Pre-proline 0 N--CA 1.467 0.422 0 CA-C-N 115.107 -0.951 . . . . 1.69 111.852 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.46 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 3.5 Cg_exo -78.85 -75.08 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.91 2.407 . . . . 0.54 112.44 -177.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.45 24.05 0.28 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.469 -0.332 . . . . 0.55 111.81 -177.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.48 -123.14 15.98 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.118 -0.563 . . . . 0.69 111.837 -178.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -87.11 154.44 8.29 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.836 2.357 . . . . 0.83 111.494 175.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -70.02 -7.25 39.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.114 0.483 . . . . 3.42 110.364 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.84 -34.51 51.82 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.0 -0.545 . . . . 0.65 110.127 173.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.457 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . . . -71.86 -52.41 17.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.753 -0.658 . . . . 0.41 109.492 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.411 ' CA ' ' HA ' ' A' ' 38' ' ' CYS . . . -156.86 159.39 29.55 Favored Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 120.57 -0.824 . . . . 0.61 111.79 177.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.8 m -83.44 138.08 33.62 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.985 -0.746 . . . . 0.87 108.985 176.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.42 ' O ' HG12 ' A' ' 5' ' ' VAL . 41.7 t -98.7 112.94 24.85 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.394 0.616 . . . . 1.42 109.535 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.453 ' HB3' HG13 ' A' ' 35' ' ' ILE . 1.7 tmtp? -110.31 102.76 11.38 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.549 -0.75 . . . . 1.92 109.18 -175.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.907 ' HG2' ' HB3' ' A' ' 13' ' ' ALA . 28.6 mt-10 -73.7 122.66 22.69 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.705 -0.68 . . . . 1.66 110.401 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 35.8 p -102.42 -175.07 2.72 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.468 -0.787 . . . . 0.62 110.228 -177.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -74.61 -26.17 59.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.514 0.673 . . . . 2.43 109.296 176.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.6 m -84.56 -8.44 58.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.312 -0.858 . . . . 1.44 111.092 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 142.07 -93.41 0.18 Allowed Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.392 -0.683 . . . . 0.37 111.392 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.544 ' HB3' ' HB1' ' A' ' 13' ' ' ALA . 50.2 p90 -153.46 154.69 34.88 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.314 0.578 . . . . 0.57 111.178 177.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.453 HG13 ' HB3' ' A' ' 28' ' ' LYS . 44.7 pt -129.42 160.2 40.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 108.186 -1.042 . . . . 0.64 108.186 168.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 99.4 m -120.83 134.8 55.28 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.041 0.448 . . . . 0.29 110.743 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.586 ' NE ' ' HA ' ' A' ' 37' ' ' ARG . 1.5 tpm_? -117.13 99.98 7.41 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.74 -0.664 . . . . 4.43 109.358 177.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.505 ' HB3' ' HB2' ' A' ' 42' ' ' TYR . 81.1 m -73.47 141.66 46.83 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.049 0.452 . . . . 0.27 110.855 -176.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -73.88 168.67 18.97 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.86 -0.609 . . . . 0.71 109.763 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -59.0 118.7 6.11 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.989 0.424 . . . . 2.9 110.245 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.486 ' HA2' ' N ' ' A' ' 61' ' ' GLY . . . 116.18 -14.26 16.14 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.715 -0.755 . . . . 0.48 112.017 -175.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.505 ' HB2' ' HB3' ' A' ' 38' ' ' CYS . 84.1 m-85 -120.59 162.8 19.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.654 0.264 . . . . 0.54 110.657 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -143.78 157.65 44.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.423 -0.353 . . . . 3.05 110.709 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.9 mm -77.27 136.04 25.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.014 -0.539 . . . . 0.34 111.282 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 36.3 t -138.48 152.62 48.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.509 -0.768 . . . . 0.49 109.333 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.493 HD13 ' HA2' ' A' ' 50' ' ' GLY . 75.9 mt -107.1 145.31 32.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.173 0.511 . . . . 0.95 109.869 175.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -65.86 -21.66 66.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.524 -0.762 . . . . 2.52 111.476 -176.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 127.81 -28.69 4.36 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 111.261 -0.735 . . . . 1.42 111.261 -176.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.5 p -100.5 -7.28 24.35 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.449 0.642 . . . . 1.27 109.951 176.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.493 ' HA2' HD13 ' A' ' 46' ' ' LEU . . . 109.78 13.75 15.56 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.438 -0.801 . . . . 0.79 113.09 172.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -76.34 133.9 39.85 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.477 -0.564 . . . . 1.5 109.477 174.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.1 t -79.61 111.71 16.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.047 0.451 . . . . 0.5 110.683 -175.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.4 p -121.38 177.04 5.35 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.81 -0.632 . . . . 1.05 110.085 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 45.4 t -133.98 130.7 38.02 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.037 0.446 . . . . 0.29 110.552 -176.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 32.9 pt -132.09 172.07 16.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.7 -0.682 . . . . 0.47 109.443 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.9 p -65.66 141.42 18.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.84 0.352 . . . . 0.74 110.243 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -76.49 -75.8 0.18 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.112 -0.699 . . . . 4.7 109.112 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -114.88 -62.03 1.66 Allowed 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.778 -0.823 . . . . 3.32 108.778 168.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 178.38 86.23 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.323 -0.853 . . . . 5.99 109.023 176.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.9 m 57.18 33.4 23.26 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.987 0.899 . . . . 4.66 109.938 -171.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.486 ' N ' ' HA2' ' A' ' 41' ' ' GLY . . . . . . . . 0 N--CA 1.438 -1.217 0 N-CA-C 109.415 -1.474 . . . . 4.74 109.415 -177.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.527 ' HA ' ' CB ' ' A' ' 11' ' ' PRO . 15.6 t . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 121.115 0.483 . . . . 2.8 110.434 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.49 ' HG2' ' CD ' ' A' ' 29' ' ' GLU . 54.4 mm-40 -97.68 -177.58 3.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.419 . . . . 6.69 109.978 176.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.6 mp 62.33 -177.64 0.13 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.634 0.584 . . . . 2.82 111.66 177.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.2 m -121.56 -3.86 9.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.162 -0.472 . . . . 3.77 111.517 -175.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -115.22 -69.32 0.86 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.954 -0.387 . . . . 4.59 109.954 174.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.52 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 18.8 p -126.54 128.71 24.28 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.363 -0.38 . . . . 2.42 110.609 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.527 ' CB ' ' HA ' ' A' ' 5' ' ' VAL . 58.9 Cg_endo -75.85 53.43 3.69 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 123.16 2.573 . . . . 1.69 114.15 -172.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.518 ' O ' ' HB3' ' A' ' 15' ' ' SER . . . 43.56 -93.04 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.318 1.229 . . . . 1.42 114.318 173.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.567 ' HB3' ' HG3' ' A' ' 29' ' ' GLU . . . -73.71 -35.14 65.09 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.105 0.478 . . . . 0.64 110.659 -177.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.416 ' HB2' ' HB2' ' A' ' 11' ' ' PRO . 68.5 m -84.9 3.3 38.72 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.711 -0.677 . . . . 1.47 110.117 178.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.52 ' OG ' ' HB ' ' A' ' 10' ' ' THR . 30.5 t -70.3 -15.35 62.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.657 -0.701 . . . . 1.36 111.218 -176.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.2 p -89.53 -0.26 57.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.924 0.393 . . . . 1.64 110.871 177.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.6 m120 58.93 63.9 3.54 Favored Pre-proline 0 N--CA 1.467 0.409 0 CA-C-N 115.064 -0.971 . . . . 1.69 111.43 -175.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.509 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 20.2 Cg_exo -65.26 -50.41 2.03 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.723 2.282 . . . . 0.54 111.782 -177.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.517 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 0.7 OUTLIER -87.44 8.01 26.64 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.861 -0.608 . . . . 0.55 110.252 -179.266 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.433 ' HA3' ' HD3' ' A' ' 21' ' ' PRO . . . 76.72 -122.95 6.47 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.743 -0.662 . . . . 0.69 112.783 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.433 ' HD3' ' HA3' ' A' ' 20' ' ' GLY . 4.5 Cg_endo -83.29 162.41 15.15 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.617 2.878 . . . . 0.83 112.554 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -67.61 -18.78 65.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.356 -0.838 . . . . 3.42 111.85 -177.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.51 -16.63 47.98 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.82 0.343 . . . . 0.65 111.111 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.43 -60.73 2.25 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.266 -0.424 . . . . 0.41 110.88 -177.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -161.14 164.56 34.94 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.009 -1.091 . . . . 0.61 113.224 -177.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.25 134.75 34.93 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.995 -0.372 . . . . 0.87 109.995 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.517 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 49.4 t -117.5 119.79 36.11 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.843 0.354 . . . . 1.42 110.905 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -118.48 126.24 51.6 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.786 -0.643 . . . . 1.92 110.246 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.567 ' HG3' ' HB3' ' A' ' 13' ' ' ALA . 49.4 mp0 -70.71 123.78 22.71 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.116 -0.493 . . . . 1.66 109.857 175.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 73.3 p -115.3 -174.72 2.56 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.244 -0.435 . . . . 0.62 110.763 -178.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -77.78 -26.37 49.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.299 0.571 . . . . 2.43 109.868 175.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.85 -25.86 60.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.709 -0.678 . . . . 1.44 109.588 175.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 147.93 -82.69 0.19 Allowed Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.525 -1.03 . . . . 0.37 110.525 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.447 ' HD2' ' HB1' ' A' ' 13' ' ' ALA . 28.0 p90 -154.83 163.64 39.98 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 110.111 -0.329 . . . . 0.57 110.111 175.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.1 pt -128.59 151.5 35.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 116.182 -0.463 . . . . 0.64 110.369 175.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.509 ' SG ' ' HB2' ' A' ' 18' ' ' PRO . 20.9 m -121.23 118.81 30.54 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.191 0.519 . . . . 0.29 110.306 178.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -108.78 100.55 9.76 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.514 -0.766 . . . . 4.43 110.075 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 98.6 m -75.72 139.65 42.01 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.078 0.466 . . . . 0.27 111.469 -175.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -84.54 175.99 8.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.55 -0.75 . . . . 0.71 110.486 177.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.804 ' HG3' ' HA2' ' A' ' 61' ' ' GLY . 48.6 tt0 -54.77 119.31 5.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.052 -0.522 . . . . 2.9 110.765 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.82 2.22 46.07 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.577 -0.82 . . . . 0.48 112.327 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -127.79 162.16 27.28 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.145 -0.317 . . . . 0.54 110.145 177.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -145.96 154.47 41.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.858 0.361 . . . . 3.05 110.978 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.48 HD11 ' O ' ' A' ' 36' ' ' CYS . 20.9 mm -78.33 133.49 30.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.797 -0.638 . . . . 0.34 110.346 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.4 t -140.01 151.37 45.41 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.137 -0.69 . . . . 0.49 109.137 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.406 ' HB3' ' HA2' ' A' ' 50' ' ' GLY . 55.8 mt -102.85 145.35 29.92 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.519 -0.549 . . . . 0.95 109.519 173.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -84.43 -160.24 0.46 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.705 -0.68 . . . . 2.52 109.776 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -65.67 -28.07 73.26 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.647 -0.787 . . . . 1.42 112.938 177.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 82.6 p -90.76 -30.38 17.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 117.261 0.53 . . . . 1.27 111.407 -176.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.406 ' HA2' ' HB3' ' A' ' 46' ' ' LEU . . . 111.82 18.49 7.85 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.681 -0.771 . . . . 0.79 111.403 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 -74.73 141.97 44.41 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.401 -0.4 . . . . 1.5 109.961 177.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.9 t -78.3 110.84 14.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.103 0.477 . . . . 0.5 109.933 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.0 p -124.99 169.79 11.76 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.818 -0.628 . . . . 1.05 110.464 -177.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 25.2 t -121.81 129.93 53.01 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.084 -0.71 . . . . 0.29 109.084 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 33.9 pt -128.49 157.21 41.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.527 -0.306 . . . . 0.47 110.383 -177.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.91 123.85 22.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.422 0.629 . . . . 0.74 110.369 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.577 ' HG2' ' H ' ' A' ' 59' ' ' GLU . 74.7 ttt180 -88.49 142.09 28.0 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.668 -0.696 . . . . 4.7 109.866 -177.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -72.49 4.03 4.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.019 -0.537 . . . . 3.32 111.083 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.577 ' H ' ' HG2' ' A' ' 57' ' ' ARG . 9.6 tp10 -127.43 123.85 37.07 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.587 -0.894 . . . . 5.99 108.587 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.1 p -79.62 65.98 4.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.558 0.694 . . . . 4.66 110.849 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.804 ' HA2' ' HG3' ' A' ' 40' ' ' GLN . . . . . . . . 0 N--CA 1.441 -1.016 0 CA-C-O 118.718 -1.045 . . . . 4.74 110.944 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.634 HG22 ' HG3' ' A' ' 11' ' ' PRO . 11.8 t . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 121.162 0.506 . . . . 2.8 110.159 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.476 ' OE1' ' HB2' ' A' ' 29' ' ' GLU . 55.4 mt-30 -94.4 -10.77 31.48 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.267 0.469 . . . . 6.69 112.267 -178.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.407 HD11 ' HB2' ' A' ' 12' ' ' ALA . 62.1 mt -81.99 -87.53 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.674 -0.41 . . . . 2.82 110.935 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.7 m -147.11 -67.07 0.26 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.022 0.439 . . . . 3.77 110.05 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.432 ' HG3' HG23 ' A' ' 10' ' ' THR . 10.8 pt-20 -118.12 -30.05 5.42 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.205 -0.452 . . . . 4.59 110.126 177.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.5 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 37.8 p -100.35 132.03 23.12 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.054 -0.521 . . . . 2.42 110.686 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.963 ' HB2' ' HB2' ' A' ' 14' ' ' CYS . 4.1 Cg_exo -78.0 29.39 0.45 Allowed 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 123.489 2.793 . . . . 1.69 113.458 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.407 ' HB2' HD11 ' A' ' 7' ' ' LEU . . . 50.98 -99.72 0.08 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.879 0.696 . . . . 1.42 112.879 176.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . . . -66.66 -27.34 67.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.457 0.646 . . . . 0.64 110.334 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.963 ' HB2' ' HB2' ' A' ' 11' ' ' PRO . 69.0 m -93.85 3.35 55.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.4 -0.818 . . . . 1.47 110.78 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.756 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 20.7 t -69.96 -22.3 63.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.366 -0.379 . . . . 1.36 110.97 -176.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.6 m -89.09 7.1 36.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.492 -0.322 . . . . 1.64 111.357 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 54.03 72.59 1.08 Allowed Pre-proline 0 N--CA 1.466 0.369 0 CA-C-N 115.693 -0.685 . . . . 1.69 111.183 -176.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.417 ' HG2' ' SG ' ' A' ' 27' ' ' CYS . 14.4 Cg_exo -66.29 -42.22 10.78 Favored 'Trans proline' 0 CA--C 1.52 -0.213 0 C-N-CA 123.13 2.554 . . . . 0.54 111.803 -175.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.504 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -82.02 -3.11 53.82 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.542 -0.753 . . . . 0.55 110.337 -178.189 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.16 -137.59 13.52 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.433 -0.803 . . . . 0.69 111.324 -176.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.489 ' HD2' ' CB ' ' A' ' 24' ' ' ALA . 6.2 Cg_exo -77.72 171.34 17.57 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.593 2.195 . . . . 0.83 111.769 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.34 -39.53 94.79 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.905 0.383 . . . . 3.42 110.318 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.47 -23.62 66.01 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.512 -0.767 . . . . 0.65 111.397 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.489 ' CB ' ' HD2' ' A' ' 21' ' ' PRO . . . -81.36 -56.57 3.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.908 0.385 . . . . 0.41 110.363 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -171.39 161.1 33.46 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.619 -0.801 . . . . 0.61 111.965 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.6 m -102.33 140.74 36.21 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.548 -0.538 . . . . 0.87 109.548 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.504 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 38.2 t -105.35 143.28 33.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.189 0.518 . . . . 1.42 110.752 -177.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.761 ' HA ' ' HE2' ' A' ' 28' ' ' LYS . 0.5 OUTLIER -131.88 122.07 25.08 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.725 -0.67 . . . . 1.92 110.139 -177.917 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.476 ' HB2' ' OE1' ' A' ' 6' ' ' GLN . 5.0 mp0 -66.99 125.79 27.09 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.356 -0.609 . . . . 1.66 109.356 175.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 31.8 p -106.98 173.71 6.2 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.851 -0.613 . . . . 0.62 110.494 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -79.82 46.83 0.81 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 122.027 0.918 . . . . 2.43 109.974 175.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.5 t -162.9 -41.43 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.816 -1.083 . . . . 1.44 108.325 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -179.52 -100.08 0.13 Allowed Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.298 -0.864 . . . . 0.37 111.276 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.422 ' HB3' ' HB3' ' A' ' 13' ' ' ALA . 36.9 p90 -148.93 151.23 34.27 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.748 -0.464 . . . . 0.57 109.748 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.8 pt -129.87 161.88 38.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.936 -0.394 . . . . 0.64 109.936 172.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 33.3 m -121.22 130.95 53.95 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.239 -0.437 . . . . 0.29 110.821 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.403 ' HD2' ' HA ' ' A' ' 37' ' ' ARG . 27.0 tpt180 -111.02 101.52 10.07 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.946 -0.761 . . . . 4.43 108.946 175.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 42' ' ' TYR . 88.9 m -73.56 145.31 45.6 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.911 -0.586 . . . . 0.27 110.876 -177.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -77.69 170.88 15.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.537 -0.756 . . . . 0.71 109.772 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.447 ' HG3' ' HB3' ' A' ' 60' ' ' SER . 62.3 tt0 -66.2 103.23 0.95 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.049 0.452 . . . . 2.9 110.335 -178.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 128.6 -1.03 6.41 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.529 -0.76 . . . . 0.48 111.456 -175.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.53 ' HB2' ' HB3' ' A' ' 38' ' ' CYS . 80.2 m-85 -130.23 162.44 28.94 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.673 -0.491 . . . . 0.54 109.673 177.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.811 ' HG2' ' HB2' ' A' ' 57' ' ' ARG . 2.7 ptp180 -143.55 161.47 38.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.612 0.244 . . . . 3.05 110.72 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 44' ' ' ILE . 12.5 mm -81.3 140.03 17.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 121.059 0.457 . . . . 0.34 111.38 -176.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.4 t -147.12 154.68 41.41 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.693 -0.685 . . . . 0.49 109.36 177.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.404 HD13 ' HA2' ' A' ' 50' ' ' GLY . 80.9 mt -96.79 145.99 25.32 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.435 -0.58 . . . . 0.95 109.435 174.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -64.79 -15.04 61.15 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.546 -0.752 . . . . 2.52 111.901 -177.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.49 -30.26 4.76 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.353 -0.699 . . . . 1.42 111.353 -176.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.5 p -102.84 -24.43 13.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.103 0.478 . . . . 1.27 110.219 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.404 ' HA2' HD13 ' A' ' 46' ' ' LEU . . . 131.04 20.85 1.13 Allowed Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.543 -0.753 . . . . 0.79 112.897 174.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -83.82 133.08 34.77 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.618 -0.512 . . . . 1.5 109.618 174.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.6 t -80.02 111.8 17.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.023 0.439 . . . . 0.5 110.333 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.7 t -127.45 173.85 9.49 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.909 -0.587 . . . . 1.05 109.582 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.501 ' HB3' ' O ' ' A' ' 19' ' ' CYS . 48.5 t -122.83 131.19 53.65 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.555 -0.535 . . . . 0.29 109.555 -176.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 20.9 pt -123.54 142.15 41.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.14 0.495 . . . . 0.47 110.945 -176.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.1 p -66.55 126.77 26.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.424 -0.807 . . . . 0.74 110.514 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.811 ' HB2' ' HG2' ' A' ' 43' ' ' ARG . 4.2 tpm_? -123.34 131.89 53.81 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.979 -0.748 . . . . 4.7 108.979 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -45.67 -54.21 8.13 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-O 121.062 0.458 . . . . 3.32 111.265 -176.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -94.72 147.71 23.03 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.361 -0.836 . . . . 5.99 108.969 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.447 ' HB3' ' HG3' ' A' ' 40' ' ' GLN . 22.2 m -75.01 64.13 1.3 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.506 0.67 . . . . 4.66 110.761 -178.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.082 0 CA-C-O 118.681 -1.066 . . . . 4.74 110.903 179.338 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.445 HG13 ' SG ' ' A' ' 27' ' ' CYS . 16.9 m . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.933 0.397 . . . . 2.8 111.436 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -90.88 -32.85 15.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.955 0.407 . . . . 6.69 110.34 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.575 HD12 ' HA ' ' A' ' 11' ' ' PRO . 95.7 mt -85.67 -175.57 5.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.989 -0.551 . . . . 2.82 110.939 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.4 t -69.51 -72.52 0.19 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.394 -0.366 . . . . 3.77 111.804 -173.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.415 ' HB2' ' H ' ' A' ' 10' ' ' THR . 13.0 mm-40 -98.92 -88.92 0.32 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.095 0.474 . . . . 4.59 110.759 -171.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.52 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 0.7 OUTLIER -102.47 108.1 56.23 Favored Pre-proline 0 N--CA 1.446 -0.642 0 CA-C-N 115.754 -0.657 . . . . 2.42 109.499 175.118 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.575 ' HA ' HD12 ' A' ' 7' ' ' LEU . 0.9 OUTLIER -81.9 64.8 8.51 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.581 2.854 . . . . 1.69 113.568 -169.869 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.444 ' O ' ' HB3' ' A' ' 15' ' ' SER . . . 43.65 -87.44 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 O-C-N 124.339 1.024 . . . . 1.42 113.712 174.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.449 ' HB1' ' CD1' ' A' ' 34' ' ' TYR . . . -62.55 -41.59 98.99 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.301 -0.409 . . . . 0.64 111.532 -177.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.598 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 52.5 t -85.37 -3.15 58.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.143 0.497 . . . . 1.47 110.774 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.444 ' HB3' ' O ' ' A' ' 12' ' ' ALA . 36.6 t -65.59 -17.52 64.64 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.283 -0.417 . . . . 1.36 111.463 -177.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 36.5 m -108.1 14.89 24.74 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.925 0.393 . . . . 1.64 111.49 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 55.95 73.29 0.86 Allowed Pre-proline 0 N--CA 1.47 0.544 0 CA-C-N 115.313 -0.858 . . . . 1.69 112.283 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.598 ' HD3' ' HA ' ' A' ' 14' ' ' CYS . 24.6 Cg_endo -62.19 -43.56 23.28 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.829 2.353 . . . . 0.54 112.191 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 2.6 m -90.56 17.9 6.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.266 -0.425 . . . . 0.55 111.109 -176.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.463 ' HA3' ' HD3' ' A' ' 21' ' ' PRO . . . 70.98 -123.74 10.95 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 116.102 -0.499 . . . . 0.69 112.553 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.463 ' HD3' ' HA3' ' A' ' 20' ' ' GLY . 1.6 Cg_endo -78.76 157.87 27.92 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 123.287 2.658 . . . . 0.83 112.063 178.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -67.42 -27.9 67.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.664 -0.698 . . . . 3.42 110.565 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.04 -15.04 61.09 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.61 -0.723 . . . . 0.65 111.288 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.91 -52.37 6.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.341 -0.39 . . . . 0.41 110.351 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -169.76 174.31 43.99 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.3 -0.952 . . . . 0.61 113.083 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.5 m -101.38 140.89 35.06 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 122.46 0.304 . . . . 0.87 110.86 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.445 ' SG ' HG13 ' A' ' 5' ' ' VAL . 27.9 p -102.55 130.09 49.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.899 0.381 . . . . 1.42 110.517 177.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -124.5 117.06 23.54 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.203 -0.666 . . . . 1.92 109.203 176.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -71.95 119.1 15.65 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.192 0.52 . . . . 1.66 109.973 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.9 p -112.17 -175.68 2.74 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.876 -0.602 . . . . 0.62 110.683 -176.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -68.19 -24.01 64.9 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.395 0.617 . . . . 2.43 109.728 174.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.9 m -78.77 -19.32 52.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.614 -0.721 . . . . 1.44 110.038 177.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 133.2 -71.77 0.49 Allowed Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.985 -0.846 . . . . 0.37 110.985 -177.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.449 ' CD1' ' HB1' ' A' ' 13' ' ' ALA . 50.2 p90 -155.98 158.93 38.71 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.306 -0.257 . . . . 0.57 110.306 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.2 pt -131.74 157.07 43.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.272 -0.64 . . . . 0.64 109.272 170.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.0 m -121.06 119.22 31.84 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.634 0.73 . . . . 0.29 111.06 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -105.72 99.46 9.06 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.992 -1.003 . . . . 4.43 109.975 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 77.8 m -77.88 146.2 35.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.979 0.418 . . . . 0.27 110.845 -176.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -84.06 179.02 7.61 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.833 -0.622 . . . . 0.71 109.996 176.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -58.77 132.44 53.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.674 0.273 . . . . 2.9 110.544 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.85 5.65 80.84 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.477 -0.868 . . . . 0.48 112.398 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -125.54 154.5 42.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.025 0.441 . . . . 0.54 110.624 177.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.549 ' HG3' HG13 ' A' ' 55' ' ' ILE . 24.7 ptt180 -140.43 160.85 39.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.779 -0.646 . . . . 3.05 111.172 -171.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.405 ' HA ' HD13 ' A' ' 44' ' ' ILE . 20.4 mm -87.51 134.36 27.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.798 -0.637 . . . . 0.34 110.65 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.0 t -143.53 173.54 11.55 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.442 -0.799 . . . . 0.49 109.217 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.409 ' HA ' ' O ' ' A' ' 51' ' ' ASN . 78.8 mt -107.69 145.02 33.97 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.247 0.546 . . . . 0.95 109.998 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -61.85 -23.91 66.57 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.027 -0.988 . . . . 2.52 111.509 -177.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 133.61 -22.56 3.89 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 111.223 -0.751 . . . . 1.42 111.223 -175.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 37.4 p -111.71 -27.09 8.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.042 0.449 . . . . 1.27 110.393 177.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 133.57 24.02 0.7 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.766 -0.73 . . . . 0.79 112.901 175.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.409 ' O ' ' HA ' ' A' ' 46' ' ' LEU . 20.7 m120 -87.26 145.9 26.18 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.417 -0.586 . . . . 1.5 109.417 174.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.1 t -79.4 111.16 15.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.953 0.406 . . . . 0.5 110.087 -176.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 18' ' ' PRO . 65.7 p -124.78 169.13 12.31 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.989 -0.55 . . . . 1.05 110.472 -178.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 34.0 t -121.81 131.23 53.95 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.023 -0.535 . . . . 0.29 109.656 -178.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.549 HG13 ' HG3' ' A' ' 43' ' ' ARG . 34.5 pt -131.73 167.13 27.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.249 -0.432 . . . . 0.47 110.115 -177.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.9 p -76.91 137.35 22.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.474 0.654 . . . . 0.74 111.28 -175.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 59' ' ' GLU . 19.1 tpt180 -101.14 106.72 17.99 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.17 -1.048 . . . . 4.7 108.17 173.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.51 -4.08 13.83 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.209 0.448 . . . . 3.32 112.209 -171.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 10.1 tp10 -126.11 115.86 20.48 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.286 -1.005 . . . . 5.99 108.286 175.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.4 p -48.42 122.95 5.9 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.604 0.565 . . . . 4.66 111.984 -171.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.747 -1.029 . . . . 4.74 111.168 -178.024 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.478 0.934 0 CA-C-O 122.146 0.974 . . . . 2.8 109.93 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -81.65 -38.49 25.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.822 -0.626 . . . . 6.69 110.718 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.662 ' HB2' ' HA ' ' A' ' 11' ' ' PRO . 85.3 mt -88.11 155.18 19.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.182 -0.463 . . . . 2.82 110.039 178.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.3 t -85.68 -33.67 21.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.445 -0.798 . . . . 3.77 111.823 -167.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -93.71 -79.7 0.4 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.316 -0.624 . . . . 4.59 109.316 177.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.5 p -124.04 129.61 24.69 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 115.849 -0.614 . . . . 2.42 109.905 172.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.662 ' HA ' ' HB2' ' A' ' 7' ' ' LEU . 62.6 Cg_endo -76.78 -163.05 0.18 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.604 2.203 . . . . 1.69 111.84 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -103.89 -65.43 1.02 Allowed 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.469 -0.492 . . . . 1.42 110.23 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.756 ' HB3' ' HG2' ' A' ' 29' ' ' GLU . . . -71.78 -48.22 48.1 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.122 -0.49 . . . . 0.64 110.59 -177.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.52 ' HB2' ' CG ' ' A' ' 11' ' ' PRO . 65.7 m -66.63 -23.16 66.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.366 -0.379 . . . . 1.47 111.048 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.7 t -67.94 -28.11 67.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.022 0.439 . . . . 1.36 110.402 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.0 t -82.72 -0.89 49.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.262 0.553 . . . . 1.64 110.291 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 62.29 73.04 0.57 Allowed Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 115.056 -0.975 . . . . 1.69 111.146 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.534 ' O ' ' HA ' ' A' ' 53' ' ' THR . 5.7 Cg_exo -74.69 -64.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.499 2.133 . . . . 0.54 111.162 -177.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -84.13 27.36 0.68 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.851 -0.613 . . . . 0.55 110.869 -178.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.94 -125.5 22.24 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.142 -0.551 . . . . 0.69 112.071 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.562 ' HG2' ' HB2' ' A' ' 24' ' ' ALA . 90.6 Cg_endo -78.51 156.78 28.65 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.778 2.319 . . . . 0.83 112.379 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -68.43 -11.95 60.45 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.249 -0.887 . . . . 3.42 110.39 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.81 -14.5 34.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.698 -0.683 . . . . 0.65 111.526 177.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.562 ' HB2' ' HG2' ' A' ' 21' ' ' PRO . . . -78.27 -35.89 47.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.412 0.625 . . . . 0.41 110.453 -177.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -177.92 -171.73 41.63 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.632 -0.794 . . . . 0.61 112.093 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.9 m -92.12 134.1 35.16 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 110.083 -0.34 . . . . 0.87 110.083 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.44 ' SG ' ' HG2' ' A' ' 18' ' ' PRO . 43.0 t -106.1 112.67 25.81 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.375 -0.602 . . . . 1.42 109.375 177.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.459 ' HB3' ' CG1' ' A' ' 35' ' ' ILE . 17.8 tppt? -116.05 107.66 15.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.122 -0.49 . . . . 1.92 110.108 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.756 ' HG2' ' HB3' ' A' ' 13' ' ' ALA . 36.2 mt-10 -74.38 118.74 17.68 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.073 -0.512 . . . . 1.66 109.973 178.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 70.9 p -109.98 -175.11 2.65 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.775 -0.648 . . . . 0.62 110.372 -175.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -76.1 -17.61 59.54 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.319 0.581 . . . . 2.43 109.755 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.8 t -88.94 -1.2 57.99 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.664 -0.698 . . . . 1.44 109.937 175.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 124.52 -79.89 0.36 Allowed Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 111.064 -0.814 . . . . 0.37 111.064 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.469 ' HB3' ' CB ' ' A' ' 13' ' ' ALA . 54.8 p90 -156.2 154.46 30.82 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.149 -0.315 . . . . 0.57 110.149 178.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.459 ' CG1' ' HB3' ' A' ' 28' ' ' LYS . 44.2 pt -122.68 148.92 26.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 108.794 -0.817 . . . . 0.64 108.794 166.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.413 ' SG ' ' HB2' ' A' ' 18' ' ' PRO . 50.3 m -120.63 123.03 41.81 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.279 0.561 . . . . 0.29 110.791 -177.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 48.6 ttp85 -116.08 100.73 8.16 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.354 -0.839 . . . . 4.43 109.885 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 81.8 m -77.39 155.13 32.08 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.256 0.551 . . . . 0.27 111.86 -175.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -79.07 -179.63 6.8 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.061 -0.972 . . . . 0.71 109.684 174.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -64.42 -39.15 93.28 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.981 0.419 . . . . 2.9 111.588 -172.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.457 ' HA3' ' H ' ' A' ' 61' ' ' GLY . . . -80.29 6.79 59.27 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.545 -0.836 . . . . 0.48 112.743 -178.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.478 ' HB3' ' SG ' ' A' ' 54' ' ' CYS . 96.1 m-85 -128.78 161.43 29.77 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 122.583 -0.363 . . . . 0.54 110.938 -176.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -142.73 162.43 35.49 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.883 0.373 . . . . 3.05 110.639 -176.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.0 mm -84.91 128.94 38.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.898 -0.592 . . . . 0.34 110.891 -178.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.7 t -133.98 151.98 51.67 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.322 -0.854 . . . . 0.49 109.235 178.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 86.5 mt -101.82 142.54 32.97 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.122 0.487 . . . . 0.95 109.786 176.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -64.35 -22.02 66.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.312 -0.858 . . . . 2.52 111.959 -174.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 129.38 -23.62 4.82 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.904 -0.665 . . . . 1.42 111.508 -175.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.6 p -106.55 -25.5 11.79 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.005 0.431 . . . . 1.27 109.85 175.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 131.47 15.56 1.6 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.928 -0.654 . . . . 0.79 112.952 174.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -74.53 134.53 42.2 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.446 -0.576 . . . . 1.5 109.446 174.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.8 t -79.71 110.27 15.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.668 -0.493 . . . . 0.5 109.668 -178.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 18' ' ' PRO . 65.9 p -121.4 171.13 8.99 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.962 -0.563 . . . . 1.05 109.846 -178.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.478 ' SG ' ' HB3' ' A' ' 42' ' ' TYR . 15.6 t -126.72 130.68 50.82 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.328 -0.396 . . . . 0.29 110.046 -176.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 41.2 pt -133.68 165.32 32.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.06 -0.518 . . . . 0.47 109.937 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.0 p -65.11 127.83 26.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.336 0.588 . . . . 0.74 110.726 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 57' ' ' ARG . 13.2 ttm180 -82.64 -40.82 20.22 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.498 -0.774 . . . . 4.7 110.249 -178.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.415 ' HG2' ' HG2' ' A' ' 59' ' ' GLU . 33.9 tt0 -165.77 -72.73 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.419 -0.81 . . . . 3.32 109.631 -178.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.415 ' HG2' ' HG2' ' A' ' 58' ' ' GLN . 50.2 mm-40 -128.71 121.98 29.68 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.282 -0.872 . . . . 5.99 109.318 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.9 m -56.85 116.11 2.98 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.233 0.54 . . . . 4.66 112.251 -173.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.457 ' H ' ' HA3' ' A' ' 41' ' ' GLY . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.013 -1.437 . . . . 4.74 111.018 178.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.659 HG13 ' H ' ' A' ' 6' ' ' GLN . 2.8 p . . . . . 0 N--CA 1.474 0.745 0 CA-C-O 119.491 -0.29 . . . . 2.8 111.077 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.659 ' H ' HG13 ' A' ' 5' ' ' VAL . 25.0 tp60 -177.59 -48.07 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.952 0.406 . . . . 6.69 110.148 -176.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.4 mt 69.88 -95.69 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.297 -0.865 . . . . 2.82 112.021 173.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.3 m -154.51 -82.05 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.493 0.187 . . . . 3.77 110.893 -176.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -67.68 -64.68 0.81 Allowed 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.52 -0.548 . . . . 4.59 109.52 177.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.6 p -141.35 143.41 30.2 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 115.449 -0.796 . . . . 2.42 109.85 176.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.467 ' HB2' ' HB2' ' A' ' 14' ' ' CYS . 48.8 Cg_endo -75.33 90.43 1.11 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 121.599 1.533 . . . . 1.69 109.098 171.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -46.97 -33.01 4.27 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.591 0.96 . . . . 1.42 113.591 -166.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.86 ' HB3' ' HG2' ' A' ' 29' ' ' GLU . . . -94.95 -29.89 14.42 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.218 0.451 . . . . 0.64 112.218 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.467 ' HB2' ' HB2' ' A' ' 11' ' ' PRO . 35.7 m -97.1 2.55 51.38 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 122.039 -0.413 . . . . 1.47 111.164 -178.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.5 t -66.31 -17.88 65.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.09 -0.504 . . . . 1.36 111.25 -173.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.7 m -97.47 4.19 50.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.605 -0.27 . . . . 1.64 111.543 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 57.5 76.37 0.48 Allowed Pre-proline 0 N--CA 1.469 0.525 0 CA-C-N 115.616 -0.72 . . . . 1.69 111.394 -175.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -73.23 -73.02 0.01 OUTLIER 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 122.902 2.401 . . . . 0.54 112.784 -177.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -71.1 -28.39 64.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.191 0.519 . . . . 0.55 111.158 -176.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.412 ' HA3' ' HD3' ' A' ' 21' ' ' PRO . . . 105.67 -122.86 7.32 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.611 -0.722 . . . . 0.69 112.312 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.506 ' HD2' ' HB3' ' A' ' 24' ' ' ALA . 10.2 Cg_endo -86.3 156.12 9.51 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.302 2.668 . . . . 0.83 112.49 -177.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -62.62 -23.29 66.98 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 114.984 -1.007 . . . . 3.42 111.003 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.12 -34.58 76.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.288 -0.415 . . . . 0.65 110.8 175.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.506 ' HB3' ' HD2' ' A' ' 21' ' ' PRO . . . -83.74 -57.89 3.03 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.032 -0.531 . . . . 0.41 110.578 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -168.39 143.61 8.24 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.276 -0.964 . . . . 0.61 112.452 -177.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.8 m -83.73 145.02 28.96 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.201 -0.296 . . . . 0.87 110.201 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 53.4 t -100.24 113.53 26.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.202 0.525 . . . . 1.42 110.304 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -109.99 114.35 27.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.658 -0.701 . . . . 1.92 109.902 -176.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.86 ' HG2' ' HB3' ' A' ' 13' ' ' ALA . 45.5 mt-10 -78.2 119.71 21.97 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.114 0.483 . . . . 1.66 110.143 -177.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 78.7 p -119.01 -173.31 2.47 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.417 -0.81 . . . . 0.62 110.946 -173.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -64.51 -32.71 74.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.014 0.435 . . . . 2.43 110.176 175.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.0 m -73.93 -2.67 24.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.946 -0.57 . . . . 1.44 110.437 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.06 -74.94 0.24 Allowed Glycine 0 N--CA 1.44 -1.058 0 N-CA-C 110.496 -1.042 . . . . 0.37 110.496 -177.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.715 ' HB3' ' HB1' ' A' ' 13' ' ' ALA . 51.9 p90 -153.45 151.45 29.88 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.068 0.461 . . . . 0.57 110.174 176.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 47.2 pt -128.5 162.07 35.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 108.384 -0.969 . . . . 0.64 108.384 169.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.414 ' HB2' ' CD1' ' A' ' 44' ' ' ILE . 68.3 m -120.85 129.85 53.7 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.153 0.501 . . . . 0.29 110.319 -178.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.792 ' HA ' ' HE ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -105.93 99.97 9.54 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.885 -0.598 . . . . 4.43 109.627 178.674 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.463 ' HB3' ' HB2' ' A' ' 42' ' ' TYR . 84.3 m -83.86 133.8 34.72 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.694 -0.684 . . . . 0.27 110.932 -176.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -68.88 151.69 46.24 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.995 -1.002 . . . . 0.71 109.038 175.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.439 ' HB2' ' O ' ' A' ' 61' ' ' GLY . 28.7 pt20 -59.46 120.53 9.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.479 0.657 . . . . 2.9 110.678 -176.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.25 -8.14 14.09 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 110.513 -1.035 . . . . 0.48 110.513 -171.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.463 ' HB2' ' HB3' ' A' ' 38' ' ' CYS . 71.6 m-85 -128.02 162.8 25.96 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.915 -0.772 . . . . 0.54 108.915 176.128 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.803 ' HG2' ' HB2' ' A' ' 57' ' ' ARG . 9.2 ptp180 -152.39 165.15 35.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.075 0.464 . . . . 3.05 111.587 174.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.414 ' CD1' ' HB2' ' A' ' 36' ' ' CYS . 38.3 mm -70.29 137.64 23.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.207 -0.906 . . . . 0.34 110.895 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.44 ' HB2' HG12 ' A' ' 55' ' ' ILE . 23.0 t -145.72 165.75 27.87 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.985 -0.746 . . . . 0.49 108.985 178.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 87.8 mt -104.72 138.03 41.64 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.671 -0.492 . . . . 0.95 109.671 178.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -60.6 -24.18 65.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.068 -0.969 . . . . 2.52 111.911 -174.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 131.76 -26.5 3.82 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 111.015 -0.834 . . . . 1.42 111.015 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.2 p -100.57 -30.38 11.81 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.707 -0.479 . . . . 1.27 109.707 175.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 131.77 22.55 0.93 Allowed Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.597 -0.729 . . . . 0.79 112.447 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -85.41 142.83 28.99 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.662 -0.496 . . . . 1.5 109.662 176.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.7 t -79.71 110.81 15.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.187 0.518 . . . . 0.5 110.138 -176.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.1 p -125.6 171.67 10.37 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.924 -0.58 . . . . 1.05 110.188 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 44.3 t -124.65 129.94 51.48 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.498 -0.556 . . . . 0.29 109.498 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.44 HG12 ' HB2' ' A' ' 45' ' ' SER . 26.0 pt -131.27 148.02 32.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.03 0.443 . . . . 0.47 110.723 -176.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.449 ' HA ' ' CD2' ' A' ' 42' ' ' TYR . 7.6 p -62.48 123.92 16.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.635 -0.711 . . . . 0.74 110.442 177.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.803 ' HB2' ' HG2' ' A' ' 43' ' ' ARG . 21.5 tpt180 -125.59 114.11 18.3 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.263 -0.426 . . . . 4.7 110.536 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.441 ' HG3' ' HG3' ' A' ' 59' ' ' GLU . 11.1 pt20 -58.19 -33.17 68.96 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.739 -0.664 . . . . 3.32 111.182 178.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.441 ' HG3' ' HG3' ' A' ' 58' ' ' GLN . 38.7 mt-10 -105.19 67.29 0.78 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.909 -0.587 . . . . 5.99 111.742 -176.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 62.7 m -127.03 -52.41 1.42 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.625 -0.716 . . . . 4.66 109.921 172.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 40' ' ' GLN . . . . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.544 -1.142 . . . . 4.74 111.674 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.0 t . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 120.928 0.394 . . . . 2.8 110.422 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.622 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 60.9 tt0 -72.03 132.8 44.76 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.094 -0.503 . . . . 6.69 110.513 176.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.403 ' H ' HD23 ' A' ' 7' ' ' LEU . 2.5 pt? -137.19 9.78 2.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.054 -0.521 . . . . 2.82 110.153 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.7 p -169.55 -174.94 2.02 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.681 -0.691 . . . . 3.77 110.265 -172.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -45.17 -56.93 4.29 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.41 0.624 . . . . 4.59 110.285 175.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.0 p -97.72 128.15 35.17 Favored Pre-proline 0 N--CA 1.441 -0.91 0 CA-C-N 115.268 -0.878 . . . . 2.42 109.796 173.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.622 ' HA ' ' HA ' ' A' ' 6' ' ' GLN . 51.1 Cg_exo -57.95 -19.08 38.3 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.05 2.5 . . . . 1.69 112.759 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.673 ' H ' ' HB3' ' A' ' 15' ' ' SER . . . 66.9 121.19 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.89 0.744 . . . . 1.42 111.602 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.59 ' HB1' ' CD1' ' A' ' 34' ' ' TYR . . . 70.68 -58.37 0.56 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.655 -0.702 . . . . 0.64 110.978 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.9 t -83.18 7.62 15.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.755 0.788 . . . . 1.47 109.447 174.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.673 ' HB3' ' H ' ' A' ' 12' ' ' ALA . 6.3 p -70.15 -25.24 63.37 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.299 -0.864 . . . . 1.36 112.317 -175.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.9 t -93.6 11.37 29.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.975 0.417 . . . . 1.64 110.745 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 55.71 63.57 6.14 Favored Pre-proline 0 N--CA 1.468 0.451 0 CA-C-N 115.396 -0.82 . . . . 1.69 111.041 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.532 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 23.6 Cg_exo -63.95 -56.01 0.55 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.994 2.463 . . . . 0.54 112.512 -174.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.476 ' SG ' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -96.56 7.61 46.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.91 -0.587 . . . . 0.55 111.212 -178.692 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.417 ' HA3' ' HD3' ' A' ' 21' ' ' PRO . . . 73.22 -130.5 13.76 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.009 -0.615 . . . . 0.69 112.789 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 24' ' ' ALA . 10.6 Cg_endo -91.24 170.89 3.14 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 123.709 2.94 . . . . 0.83 112.555 -178.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -63.75 -21.0 66.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.633 -0.712 . . . . 3.42 110.588 176.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.58 -32.78 74.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.941 0.4 . . . . 0.65 110.56 175.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.509 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . . . -94.61 -63.61 1.16 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.96 -0.564 . . . . 0.41 110.952 -177.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -162.25 142.05 7.67 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.69 -0.767 . . . . 0.61 112.277 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.2 m -84.38 141.18 31.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.786 0.327 . . . . 0.87 110.215 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.476 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 6.9 p -100.17 129.35 46.18 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.215 -0.448 . . . . 1.42 110.068 177.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -128.31 111.48 13.42 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.399 -0.593 . . . . 1.92 109.399 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.45 ' HG3' ' HB3' ' A' ' 13' ' ' ALA . 2.9 mp0 -68.33 119.71 13.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.127 0.489 . . . . 1.66 110.93 -178.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 60.7 p -102.66 -175.69 2.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.581 -0.736 . . . . 0.62 110.403 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -64.78 -44.84 88.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.693 0.283 . . . . 2.43 110.258 175.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.5 m -62.75 -41.09 99.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.091 0.472 . . . . 1.44 110.667 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 172.64 -82.19 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.81 -0.709 . . . . 0.37 111.657 177.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.59 ' CD1' ' HB1' ' A' ' 13' ' ' ALA . 42.4 p90 -155.5 156.01 34.45 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.91 0.385 . . . . 0.57 110.886 176.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 46.3 pt -125.06 159.69 31.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.716 -0.675 . . . . 0.64 109.485 172.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.532 ' SG ' ' HB2' ' A' ' 18' ' ' PRO . 36.4 m -123.57 121.1 34.75 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.108 0.48 . . . . 0.29 110.539 178.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -101.92 100.18 10.45 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.048 -0.723 . . . . 4.43 109.048 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 75.1 m -80.72 136.63 36.2 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.967 -0.56 . . . . 0.27 111.108 -175.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -71.83 155.07 40.83 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.254 -0.885 . . . . 0.71 109.327 175.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -60.49 121.2 11.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.154 0.502 . . . . 2.9 110.105 -178.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.48 -10.42 11.53 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.721 -0.952 . . . . 0.48 110.721 -170.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.509 ' CE2' ' HA ' ' A' ' 24' ' ' ALA . 92.9 m-85 -123.91 162.62 22.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.96 -0.62 . . . . 0.54 110.099 176.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.476 ' HG3' HG13 ' A' ' 55' ' ' ILE . 31.6 ptt180 -139.04 156.51 47.14 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.906 0.384 . . . . 3.05 110.665 -177.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.437 HD13 ' HA ' ' A' ' 44' ' ' ILE . 14.1 mm -83.08 130.31 35.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.949 -0.569 . . . . 0.34 110.705 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 44.1 t -132.21 155.99 47.25 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.579 -0.737 . . . . 0.49 109.809 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 84.3 mt -105.34 136.84 44.14 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.331 -0.618 . . . . 0.95 109.331 175.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -59.22 -28.13 66.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.059 -0.973 . . . . 2.52 111.832 -176.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 137.07 -34.69 2.17 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.804 -0.918 . . . . 1.42 110.804 -174.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 56.2 p -87.26 -29.72 21.44 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.368 0.604 . . . . 1.27 109.398 175.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 127.78 14.73 2.5 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.314 -0.857 . . . . 0.79 112.333 176.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -82.02 142.34 32.44 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.845 0.355 . . . . 1.5 110.248 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.3 t -79.21 111.64 16.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.898 -0.592 . . . . 0.5 111.163 -172.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.9 p -120.64 169.95 9.89 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.983 -0.553 . . . . 1.05 110.263 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.416 ' HB2' ' HB3' ' A' ' 19' ' ' CYS . 17.3 t -125.0 131.85 53.35 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 110.04 -0.356 . . . . 0.29 110.04 -178.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.476 HG13 ' HG3' ' A' ' 43' ' ' ARG . 29.0 pt -133.02 169.99 20.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.053 -0.521 . . . . 0.47 110.204 -179.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.407 HG21 ' HA ' ' A' ' 59' ' ' GLU . 11.0 p -72.85 140.74 17.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.995 0.426 . . . . 0.74 110.801 -177.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -76.75 -37.79 55.32 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.82 -0.627 . . . . 4.7 110.409 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -150.44 -65.45 0.2 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.155 -0.683 . . . . 3.32 109.155 172.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.407 ' HA ' HG21 ' A' ' 56' ' ' VAL . 9.8 tp10 -174.96 100.56 0.08 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.306 -0.861 . . . . 5.99 109.378 177.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.9 t 52.59 38.87 27.01 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 121.546 0.689 . . . . 4.66 109.813 -174.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.948 0 CA-C-O 117.761 -1.577 . . . . 4.74 110.132 -173.429 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.9 m . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 120.892 0.377 . . . . 2.8 110.557 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.579 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 52.9 tt0 -93.84 94.42 8.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.879 0.371 . . . . 6.69 110.092 -177.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.0 mt -85.74 99.71 11.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.959 -0.564 . . . . 2.82 111.595 -175.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.7 m 72.11 -62.52 0.46 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.513 -0.767 . . . . 3.77 112.368 173.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -132.44 -63.95 0.78 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.888 0.375 . . . . 4.59 110.484 -176.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.485 ' C ' ' H ' ' A' ' 12' ' ' ALA . 14.7 p -90.26 142.18 28.24 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.92 -0.582 . . . . 2.42 110.868 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.579 ' HA ' ' HA ' ' A' ' 6' ' ' GLN . 11.4 Cg_exo -72.47 29.04 0.27 Allowed 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 123.009 2.473 . . . . 1.69 112.144 171.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.518 ' HB3' ' OE2' ' A' ' 29' ' ' GLU . . . 43.63 -96.01 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.633 1.346 . . . . 1.42 114.633 175.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.707 ' HB3' ' HG2' ' A' ' 29' ' ' GLU . . . -86.23 -18.09 33.04 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.261 0.553 . . . . 0.64 110.802 -174.074 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 41.9 t -104.15 11.81 34.63 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.773 -0.825 . . . . 1.47 108.773 175.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 39.3 t -65.94 -28.53 68.99 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.073 -0.967 . . . . 1.36 111.151 -174.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.1 m -101.45 13.21 35.69 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.968 0.413 . . . . 1.64 111.472 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.6 m120 55.79 84.54 0.21 Allowed Pre-proline 0 N--CA 1.469 0.509 0 CA-C-N 115.389 -0.823 . . . . 1.69 112.103 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.441 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 2.9 Cg_exo -73.13 -58.26 0.07 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.998 2.465 . . . . 0.54 112.36 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.463 ' HB3' ' HB2' ' A' ' 54' ' ' CYS . 0.0 OUTLIER -86.39 17.52 3.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.069 -0.514 . . . . 0.55 111.796 -175.048 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.477 ' HA3' ' HD3' ' A' ' 21' ' ' PRO . . . 76.01 -124.82 7.54 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.036 -0.602 . . . . 0.69 112.938 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.477 ' HD3' ' HA3' ' A' ' 20' ' ' GLY . 9.2 Cg_endo -90.52 160.73 4.4 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.725 2.95 . . . . 0.83 112.362 -178.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -64.31 -21.31 66.56 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.642 -0.708 . . . . 3.42 111.325 -178.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.69 -31.96 67.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.324 -0.398 . . . . 0.65 110.78 177.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.448 ' HB3' ' HD2' ' A' ' 21' ' ' PRO . . . -76.92 -50.16 13.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.812 -0.631 . . . . 0.41 110.59 -177.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -172.82 166.6 39.26 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.23 -0.986 . . . . 0.61 112.866 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.5 m -93.41 139.37 30.77 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.997 -0.372 . . . . 0.87 109.997 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.45 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 6.0 p -100.52 115.63 30.56 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.258 0.551 . . . . 1.42 110.39 177.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -114.6 119.78 37.94 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.911 -0.586 . . . . 1.92 109.696 -176.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.707 ' HG2' ' HB3' ' A' ' 13' ' ' ALA . 31.6 mt-10 -79.8 130.14 35.07 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.01 -0.541 . . . . 1.66 110.568 -175.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.3 p -121.54 -174.86 2.95 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.854 -0.612 . . . . 0.62 111.43 -173.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -68.67 -29.3 67.74 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.961 0.41 . . . . 2.43 110.904 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.6 t -85.85 -4.76 59.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.178 0.513 . . . . 1.44 110.165 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 133.08 -83.12 0.3 Allowed Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 111.144 -0.782 . . . . 0.37 111.144 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.441 ' CE1' ' HB3' ' A' ' 18' ' ' PRO . 46.3 p90 -156.62 153.48 28.63 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.072 0.463 . . . . 0.57 110.593 178.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 47.6 pt -125.7 165.19 23.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 108.764 -0.828 . . . . 0.64 108.764 169.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.417 ' O ' HD11 ' A' ' 44' ' ' ILE . 62.6 m -121.38 131.25 54.07 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.225 0.536 . . . . 0.29 110.443 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -107.73 98.07 7.71 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.302 -0.863 . . . . 4.43 108.775 177.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 90.6 m -79.85 133.25 36.25 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.192 0.52 . . . . 0.27 110.865 -176.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -64.9 143.99 57.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.17 -0.923 . . . . 0.71 109.439 177.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.46 ' CD ' ' H ' ' A' ' 40' ' ' GLN . 2.7 pm0 -44.69 111.13 0.28 Allowed 'General case' 0 C--O 1.234 0.271 0 O-C-N 123.864 0.728 . . . . 2.9 111.268 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.684 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 125.96 -20.49 6.35 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.375 -0.829 . . . . 0.48 111.124 -174.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -112.91 162.43 15.84 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.126 -0.537 . . . . 0.54 109.682 174.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.428 ' HG3' HG13 ' A' ' 55' ' ' ILE . 30.3 ptt180 -140.72 157.25 45.69 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.976 0.417 . . . . 3.05 110.882 -176.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.449 HD13 ' HA ' ' A' ' 44' ' ' ILE . 21.1 mm -82.11 128.12 39.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.463 -0.789 . . . . 0.34 111.223 -178.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.406 ' HB2' HG12 ' A' ' 55' ' ' ILE . 33.4 t -129.59 150.47 50.9 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.633 -0.712 . . . . 0.49 109.083 176.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 52' ' ' VAL . 64.5 mt -115.53 124.17 50.37 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.033 -0.729 . . . . 0.95 109.033 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.43 56.61 1.41 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.023 -0.535 . . . . 2.52 112.228 -175.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.75 -56.88 4.24 Favored Glycine 0 N--CA 1.453 -0.195 0 CA-C-N 116.225 -0.443 . . . . 1.42 113.298 174.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.1 p -78.92 7.56 7.0 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.161 0.43 . . . . 1.27 112.161 -176.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.85 10.75 84.69 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.983 -0.627 . . . . 0.79 112.552 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.427 ' O ' ' HA ' ' A' ' 46' ' ' LEU . 12.9 m120 -72.41 128.08 34.53 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.122 -0.696 . . . . 1.5 109.122 176.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.468 ' HA ' HD23 ' A' ' 46' ' ' LEU . 31.5 t -79.69 111.49 16.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.024 -0.534 . . . . 0.5 110.631 -174.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.9 p -122.34 177.79 5.23 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.593 -0.521 . . . . 1.05 109.593 177.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.463 ' HB2' ' HB3' ' A' ' 19' ' ' CYS . 25.4 t -129.19 129.85 45.58 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.928 0.394 . . . . 0.29 110.051 -176.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.428 HG13 ' HG3' ' A' ' 43' ' ' ARG . 26.3 pt -131.59 164.94 33.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.081 -0.509 . . . . 0.47 110.35 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.8 p -69.35 138.44 22.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.271 0.558 . . . . 0.74 110.911 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.2 ttp180 -85.02 -53.81 5.05 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.076 -0.712 . . . . 4.7 109.076 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -177.74 89.59 0.03 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.433 -0.803 . . . . 3.32 110.33 173.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 60.13 23.7 12.98 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.216 0.821 . . . . 5.99 113.216 173.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.684 ' HA ' ' HA3' ' A' ' 41' ' ' GLY . 23.1 t 68.53 161.09 0.19 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.256 0.551 . . . . 4.66 111.515 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.928 0 CA-C-O 118.752 -1.027 . . . . 4.74 111.772 -178.842 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.526 ' HA ' ' HB3' ' A' ' 11' ' ' PRO . 47.5 t . . . . . 0 N--CA 1.479 1.018 0 CA-C-O 120.747 0.308 . . . . 2.8 110.404 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.661 ' NE2' ' HB2' ' A' ' 29' ' ' GLU . 44.0 mt-30 -139.44 179.14 6.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.273 -0.422 . . . . 6.69 110.166 177.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.1 mt 69.53 167.26 0.28 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.838 0.827 . . . . 2.82 112.195 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.0 m -109.9 30.21 6.91 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.079 -0.964 . . . . 3.77 110.836 -176.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -142.12 -76.42 0.28 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.953 -0.758 . . . . 4.59 108.953 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.424 ' C ' ' H ' ' A' ' 12' ' ' ALA . 8.9 p -137.65 146.94 55.26 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 108.546 -0.909 . . . . 2.42 108.546 173.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.758 ' HB2' ' HB3' ' A' ' 14' ' ' CYS . 44.4 Cg_endo -71.5 20.39 0.25 Allowed 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 122.558 2.172 . . . . 1.69 113.32 -177.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.424 ' H ' ' C ' ' A' ' 10' ' ' THR . . . 48.73 -94.52 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.877 0.871 . . . . 1.42 112.879 175.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.536 ' HB1' ' CD1' ' A' ' 34' ' ' TYR . . . -65.33 -27.46 68.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.272 -0.422 . . . . 0.64 111.309 -177.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.758 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 33.4 t -95.87 -2.86 46.5 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.063 -0.517 . . . . 1.47 110.559 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.42 ' HA ' ' HG2' ' A' ' 11' ' ' PRO . 9.7 t -70.72 -9.6 57.61 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.89 0.376 . . . . 1.36 111.504 -174.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.5 m -90.45 4.85 49.84 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.034 0.445 . . . . 1.64 111.275 177.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.436 ' N ' ' HD3' ' A' ' 18' ' ' PRO . 4.1 m-20 54.14 59.94 11.4 Favored Pre-proline 0 N--CA 1.467 0.423 0 CA-C-N 115.219 -0.9 . . . . 1.69 110.984 -174.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.436 ' HD3' ' N ' ' A' ' 17' ' ' ASN . 11.5 Cg_exo -70.22 -52.62 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.952 2.434 . . . . 0.54 112.131 -174.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.542 ' SG ' ' HB3' ' A' ' 27' ' ' CYS . 1.8 m -82.3 -7.3 59.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.757 -0.656 . . . . 0.55 110.754 -177.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.34 -144.83 17.42 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.779 -0.724 . . . . 0.69 112.389 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.452 ' HD2' ' CB ' ' A' ' 24' ' ' ALA . 9.6 Cg_endo -88.64 175.04 3.89 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.377 2.718 . . . . 0.83 112.761 -177.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -53.04 -46.02 68.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.401 -0.363 . . . . 3.42 111.193 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.1 -24.09 66.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.476 0.547 . . . . 0.65 112.476 -176.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.452 ' CB ' ' HD2' ' A' ' 21' ' ' PRO . . . -85.96 -65.85 0.97 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.751 0.31 . . . . 0.41 110.853 -177.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -168.56 155.97 27.0 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 119.971 -1.109 . . . . 0.61 112.901 -177.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.2 m -90.29 142.58 27.58 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.772 0.32 . . . . 0.87 110.526 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.542 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 14.9 p -100.55 129.08 46.44 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.079 0.466 . . . . 1.42 110.5 178.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.443 ' HB3' HG13 ' A' ' 35' ' ' ILE . 29.4 tptp -117.43 106.56 13.33 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.638 -0.71 . . . . 1.92 110.046 -178.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.661 ' HB2' ' NE2' ' A' ' 6' ' ' GLN . 57.4 mp0 -67.4 119.48 12.31 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.315 -0.624 . . . . 1.66 109.315 176.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 48.1 p -102.13 -173.42 2.34 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.849 -0.614 . . . . 0.62 111.037 -174.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -71.41 -37.99 71.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.18 0.514 . . . . 2.43 110.164 177.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.7 m -83.3 -28.17 29.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.76 -0.654 . . . . 1.44 111.277 -177.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 174.3 -94.56 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.878 -0.677 . . . . 0.37 111.658 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.564 ' OH ' ' HB2' ' A' ' 51' ' ' ASN . 38.1 p90 -156.1 154.21 30.57 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.628 0.252 . . . . 0.57 110.556 177.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.443 HG13 ' HB3' ' A' ' 28' ' ' LYS . 40.1 pt -129.38 165.99 28.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.876 -0.602 . . . . 0.64 109.412 171.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.45 ' O ' HD11 ' A' ' 44' ' ' ILE . 55.9 m -121.49 131.45 54.16 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.261 -0.427 . . . . 0.29 110.404 -179.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 -114.86 101.56 9.16 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.05 -0.523 . . . . 4.43 109.811 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.507 ' HB3' ' HB2' ' A' ' 42' ' ' TYR . 85.0 m -81.58 151.12 27.84 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.686 -0.688 . . . . 0.27 111.375 -174.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -84.73 159.71 20.45 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.431 -0.804 . . . . 0.71 109.325 175.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -51.19 122.68 8.07 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 120.991 0.424 . . . . 2.9 111.276 -178.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 112.45 -16.22 24.39 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.601 -0.727 . . . . 0.48 111.421 -175.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.507 ' HB2' ' HB3' ' A' ' 38' ' ' CYS . 89.6 m-85 -114.74 162.62 16.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.937 0.398 . . . . 0.54 110.597 179.04 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.554 ' HG3' HG13 ' A' ' 55' ' ' ILE . 21.9 ptt180 -140.86 158.16 44.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.141 -0.481 . . . . 3.05 111.181 -174.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.45 HD11 ' O ' ' A' ' 36' ' ' CYS . 16.0 mm -84.41 132.39 31.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.785 -0.643 . . . . 0.34 110.708 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.491 ' HB2' HG12 ' A' ' 55' ' ' ILE . 33.8 t -133.02 164.37 27.16 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.753 -0.658 . . . . 0.49 109.545 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.404 ' HA ' ' O ' ' A' ' 51' ' ' ASN . 77.5 mt -124.1 121.8 36.15 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.295 -0.631 . . . . 0.95 109.295 178.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.98 69.31 10.52 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.361 -0.382 . . . . 2.52 111.96 -176.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.44 -72.32 2.83 Favored Glycine 0 CA--C 1.517 0.216 0 CA-C-N 115.957 -0.565 . . . . 1.42 113.472 173.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.8 p -73.42 -0.41 14.77 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.397 0.517 . . . . 1.27 112.397 -173.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.35 20.3 52.52 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.32 -0.943 . . . . 0.79 111.657 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.564 ' HB2' ' OH ' ' A' ' 34' ' ' TYR . 9.5 p30 -81.76 135.91 35.45 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.116 -0.698 . . . . 1.5 109.116 175.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.402 ' HA ' HD23 ' A' ' 46' ' ' LEU . 39.4 t -79.98 118.57 27.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.061 -0.518 . . . . 0.5 111.271 -172.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 81.1 p -128.01 172.44 10.93 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.082 -0.508 . . . . 1.05 110.619 177.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 19' ' ' CYS . 40.0 t -122.79 131.64 53.86 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.961 -0.563 . . . . 0.29 109.551 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.554 HG13 ' HG3' ' A' ' 43' ' ' ARG . 23.9 pt -134.59 164.56 33.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.974 -0.557 . . . . 0.47 109.835 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.3 p -71.75 136.22 26.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.418 0.628 . . . . 0.74 110.952 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -87.93 -65.14 1.05 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.13 -1.063 . . . . 4.7 108.13 171.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 172.53 127.82 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.461 -1.245 . . . . 3.32 108.383 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 65.66 -175.43 0.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 O-C-N 123.503 0.502 . . . . 5.99 110.323 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 42.1 m -141.08 130.16 23.33 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.929 0.395 . . . . 4.66 110.641 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.91 0 CA-C-O 118.713 -1.048 . . . . 4.74 111.992 -179.323 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 52.9 t . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 109.99 -0.374 . . . . 2.7999999999999998 109.99 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.437 ' HA ' ' HB3' ' A' ' 11' ' ' PRO . 29.4 tt0 -78.54 104.1 8.92 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.107 0.479 . . . . 6.6900000000000004 110.527 -178.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.47 ' H ' ' HA ' ' A' ' 11' ' ' PRO . 86.8 mt -69.21 -65.27 0.73 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.459 -0.792 . . . . 2.8199999999999998 111.017 -178.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.3 p -162.62 -72.05 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.482 -0.326 . . . . 3.77 110.928 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -88.04 -65.06 1.06 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.675 -0.491 . . . . 4.5899999999999999 109.675 178.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.45 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 24.3 p -108.27 125.73 31.27 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-O 121.085 0.469 . . . . 2.4199999999999999 109.994 172.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.47 ' HA ' ' H ' ' A' ' 7' ' ' LEU . 34.9 Cg_exo -62.91 -17.11 58.14 Favored 'Trans proline' 0 CA--C 1.528 0.196 0 C-N-CA 122.958 2.439 . . . . 1.6899999999999999 112.818 178.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 68.09 123.78 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.778 0.674 . . . . 1.4199999999999999 110.947 -176.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.516 ' HB1' ' HB3' ' A' ' 34' ' ' TYR . . . 69.57 -56.67 0.56 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.41 0.684 . . . . 0.64000000000000001 110.866 -176.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.496 ' HA ' ' CD ' ' A' ' 18' ' ' PRO . 87.8 m -77.02 -0.34 24.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.072 0.463 . . . . 1.47 110.221 175.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.401 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 25.2 t -69.51 -18.55 63.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.887 -0.597 . . . . 1.3600000000000001 111.185 -176.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.8 m -105.94 8.86 32.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.626 0.251 . . . . 1.6399999999999999 111.544 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.5 m120 53.81 66.46 4.45 Favored Pre-proline 0 N--CA 1.467 0.41 0 CA-C-N 115.901 -0.59 . . . . 1.6899999999999999 110.96 -173.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.496 ' CD ' ' HA ' ' A' ' 14' ' ' CYS . 11.1 Cg_endo -54.88 -53.05 6.62 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.822 2.348 . . . . 0.54000000000000004 112.035 -177.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.593 ' SG ' ' HB3' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -91.21 18.9 6.38 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.941 -0.572 . . . . 0.55000000000000004 110.876 -177.327 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.443 ' HA3' ' HD3' ' A' ' 21' ' ' PRO . . . 72.93 -128.2 11.84 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.838 -0.619 . . . . 0.68999999999999995 111.867 -176.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.539 ' HD2' ' HB3' ' A' ' 24' ' ' ALA . 2.8 Cg_endo -87.05 169.88 7.34 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.462 2.774 . . . . 0.82999999999999996 112.044 178.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -66.53 -35.45 80.27 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.048 0.452 . . . . 3.4199999999999999 110.693 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.91 -28.98 70.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.83 -0.623 . . . . 0.65000000000000002 110.869 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.539 ' HB3' ' HD2' ' A' ' 21' ' ' PRO . . . -78.54 -63.53 1.38 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.40999999999999998 110.141 177.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -160.83 148.1 15.71 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.436 -0.887 . . . . 0.60999999999999999 112.259 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.8 m -94.0 140.31 29.87 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.122 -0.325 . . . . 0.87 110.122 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.593 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 19.6 p -102.86 140.75 36.73 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.015 0.436 . . . . 1.4199999999999999 110.939 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -130.59 125.27 33.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.787 -0.642 . . . . 1.9199999999999999 109.997 176.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 3.0 mp0 -66.84 122.73 18.33 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.192 0.52 . . . . 1.6599999999999999 110.326 176.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 49.3 p -122.76 -173.9 2.8 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.413 -0.812 . . . . 0.62 110.796 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -55.35 -41.38 72.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.968 0.413 . . . . 2.4300000000000002 110.907 177.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.6 m -80.18 -5.18 55.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 1.4399999999999999 111.439 -177.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 29' ' ' GLU . . . 126.89 -68.77 0.53 Allowed Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.37 -0.692 . . . . 0.37 111.37 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.516 ' HB3' ' HB1' ' A' ' 13' ' ' ALA . 54.5 p90 -155.55 156.6 35.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.832 0.348 . . . . 0.56999999999999995 110.391 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.2 pt -129.58 164.98 30.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.81 -0.632 . . . . 0.64000000000000001 109.462 170.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.9 m -123.4 128.8 50.36 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.171 0.51 . . . . 0.28999999999999998 111.39 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -112.92 100.9 9.0 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.071 -0.715 . . . . 4.4299999999999997 109.071 177.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 85.1 m -76.02 143.78 41.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.135 0.493 . . . . 0.27000000000000002 110.981 -177.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -77.06 167.96 20.9 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.198 -0.91 . . . . 0.70999999999999996 110.088 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -60.74 106.59 0.58 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.935 -0.575 . . . . 2.8999999999999999 110.685 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 122.05 -5.59 10.36 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 121.01 -0.614 . . . . 0.47999999999999998 111.714 -175.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -124.7 163.51 21.89 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 122.35 0.26 . . . . 0.54000000000000004 110.59 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.495 ' HG3' HG13 ' A' ' 55' ' ' ILE . 24.5 ptt180 -144.37 158.71 43.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.932 0.396 . . . . 3.0499999999999998 111.189 -174.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.435 HD13 ' HA ' ' A' ' 44' ' ' ILE . 15.1 mm -85.06 136.96 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.907 -0.588 . . . . 0.34000000000000002 110.485 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 37.9 t -143.84 145.02 32.03 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.935 -0.575 . . . . 0.48999999999999999 109.987 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.476 ' HB3' ' HA2' ' A' ' 50' ' ' GLY . 81.6 mt -95.08 112.99 24.64 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.466 -0.938 . . . . 0.94999999999999996 108.466 172.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -85.66 75.49 10.1 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.949 0.404 . . . . 2.52 112.014 -170.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.53 -59.0 3.74 Favored Glycine 0 CA--C 1.518 0.253 0 CA-C-N 115.859 -0.609 . . . . 1.4199999999999999 113.375 173.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.3 p -91.24 5.74 47.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.779 0.323 . . . . 1.27 111.793 -174.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.476 ' HA2' ' HB3' ' A' ' 46' ' ' LEU . . . 86.58 4.45 83.01 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.57 -0.824 . . . . 0.79000000000000004 112.681 177.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -66.05 134.52 53.04 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.685 -0.487 . . . . 1.5 109.685 175.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.7 t -79.4 109.89 14.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.185 -0.672 . . . . 0.5 109.185 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 18' ' ' PRO . 12.7 t -128.3 169.67 13.95 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 116.009 -0.541 . . . . 1.05 109.825 -179.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 35.5 t -116.39 130.18 56.63 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.521 -0.548 . . . . 0.28999999999999998 109.521 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.495 HG13 ' HG3' ' A' ' 43' ' ' ARG . 32.2 pt -127.52 166.72 23.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.954 -0.566 . . . . 0.46999999999999997 109.503 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.4 p -73.13 136.64 25.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 121.233 0.539 . . . . 0.73999999999999999 110.37 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -76.23 -33.48 59.21 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.227 -0.657 . . . . 4.7000000000000002 109.227 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 . . . . . 0 C--N 1.327 -0.405 0 CA-C-N 114.648 -1.16 . . . . 3.3199999999999998 108.473 174.523 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 27' ' ' CYS . 10.7 p . . . . . 0 N--CA 1.481 1.115 0 CA-C-O 121.806 0.812 . . . . 2.7999999999999998 110.695 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.546 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 21.8 tp60 -78.8 -42.99 26.36 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.187 -0.671 . . . . 6.6900000000000004 109.187 177.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.723 HD23 ' H ' ' A' ' 7' ' ' LEU . 1.3 pt? -106.33 164.26 12.17 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.664 -0.698 . . . . 2.8199999999999998 109.628 172.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.8 m -99.06 -12.56 20.44 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.83 0.678 . . . . 3.77 112.83 -169.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -81.74 -92.49 0.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.875 -0.417 . . . . 4.5899999999999999 109.875 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.3 p -122.18 113.37 31.13 Favored Pre-proline 0 CA--C 1.507 -0.708 0 N-CA-C 109.218 -0.66 . . . . 2.4199999999999999 109.218 168.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.823 ' HB2' ' HB2' ' A' ' 14' ' ' CYS . 26.4 Cg_exo -62.62 101.48 0.26 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.523 2.149 . . . . 1.6899999999999999 109.668 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.07 -34.97 46.13 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.611 0.597 . . . . 1.4199999999999999 112.611 -170.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.907 ' HB3' ' HG2' ' A' ' 29' ' ' GLU . . . -84.22 -36.9 22.43 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.967 0.413 . . . . 0.64000000000000001 110.931 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.823 ' HB2' ' HB2' ' A' ' 11' ' ' PRO . 33.5 m -83.09 -18.5 39.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.314 -0.403 . . . . 1.47 111.45 -176.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 34.5 t -68.41 -8.99 45.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.127 0.489 . . . . 1.3600000000000001 109.81 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.0 m -88.81 -0.08 57.01 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.97 -0.559 . . . . 1.6399999999999999 110.882 175.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 59.43 68.71 1.48 Allowed Pre-proline 0 N--CA 1.467 0.422 0 CA-C-N 115.107 -0.951 . . . . 1.6899999999999999 111.852 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.46 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 3.5 Cg_exo -78.85 -75.08 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.91 2.407 . . . . 0.54000000000000004 112.44 -177.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.45 24.05 0.28 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.469 -0.332 . . . . 0.55000000000000004 111.81 -177.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.48 -123.14 15.98 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.118 -0.563 . . . . 0.68999999999999995 111.837 -178.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -87.11 154.44 8.29 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.836 2.357 . . . . 0.82999999999999996 111.494 175.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -70.02 -7.25 39.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.114 0.483 . . . . 3.4199999999999999 110.364 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.84 -34.51 51.82 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.0 -0.545 . . . . 0.65000000000000002 110.127 173.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.457 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . . . -71.86 -52.41 17.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.753 -0.658 . . . . 0.40999999999999998 109.492 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.411 ' CA ' ' HA ' ' A' ' 38' ' ' CYS . . . -156.86 159.39 29.55 Favored Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 120.57 -0.824 . . . . 0.60999999999999999 111.79 177.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.8 m -83.44 138.08 33.62 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.985 -0.746 . . . . 0.87 108.985 176.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.42 ' O ' HG12 ' A' ' 5' ' ' VAL . 41.7 t -98.7 112.94 24.85 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.394 0.616 . . . . 1.4199999999999999 109.535 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.453 ' HB3' HG13 ' A' ' 35' ' ' ILE . 1.7 tmtp? -110.31 102.76 11.38 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.549 -0.75 . . . . 1.9199999999999999 109.18 -175.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.907 ' HG2' ' HB3' ' A' ' 13' ' ' ALA . 28.6 mt-10 -73.7 122.66 22.69 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.705 -0.68 . . . . 1.6599999999999999 110.401 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 35.8 p -102.42 -175.07 2.72 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.468 -0.787 . . . . 0.62 110.228 -177.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -74.61 -26.17 59.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.514 0.673 . . . . 2.4300000000000002 109.296 176.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.6 m -84.56 -8.44 58.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.312 -0.858 . . . . 1.4399999999999999 111.092 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 142.07 -93.41 0.18 Allowed Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.392 -0.683 . . . . 0.37 111.392 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.544 ' HB3' ' HB1' ' A' ' 13' ' ' ALA . 50.2 p90 -153.46 154.69 34.88 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.314 0.578 . . . . 0.56999999999999995 111.178 177.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.453 HG13 ' HB3' ' A' ' 28' ' ' LYS . 44.7 pt -129.42 160.2 40.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 108.186 -1.042 . . . . 0.64000000000000001 108.186 168.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 99.4 m -120.83 134.8 55.28 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.041 0.448 . . . . 0.28999999999999998 110.743 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.586 ' HA ' ' NE ' ' A' ' 37' ' ' ARG . 1.5 tpm_? -117.13 99.98 7.41 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.74 -0.664 . . . . 4.4299999999999997 109.358 177.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.505 ' HB3' ' HB2' ' A' ' 42' ' ' TYR . 81.1 m -73.47 141.66 46.83 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.049 0.452 . . . . 0.27000000000000002 110.855 -176.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -73.88 168.67 18.97 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.86 -0.609 . . . . 0.70999999999999996 109.763 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -59.0 118.7 6.11 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.989 0.424 . . . . 2.8999999999999999 110.245 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 116.18 -14.26 16.14 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.715 -0.755 . . . . 0.47999999999999998 112.017 -175.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.505 ' HB2' ' HB3' ' A' ' 38' ' ' CYS . 84.1 m-85 -120.59 162.8 19.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.654 0.264 . . . . 0.54000000000000004 110.657 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -143.78 157.65 44.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.423 -0.353 . . . . 3.0499999999999998 110.709 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.9 mm -77.27 136.04 25.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.014 -0.539 . . . . 0.34000000000000002 111.282 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 36.3 t -138.48 152.62 48.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.509 -0.768 . . . . 0.48999999999999999 109.333 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.493 HD13 ' HA2' ' A' ' 50' ' ' GLY . 75.9 mt -107.1 145.31 32.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.173 0.511 . . . . 0.94999999999999996 109.869 175.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -65.86 -21.66 66.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.524 -0.762 . . . . 2.52 111.476 -176.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 127.81 -28.69 4.36 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 111.261 -0.735 . . . . 1.4199999999999999 111.261 -176.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.5 p -100.5 -7.28 24.35 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.449 0.642 . . . . 1.27 109.951 176.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.493 ' HA2' HD13 ' A' ' 46' ' ' LEU . . . 109.78 13.75 15.56 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.438 -0.801 . . . . 0.79000000000000004 113.09 172.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -76.34 133.9 39.85 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.477 -0.564 . . . . 1.5 109.477 174.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.1 t -79.61 111.71 16.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.047 0.451 . . . . 0.5 110.683 -175.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.4 p -121.38 177.04 5.35 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.81 -0.632 . . . . 1.05 110.085 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 45.4 t -133.98 130.7 38.02 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.037 0.446 . . . . 0.28999999999999998 110.552 -176.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 32.9 pt -132.09 172.07 16.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.7 -0.682 . . . . 0.46999999999999997 109.443 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.9 p -65.66 141.42 18.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.84 0.352 . . . . 0.73999999999999999 110.243 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -76.49 -75.8 0.18 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.112 -0.699 . . . . 4.7000000000000002 109.112 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 . . . . . 0 C--N 1.319 -0.719 0 N-CA-C 108.778 -0.823 . . . . 3.3199999999999998 108.778 168.857 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.527 ' HA ' ' CB ' ' A' ' 11' ' ' PRO . 15.6 t . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 121.115 0.483 . . . . 2.7999999999999998 110.434 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.49 ' HG2' ' CD ' ' A' ' 29' ' ' GLU . 54.4 mm-40 -97.68 -177.58 3.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.419 . . . . 6.6900000000000004 109.978 176.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.6 mp 62.33 -177.64 0.13 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.634 0.584 . . . . 2.8199999999999998 111.66 177.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.2 m -121.56 -3.86 9.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.162 -0.472 . . . . 3.77 111.517 -175.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -115.22 -69.32 0.86 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.954 -0.387 . . . . 4.5899999999999999 109.954 174.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.52 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 18.8 p -126.54 128.71 24.28 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.363 -0.38 . . . . 2.4199999999999999 110.609 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.527 ' CB ' ' HA ' ' A' ' 5' ' ' VAL . 58.9 Cg_endo -75.85 53.43 3.69 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 123.16 2.573 . . . . 1.6899999999999999 114.15 -172.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.518 ' O ' ' HB3' ' A' ' 15' ' ' SER . . . 43.56 -93.04 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.318 1.229 . . . . 1.4199999999999999 114.318 173.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.567 ' HB3' ' HG3' ' A' ' 29' ' ' GLU . . . -73.71 -35.14 65.09 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.105 0.478 . . . . 0.64000000000000001 110.659 -177.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.416 ' HB2' ' HB2' ' A' ' 11' ' ' PRO . 68.5 m -84.9 3.3 38.72 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.711 -0.677 . . . . 1.47 110.117 178.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.52 ' OG ' ' HB ' ' A' ' 10' ' ' THR . 30.5 t -70.3 -15.35 62.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.657 -0.701 . . . . 1.3600000000000001 111.218 -176.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.2 p -89.53 -0.26 57.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.924 0.393 . . . . 1.6399999999999999 110.871 177.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.6 m120 58.93 63.9 3.54 Favored Pre-proline 0 N--CA 1.467 0.409 0 CA-C-N 115.064 -0.971 . . . . 1.6899999999999999 111.43 -175.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.509 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 20.2 Cg_exo -65.26 -50.41 2.03 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.723 2.282 . . . . 0.54000000000000004 111.782 -177.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.517 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 0.7 OUTLIER -87.44 8.01 26.64 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.861 -0.608 . . . . 0.55000000000000004 110.252 -179.266 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.433 ' HA3' ' HD3' ' A' ' 21' ' ' PRO . . . 76.72 -122.95 6.47 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.743 -0.662 . . . . 0.68999999999999995 112.783 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.433 ' HD3' ' HA3' ' A' ' 20' ' ' GLY . 4.5 Cg_endo -83.29 162.41 15.15 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.617 2.878 . . . . 0.82999999999999996 112.554 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -67.61 -18.78 65.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.356 -0.838 . . . . 3.4199999999999999 111.85 -177.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.51 -16.63 47.98 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.82 0.343 . . . . 0.65000000000000002 111.111 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.43 -60.73 2.25 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.266 -0.424 . . . . 0.40999999999999998 110.88 -177.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -161.14 164.56 34.94 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.009 -1.091 . . . . 0.60999999999999999 113.224 -177.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.25 134.75 34.93 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.995 -0.372 . . . . 0.87 109.995 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.517 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 49.4 t -117.5 119.79 36.11 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.843 0.354 . . . . 1.4199999999999999 110.905 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -118.48 126.24 51.6 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.786 -0.643 . . . . 1.9199999999999999 110.246 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.567 ' HG3' ' HB3' ' A' ' 13' ' ' ALA . 49.4 mp0 -70.71 123.78 22.71 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.116 -0.493 . . . . 1.6599999999999999 109.857 175.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 73.3 p -115.3 -174.72 2.56 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.244 -0.435 . . . . 0.62 110.763 -178.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -77.78 -26.37 49.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.299 0.571 . . . . 2.4300000000000002 109.868 175.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.85 -25.86 60.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.709 -0.678 . . . . 1.4399999999999999 109.588 175.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 147.93 -82.69 0.19 Allowed Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.525 -1.03 . . . . 0.37 110.525 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.447 ' HD2' ' HB1' ' A' ' 13' ' ' ALA . 28.0 p90 -154.83 163.64 39.98 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 110.111 -0.329 . . . . 0.56999999999999995 110.111 175.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.1 pt -128.59 151.5 35.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 116.182 -0.463 . . . . 0.64000000000000001 110.369 175.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.509 ' SG ' ' HB2' ' A' ' 18' ' ' PRO . 20.9 m -121.23 118.81 30.54 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.191 0.519 . . . . 0.28999999999999998 110.306 178.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -108.78 100.55 9.76 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.514 -0.766 . . . . 4.4299999999999997 110.075 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 98.6 m -75.72 139.65 42.01 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.078 0.466 . . . . 0.27000000000000002 111.469 -175.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -84.54 175.99 8.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.55 -0.75 . . . . 0.70999999999999996 110.486 177.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -54.77 119.31 5.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.052 -0.522 . . . . 2.8999999999999999 110.765 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.82 2.22 46.07 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.577 -0.82 . . . . 0.47999999999999998 112.327 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -127.79 162.16 27.28 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.145 -0.317 . . . . 0.54000000000000004 110.145 177.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -145.96 154.47 41.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.858 0.361 . . . . 3.0499999999999998 110.978 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.48 HD11 ' O ' ' A' ' 36' ' ' CYS . 20.9 mm -78.33 133.49 30.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.797 -0.638 . . . . 0.34000000000000002 110.346 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.4 t -140.01 151.37 45.41 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.137 -0.69 . . . . 0.48999999999999999 109.137 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.406 ' HB3' ' HA2' ' A' ' 50' ' ' GLY . 55.8 mt -102.85 145.35 29.92 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.519 -0.549 . . . . 0.94999999999999996 109.519 173.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -84.43 -160.24 0.46 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.705 -0.68 . . . . 2.52 109.776 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -65.67 -28.07 73.26 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.647 -0.787 . . . . 1.4199999999999999 112.938 177.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 82.6 p -90.76 -30.38 17.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 117.261 0.53 . . . . 1.27 111.407 -176.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.406 ' HA2' ' HB3' ' A' ' 46' ' ' LEU . . . 111.82 18.49 7.85 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.681 -0.771 . . . . 0.79000000000000004 111.403 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 -74.73 141.97 44.41 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.401 -0.4 . . . . 1.5 109.961 177.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.9 t -78.3 110.84 14.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.103 0.477 . . . . 0.5 109.933 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.0 p -124.99 169.79 11.76 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.818 -0.628 . . . . 1.05 110.464 -177.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 25.2 t -121.81 129.93 53.01 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.084 -0.71 . . . . 0.28999999999999998 109.084 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 33.9 pt -128.49 157.21 41.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.527 -0.306 . . . . 0.46999999999999997 110.383 -177.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.91 123.85 22.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.422 0.629 . . . . 0.73999999999999999 110.369 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -88.49 142.09 28.0 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.668 -0.696 . . . . 4.7000000000000002 109.866 -177.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.019 -0.537 . . . . 3.3199999999999998 111.083 178.097 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.634 HG22 ' HG3' ' A' ' 11' ' ' PRO . 11.8 t . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 121.162 0.506 . . . . 2.7999999999999998 110.159 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.476 ' OE1' ' HB2' ' A' ' 29' ' ' GLU . 55.4 mt-30 -94.4 -10.77 31.48 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.267 0.469 . . . . 6.6900000000000004 112.267 -178.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.407 HD11 ' HB2' ' A' ' 12' ' ' ALA . 62.1 mt -81.99 -87.53 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.674 -0.41 . . . . 2.8199999999999998 110.935 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.7 m -147.11 -67.07 0.26 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.022 0.439 . . . . 3.77 110.05 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.432 ' HG3' HG23 ' A' ' 10' ' ' THR . 10.8 pt-20 -118.12 -30.05 5.42 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.205 -0.452 . . . . 4.5899999999999999 110.126 177.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.5 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 37.8 p -100.35 132.03 23.12 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.054 -0.521 . . . . 2.4199999999999999 110.686 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.963 ' HB2' ' HB2' ' A' ' 14' ' ' CYS . 4.1 Cg_exo -78.0 29.39 0.45 Allowed 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 123.489 2.793 . . . . 1.6899999999999999 113.458 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.407 ' HB2' HD11 ' A' ' 7' ' ' LEU . . . 50.98 -99.72 0.08 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.879 0.696 . . . . 1.4199999999999999 112.879 176.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . . . -66.66 -27.34 67.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.457 0.646 . . . . 0.64000000000000001 110.334 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.963 ' HB2' ' HB2' ' A' ' 11' ' ' PRO . 69.0 m -93.85 3.35 55.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.4 -0.818 . . . . 1.47 110.78 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.756 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 20.7 t -69.96 -22.3 63.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.366 -0.379 . . . . 1.3600000000000001 110.97 -176.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.6 m -89.09 7.1 36.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.492 -0.322 . . . . 1.6399999999999999 111.357 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 54.03 72.59 1.08 Allowed Pre-proline 0 N--CA 1.466 0.369 0 CA-C-N 115.693 -0.685 . . . . 1.6899999999999999 111.183 -176.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.417 ' HG2' ' SG ' ' A' ' 27' ' ' CYS . 14.4 Cg_exo -66.29 -42.22 10.78 Favored 'Trans proline' 0 CA--C 1.52 -0.213 0 C-N-CA 123.13 2.554 . . . . 0.54000000000000004 111.803 -175.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.504 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -82.02 -3.11 53.82 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.542 -0.753 . . . . 0.55000000000000004 110.337 -178.189 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.16 -137.59 13.52 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.433 -0.803 . . . . 0.68999999999999995 111.324 -176.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.489 ' HD2' ' CB ' ' A' ' 24' ' ' ALA . 6.2 Cg_exo -77.72 171.34 17.57 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.593 2.195 . . . . 0.82999999999999996 111.769 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.34 -39.53 94.79 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.905 0.383 . . . . 3.4199999999999999 110.318 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.47 -23.62 66.01 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.512 -0.767 . . . . 0.65000000000000002 111.397 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.489 ' CB ' ' HD2' ' A' ' 21' ' ' PRO . . . -81.36 -56.57 3.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.908 0.385 . . . . 0.40999999999999998 110.363 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -171.39 161.1 33.46 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.619 -0.801 . . . . 0.60999999999999999 111.965 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.6 m -102.33 140.74 36.21 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.548 -0.538 . . . . 0.87 109.548 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.504 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 38.2 t -105.35 143.28 33.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.189 0.518 . . . . 1.4199999999999999 110.752 -177.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.761 ' HE2' ' HA ' ' A' ' 28' ' ' LYS . 0.5 OUTLIER -131.88 122.07 25.08 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.725 -0.67 . . . . 1.9199999999999999 110.139 -177.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.476 ' HB2' ' OE1' ' A' ' 6' ' ' GLN . 5.0 mp0 -66.99 125.79 27.09 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.356 -0.609 . . . . 1.6599999999999999 109.356 175.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 31.8 p -106.98 173.71 6.2 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.851 -0.613 . . . . 0.62 110.494 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -79.82 46.83 0.81 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 122.027 0.918 . . . . 2.4300000000000002 109.974 175.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.5 t -162.9 -41.43 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.816 -1.083 . . . . 1.4399999999999999 108.325 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -179.52 -100.08 0.13 Allowed Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.298 -0.864 . . . . 0.37 111.276 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.422 ' HB3' ' HB3' ' A' ' 13' ' ' ALA . 36.9 p90 -148.93 151.23 34.27 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.748 -0.464 . . . . 0.56999999999999995 109.748 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.8 pt -129.87 161.88 38.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.936 -0.394 . . . . 0.64000000000000001 109.936 172.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 33.3 m -121.22 130.95 53.95 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.239 -0.437 . . . . 0.28999999999999998 110.821 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.403 ' HD2' ' HA ' ' A' ' 37' ' ' ARG . 27.0 tpt180 -111.02 101.52 10.07 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.946 -0.761 . . . . 4.4299999999999997 108.946 175.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 42' ' ' TYR . 88.9 m -73.56 145.31 45.6 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.911 -0.586 . . . . 0.27000000000000002 110.876 -177.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -77.69 170.88 15.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.537 -0.756 . . . . 0.70999999999999996 109.772 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -66.2 103.23 0.95 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.049 0.452 . . . . 2.8999999999999999 110.335 -178.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 128.6 -1.03 6.41 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.529 -0.76 . . . . 0.47999999999999998 111.456 -175.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.53 ' HB2' ' HB3' ' A' ' 38' ' ' CYS . 80.2 m-85 -130.23 162.44 28.94 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.673 -0.491 . . . . 0.54000000000000004 109.673 177.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.811 ' HG2' ' HB2' ' A' ' 57' ' ' ARG . 2.7 ptp180 -143.55 161.47 38.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.612 0.244 . . . . 3.0499999999999998 110.72 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 44' ' ' ILE . 12.5 mm -81.3 140.03 17.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 121.059 0.457 . . . . 0.34000000000000002 111.38 -176.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.4 t -147.12 154.68 41.41 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.693 -0.685 . . . . 0.48999999999999999 109.36 177.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.404 HD13 ' HA2' ' A' ' 50' ' ' GLY . 80.9 mt -96.79 145.99 25.32 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.435 -0.58 . . . . 0.94999999999999996 109.435 174.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -64.79 -15.04 61.15 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.546 -0.752 . . . . 2.52 111.901 -177.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.49 -30.26 4.76 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.353 -0.699 . . . . 1.4199999999999999 111.353 -176.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.5 p -102.84 -24.43 13.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.103 0.478 . . . . 1.27 110.219 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.404 ' HA2' HD13 ' A' ' 46' ' ' LEU . . . 131.04 20.85 1.13 Allowed Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.543 -0.753 . . . . 0.79000000000000004 112.897 174.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -83.82 133.08 34.77 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.618 -0.512 . . . . 1.5 109.618 174.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.6 t -80.02 111.8 17.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.023 0.439 . . . . 0.5 110.333 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.7 t -127.45 173.85 9.49 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.909 -0.587 . . . . 1.05 109.582 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.501 ' HB3' ' O ' ' A' ' 19' ' ' CYS . 48.5 t -122.83 131.19 53.65 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.555 -0.535 . . . . 0.28999999999999998 109.555 -176.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 20.9 pt -123.54 142.15 41.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.14 0.495 . . . . 0.46999999999999997 110.945 -176.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.1 p -66.55 126.77 26.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.424 -0.807 . . . . 0.73999999999999999 110.514 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.811 ' HB2' ' HG2' ' A' ' 43' ' ' ARG . 4.2 tpm_? -123.34 131.89 53.81 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.979 -0.748 . . . . 4.7000000000000002 108.979 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 . . . . . 0 C--O 1.239 0.5 0 CA-C-O 121.062 0.458 . . . . 3.3199999999999998 111.265 -176.137 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.445 HG13 ' SG ' ' A' ' 27' ' ' CYS . 16.9 m . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.933 0.397 . . . . 2.7999999999999998 111.436 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.88 -32.85 15.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.955 0.407 . . . . 6.6900000000000004 110.34 178.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.575 HD12 ' HA ' ' A' ' 11' ' ' PRO . 95.7 mt -85.67 -175.57 5.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.989 -0.551 . . . . 2.8199999999999998 110.939 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.4 t -69.51 -72.52 0.19 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.394 -0.366 . . . . 3.77 111.804 -173.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.415 ' HB2' ' H ' ' A' ' 10' ' ' THR . 13.0 mm-40 -98.92 -88.92 0.32 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.095 0.474 . . . . 4.5899999999999999 110.759 -171.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.52 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 0.7 OUTLIER -102.47 108.1 56.23 Favored Pre-proline 0 N--CA 1.446 -0.642 0 CA-C-N 115.754 -0.657 . . . . 2.4199999999999999 109.499 175.118 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.575 ' HA ' HD12 ' A' ' 7' ' ' LEU . 0.9 OUTLIER -81.9 64.8 8.51 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.581 2.854 . . . . 1.6899999999999999 113.568 -169.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.444 ' O ' ' HB3' ' A' ' 15' ' ' SER . . . 43.65 -87.44 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 O-C-N 124.339 1.024 . . . . 1.4199999999999999 113.712 174.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.449 ' HB1' ' CD1' ' A' ' 34' ' ' TYR . . . -62.55 -41.59 98.99 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.301 -0.409 . . . . 0.64000000000000001 111.532 -177.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.598 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 52.5 t -85.37 -3.15 58.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.143 0.497 . . . . 1.47 110.774 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.444 ' HB3' ' O ' ' A' ' 12' ' ' ALA . 36.6 t -65.59 -17.52 64.64 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.283 -0.417 . . . . 1.3600000000000001 111.463 -177.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 36.5 m -108.1 14.89 24.74 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.925 0.393 . . . . 1.6399999999999999 111.49 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 55.95 73.29 0.86 Allowed Pre-proline 0 N--CA 1.47 0.544 0 CA-C-N 115.313 -0.858 . . . . 1.6899999999999999 112.283 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.598 ' HD3' ' HA ' ' A' ' 14' ' ' CYS . 24.6 Cg_endo -62.19 -43.56 23.28 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.829 2.353 . . . . 0.54000000000000004 112.191 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 2.6 m -90.56 17.9 6.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.266 -0.425 . . . . 0.55000000000000004 111.109 -176.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.463 ' HA3' ' HD3' ' A' ' 21' ' ' PRO . . . 70.98 -123.74 10.95 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 116.102 -0.499 . . . . 0.68999999999999995 112.553 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.463 ' HD3' ' HA3' ' A' ' 20' ' ' GLY . 1.6 Cg_endo -78.76 157.87 27.92 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 123.287 2.658 . . . . 0.82999999999999996 112.063 178.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -67.42 -27.9 67.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.664 -0.698 . . . . 3.4199999999999999 110.565 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.04 -15.04 61.09 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.61 -0.723 . . . . 0.65000000000000002 111.288 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.91 -52.37 6.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.341 -0.39 . . . . 0.40999999999999998 110.351 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -169.76 174.31 43.99 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.3 -0.952 . . . . 0.60999999999999999 113.083 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.5 m -101.38 140.89 35.06 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 122.46 0.304 . . . . 0.87 110.86 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.445 ' SG ' HG13 ' A' ' 5' ' ' VAL . 27.9 p -102.55 130.09 49.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.899 0.381 . . . . 1.4199999999999999 110.517 177.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -124.5 117.06 23.54 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.203 -0.666 . . . . 1.9199999999999999 109.203 176.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -71.95 119.1 15.65 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.192 0.52 . . . . 1.6599999999999999 109.973 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.9 p -112.17 -175.68 2.74 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.876 -0.602 . . . . 0.62 110.683 -176.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -68.19 -24.01 64.9 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.395 0.617 . . . . 2.4300000000000002 109.728 174.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.9 m -78.77 -19.32 52.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.614 -0.721 . . . . 1.4399999999999999 110.038 177.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 133.2 -71.77 0.49 Allowed Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.985 -0.846 . . . . 0.37 110.985 -177.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.449 ' CD1' ' HB1' ' A' ' 13' ' ' ALA . 50.2 p90 -155.98 158.93 38.71 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.306 -0.257 . . . . 0.56999999999999995 110.306 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.2 pt -131.74 157.07 43.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.272 -0.64 . . . . 0.64000000000000001 109.272 170.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.0 m -121.06 119.22 31.84 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.634 0.73 . . . . 0.28999999999999998 111.06 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -105.72 99.46 9.06 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.992 -1.003 . . . . 4.4299999999999997 109.975 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 77.8 m -77.88 146.2 35.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.979 0.418 . . . . 0.27000000000000002 110.845 -176.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -84.06 179.02 7.61 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.833 -0.622 . . . . 0.70999999999999996 109.996 176.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -58.77 132.44 53.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.674 0.273 . . . . 2.8999999999999999 110.544 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.85 5.65 80.84 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.477 -0.868 . . . . 0.47999999999999998 112.398 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -125.54 154.5 42.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.025 0.441 . . . . 0.54000000000000004 110.624 177.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.549 ' HG3' HG13 ' A' ' 55' ' ' ILE . 24.7 ptt180 -140.43 160.85 39.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.779 -0.646 . . . . 3.0499999999999998 111.172 -171.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.405 ' HA ' HD13 ' A' ' 44' ' ' ILE . 20.4 mm -87.51 134.36 27.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.798 -0.637 . . . . 0.34000000000000002 110.65 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.0 t -143.53 173.54 11.55 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.442 -0.799 . . . . 0.48999999999999999 109.217 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.409 ' HA ' ' O ' ' A' ' 51' ' ' ASN . 78.8 mt -107.69 145.02 33.97 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.247 0.546 . . . . 0.94999999999999996 109.998 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -61.85 -23.91 66.57 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.027 -0.988 . . . . 2.52 111.509 -177.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 133.61 -22.56 3.89 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 111.223 -0.751 . . . . 1.4199999999999999 111.223 -175.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 37.4 p -111.71 -27.09 8.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.042 0.449 . . . . 1.27 110.393 177.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 133.57 24.02 0.7 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.766 -0.73 . . . . 0.79000000000000004 112.901 175.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.409 ' O ' ' HA ' ' A' ' 46' ' ' LEU . 52.1 m-80 -87.26 145.9 26.18 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.417 -0.586 . . . . 1.5 109.417 174.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.1 t -79.4 111.16 15.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.953 0.406 . . . . 0.5 110.087 -176.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 18' ' ' PRO . 65.7 p -124.78 169.13 12.31 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.989 -0.55 . . . . 1.05 110.472 -178.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 34.0 t -121.81 131.23 53.95 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.023 -0.535 . . . . 0.28999999999999998 109.656 -178.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.549 HG13 ' HG3' ' A' ' 43' ' ' ARG . 34.5 pt -131.73 167.13 27.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.249 -0.432 . . . . 0.46999999999999997 110.115 -177.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.9 p -76.91 137.35 22.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.474 0.654 . . . . 0.73999999999999999 111.28 -175.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.446 ' HD3' ' HD3' ' A' ' 43' ' ' ARG . 19.1 tpt180 -101.14 106.72 17.99 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.17 -1.048 . . . . 4.7000000000000002 108.17 173.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.469 0.489 0 N-CA-C 112.209 0.448 . . . . 3.3199999999999998 112.209 -171.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.478 0.934 0 CA-C-O 122.146 0.974 . . . . 2.7999999999999998 109.93 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -81.65 -38.49 25.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.822 -0.626 . . . . 6.6900000000000004 110.718 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.662 ' HB2' ' HA ' ' A' ' 11' ' ' PRO . 85.3 mt -88.11 155.18 19.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.182 -0.463 . . . . 2.8199999999999998 110.039 178.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.3 t -85.68 -33.67 21.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.445 -0.798 . . . . 3.77 111.823 -167.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -93.71 -79.7 0.4 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.316 -0.624 . . . . 4.5899999999999999 109.316 177.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.5 p -124.04 129.61 24.69 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 115.849 -0.614 . . . . 2.4199999999999999 109.905 172.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.662 ' HA ' ' HB2' ' A' ' 7' ' ' LEU . 62.6 Cg_endo -76.78 -163.05 0.18 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.604 2.203 . . . . 1.6899999999999999 111.84 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -103.89 -65.43 1.02 Allowed 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.469 -0.492 . . . . 1.4199999999999999 110.23 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.756 ' HB3' ' HG2' ' A' ' 29' ' ' GLU . . . -71.78 -48.22 48.1 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.122 -0.49 . . . . 0.64000000000000001 110.59 -177.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.52 ' HB2' ' CG ' ' A' ' 11' ' ' PRO . 65.7 m -66.63 -23.16 66.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.366 -0.379 . . . . 1.47 111.048 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.7 t -67.94 -28.11 67.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.022 0.439 . . . . 1.3600000000000001 110.402 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.0 t -82.72 -0.89 49.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.262 0.553 . . . . 1.6399999999999999 110.291 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 62.29 73.04 0.57 Allowed Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 115.056 -0.975 . . . . 1.6899999999999999 111.146 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.534 ' O ' ' HA ' ' A' ' 53' ' ' THR . 5.7 Cg_exo -74.69 -64.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.499 2.133 . . . . 0.54000000000000004 111.162 -177.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -84.13 27.36 0.68 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.851 -0.613 . . . . 0.55000000000000004 110.869 -178.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.94 -125.5 22.24 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.142 -0.551 . . . . 0.68999999999999995 112.071 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.562 ' HG2' ' HB2' ' A' ' 24' ' ' ALA . 90.6 Cg_endo -78.51 156.78 28.65 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.778 2.319 . . . . 0.82999999999999996 112.379 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -68.43 -11.95 60.45 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.249 -0.887 . . . . 3.4199999999999999 110.39 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.81 -14.5 34.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.698 -0.683 . . . . 0.65000000000000002 111.526 177.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.562 ' HB2' ' HG2' ' A' ' 21' ' ' PRO . . . -78.27 -35.89 47.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.412 0.625 . . . . 0.40999999999999998 110.453 -177.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -177.92 -171.73 41.63 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.632 -0.794 . . . . 0.60999999999999999 112.093 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.9 m -92.12 134.1 35.16 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 110.083 -0.34 . . . . 0.87 110.083 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.44 ' SG ' ' HG2' ' A' ' 18' ' ' PRO . 43.0 t -106.1 112.67 25.81 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.375 -0.602 . . . . 1.4199999999999999 109.375 177.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.459 ' HB3' ' CG1' ' A' ' 35' ' ' ILE . 17.8 tppt? -116.05 107.66 15.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.122 -0.49 . . . . 1.9199999999999999 110.108 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.756 ' HG2' ' HB3' ' A' ' 13' ' ' ALA . 36.2 mt-10 -74.38 118.74 17.68 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.073 -0.512 . . . . 1.6599999999999999 109.973 178.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 70.9 p -109.98 -175.11 2.65 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.775 -0.648 . . . . 0.62 110.372 -175.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -76.1 -17.61 59.54 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.319 0.581 . . . . 2.4300000000000002 109.755 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.8 t -88.94 -1.2 57.99 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.664 -0.698 . . . . 1.4399999999999999 109.937 175.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 124.52 -79.89 0.36 Allowed Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 111.064 -0.814 . . . . 0.37 111.064 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.469 ' HB3' ' CB ' ' A' ' 13' ' ' ALA . 54.8 p90 -156.2 154.46 30.82 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.149 -0.315 . . . . 0.56999999999999995 110.149 178.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.459 ' CG1' ' HB3' ' A' ' 28' ' ' LYS . 44.2 pt -122.68 148.92 26.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 108.794 -0.817 . . . . 0.64000000000000001 108.794 166.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.413 ' SG ' ' HB2' ' A' ' 18' ' ' PRO . 50.3 m -120.63 123.03 41.81 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.279 0.561 . . . . 0.28999999999999998 110.791 -177.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 48.6 ttp85 -116.08 100.73 8.16 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.354 -0.839 . . . . 4.4299999999999997 109.885 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 81.8 m -77.39 155.13 32.08 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.256 0.551 . . . . 0.27000000000000002 111.86 -175.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -79.07 -179.63 6.8 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.061 -0.972 . . . . 0.70999999999999996 109.684 174.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -64.42 -39.15 93.28 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.981 0.419 . . . . 2.8999999999999999 111.588 -172.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.29 6.79 59.27 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.545 -0.836 . . . . 0.47999999999999998 112.743 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.478 ' HB3' ' SG ' ' A' ' 54' ' ' CYS . 96.1 m-85 -128.78 161.43 29.77 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 122.583 -0.363 . . . . 0.54000000000000004 110.938 -176.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -142.73 162.43 35.49 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.883 0.373 . . . . 3.0499999999999998 110.639 -176.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.0 mm -84.91 128.94 38.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.898 -0.592 . . . . 0.34000000000000002 110.891 -178.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.7 t -133.98 151.98 51.67 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.322 -0.854 . . . . 0.48999999999999999 109.235 178.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 86.5 mt -101.82 142.54 32.97 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.122 0.487 . . . . 0.94999999999999996 109.786 176.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -64.35 -22.02 66.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.312 -0.858 . . . . 2.52 111.959 -174.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 129.38 -23.62 4.82 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.904 -0.665 . . . . 1.4199999999999999 111.508 -175.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.6 p -106.55 -25.5 11.79 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.005 0.431 . . . . 1.27 109.85 175.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 131.47 15.56 1.6 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.928 -0.654 . . . . 0.79000000000000004 112.952 174.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -74.53 134.53 42.2 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.446 -0.576 . . . . 1.5 109.446 174.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.8 t -79.71 110.27 15.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.668 -0.493 . . . . 0.5 109.668 -178.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 18' ' ' PRO . 65.9 p -121.4 171.13 8.99 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.962 -0.563 . . . . 1.05 109.846 -178.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.478 ' SG ' ' HB3' ' A' ' 42' ' ' TYR . 15.6 t -126.72 130.68 50.82 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.328 -0.396 . . . . 0.28999999999999998 110.046 -176.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 41.2 pt -133.68 165.32 32.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.06 -0.518 . . . . 0.46999999999999997 109.937 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.0 p -65.11 127.83 26.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.336 0.588 . . . . 0.73999999999999999 110.726 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 57' ' ' ARG . 13.2 ttm180 -82.64 -40.82 20.22 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.498 -0.774 . . . . 4.7000000000000002 110.249 -178.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 . . . . . 0 C--N 1.324 -0.515 0 CA-C-N 115.419 -0.81 . . . . 3.3199999999999998 109.631 -178.371 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.659 HG13 ' H ' ' A' ' 6' ' ' GLN . 2.8 p . . . . . 0 N--CA 1.474 0.745 0 CA-C-O 119.491 -0.29 . . . . 2.7999999999999998 111.077 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.659 ' H ' HG13 ' A' ' 5' ' ' VAL . 25.0 tp60 -177.59 -48.07 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.952 0.406 . . . . 6.6900000000000004 110.148 -176.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.4 mt 69.88 -95.69 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.297 -0.865 . . . . 2.8199999999999998 112.021 173.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.3 m -154.51 -82.05 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.493 0.187 . . . . 3.77 110.893 -176.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -67.68 -64.68 0.81 Allowed 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.52 -0.548 . . . . 4.5899999999999999 109.52 177.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.6 p -141.35 143.41 30.2 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 115.449 -0.796 . . . . 2.4199999999999999 109.85 176.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.467 ' HB3' ' HA ' ' A' ' 6' ' ' GLN . 48.8 Cg_endo -75.33 90.43 1.11 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 121.599 1.533 . . . . 1.6899999999999999 109.098 171.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -46.97 -33.01 4.27 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.591 0.96 . . . . 1.4199999999999999 113.591 -166.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.86 ' HB3' ' HG2' ' A' ' 29' ' ' GLU . . . -94.95 -29.89 14.42 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.218 0.451 . . . . 0.64000000000000001 112.218 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.467 ' HB2' ' HB2' ' A' ' 11' ' ' PRO . 35.7 m -97.1 2.55 51.38 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 122.039 -0.413 . . . . 1.47 111.164 -178.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.5 t -66.31 -17.88 65.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.09 -0.504 . . . . 1.3600000000000001 111.25 -173.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.7 m -97.47 4.19 50.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.605 -0.27 . . . . 1.6399999999999999 111.543 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 57.5 76.37 0.48 Allowed Pre-proline 0 N--CA 1.469 0.525 0 CA-C-N 115.616 -0.72 . . . . 1.6899999999999999 111.394 -175.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -73.23 -73.02 0.01 OUTLIER 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 122.902 2.401 . . . . 0.54000000000000004 112.784 -177.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -71.1 -28.39 64.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.191 0.519 . . . . 0.55000000000000004 111.158 -176.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.412 ' HA3' ' HD3' ' A' ' 21' ' ' PRO . . . 105.67 -122.86 7.32 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.611 -0.722 . . . . 0.68999999999999995 112.312 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.506 ' HD2' ' HB3' ' A' ' 24' ' ' ALA . 10.2 Cg_endo -86.3 156.12 9.51 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.302 2.668 . . . . 0.82999999999999996 112.49 -177.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -62.62 -23.29 66.98 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 114.984 -1.007 . . . . 3.4199999999999999 111.003 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.12 -34.58 76.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.288 -0.415 . . . . 0.65000000000000002 110.8 175.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.506 ' HB3' ' HD2' ' A' ' 21' ' ' PRO . . . -83.74 -57.89 3.03 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.032 -0.531 . . . . 0.40999999999999998 110.578 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -168.39 143.61 8.24 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.276 -0.964 . . . . 0.60999999999999999 112.452 -177.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.8 m -83.73 145.02 28.96 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.201 -0.296 . . . . 0.87 110.201 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 53.4 t -100.24 113.53 26.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.202 0.525 . . . . 1.4199999999999999 110.304 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -109.99 114.35 27.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.658 -0.701 . . . . 1.9199999999999999 109.902 -176.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.86 ' HG2' ' HB3' ' A' ' 13' ' ' ALA . 45.5 mt-10 -78.2 119.71 21.97 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.114 0.483 . . . . 1.6599999999999999 110.143 -177.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 78.7 p -119.01 -173.31 2.47 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.417 -0.81 . . . . 0.62 110.946 -173.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -64.51 -32.71 74.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.014 0.435 . . . . 2.4300000000000002 110.176 175.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.0 m -73.93 -2.67 24.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.946 -0.57 . . . . 1.4399999999999999 110.437 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.06 -74.94 0.24 Allowed Glycine 0 N--CA 1.44 -1.058 0 N-CA-C 110.496 -1.042 . . . . 0.37 110.496 -177.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.715 ' HB3' ' HB1' ' A' ' 13' ' ' ALA . 51.9 p90 -153.45 151.45 29.88 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.068 0.461 . . . . 0.56999999999999995 110.174 176.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 47.2 pt -128.5 162.07 35.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 108.384 -0.969 . . . . 0.64000000000000001 108.384 169.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.414 ' HB2' ' CD1' ' A' ' 44' ' ' ILE . 68.3 m -120.85 129.85 53.7 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.153 0.501 . . . . 0.28999999999999998 110.319 -178.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.792 ' HA ' ' HE ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -105.93 99.97 9.54 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.885 -0.598 . . . . 4.4299999999999997 109.627 178.674 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.463 ' HB3' ' HB2' ' A' ' 42' ' ' TYR . 84.3 m -83.86 133.8 34.72 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.694 -0.684 . . . . 0.27000000000000002 110.932 -176.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -68.88 151.69 46.24 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.995 -1.002 . . . . 0.70999999999999996 109.038 175.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -59.46 120.53 9.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.479 0.657 . . . . 2.8999999999999999 110.678 -176.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.25 -8.14 14.09 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 110.513 -1.035 . . . . 0.47999999999999998 110.513 -171.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.463 ' HB2' ' HB3' ' A' ' 38' ' ' CYS . 71.6 m-85 -128.02 162.8 25.96 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.915 -0.772 . . . . 0.54000000000000004 108.915 176.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.803 ' HG2' ' HB2' ' A' ' 57' ' ' ARG . 9.2 ptp180 -152.39 165.15 35.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.075 0.464 . . . . 3.0499999999999998 111.587 174.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.414 ' CD1' ' HB2' ' A' ' 36' ' ' CYS . 38.3 mm -70.29 137.64 23.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.207 -0.906 . . . . 0.34000000000000002 110.895 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.44 ' HB2' HG12 ' A' ' 55' ' ' ILE . 23.0 t -145.72 165.75 27.87 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.985 -0.746 . . . . 0.48999999999999999 108.985 178.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 87.8 mt -104.72 138.03 41.64 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.671 -0.492 . . . . 0.94999999999999996 109.671 178.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -60.6 -24.18 65.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.068 -0.969 . . . . 2.52 111.911 -174.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 131.76 -26.5 3.82 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 111.015 -0.834 . . . . 1.4199999999999999 111.015 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.2 p -100.57 -30.38 11.81 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.707 -0.479 . . . . 1.27 109.707 175.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 131.77 22.55 0.93 Allowed Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.597 -0.729 . . . . 0.79000000000000004 112.447 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -85.41 142.83 28.99 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.662 -0.496 . . . . 1.5 109.662 176.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.7 t -79.71 110.81 15.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.187 0.518 . . . . 0.5 110.138 -176.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.1 p -125.6 171.67 10.37 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.924 -0.58 . . . . 1.05 110.188 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 44.3 t -124.65 129.94 51.48 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.498 -0.556 . . . . 0.28999999999999998 109.498 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.44 HG12 ' HB2' ' A' ' 45' ' ' SER . 26.0 pt -131.27 148.02 32.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.03 0.443 . . . . 0.46999999999999997 110.723 -176.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.449 ' HA ' ' CD2' ' A' ' 42' ' ' TYR . 7.6 p -62.48 123.92 16.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.635 -0.711 . . . . 0.73999999999999999 110.442 177.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.803 ' HB2' ' HG2' ' A' ' 43' ' ' ARG . 21.5 tpt180 -125.59 114.11 18.3 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.263 -0.426 . . . . 4.7000000000000002 110.536 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 . . . . . 0 C--N 1.326 -0.452 0 CA-C-N 115.739 -0.664 . . . . 3.3199999999999998 111.182 178.812 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.0 t . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 120.928 0.394 . . . . 2.7999999999999998 110.422 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.622 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 60.9 tt0 -72.03 132.8 44.76 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.094 -0.503 . . . . 6.6900000000000004 110.513 176.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.403 ' H ' HD23 ' A' ' 7' ' ' LEU . 2.5 pt? -137.19 9.78 2.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.054 -0.521 . . . . 2.8199999999999998 110.153 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.7 p -169.55 -174.94 2.02 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.681 -0.691 . . . . 3.77 110.265 -172.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -45.17 -56.93 4.29 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.41 0.624 . . . . 4.5899999999999999 110.285 175.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.0 p -97.72 128.15 35.17 Favored Pre-proline 0 N--CA 1.441 -0.91 0 CA-C-N 115.268 -0.878 . . . . 2.4199999999999999 109.796 173.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.622 ' HA ' ' HA ' ' A' ' 6' ' ' GLN . 51.1 Cg_exo -57.95 -19.08 38.3 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.05 2.5 . . . . 1.6899999999999999 112.759 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.673 ' H ' ' HB3' ' A' ' 15' ' ' SER . . . 66.9 121.19 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.89 0.744 . . . . 1.4199999999999999 111.602 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.59 ' HB1' ' CD1' ' A' ' 34' ' ' TYR . . . 70.68 -58.37 0.56 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.655 -0.702 . . . . 0.64000000000000001 110.978 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.9 t -83.18 7.62 15.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.755 0.788 . . . . 1.47 109.447 174.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.673 ' HB3' ' H ' ' A' ' 12' ' ' ALA . 6.3 p -70.15 -25.24 63.37 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.299 -0.864 . . . . 1.3600000000000001 112.317 -175.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.9 t -93.6 11.37 29.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.975 0.417 . . . . 1.6399999999999999 110.745 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 55.71 63.57 6.14 Favored Pre-proline 0 N--CA 1.468 0.451 0 CA-C-N 115.396 -0.82 . . . . 1.6899999999999999 111.041 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.532 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 23.6 Cg_exo -63.95 -56.01 0.55 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.994 2.463 . . . . 0.54000000000000004 112.512 -174.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.476 ' SG ' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -96.56 7.61 46.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.91 -0.587 . . . . 0.55000000000000004 111.212 -178.692 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.417 ' HA3' ' HD3' ' A' ' 21' ' ' PRO . . . 73.22 -130.5 13.76 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.009 -0.615 . . . . 0.68999999999999995 112.789 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 24' ' ' ALA . 10.6 Cg_endo -91.24 170.89 3.14 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 123.709 2.94 . . . . 0.82999999999999996 112.555 -178.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -63.75 -21.0 66.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.633 -0.712 . . . . 3.4199999999999999 110.588 176.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.58 -32.78 74.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.941 0.4 . . . . 0.65000000000000002 110.56 175.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.509 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . . . -94.61 -63.61 1.16 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.96 -0.564 . . . . 0.40999999999999998 110.952 -177.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -162.25 142.05 7.67 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.69 -0.767 . . . . 0.60999999999999999 112.277 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.2 m -84.38 141.18 31.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.786 0.327 . . . . 0.87 110.215 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.476 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 6.9 p -100.17 129.35 46.18 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.215 -0.448 . . . . 1.4199999999999999 110.068 177.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -128.31 111.48 13.42 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.399 -0.593 . . . . 1.9199999999999999 109.399 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.45 ' HG3' ' HB3' ' A' ' 13' ' ' ALA . 2.9 mp0 -68.33 119.71 13.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.127 0.489 . . . . 1.6599999999999999 110.93 -178.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 60.7 p -102.66 -175.69 2.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.581 -0.736 . . . . 0.62 110.403 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -64.78 -44.84 88.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.693 0.283 . . . . 2.4300000000000002 110.258 175.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.5 m -62.75 -41.09 99.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.091 0.472 . . . . 1.4399999999999999 110.667 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 172.64 -82.19 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.81 -0.709 . . . . 0.37 111.657 177.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.59 ' CD1' ' HB1' ' A' ' 13' ' ' ALA . 42.4 p90 -155.5 156.01 34.45 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.91 0.385 . . . . 0.56999999999999995 110.886 176.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 46.3 pt -125.06 159.69 31.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.716 -0.675 . . . . 0.64000000000000001 109.485 172.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.532 ' SG ' ' HB2' ' A' ' 18' ' ' PRO . 36.4 m -123.57 121.1 34.75 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.108 0.48 . . . . 0.28999999999999998 110.539 178.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -101.92 100.18 10.45 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.048 -0.723 . . . . 4.4299999999999997 109.048 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 75.1 m -80.72 136.63 36.2 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.967 -0.56 . . . . 0.27000000000000002 111.108 -175.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -71.83 155.07 40.83 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.254 -0.885 . . . . 0.70999999999999996 109.327 175.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -60.49 121.2 11.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.154 0.502 . . . . 2.8999999999999999 110.105 -178.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.48 -10.42 11.53 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.721 -0.952 . . . . 0.47999999999999998 110.721 -170.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.509 ' CE2' ' HA ' ' A' ' 24' ' ' ALA . 92.9 m-85 -123.91 162.62 22.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.96 -0.62 . . . . 0.54000000000000004 110.099 176.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.476 ' HG3' HG13 ' A' ' 55' ' ' ILE . 31.6 ptt180 -139.04 156.51 47.14 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.906 0.384 . . . . 3.0499999999999998 110.665 -177.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.437 HD13 ' HA ' ' A' ' 44' ' ' ILE . 14.1 mm -83.08 130.31 35.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.949 -0.569 . . . . 0.34000000000000002 110.705 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 44.1 t -132.21 155.99 47.25 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.579 -0.737 . . . . 0.48999999999999999 109.809 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 84.3 mt -105.34 136.84 44.14 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.331 -0.618 . . . . 0.94999999999999996 109.331 175.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -59.22 -28.13 66.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.059 -0.973 . . . . 2.52 111.832 -176.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 137.07 -34.69 2.17 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.804 -0.918 . . . . 1.4199999999999999 110.804 -174.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 56.2 p -87.26 -29.72 21.44 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.368 0.604 . . . . 1.27 109.398 175.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 127.78 14.73 2.5 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.314 -0.857 . . . . 0.79000000000000004 112.333 176.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -82.02 142.34 32.44 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.845 0.355 . . . . 1.5 110.248 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.3 t -79.21 111.64 16.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.898 -0.592 . . . . 0.5 111.163 -172.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.9 p -120.64 169.95 9.89 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.983 -0.553 . . . . 1.05 110.263 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.416 ' HB2' ' HB3' ' A' ' 19' ' ' CYS . 17.3 t -125.0 131.85 53.35 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 110.04 -0.356 . . . . 0.28999999999999998 110.04 -178.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.476 HG13 ' HG3' ' A' ' 43' ' ' ARG . 29.0 pt -133.02 169.99 20.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.053 -0.521 . . . . 0.46999999999999997 110.204 -179.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.0 p -72.85 140.74 17.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.995 0.426 . . . . 0.73999999999999999 110.801 -177.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -76.75 -37.79 55.32 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.82 -0.627 . . . . 4.7000000000000002 110.409 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 . . . . . 0 C--N 1.324 -0.543 0 N-CA-C 109.155 -0.683 . . . . 3.3199999999999998 109.155 172.841 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.9 m . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 120.892 0.377 . . . . 2.7999999999999998 110.557 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.579 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 7.6 tt0 -93.84 94.42 8.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.879 0.371 . . . . 6.6900000000000004 110.092 -177.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.0 mt -85.74 99.71 11.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.959 -0.564 . . . . 2.8199999999999998 111.595 -175.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.7 m 72.11 -62.52 0.46 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.513 -0.767 . . . . 3.77 112.368 173.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -132.44 -63.95 0.78 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.888 0.375 . . . . 4.5899999999999999 110.484 -176.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.485 ' C ' ' H ' ' A' ' 12' ' ' ALA . 14.7 p -90.26 142.18 28.24 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.92 -0.582 . . . . 2.4199999999999999 110.868 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.579 ' HA ' ' HA ' ' A' ' 6' ' ' GLN . 11.4 Cg_exo -72.47 29.04 0.27 Allowed 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 123.009 2.473 . . . . 1.6899999999999999 112.144 171.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.518 ' HB3' ' OE2' ' A' ' 29' ' ' GLU . . . 43.63 -96.01 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.633 1.346 . . . . 1.4199999999999999 114.633 175.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.707 ' HB3' ' HG2' ' A' ' 29' ' ' GLU . . . -86.23 -18.09 33.04 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.261 0.553 . . . . 0.64000000000000001 110.802 -174.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 41.9 t -104.15 11.81 34.63 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.773 -0.825 . . . . 1.47 108.773 175.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 39.3 t -65.94 -28.53 68.99 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.073 -0.967 . . . . 1.3600000000000001 111.151 -174.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.1 m -101.45 13.21 35.69 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.968 0.413 . . . . 1.6399999999999999 111.472 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.6 m120 55.79 84.54 0.21 Allowed Pre-proline 0 N--CA 1.469 0.509 0 CA-C-N 115.389 -0.823 . . . . 1.6899999999999999 112.103 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.441 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 2.9 Cg_exo -73.13 -58.26 0.07 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.998 2.465 . . . . 0.54000000000000004 112.36 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.463 ' HB3' ' HB2' ' A' ' 54' ' ' CYS . 0.0 OUTLIER -86.39 17.52 3.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.069 -0.514 . . . . 0.55000000000000004 111.796 -175.048 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.477 ' HA3' ' HD3' ' A' ' 21' ' ' PRO . . . 76.01 -124.82 7.54 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.036 -0.602 . . . . 0.68999999999999995 112.938 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.477 ' HD3' ' HA3' ' A' ' 20' ' ' GLY . 9.2 Cg_endo -90.52 160.73 4.4 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.725 2.95 . . . . 0.82999999999999996 112.362 -178.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -64.31 -21.31 66.56 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.642 -0.708 . . . . 3.4199999999999999 111.325 -178.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.69 -31.96 67.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.324 -0.398 . . . . 0.65000000000000002 110.78 177.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.448 ' HB3' ' HD2' ' A' ' 21' ' ' PRO . . . -76.92 -50.16 13.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.812 -0.631 . . . . 0.40999999999999998 110.59 -177.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -172.82 166.6 39.26 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.23 -0.986 . . . . 0.60999999999999999 112.866 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.5 m -93.41 139.37 30.77 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.997 -0.372 . . . . 0.87 109.997 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.45 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 6.0 p -100.52 115.63 30.56 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.258 0.551 . . . . 1.4199999999999999 110.39 177.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -114.6 119.78 37.94 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.911 -0.586 . . . . 1.9199999999999999 109.696 -176.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.707 ' HG2' ' HB3' ' A' ' 13' ' ' ALA . 31.6 mt-10 -79.8 130.14 35.07 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.01 -0.541 . . . . 1.6599999999999999 110.568 -175.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.3 p -121.54 -174.86 2.95 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.854 -0.612 . . . . 0.62 111.43 -173.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -68.67 -29.3 67.74 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.961 0.41 . . . . 2.4300000000000002 110.904 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.6 t -85.85 -4.76 59.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.178 0.513 . . . . 1.4399999999999999 110.165 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 133.08 -83.12 0.3 Allowed Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 111.144 -0.782 . . . . 0.37 111.144 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.441 ' CE1' ' HB3' ' A' ' 18' ' ' PRO . 46.3 p90 -156.62 153.48 28.63 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.072 0.463 . . . . 0.56999999999999995 110.593 178.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 47.6 pt -125.7 165.19 23.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 108.764 -0.828 . . . . 0.64000000000000001 108.764 169.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.417 ' O ' HD11 ' A' ' 44' ' ' ILE . 62.6 m -121.38 131.25 54.07 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.225 0.536 . . . . 0.28999999999999998 110.443 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -107.73 98.07 7.71 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.302 -0.863 . . . . 4.4299999999999997 108.775 177.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 90.6 m -79.85 133.25 36.25 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.192 0.52 . . . . 0.27000000000000002 110.865 -176.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -64.9 143.99 57.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.17 -0.923 . . . . 0.70999999999999996 109.439 177.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.46 ' H ' ' CD ' ' A' ' 40' ' ' GLN . 2.7 pm0 -44.69 111.13 0.28 Allowed 'General case' 0 C--O 1.234 0.271 0 O-C-N 123.864 0.728 . . . . 2.8999999999999999 111.268 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 125.96 -20.49 6.35 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.375 -0.829 . . . . 0.47999999999999998 111.124 -174.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -112.91 162.43 15.84 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.126 -0.537 . . . . 0.54000000000000004 109.682 174.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.428 ' HG3' HG13 ' A' ' 55' ' ' ILE . 30.3 ptt180 -140.72 157.25 45.69 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.976 0.417 . . . . 3.0499999999999998 110.882 -176.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.449 HD13 ' HA ' ' A' ' 44' ' ' ILE . 21.1 mm -82.11 128.12 39.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.463 -0.789 . . . . 0.34000000000000002 111.223 -178.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.406 ' HB2' HG12 ' A' ' 55' ' ' ILE . 33.4 t -129.59 150.47 50.9 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.633 -0.712 . . . . 0.48999999999999999 109.083 176.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 52' ' ' VAL . 64.5 mt -115.53 124.17 50.37 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.033 -0.729 . . . . 0.94999999999999996 109.033 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.43 56.61 1.41 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.023 -0.535 . . . . 2.52 112.228 -175.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.75 -56.88 4.24 Favored Glycine 0 N--CA 1.453 -0.195 0 CA-C-N 116.225 -0.443 . . . . 1.4199999999999999 113.298 174.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.1 p -78.92 7.56 7.0 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.161 0.43 . . . . 1.27 112.161 -176.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.85 10.75 84.69 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.983 -0.627 . . . . 0.79000000000000004 112.552 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.427 ' O ' ' HA ' ' A' ' 46' ' ' LEU . 12.9 m120 -72.41 128.08 34.53 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.122 -0.696 . . . . 1.5 109.122 176.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.468 ' HA ' HD23 ' A' ' 46' ' ' LEU . 31.5 t -79.69 111.49 16.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.024 -0.534 . . . . 0.5 110.631 -174.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.9 p -122.34 177.79 5.23 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.593 -0.521 . . . . 1.05 109.593 177.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.463 ' HB2' ' HB3' ' A' ' 19' ' ' CYS . 25.4 t -129.19 129.85 45.58 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.928 0.394 . . . . 0.28999999999999998 110.051 -176.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.428 HG13 ' HG3' ' A' ' 43' ' ' ARG . 26.3 pt -131.59 164.94 33.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.081 -0.509 . . . . 0.46999999999999997 110.35 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.8 p -69.35 138.44 22.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.271 0.558 . . . . 0.73999999999999999 110.911 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.2 ttp180 -85.02 -53.81 5.05 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.076 -0.712 . . . . 4.7000000000000002 109.076 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 . . . . . 0 C--O 1.232 0.151 0 CA-C-N 115.433 -0.803 . . . . 3.3199999999999998 110.33 173.1 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.526 ' HA ' ' HB3' ' A' ' 11' ' ' PRO . 47.5 t . . . . . 0 N--CA 1.479 1.018 0 CA-C-O 120.747 0.308 . . . . 2.7999999999999998 110.404 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.661 ' NE2' ' HB2' ' A' ' 29' ' ' GLU . 44.0 mt-30 -139.44 179.14 6.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.273 -0.422 . . . . 6.6900000000000004 110.166 177.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.1 mt 69.53 167.26 0.28 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.838 0.827 . . . . 2.8199999999999998 112.195 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.0 m -109.9 30.21 6.91 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.079 -0.964 . . . . 3.77 110.836 -176.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -142.12 -76.42 0.28 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.953 -0.758 . . . . 4.5899999999999999 108.953 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.424 ' C ' ' H ' ' A' ' 12' ' ' ALA . 8.9 p -137.65 146.94 55.26 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 108.546 -0.909 . . . . 2.4199999999999999 108.546 173.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.758 ' HB2' ' HB3' ' A' ' 14' ' ' CYS . 44.4 Cg_endo -71.5 20.39 0.25 Allowed 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 122.558 2.172 . . . . 1.6899999999999999 113.32 -177.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.424 ' H ' ' C ' ' A' ' 10' ' ' THR . . . 48.73 -94.52 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.877 0.871 . . . . 1.4199999999999999 112.879 175.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.536 ' HB1' ' CD1' ' A' ' 34' ' ' TYR . . . -65.33 -27.46 68.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.272 -0.422 . . . . 0.64000000000000001 111.309 -177.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.758 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 33.4 t -95.87 -2.86 46.5 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.063 -0.517 . . . . 1.47 110.559 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.42 ' HA ' ' HG2' ' A' ' 11' ' ' PRO . 9.7 t -70.72 -9.6 57.61 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.89 0.376 . . . . 1.3600000000000001 111.504 -174.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.5 m -90.45 4.85 49.84 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.034 0.445 . . . . 1.6399999999999999 111.275 177.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.436 ' N ' ' HD3' ' A' ' 18' ' ' PRO . 4.1 m-20 54.14 59.94 11.4 Favored Pre-proline 0 N--CA 1.467 0.423 0 CA-C-N 115.219 -0.9 . . . . 1.6899999999999999 110.984 -174.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.436 ' HD3' ' N ' ' A' ' 17' ' ' ASN . 11.5 Cg_exo -70.22 -52.62 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.952 2.434 . . . . 0.54000000000000004 112.131 -174.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.542 ' SG ' ' HB3' ' A' ' 27' ' ' CYS . 1.8 m -82.3 -7.3 59.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.757 -0.656 . . . . 0.55000000000000004 110.754 -177.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.34 -144.83 17.42 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.779 -0.724 . . . . 0.68999999999999995 112.389 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.452 ' HD2' ' CB ' ' A' ' 24' ' ' ALA . 9.6 Cg_endo -88.64 175.04 3.89 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.377 2.718 . . . . 0.82999999999999996 112.761 -177.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -53.04 -46.02 68.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.401 -0.363 . . . . 3.4199999999999999 111.193 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.1 -24.09 66.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.476 0.547 . . . . 0.65000000000000002 112.476 -176.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.452 ' CB ' ' HD2' ' A' ' 21' ' ' PRO . . . -85.96 -65.85 0.97 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.751 0.31 . . . . 0.40999999999999998 110.853 -177.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -168.56 155.97 27.0 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 119.971 -1.109 . . . . 0.60999999999999999 112.901 -177.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.2 m -90.29 142.58 27.58 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.772 0.32 . . . . 0.87 110.526 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.542 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 14.9 p -100.55 129.08 46.44 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.079 0.466 . . . . 1.4199999999999999 110.5 178.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.443 ' HB3' HG13 ' A' ' 35' ' ' ILE . 29.4 tptp -117.43 106.56 13.33 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.638 -0.71 . . . . 1.9199999999999999 110.046 -178.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.661 ' HB2' ' NE2' ' A' ' 6' ' ' GLN . 57.4 mp0 -67.4 119.48 12.31 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.315 -0.624 . . . . 1.6599999999999999 109.315 176.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 48.1 p -102.13 -173.42 2.34 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.849 -0.614 . . . . 0.62 111.037 -174.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -71.41 -37.99 71.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.18 0.514 . . . . 2.4300000000000002 110.164 177.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.7 m -83.3 -28.17 29.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.76 -0.654 . . . . 1.4399999999999999 111.277 -177.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 174.3 -94.56 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.878 -0.677 . . . . 0.37 111.658 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.564 ' OH ' ' HB2' ' A' ' 51' ' ' ASN . 38.1 p90 -156.1 154.21 30.57 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.628 0.252 . . . . 0.56999999999999995 110.556 177.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.443 HG13 ' HB3' ' A' ' 28' ' ' LYS . 40.1 pt -129.38 165.99 28.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.876 -0.602 . . . . 0.64000000000000001 109.412 171.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.45 ' O ' HD11 ' A' ' 44' ' ' ILE . 55.9 m -121.49 131.45 54.16 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.261 -0.427 . . . . 0.28999999999999998 110.404 -179.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 -114.86 101.56 9.16 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.05 -0.523 . . . . 4.4299999999999997 109.811 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.507 ' HB3' ' HB2' ' A' ' 42' ' ' TYR . 85.0 m -81.58 151.12 27.84 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.686 -0.688 . . . . 0.27000000000000002 111.375 -174.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -84.73 159.71 20.45 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.431 -0.804 . . . . 0.70999999999999996 109.325 175.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -51.19 122.68 8.07 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 120.991 0.424 . . . . 2.8999999999999999 111.276 -178.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 112.45 -16.22 24.39 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.601 -0.727 . . . . 0.47999999999999998 111.421 -175.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.507 ' HB2' ' HB3' ' A' ' 38' ' ' CYS . 89.6 m-85 -114.74 162.62 16.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.937 0.398 . . . . 0.54000000000000004 110.597 179.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.554 ' HG3' HG13 ' A' ' 55' ' ' ILE . 21.9 ptt180 -140.86 158.16 44.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.141 -0.481 . . . . 3.0499999999999998 111.181 -174.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.45 HD11 ' O ' ' A' ' 36' ' ' CYS . 16.0 mm -84.41 132.39 31.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.785 -0.643 . . . . 0.34000000000000002 110.708 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.491 ' HB2' HG12 ' A' ' 55' ' ' ILE . 33.8 t -133.02 164.37 27.16 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.753 -0.658 . . . . 0.48999999999999999 109.545 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.404 ' HA ' ' O ' ' A' ' 51' ' ' ASN . 77.5 mt -124.1 121.8 36.15 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.295 -0.631 . . . . 0.94999999999999996 109.295 178.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.98 69.31 10.52 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.361 -0.382 . . . . 2.52 111.96 -176.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.44 -72.32 2.83 Favored Glycine 0 CA--C 1.517 0.216 0 CA-C-N 115.957 -0.565 . . . . 1.4199999999999999 113.472 173.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.8 p -73.42 -0.41 14.77 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.397 0.517 . . . . 1.27 112.397 -173.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.35 20.3 52.52 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.32 -0.943 . . . . 0.79000000000000004 111.657 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.564 ' HB2' ' OH ' ' A' ' 34' ' ' TYR . 9.5 p30 -81.76 135.91 35.45 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.116 -0.698 . . . . 1.5 109.116 175.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.402 ' HA ' HD23 ' A' ' 46' ' ' LEU . 39.4 t -79.98 118.57 27.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.061 -0.518 . . . . 0.5 111.271 -172.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 81.1 p -128.01 172.44 10.93 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.082 -0.508 . . . . 1.05 110.619 177.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 19' ' ' CYS . 40.0 t -122.79 131.64 53.86 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.961 -0.563 . . . . 0.28999999999999998 109.551 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.554 HG13 ' HG3' ' A' ' 43' ' ' ARG . 23.9 pt -134.59 164.56 33.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.974 -0.557 . . . . 0.46999999999999997 109.835 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.3 p -71.75 136.22 26.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.418 0.628 . . . . 0.73999999999999999 110.952 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -87.93 -65.14 1.05 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.13 -1.063 . . . . 4.7000000000000002 108.13 171.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 114.461 -1.245 . . . . 3.3199999999999998 108.383 179.585 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 52.9 t . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 109.99 -0.374 . . . . 2.7999999999999998 109.99 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.437 ' HA ' ' HB3' ' A' ' 11' ' ' PRO . 29.4 tt0 -78.54 104.1 8.92 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.107 0.479 . . . . 6.6900000000000004 110.527 -178.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.47 ' H ' ' HA ' ' A' ' 11' ' ' PRO . 86.8 mt -69.21 -65.27 0.73 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.459 -0.792 . . . . 2.8199999999999998 111.017 -178.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.3 p -162.62 -72.05 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.482 -0.326 . . . . 3.77 110.928 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -88.04 -65.06 1.06 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.675 -0.491 . . . . 4.5899999999999999 109.675 178.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.45 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 24.3 p -108.27 125.73 31.27 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-O 121.085 0.469 . . . . 2.4199999999999999 109.994 172.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.47 ' HA ' ' H ' ' A' ' 7' ' ' LEU . 34.9 Cg_exo -62.91 -17.11 58.14 Favored 'Trans proline' 0 CA--C 1.528 0.196 0 C-N-CA 122.958 2.439 . . . . 1.6899999999999999 112.818 178.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 68.09 123.78 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.778 0.674 . . . . 1.4199999999999999 110.947 -176.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.516 ' HB1' ' HB3' ' A' ' 34' ' ' TYR . . . 69.57 -56.67 0.56 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.41 0.684 . . . . 0.64000000000000001 110.866 -176.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.496 ' HA ' ' CD ' ' A' ' 18' ' ' PRO . 87.8 m -77.02 -0.34 24.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.072 0.463 . . . . 1.47 110.221 175.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.401 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 25.2 t -69.51 -18.55 63.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.887 -0.597 . . . . 1.3600000000000001 111.185 -176.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.8 m -105.94 8.86 32.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.626 0.251 . . . . 1.6399999999999999 111.544 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.5 m120 53.81 66.46 4.45 Favored Pre-proline 0 N--CA 1.467 0.41 0 CA-C-N 115.901 -0.59 . . . . 1.6899999999999999 110.96 -173.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.496 ' CD ' ' HA ' ' A' ' 14' ' ' CYS . 11.1 Cg_endo -54.88 -53.05 6.62 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.822 2.348 . . . . 0.54000000000000004 112.035 -177.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.593 ' SG ' ' HB3' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -91.21 18.9 6.38 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.941 -0.572 . . . . 0.55000000000000004 110.876 -177.327 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.443 ' HA3' ' HD3' ' A' ' 21' ' ' PRO . . . 72.93 -128.2 11.84 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.838 -0.619 . . . . 0.68999999999999995 111.867 -176.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.539 ' HD2' ' HB3' ' A' ' 24' ' ' ALA . 2.8 Cg_endo -87.05 169.88 7.34 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.462 2.774 . . . . 0.82999999999999996 112.044 178.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -66.53 -35.45 80.27 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.048 0.452 . . . . 3.4199999999999999 110.693 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.91 -28.98 70.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.83 -0.623 . . . . 0.65000000000000002 110.869 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.539 ' HB3' ' HD2' ' A' ' 21' ' ' PRO . . . -78.54 -63.53 1.38 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.40999999999999998 110.141 177.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -160.83 148.1 15.71 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.436 -0.887 . . . . 0.60999999999999999 112.259 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.8 m -94.0 140.31 29.87 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.122 -0.325 . . . . 0.87 110.122 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.593 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 19.6 p -102.86 140.75 36.73 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.015 0.436 . . . . 1.4199999999999999 110.939 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -130.59 125.27 33.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.787 -0.642 . . . . 1.9199999999999999 109.997 176.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 3.0 mp0 -66.84 122.73 18.33 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.192 0.52 . . . . 1.6599999999999999 110.326 176.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 49.3 p -122.76 -173.9 2.8 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.413 -0.812 . . . . 0.62 110.796 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -55.35 -41.38 72.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.968 0.413 . . . . 2.4300000000000002 110.907 177.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.6 m -80.18 -5.18 55.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 1.4399999999999999 111.439 -177.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 29' ' ' GLU . . . 126.89 -68.77 0.53 Allowed Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.37 -0.692 . . . . 0.37 111.37 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.516 ' HB3' ' HB1' ' A' ' 13' ' ' ALA . 54.5 p90 -155.55 156.6 35.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.832 0.348 . . . . 0.56999999999999995 110.391 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.2 pt -129.58 164.98 30.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.81 -0.632 . . . . 0.64000000000000001 109.462 170.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.9 m -123.4 128.8 50.36 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.171 0.51 . . . . 0.28999999999999998 111.39 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -112.92 100.9 9.0 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.071 -0.715 . . . . 4.4299999999999997 109.071 177.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 85.1 m -76.02 143.78 41.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.135 0.493 . . . . 0.27000000000000002 110.981 -177.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -77.06 167.96 20.9 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.198 -0.91 . . . . 0.70999999999999996 110.088 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -60.74 106.59 0.58 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.935 -0.575 . . . . 2.8999999999999999 110.685 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 122.05 -5.59 10.36 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 121.01 -0.614 . . . . 0.47999999999999998 111.714 -175.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -124.7 163.51 21.89 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 122.35 0.26 . . . . 0.54000000000000004 110.59 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.495 ' HG3' HG13 ' A' ' 55' ' ' ILE . 24.5 ptt180 -144.37 158.71 43.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.932 0.396 . . . . 3.0499999999999998 111.189 -174.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.435 HD13 ' HA ' ' A' ' 44' ' ' ILE . 15.1 mm -85.06 136.96 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.907 -0.588 . . . . 0.34000000000000002 110.485 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 37.9 t -143.84 145.02 32.03 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.935 -0.575 . . . . 0.48999999999999999 109.987 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.476 ' HB3' ' HA2' ' A' ' 50' ' ' GLY . 81.6 mt -95.08 112.99 24.64 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.466 -0.938 . . . . 0.94999999999999996 108.466 172.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -85.66 75.49 10.1 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.949 0.404 . . . . 2.52 112.014 -170.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.53 -59.0 3.74 Favored Glycine 0 CA--C 1.518 0.253 0 CA-C-N 115.859 -0.609 . . . . 1.4199999999999999 113.375 173.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.3 p -91.24 5.74 47.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.779 0.323 . . . . 1.27 111.793 -174.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.476 ' HA2' ' HB3' ' A' ' 46' ' ' LEU . . . 86.58 4.45 83.01 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.57 -0.824 . . . . 0.79000000000000004 112.681 177.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -66.05 134.52 53.04 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.685 -0.487 . . . . 1.5 109.685 175.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.7 t -79.4 109.89 14.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.185 -0.672 . . . . 0.5 109.185 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 18' ' ' PRO . 12.7 t -128.3 169.67 13.95 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 116.009 -0.541 . . . . 1.05 109.825 -179.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 35.5 t -116.39 130.18 56.63 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.521 -0.548 . . . . 0.28999999999999998 109.521 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.495 HG13 ' HG3' ' A' ' 43' ' ' ARG . 32.2 pt -127.52 166.72 23.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.954 -0.566 . . . . 0.46999999999999997 109.503 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.4 p -73.13 136.64 25.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 121.233 0.539 . . . . 0.73999999999999999 110.37 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -76.23 -33.48 59.21 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.227 -0.657 . . . . 4.7000000000000002 109.227 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.425 ' HB3' ' O ' ' A' ' 61' ' ' GLY . 6.2 tp-100 -177.79 -71.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.648 -1.16 . . . . 3.3199999999999998 108.473 174.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -138.72 -73.83 0.39 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.38 -0.827 . . . . 5.9900000000000002 109.448 174.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 45.6 m -131.35 42.17 3.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.597 0.713 . . . . 4.6600000000000001 109.273 173.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.425 ' O ' ' HB3' ' A' ' 58' ' ' GLN . . . . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.076 -1.402 . . . . 4.7400000000000002 111.241 -176.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 27' ' ' CYS . 10.7 p . . . . . 0 N--CA 1.481 1.115 0 CA-C-O 121.806 0.812 . . . . 2.7999999999999998 110.695 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.546 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 21.8 tp60 -78.8 -42.99 26.36 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.187 -0.671 . . . . 6.6900000000000004 109.187 177.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.723 HD23 ' H ' ' A' ' 7' ' ' LEU . 1.3 pt? -106.33 164.26 12.17 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.664 -0.698 . . . . 2.8199999999999998 109.628 172.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.8 m -99.06 -12.56 20.44 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.83 0.678 . . . . 3.77 112.83 -169.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -81.74 -92.49 0.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.875 -0.417 . . . . 4.5899999999999999 109.875 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.3 p -122.18 113.37 31.13 Favored Pre-proline 0 CA--C 1.507 -0.708 0 N-CA-C 109.218 -0.66 . . . . 2.4199999999999999 109.218 168.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.823 ' HB2' ' HB2' ' A' ' 14' ' ' CYS . 26.4 Cg_exo -62.62 101.48 0.26 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.523 2.149 . . . . 1.6899999999999999 109.668 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.07 -34.97 46.13 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.611 0.597 . . . . 1.4199999999999999 112.611 -170.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.907 ' HB3' ' HG2' ' A' ' 29' ' ' GLU . . . -84.22 -36.9 22.43 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.967 0.413 . . . . 0.64000000000000001 110.931 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.823 ' HB2' ' HB2' ' A' ' 11' ' ' PRO . 33.5 m -83.09 -18.5 39.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.314 -0.403 . . . . 1.47 111.45 -176.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 34.5 t -68.41 -8.99 45.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.127 0.489 . . . . 1.3600000000000001 109.81 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.0 m -88.81 -0.08 57.01 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.97 -0.559 . . . . 1.6399999999999999 110.882 175.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 59.43 68.71 1.48 Allowed Pre-proline 0 N--CA 1.467 0.422 0 CA-C-N 115.107 -0.951 . . . . 1.6899999999999999 111.852 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.46 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 3.5 Cg_exo -78.85 -75.08 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.91 2.407 . . . . 0.54000000000000004 112.44 -177.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.45 24.05 0.28 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.469 -0.332 . . . . 0.55000000000000004 111.81 -177.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.48 -123.14 15.98 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.118 -0.563 . . . . 0.68999999999999995 111.837 -178.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -87.11 154.44 8.29 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.836 2.357 . . . . 0.82999999999999996 111.494 175.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -70.02 -7.25 39.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.114 0.483 . . . . 3.4199999999999999 110.364 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.84 -34.51 51.82 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.0 -0.545 . . . . 0.65000000000000002 110.127 173.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.457 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . . . -71.86 -52.41 17.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.753 -0.658 . . . . 0.40999999999999998 109.492 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.411 ' CA ' ' HA ' ' A' ' 38' ' ' CYS . . . -156.86 159.39 29.55 Favored Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 120.57 -0.824 . . . . 0.60999999999999999 111.79 177.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.8 m -83.44 138.08 33.62 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.985 -0.746 . . . . 0.87 108.985 176.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.42 ' O ' HG12 ' A' ' 5' ' ' VAL . 41.7 t -98.7 112.94 24.85 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.394 0.616 . . . . 1.4199999999999999 109.535 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.453 ' HB3' HG13 ' A' ' 35' ' ' ILE . 1.7 tmtp? -110.31 102.76 11.38 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.549 -0.75 . . . . 1.9199999999999999 109.18 -175.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.907 ' HG2' ' HB3' ' A' ' 13' ' ' ALA . 28.6 mt-10 -73.7 122.66 22.69 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.705 -0.68 . . . . 1.6599999999999999 110.401 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 35.8 p -102.42 -175.07 2.72 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.468 -0.787 . . . . 0.62 110.228 -177.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -74.61 -26.17 59.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.514 0.673 . . . . 2.4300000000000002 109.296 176.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.6 m -84.56 -8.44 58.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.312 -0.858 . . . . 1.4399999999999999 111.092 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 142.07 -93.41 0.18 Allowed Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.392 -0.683 . . . . 0.37 111.392 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.544 ' HB3' ' HB1' ' A' ' 13' ' ' ALA . 50.2 p90 -153.46 154.69 34.88 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.314 0.578 . . . . 0.56999999999999995 111.178 177.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.453 HG13 ' HB3' ' A' ' 28' ' ' LYS . 44.7 pt -129.42 160.2 40.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 108.186 -1.042 . . . . 0.64000000000000001 108.186 168.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 99.4 m -120.83 134.8 55.28 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.041 0.448 . . . . 0.28999999999999998 110.743 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.586 ' HA ' ' NE ' ' A' ' 37' ' ' ARG . 1.5 tpm_? -117.13 99.98 7.41 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.74 -0.664 . . . . 4.4299999999999997 109.358 177.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.505 ' HB3' ' HB2' ' A' ' 42' ' ' TYR . 81.1 m -73.47 141.66 46.83 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.049 0.452 . . . . 0.27000000000000002 110.855 -176.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -73.88 168.67 18.97 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.86 -0.609 . . . . 0.70999999999999996 109.763 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -59.0 118.7 6.11 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.989 0.424 . . . . 2.8999999999999999 110.245 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.486 ' HA2' ' N ' ' A' ' 61' ' ' GLY . . . 116.18 -14.26 16.14 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.715 -0.755 . . . . 0.47999999999999998 112.017 -175.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.505 ' HB2' ' HB3' ' A' ' 38' ' ' CYS . 84.1 m-85 -120.59 162.8 19.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.654 0.264 . . . . 0.54000000000000004 110.657 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -143.78 157.65 44.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.423 -0.353 . . . . 3.0499999999999998 110.709 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.9 mm -77.27 136.04 25.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.014 -0.539 . . . . 0.34000000000000002 111.282 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 36.3 t -138.48 152.62 48.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.509 -0.768 . . . . 0.48999999999999999 109.333 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.493 HD13 ' HA2' ' A' ' 50' ' ' GLY . 75.9 mt -107.1 145.31 32.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.173 0.511 . . . . 0.94999999999999996 109.869 175.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -65.86 -21.66 66.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.524 -0.762 . . . . 2.52 111.476 -176.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 127.81 -28.69 4.36 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 111.261 -0.735 . . . . 1.4199999999999999 111.261 -176.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.5 p -100.5 -7.28 24.35 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.449 0.642 . . . . 1.27 109.951 176.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.493 ' HA2' HD13 ' A' ' 46' ' ' LEU . . . 109.78 13.75 15.56 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.438 -0.801 . . . . 0.79000000000000004 113.09 172.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -76.34 133.9 39.85 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.477 -0.564 . . . . 1.5 109.477 174.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.1 t -79.61 111.71 16.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.047 0.451 . . . . 0.5 110.683 -175.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.4 p -121.38 177.04 5.35 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.81 -0.632 . . . . 1.05 110.085 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 45.4 t -133.98 130.7 38.02 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.037 0.446 . . . . 0.28999999999999998 110.552 -176.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 32.9 pt -132.09 172.07 16.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.7 -0.682 . . . . 0.46999999999999997 109.443 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.9 p -65.66 141.42 18.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.84 0.352 . . . . 0.73999999999999999 110.243 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -76.49 -75.8 0.18 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.112 -0.699 . . . . 4.7000000000000002 109.112 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -114.88 -62.03 1.66 Allowed 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.778 -0.823 . . . . 3.3199999999999998 108.778 168.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 178.38 86.23 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.323 -0.853 . . . . 5.9900000000000002 109.023 176.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.9 m 57.18 33.4 23.26 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.987 0.899 . . . . 4.6600000000000001 109.938 -171.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.486 ' N ' ' HA2' ' A' ' 41' ' ' GLY . . . . . . . . 0 N--CA 1.438 -1.217 0 N-CA-C 109.415 -1.474 . . . . 4.7400000000000002 109.415 -177.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.527 ' HA ' ' CB ' ' A' ' 11' ' ' PRO . 15.6 t . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 121.115 0.483 . . . . 2.7999999999999998 110.434 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.49 ' HG2' ' CD ' ' A' ' 29' ' ' GLU . 54.4 mm-40 -97.68 -177.58 3.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.419 . . . . 6.6900000000000004 109.978 176.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.6 mp 62.33 -177.64 0.13 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.634 0.584 . . . . 2.8199999999999998 111.66 177.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.2 m -121.56 -3.86 9.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.162 -0.472 . . . . 3.77 111.517 -175.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -115.22 -69.32 0.86 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.954 -0.387 . . . . 4.5899999999999999 109.954 174.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.52 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 18.8 p -126.54 128.71 24.28 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.363 -0.38 . . . . 2.4199999999999999 110.609 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.527 ' CB ' ' HA ' ' A' ' 5' ' ' VAL . 58.9 Cg_endo -75.85 53.43 3.69 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 123.16 2.573 . . . . 1.6899999999999999 114.15 -172.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.518 ' O ' ' HB3' ' A' ' 15' ' ' SER . . . 43.56 -93.04 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.318 1.229 . . . . 1.4199999999999999 114.318 173.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.567 ' HB3' ' HG3' ' A' ' 29' ' ' GLU . . . -73.71 -35.14 65.09 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.105 0.478 . . . . 0.64000000000000001 110.659 -177.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.416 ' HB2' ' HB2' ' A' ' 11' ' ' PRO . 68.5 m -84.9 3.3 38.72 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.711 -0.677 . . . . 1.47 110.117 178.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.52 ' OG ' ' HB ' ' A' ' 10' ' ' THR . 30.5 t -70.3 -15.35 62.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.657 -0.701 . . . . 1.3600000000000001 111.218 -176.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.2 p -89.53 -0.26 57.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.924 0.393 . . . . 1.6399999999999999 110.871 177.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.6 m120 58.93 63.9 3.54 Favored Pre-proline 0 N--CA 1.467 0.409 0 CA-C-N 115.064 -0.971 . . . . 1.6899999999999999 111.43 -175.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.509 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 20.2 Cg_exo -65.26 -50.41 2.03 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.723 2.282 . . . . 0.54000000000000004 111.782 -177.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.517 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 0.7 OUTLIER -87.44 8.01 26.64 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.861 -0.608 . . . . 0.55000000000000004 110.252 -179.266 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.433 ' HA3' ' HD3' ' A' ' 21' ' ' PRO . . . 76.72 -122.95 6.47 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.743 -0.662 . . . . 0.68999999999999995 112.783 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.433 ' HD3' ' HA3' ' A' ' 20' ' ' GLY . 4.5 Cg_endo -83.29 162.41 15.15 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.617 2.878 . . . . 0.82999999999999996 112.554 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -67.61 -18.78 65.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.356 -0.838 . . . . 3.4199999999999999 111.85 -177.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.51 -16.63 47.98 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.82 0.343 . . . . 0.65000000000000002 111.111 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.43 -60.73 2.25 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.266 -0.424 . . . . 0.40999999999999998 110.88 -177.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -161.14 164.56 34.94 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.009 -1.091 . . . . 0.60999999999999999 113.224 -177.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.25 134.75 34.93 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.995 -0.372 . . . . 0.87 109.995 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.517 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 49.4 t -117.5 119.79 36.11 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.843 0.354 . . . . 1.4199999999999999 110.905 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -118.48 126.24 51.6 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.786 -0.643 . . . . 1.9199999999999999 110.246 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.567 ' HG3' ' HB3' ' A' ' 13' ' ' ALA . 49.4 mp0 -70.71 123.78 22.71 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.116 -0.493 . . . . 1.6599999999999999 109.857 175.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 73.3 p -115.3 -174.72 2.56 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.244 -0.435 . . . . 0.62 110.763 -178.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -77.78 -26.37 49.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.299 0.571 . . . . 2.4300000000000002 109.868 175.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.85 -25.86 60.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.709 -0.678 . . . . 1.4399999999999999 109.588 175.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 147.93 -82.69 0.19 Allowed Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.525 -1.03 . . . . 0.37 110.525 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.447 ' HD2' ' HB1' ' A' ' 13' ' ' ALA . 28.0 p90 -154.83 163.64 39.98 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 110.111 -0.329 . . . . 0.56999999999999995 110.111 175.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.1 pt -128.59 151.5 35.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 116.182 -0.463 . . . . 0.64000000000000001 110.369 175.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.509 ' SG ' ' HB2' ' A' ' 18' ' ' PRO . 20.9 m -121.23 118.81 30.54 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.191 0.519 . . . . 0.28999999999999998 110.306 178.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -108.78 100.55 9.76 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.514 -0.766 . . . . 4.4299999999999997 110.075 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 98.6 m -75.72 139.65 42.01 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.078 0.466 . . . . 0.27000000000000002 111.469 -175.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -84.54 175.99 8.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.55 -0.75 . . . . 0.70999999999999996 110.486 177.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.804 ' HG3' ' HA2' ' A' ' 61' ' ' GLY . 48.6 tt0 -54.77 119.31 5.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.052 -0.522 . . . . 2.8999999999999999 110.765 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.82 2.22 46.07 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.577 -0.82 . . . . 0.47999999999999998 112.327 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -127.79 162.16 27.28 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.145 -0.317 . . . . 0.54000000000000004 110.145 177.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -145.96 154.47 41.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.858 0.361 . . . . 3.0499999999999998 110.978 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.48 HD11 ' O ' ' A' ' 36' ' ' CYS . 20.9 mm -78.33 133.49 30.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.797 -0.638 . . . . 0.34000000000000002 110.346 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.4 t -140.01 151.37 45.41 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.137 -0.69 . . . . 0.48999999999999999 109.137 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.406 ' HB3' ' HA2' ' A' ' 50' ' ' GLY . 55.8 mt -102.85 145.35 29.92 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.519 -0.549 . . . . 0.94999999999999996 109.519 173.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -84.43 -160.24 0.46 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.705 -0.68 . . . . 2.52 109.776 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -65.67 -28.07 73.26 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.647 -0.787 . . . . 1.4199999999999999 112.938 177.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 82.6 p -90.76 -30.38 17.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 117.261 0.53 . . . . 1.27 111.407 -176.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.406 ' HA2' ' HB3' ' A' ' 46' ' ' LEU . . . 111.82 18.49 7.85 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.681 -0.771 . . . . 0.79000000000000004 111.403 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 -74.73 141.97 44.41 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.401 -0.4 . . . . 1.5 109.961 177.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.9 t -78.3 110.84 14.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.103 0.477 . . . . 0.5 109.933 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.0 p -124.99 169.79 11.76 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.818 -0.628 . . . . 1.05 110.464 -177.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 25.2 t -121.81 129.93 53.01 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.084 -0.71 . . . . 0.28999999999999998 109.084 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 33.9 pt -128.49 157.21 41.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.527 -0.306 . . . . 0.46999999999999997 110.383 -177.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.91 123.85 22.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.422 0.629 . . . . 0.73999999999999999 110.369 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.577 ' HG2' ' H ' ' A' ' 59' ' ' GLU . 74.7 ttt180 -88.49 142.09 28.0 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.668 -0.696 . . . . 4.7000000000000002 109.866 -177.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -72.49 4.03 4.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.019 -0.537 . . . . 3.3199999999999998 111.083 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.577 ' H ' ' HG2' ' A' ' 57' ' ' ARG . 9.6 tp10 -127.43 123.85 37.07 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.587 -0.894 . . . . 5.9900000000000002 108.587 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.1 p -79.62 65.98 4.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.558 0.694 . . . . 4.6600000000000001 110.849 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.804 ' HA2' ' HG3' ' A' ' 40' ' ' GLN . . . . . . . . 0 N--CA 1.441 -1.016 0 CA-C-O 118.718 -1.045 . . . . 4.7400000000000002 110.944 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.634 HG22 ' HG3' ' A' ' 11' ' ' PRO . 11.8 t . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 121.162 0.506 . . . . 2.7999999999999998 110.159 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.476 ' OE1' ' HB2' ' A' ' 29' ' ' GLU . 55.4 mt-30 -94.4 -10.77 31.48 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.267 0.469 . . . . 6.6900000000000004 112.267 -178.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.407 HD11 ' HB2' ' A' ' 12' ' ' ALA . 62.1 mt -81.99 -87.53 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.674 -0.41 . . . . 2.8199999999999998 110.935 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.7 m -147.11 -67.07 0.26 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.022 0.439 . . . . 3.77 110.05 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.432 ' HG3' HG23 ' A' ' 10' ' ' THR . 10.8 pt-20 -118.12 -30.05 5.42 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.205 -0.452 . . . . 4.5899999999999999 110.126 177.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.5 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 37.8 p -100.35 132.03 23.12 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.054 -0.521 . . . . 2.4199999999999999 110.686 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.963 ' HB2' ' HB2' ' A' ' 14' ' ' CYS . 4.1 Cg_exo -78.0 29.39 0.45 Allowed 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 123.489 2.793 . . . . 1.6899999999999999 113.458 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.407 ' HB2' HD11 ' A' ' 7' ' ' LEU . . . 50.98 -99.72 0.08 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.879 0.696 . . . . 1.4199999999999999 112.879 176.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . . . -66.66 -27.34 67.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.457 0.646 . . . . 0.64000000000000001 110.334 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.963 ' HB2' ' HB2' ' A' ' 11' ' ' PRO . 69.0 m -93.85 3.35 55.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.4 -0.818 . . . . 1.47 110.78 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.756 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 20.7 t -69.96 -22.3 63.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.366 -0.379 . . . . 1.3600000000000001 110.97 -176.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.6 m -89.09 7.1 36.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.492 -0.322 . . . . 1.6399999999999999 111.357 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 54.03 72.59 1.08 Allowed Pre-proline 0 N--CA 1.466 0.369 0 CA-C-N 115.693 -0.685 . . . . 1.6899999999999999 111.183 -176.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.417 ' HG2' ' SG ' ' A' ' 27' ' ' CYS . 14.4 Cg_exo -66.29 -42.22 10.78 Favored 'Trans proline' 0 CA--C 1.52 -0.213 0 C-N-CA 123.13 2.554 . . . . 0.54000000000000004 111.803 -175.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.504 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -82.02 -3.11 53.82 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.542 -0.753 . . . . 0.55000000000000004 110.337 -178.189 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.16 -137.59 13.52 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.433 -0.803 . . . . 0.68999999999999995 111.324 -176.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.489 ' HD2' ' CB ' ' A' ' 24' ' ' ALA . 6.2 Cg_exo -77.72 171.34 17.57 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.593 2.195 . . . . 0.82999999999999996 111.769 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.34 -39.53 94.79 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.905 0.383 . . . . 3.4199999999999999 110.318 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.47 -23.62 66.01 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.512 -0.767 . . . . 0.65000000000000002 111.397 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.489 ' CB ' ' HD2' ' A' ' 21' ' ' PRO . . . -81.36 -56.57 3.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.908 0.385 . . . . 0.40999999999999998 110.363 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -171.39 161.1 33.46 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.619 -0.801 . . . . 0.60999999999999999 111.965 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.6 m -102.33 140.74 36.21 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.548 -0.538 . . . . 0.87 109.548 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.504 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 38.2 t -105.35 143.28 33.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.189 0.518 . . . . 1.4199999999999999 110.752 -177.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.761 ' HE2' ' HA ' ' A' ' 28' ' ' LYS . 0.5 OUTLIER -131.88 122.07 25.08 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.725 -0.67 . . . . 1.9199999999999999 110.139 -177.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.476 ' HB2' ' OE1' ' A' ' 6' ' ' GLN . 5.0 mp0 -66.99 125.79 27.09 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.356 -0.609 . . . . 1.6599999999999999 109.356 175.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 31.8 p -106.98 173.71 6.2 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.851 -0.613 . . . . 0.62 110.494 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -79.82 46.83 0.81 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 122.027 0.918 . . . . 2.4300000000000002 109.974 175.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.5 t -162.9 -41.43 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.816 -1.083 . . . . 1.4399999999999999 108.325 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -179.52 -100.08 0.13 Allowed Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.298 -0.864 . . . . 0.37 111.276 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.422 ' HB3' ' HB3' ' A' ' 13' ' ' ALA . 36.9 p90 -148.93 151.23 34.27 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.748 -0.464 . . . . 0.56999999999999995 109.748 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.8 pt -129.87 161.88 38.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.936 -0.394 . . . . 0.64000000000000001 109.936 172.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 33.3 m -121.22 130.95 53.95 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.239 -0.437 . . . . 0.28999999999999998 110.821 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.403 ' HD2' ' HA ' ' A' ' 37' ' ' ARG . 27.0 tpt180 -111.02 101.52 10.07 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.946 -0.761 . . . . 4.4299999999999997 108.946 175.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 42' ' ' TYR . 88.9 m -73.56 145.31 45.6 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.911 -0.586 . . . . 0.27000000000000002 110.876 -177.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -77.69 170.88 15.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.537 -0.756 . . . . 0.70999999999999996 109.772 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.447 ' HG3' ' HB3' ' A' ' 60' ' ' SER . 62.3 tt0 -66.2 103.23 0.95 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.049 0.452 . . . . 2.8999999999999999 110.335 -178.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 128.6 -1.03 6.41 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.529 -0.76 . . . . 0.47999999999999998 111.456 -175.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.53 ' HB2' ' HB3' ' A' ' 38' ' ' CYS . 80.2 m-85 -130.23 162.44 28.94 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.673 -0.491 . . . . 0.54000000000000004 109.673 177.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.811 ' HG2' ' HB2' ' A' ' 57' ' ' ARG . 2.7 ptp180 -143.55 161.47 38.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.612 0.244 . . . . 3.0499999999999998 110.72 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 44' ' ' ILE . 12.5 mm -81.3 140.03 17.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 121.059 0.457 . . . . 0.34000000000000002 111.38 -176.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.4 t -147.12 154.68 41.41 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.693 -0.685 . . . . 0.48999999999999999 109.36 177.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.404 HD13 ' HA2' ' A' ' 50' ' ' GLY . 80.9 mt -96.79 145.99 25.32 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.435 -0.58 . . . . 0.94999999999999996 109.435 174.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -64.79 -15.04 61.15 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.546 -0.752 . . . . 2.52 111.901 -177.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.49 -30.26 4.76 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.353 -0.699 . . . . 1.4199999999999999 111.353 -176.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.5 p -102.84 -24.43 13.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.103 0.478 . . . . 1.27 110.219 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.404 ' HA2' HD13 ' A' ' 46' ' ' LEU . . . 131.04 20.85 1.13 Allowed Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.543 -0.753 . . . . 0.79000000000000004 112.897 174.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -83.82 133.08 34.77 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.618 -0.512 . . . . 1.5 109.618 174.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.6 t -80.02 111.8 17.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.023 0.439 . . . . 0.5 110.333 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.7 t -127.45 173.85 9.49 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.909 -0.587 . . . . 1.05 109.582 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.501 ' HB3' ' O ' ' A' ' 19' ' ' CYS . 48.5 t -122.83 131.19 53.65 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.555 -0.535 . . . . 0.28999999999999998 109.555 -176.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 20.9 pt -123.54 142.15 41.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.14 0.495 . . . . 0.46999999999999997 110.945 -176.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.1 p -66.55 126.77 26.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.424 -0.807 . . . . 0.73999999999999999 110.514 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.811 ' HB2' ' HG2' ' A' ' 43' ' ' ARG . 4.2 tpm_? -123.34 131.89 53.81 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.979 -0.748 . . . . 4.7000000000000002 108.979 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -45.67 -54.21 8.13 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-O 121.062 0.458 . . . . 3.3199999999999998 111.265 -176.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -94.72 147.71 23.03 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.361 -0.836 . . . . 5.9900000000000002 108.969 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.447 ' HB3' ' HG3' ' A' ' 40' ' ' GLN . 22.2 m -75.01 64.13 1.3 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.506 0.67 . . . . 4.6600000000000001 110.761 -178.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.082 0 CA-C-O 118.681 -1.066 . . . . 4.7400000000000002 110.903 179.338 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.445 HG13 ' SG ' ' A' ' 27' ' ' CYS . 16.9 m . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.933 0.397 . . . . 2.7999999999999998 111.436 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.88 -32.85 15.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.955 0.407 . . . . 6.6900000000000004 110.34 178.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.575 HD12 ' HA ' ' A' ' 11' ' ' PRO . 95.7 mt -85.67 -175.57 5.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.989 -0.551 . . . . 2.8199999999999998 110.939 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.4 t -69.51 -72.52 0.19 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.394 -0.366 . . . . 3.77 111.804 -173.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.415 ' HB2' ' H ' ' A' ' 10' ' ' THR . 13.0 mm-40 -98.92 -88.92 0.32 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.095 0.474 . . . . 4.5899999999999999 110.759 -171.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.52 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 0.7 OUTLIER -102.47 108.1 56.23 Favored Pre-proline 0 N--CA 1.446 -0.642 0 CA-C-N 115.754 -0.657 . . . . 2.4199999999999999 109.499 175.118 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.575 ' HA ' HD12 ' A' ' 7' ' ' LEU . 0.9 OUTLIER -81.9 64.8 8.51 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.581 2.854 . . . . 1.6899999999999999 113.568 -169.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.444 ' O ' ' HB3' ' A' ' 15' ' ' SER . . . 43.65 -87.44 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 O-C-N 124.339 1.024 . . . . 1.4199999999999999 113.712 174.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.449 ' HB1' ' CD1' ' A' ' 34' ' ' TYR . . . -62.55 -41.59 98.99 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.301 -0.409 . . . . 0.64000000000000001 111.532 -177.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.598 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 52.5 t -85.37 -3.15 58.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.143 0.497 . . . . 1.47 110.774 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.444 ' HB3' ' O ' ' A' ' 12' ' ' ALA . 36.6 t -65.59 -17.52 64.64 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.283 -0.417 . . . . 1.3600000000000001 111.463 -177.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 36.5 m -108.1 14.89 24.74 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.925 0.393 . . . . 1.6399999999999999 111.49 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 55.95 73.29 0.86 Allowed Pre-proline 0 N--CA 1.47 0.544 0 CA-C-N 115.313 -0.858 . . . . 1.6899999999999999 112.283 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.598 ' HD3' ' HA ' ' A' ' 14' ' ' CYS . 24.6 Cg_endo -62.19 -43.56 23.28 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.829 2.353 . . . . 0.54000000000000004 112.191 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 2.6 m -90.56 17.9 6.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.266 -0.425 . . . . 0.55000000000000004 111.109 -176.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.463 ' HA3' ' HD3' ' A' ' 21' ' ' PRO . . . 70.98 -123.74 10.95 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 116.102 -0.499 . . . . 0.68999999999999995 112.553 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.463 ' HD3' ' HA3' ' A' ' 20' ' ' GLY . 1.6 Cg_endo -78.76 157.87 27.92 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 123.287 2.658 . . . . 0.82999999999999996 112.063 178.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -67.42 -27.9 67.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.664 -0.698 . . . . 3.4199999999999999 110.565 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.04 -15.04 61.09 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.61 -0.723 . . . . 0.65000000000000002 111.288 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.91 -52.37 6.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.341 -0.39 . . . . 0.40999999999999998 110.351 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -169.76 174.31 43.99 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.3 -0.952 . . . . 0.60999999999999999 113.083 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.5 m -101.38 140.89 35.06 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 122.46 0.304 . . . . 0.87 110.86 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.445 ' SG ' HG13 ' A' ' 5' ' ' VAL . 27.9 p -102.55 130.09 49.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.899 0.381 . . . . 1.4199999999999999 110.517 177.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -124.5 117.06 23.54 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.203 -0.666 . . . . 1.9199999999999999 109.203 176.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -71.95 119.1 15.65 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.192 0.52 . . . . 1.6599999999999999 109.973 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.9 p -112.17 -175.68 2.74 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.876 -0.602 . . . . 0.62 110.683 -176.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -68.19 -24.01 64.9 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.395 0.617 . . . . 2.4300000000000002 109.728 174.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.9 m -78.77 -19.32 52.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.614 -0.721 . . . . 1.4399999999999999 110.038 177.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 133.2 -71.77 0.49 Allowed Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.985 -0.846 . . . . 0.37 110.985 -177.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.449 ' CD1' ' HB1' ' A' ' 13' ' ' ALA . 50.2 p90 -155.98 158.93 38.71 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.306 -0.257 . . . . 0.56999999999999995 110.306 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.2 pt -131.74 157.07 43.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.272 -0.64 . . . . 0.64000000000000001 109.272 170.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.0 m -121.06 119.22 31.84 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.634 0.73 . . . . 0.28999999999999998 111.06 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -105.72 99.46 9.06 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.992 -1.003 . . . . 4.4299999999999997 109.975 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 77.8 m -77.88 146.2 35.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.979 0.418 . . . . 0.27000000000000002 110.845 -176.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -84.06 179.02 7.61 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.833 -0.622 . . . . 0.70999999999999996 109.996 176.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -58.77 132.44 53.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.674 0.273 . . . . 2.8999999999999999 110.544 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.85 5.65 80.84 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.477 -0.868 . . . . 0.47999999999999998 112.398 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -125.54 154.5 42.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.025 0.441 . . . . 0.54000000000000004 110.624 177.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.549 ' HG3' HG13 ' A' ' 55' ' ' ILE . 24.7 ptt180 -140.43 160.85 39.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.779 -0.646 . . . . 3.0499999999999998 111.172 -171.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.405 ' HA ' HD13 ' A' ' 44' ' ' ILE . 20.4 mm -87.51 134.36 27.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.798 -0.637 . . . . 0.34000000000000002 110.65 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.0 t -143.53 173.54 11.55 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.442 -0.799 . . . . 0.48999999999999999 109.217 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.409 ' HA ' ' O ' ' A' ' 51' ' ' ASN . 78.8 mt -107.69 145.02 33.97 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.247 0.546 . . . . 0.94999999999999996 109.998 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -61.85 -23.91 66.57 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.027 -0.988 . . . . 2.52 111.509 -177.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 133.61 -22.56 3.89 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 111.223 -0.751 . . . . 1.4199999999999999 111.223 -175.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 37.4 p -111.71 -27.09 8.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.042 0.449 . . . . 1.27 110.393 177.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 133.57 24.02 0.7 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.766 -0.73 . . . . 0.79000000000000004 112.901 175.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.409 ' O ' ' HA ' ' A' ' 46' ' ' LEU . 52.1 m-80 -87.26 145.9 26.18 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.417 -0.586 . . . . 1.5 109.417 174.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.1 t -79.4 111.16 15.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.953 0.406 . . . . 0.5 110.087 -176.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 18' ' ' PRO . 65.7 p -124.78 169.13 12.31 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.989 -0.55 . . . . 1.05 110.472 -178.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 34.0 t -121.81 131.23 53.95 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.023 -0.535 . . . . 0.28999999999999998 109.656 -178.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.549 HG13 ' HG3' ' A' ' 43' ' ' ARG . 34.5 pt -131.73 167.13 27.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.249 -0.432 . . . . 0.46999999999999997 110.115 -177.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.9 p -76.91 137.35 22.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.474 0.654 . . . . 0.73999999999999999 111.28 -175.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 59' ' ' GLU . 19.1 tpt180 -101.14 106.72 17.99 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.17 -1.048 . . . . 4.7000000000000002 108.17 173.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.51 -4.08 13.83 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.209 0.448 . . . . 3.3199999999999998 112.209 -171.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 10.1 tp10 -126.11 115.86 20.48 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.286 -1.005 . . . . 5.9900000000000002 108.286 175.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.4 p -48.42 122.95 5.9 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.604 0.565 . . . . 4.6600000000000001 111.984 -171.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.747 -1.029 . . . . 4.7400000000000002 111.168 -178.024 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.478 0.934 0 CA-C-O 122.146 0.974 . . . . 2.7999999999999998 109.93 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -81.65 -38.49 25.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.822 -0.626 . . . . 6.6900000000000004 110.718 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.662 ' HB2' ' HA ' ' A' ' 11' ' ' PRO . 85.3 mt -88.11 155.18 19.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.182 -0.463 . . . . 2.8199999999999998 110.039 178.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.3 t -85.68 -33.67 21.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.445 -0.798 . . . . 3.77 111.823 -167.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -93.71 -79.7 0.4 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.316 -0.624 . . . . 4.5899999999999999 109.316 177.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.5 p -124.04 129.61 24.69 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 115.849 -0.614 . . . . 2.4199999999999999 109.905 172.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.662 ' HA ' ' HB2' ' A' ' 7' ' ' LEU . 62.6 Cg_endo -76.78 -163.05 0.18 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.604 2.203 . . . . 1.6899999999999999 111.84 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -103.89 -65.43 1.02 Allowed 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.469 -0.492 . . . . 1.4199999999999999 110.23 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.756 ' HB3' ' HG2' ' A' ' 29' ' ' GLU . . . -71.78 -48.22 48.1 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.122 -0.49 . . . . 0.64000000000000001 110.59 -177.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.52 ' HB2' ' CG ' ' A' ' 11' ' ' PRO . 65.7 m -66.63 -23.16 66.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.366 -0.379 . . . . 1.47 111.048 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.7 t -67.94 -28.11 67.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.022 0.439 . . . . 1.3600000000000001 110.402 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.0 t -82.72 -0.89 49.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.262 0.553 . . . . 1.6399999999999999 110.291 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 62.29 73.04 0.57 Allowed Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 115.056 -0.975 . . . . 1.6899999999999999 111.146 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.534 ' O ' ' HA ' ' A' ' 53' ' ' THR . 5.7 Cg_exo -74.69 -64.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.499 2.133 . . . . 0.54000000000000004 111.162 -177.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -84.13 27.36 0.68 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.851 -0.613 . . . . 0.55000000000000004 110.869 -178.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.94 -125.5 22.24 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.142 -0.551 . . . . 0.68999999999999995 112.071 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.562 ' HG2' ' HB2' ' A' ' 24' ' ' ALA . 90.6 Cg_endo -78.51 156.78 28.65 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.778 2.319 . . . . 0.82999999999999996 112.379 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -68.43 -11.95 60.45 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.249 -0.887 . . . . 3.4199999999999999 110.39 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.81 -14.5 34.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.698 -0.683 . . . . 0.65000000000000002 111.526 177.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.562 ' HB2' ' HG2' ' A' ' 21' ' ' PRO . . . -78.27 -35.89 47.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.412 0.625 . . . . 0.40999999999999998 110.453 -177.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -177.92 -171.73 41.63 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.632 -0.794 . . . . 0.60999999999999999 112.093 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.9 m -92.12 134.1 35.16 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 110.083 -0.34 . . . . 0.87 110.083 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.44 ' SG ' ' HG2' ' A' ' 18' ' ' PRO . 43.0 t -106.1 112.67 25.81 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.375 -0.602 . . . . 1.4199999999999999 109.375 177.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.459 ' HB3' ' CG1' ' A' ' 35' ' ' ILE . 17.8 tppt? -116.05 107.66 15.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.122 -0.49 . . . . 1.9199999999999999 110.108 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.756 ' HG2' ' HB3' ' A' ' 13' ' ' ALA . 36.2 mt-10 -74.38 118.74 17.68 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.073 -0.512 . . . . 1.6599999999999999 109.973 178.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 70.9 p -109.98 -175.11 2.65 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.775 -0.648 . . . . 0.62 110.372 -175.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -76.1 -17.61 59.54 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.319 0.581 . . . . 2.4300000000000002 109.755 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.8 t -88.94 -1.2 57.99 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.664 -0.698 . . . . 1.4399999999999999 109.937 175.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 124.52 -79.89 0.36 Allowed Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 111.064 -0.814 . . . . 0.37 111.064 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.469 ' HB3' ' CB ' ' A' ' 13' ' ' ALA . 54.8 p90 -156.2 154.46 30.82 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.149 -0.315 . . . . 0.56999999999999995 110.149 178.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.459 ' CG1' ' HB3' ' A' ' 28' ' ' LYS . 44.2 pt -122.68 148.92 26.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 108.794 -0.817 . . . . 0.64000000000000001 108.794 166.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.413 ' SG ' ' HB2' ' A' ' 18' ' ' PRO . 50.3 m -120.63 123.03 41.81 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.279 0.561 . . . . 0.28999999999999998 110.791 -177.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 48.6 ttp85 -116.08 100.73 8.16 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.354 -0.839 . . . . 4.4299999999999997 109.885 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 81.8 m -77.39 155.13 32.08 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.256 0.551 . . . . 0.27000000000000002 111.86 -175.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -79.07 -179.63 6.8 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.061 -0.972 . . . . 0.70999999999999996 109.684 174.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -64.42 -39.15 93.28 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.981 0.419 . . . . 2.8999999999999999 111.588 -172.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.457 ' HA3' ' H ' ' A' ' 61' ' ' GLY . . . -80.29 6.79 59.27 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.545 -0.836 . . . . 0.47999999999999998 112.743 -178.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.478 ' HB3' ' SG ' ' A' ' 54' ' ' CYS . 96.1 m-85 -128.78 161.43 29.77 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 122.583 -0.363 . . . . 0.54000000000000004 110.938 -176.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -142.73 162.43 35.49 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.883 0.373 . . . . 3.0499999999999998 110.639 -176.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.0 mm -84.91 128.94 38.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.898 -0.592 . . . . 0.34000000000000002 110.891 -178.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.7 t -133.98 151.98 51.67 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.322 -0.854 . . . . 0.48999999999999999 109.235 178.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 86.5 mt -101.82 142.54 32.97 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.122 0.487 . . . . 0.94999999999999996 109.786 176.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -64.35 -22.02 66.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.312 -0.858 . . . . 2.52 111.959 -174.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 129.38 -23.62 4.82 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.904 -0.665 . . . . 1.4199999999999999 111.508 -175.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.6 p -106.55 -25.5 11.79 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.005 0.431 . . . . 1.27 109.85 175.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 131.47 15.56 1.6 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.928 -0.654 . . . . 0.79000000000000004 112.952 174.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -74.53 134.53 42.2 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.446 -0.576 . . . . 1.5 109.446 174.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.8 t -79.71 110.27 15.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.668 -0.493 . . . . 0.5 109.668 -178.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 18' ' ' PRO . 65.9 p -121.4 171.13 8.99 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.962 -0.563 . . . . 1.05 109.846 -178.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.478 ' SG ' ' HB3' ' A' ' 42' ' ' TYR . 15.6 t -126.72 130.68 50.82 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.328 -0.396 . . . . 0.28999999999999998 110.046 -176.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 41.2 pt -133.68 165.32 32.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.06 -0.518 . . . . 0.46999999999999997 109.937 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.0 p -65.11 127.83 26.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.336 0.588 . . . . 0.73999999999999999 110.726 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 57' ' ' ARG . 13.2 ttm180 -82.64 -40.82 20.22 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.498 -0.774 . . . . 4.7000000000000002 110.249 -178.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.415 ' HG2' ' HG2' ' A' ' 59' ' ' GLU . 33.9 tt0 -165.77 -72.73 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.419 -0.81 . . . . 3.3199999999999998 109.631 -178.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.415 ' HG2' ' HG2' ' A' ' 58' ' ' GLN . 50.2 mm-40 -128.71 121.98 29.68 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.282 -0.872 . . . . 5.9900000000000002 109.318 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.9 m -56.85 116.11 2.98 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.233 0.54 . . . . 4.6600000000000001 112.251 -173.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.457 ' H ' ' HA3' ' A' ' 41' ' ' GLY . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.013 -1.437 . . . . 4.7400000000000002 111.018 178.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.659 HG13 ' H ' ' A' ' 6' ' ' GLN . 2.8 p . . . . . 0 N--CA 1.474 0.745 0 CA-C-O 119.491 -0.29 . . . . 2.7999999999999998 111.077 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.659 ' H ' HG13 ' A' ' 5' ' ' VAL . 25.0 tp60 -177.59 -48.07 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.952 0.406 . . . . 6.6900000000000004 110.148 -176.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.4 mt 69.88 -95.69 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.297 -0.865 . . . . 2.8199999999999998 112.021 173.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.3 m -154.51 -82.05 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.493 0.187 . . . . 3.77 110.893 -176.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -67.68 -64.68 0.81 Allowed 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.52 -0.548 . . . . 4.5899999999999999 109.52 177.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.6 p -141.35 143.41 30.2 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 115.449 -0.796 . . . . 2.4199999999999999 109.85 176.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.467 ' HB3' ' HA ' ' A' ' 6' ' ' GLN . 48.8 Cg_endo -75.33 90.43 1.11 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 121.599 1.533 . . . . 1.6899999999999999 109.098 171.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -46.97 -33.01 4.27 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.591 0.96 . . . . 1.4199999999999999 113.591 -166.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.86 ' HB3' ' HG2' ' A' ' 29' ' ' GLU . . . -94.95 -29.89 14.42 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.218 0.451 . . . . 0.64000000000000001 112.218 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.467 ' HB2' ' HB2' ' A' ' 11' ' ' PRO . 35.7 m -97.1 2.55 51.38 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 122.039 -0.413 . . . . 1.47 111.164 -178.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.5 t -66.31 -17.88 65.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.09 -0.504 . . . . 1.3600000000000001 111.25 -173.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.7 m -97.47 4.19 50.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.605 -0.27 . . . . 1.6399999999999999 111.543 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 57.5 76.37 0.48 Allowed Pre-proline 0 N--CA 1.469 0.525 0 CA-C-N 115.616 -0.72 . . . . 1.6899999999999999 111.394 -175.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -73.23 -73.02 0.01 OUTLIER 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 122.902 2.401 . . . . 0.54000000000000004 112.784 -177.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -71.1 -28.39 64.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.191 0.519 . . . . 0.55000000000000004 111.158 -176.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.412 ' HA3' ' HD3' ' A' ' 21' ' ' PRO . . . 105.67 -122.86 7.32 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.611 -0.722 . . . . 0.68999999999999995 112.312 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.506 ' HD2' ' HB3' ' A' ' 24' ' ' ALA . 10.2 Cg_endo -86.3 156.12 9.51 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.302 2.668 . . . . 0.82999999999999996 112.49 -177.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -62.62 -23.29 66.98 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 114.984 -1.007 . . . . 3.4199999999999999 111.003 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.12 -34.58 76.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.288 -0.415 . . . . 0.65000000000000002 110.8 175.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.506 ' HB3' ' HD2' ' A' ' 21' ' ' PRO . . . -83.74 -57.89 3.03 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.032 -0.531 . . . . 0.40999999999999998 110.578 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -168.39 143.61 8.24 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.276 -0.964 . . . . 0.60999999999999999 112.452 -177.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.8 m -83.73 145.02 28.96 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.201 -0.296 . . . . 0.87 110.201 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 53.4 t -100.24 113.53 26.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.202 0.525 . . . . 1.4199999999999999 110.304 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -109.99 114.35 27.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.658 -0.701 . . . . 1.9199999999999999 109.902 -176.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.86 ' HG2' ' HB3' ' A' ' 13' ' ' ALA . 45.5 mt-10 -78.2 119.71 21.97 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.114 0.483 . . . . 1.6599999999999999 110.143 -177.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 78.7 p -119.01 -173.31 2.47 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.417 -0.81 . . . . 0.62 110.946 -173.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -64.51 -32.71 74.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.014 0.435 . . . . 2.4300000000000002 110.176 175.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.0 m -73.93 -2.67 24.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.946 -0.57 . . . . 1.4399999999999999 110.437 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.06 -74.94 0.24 Allowed Glycine 0 N--CA 1.44 -1.058 0 N-CA-C 110.496 -1.042 . . . . 0.37 110.496 -177.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.715 ' HB3' ' HB1' ' A' ' 13' ' ' ALA . 51.9 p90 -153.45 151.45 29.88 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.068 0.461 . . . . 0.56999999999999995 110.174 176.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 47.2 pt -128.5 162.07 35.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 108.384 -0.969 . . . . 0.64000000000000001 108.384 169.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.414 ' HB2' ' CD1' ' A' ' 44' ' ' ILE . 68.3 m -120.85 129.85 53.7 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.153 0.501 . . . . 0.28999999999999998 110.319 -178.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.792 ' HA ' ' HE ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -105.93 99.97 9.54 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.885 -0.598 . . . . 4.4299999999999997 109.627 178.674 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.463 ' HB3' ' HB2' ' A' ' 42' ' ' TYR . 84.3 m -83.86 133.8 34.72 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.694 -0.684 . . . . 0.27000000000000002 110.932 -176.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -68.88 151.69 46.24 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.995 -1.002 . . . . 0.70999999999999996 109.038 175.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.439 ' HB2' ' O ' ' A' ' 61' ' ' GLY . 3.8 pt20 -59.46 120.53 9.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.479 0.657 . . . . 2.8999999999999999 110.678 -176.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.25 -8.14 14.09 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 110.513 -1.035 . . . . 0.47999999999999998 110.513 -171.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.463 ' HB2' ' HB3' ' A' ' 38' ' ' CYS . 71.6 m-85 -128.02 162.8 25.96 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.915 -0.772 . . . . 0.54000000000000004 108.915 176.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.803 ' HG2' ' HB2' ' A' ' 57' ' ' ARG . 9.2 ptp180 -152.39 165.15 35.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.075 0.464 . . . . 3.0499999999999998 111.587 174.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.414 ' CD1' ' HB2' ' A' ' 36' ' ' CYS . 38.3 mm -70.29 137.64 23.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.207 -0.906 . . . . 0.34000000000000002 110.895 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.44 ' HB2' HG12 ' A' ' 55' ' ' ILE . 23.0 t -145.72 165.75 27.87 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.985 -0.746 . . . . 0.48999999999999999 108.985 178.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 87.8 mt -104.72 138.03 41.64 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.671 -0.492 . . . . 0.94999999999999996 109.671 178.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -60.6 -24.18 65.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.068 -0.969 . . . . 2.52 111.911 -174.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 131.76 -26.5 3.82 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 111.015 -0.834 . . . . 1.4199999999999999 111.015 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.2 p -100.57 -30.38 11.81 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.707 -0.479 . . . . 1.27 109.707 175.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 131.77 22.55 0.93 Allowed Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.597 -0.729 . . . . 0.79000000000000004 112.447 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -85.41 142.83 28.99 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.662 -0.496 . . . . 1.5 109.662 176.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.7 t -79.71 110.81 15.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.187 0.518 . . . . 0.5 110.138 -176.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.1 p -125.6 171.67 10.37 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.924 -0.58 . . . . 1.05 110.188 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 44.3 t -124.65 129.94 51.48 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.498 -0.556 . . . . 0.28999999999999998 109.498 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.44 HG12 ' HB2' ' A' ' 45' ' ' SER . 26.0 pt -131.27 148.02 32.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.03 0.443 . . . . 0.46999999999999997 110.723 -176.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.449 ' HA ' ' CD2' ' A' ' 42' ' ' TYR . 7.6 p -62.48 123.92 16.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.635 -0.711 . . . . 0.73999999999999999 110.442 177.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.803 ' HB2' ' HG2' ' A' ' 43' ' ' ARG . 21.5 tpt180 -125.59 114.11 18.3 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.263 -0.426 . . . . 4.7000000000000002 110.536 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.441 ' HG3' ' HG3' ' A' ' 59' ' ' GLU . 3.9 pt20 -58.19 -33.17 68.96 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.739 -0.664 . . . . 3.3199999999999998 111.182 178.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.441 ' HG3' ' HG3' ' A' ' 58' ' ' GLN . 38.7 mt-10 -105.19 67.29 0.78 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.909 -0.587 . . . . 5.9900000000000002 111.742 -176.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 62.7 m -127.03 -52.41 1.42 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.625 -0.716 . . . . 4.6600000000000001 109.921 172.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 40' ' ' GLN . . . . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.544 -1.142 . . . . 4.7400000000000002 111.674 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.0 t . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 120.928 0.394 . . . . 2.7999999999999998 110.422 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.622 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 60.9 tt0 -72.03 132.8 44.76 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.094 -0.503 . . . . 6.6900000000000004 110.513 176.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.403 ' H ' HD23 ' A' ' 7' ' ' LEU . 2.5 pt? -137.19 9.78 2.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.054 -0.521 . . . . 2.8199999999999998 110.153 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.7 p -169.55 -174.94 2.02 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.681 -0.691 . . . . 3.77 110.265 -172.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -45.17 -56.93 4.29 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.41 0.624 . . . . 4.5899999999999999 110.285 175.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.0 p -97.72 128.15 35.17 Favored Pre-proline 0 N--CA 1.441 -0.91 0 CA-C-N 115.268 -0.878 . . . . 2.4199999999999999 109.796 173.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.622 ' HA ' ' HA ' ' A' ' 6' ' ' GLN . 51.1 Cg_exo -57.95 -19.08 38.3 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.05 2.5 . . . . 1.6899999999999999 112.759 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.673 ' H ' ' HB3' ' A' ' 15' ' ' SER . . . 66.9 121.19 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.89 0.744 . . . . 1.4199999999999999 111.602 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.59 ' HB1' ' CD1' ' A' ' 34' ' ' TYR . . . 70.68 -58.37 0.56 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.655 -0.702 . . . . 0.64000000000000001 110.978 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.9 t -83.18 7.62 15.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.755 0.788 . . . . 1.47 109.447 174.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.673 ' HB3' ' H ' ' A' ' 12' ' ' ALA . 6.3 p -70.15 -25.24 63.37 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.299 -0.864 . . . . 1.3600000000000001 112.317 -175.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.9 t -93.6 11.37 29.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.975 0.417 . . . . 1.6399999999999999 110.745 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 55.71 63.57 6.14 Favored Pre-proline 0 N--CA 1.468 0.451 0 CA-C-N 115.396 -0.82 . . . . 1.6899999999999999 111.041 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.532 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 23.6 Cg_exo -63.95 -56.01 0.55 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.994 2.463 . . . . 0.54000000000000004 112.512 -174.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.476 ' SG ' ' HB3' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -96.56 7.61 46.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.91 -0.587 . . . . 0.55000000000000004 111.212 -178.692 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.417 ' HA3' ' HD3' ' A' ' 21' ' ' PRO . . . 73.22 -130.5 13.76 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.009 -0.615 . . . . 0.68999999999999995 112.789 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 24' ' ' ALA . 10.6 Cg_endo -91.24 170.89 3.14 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 123.709 2.94 . . . . 0.82999999999999996 112.555 -178.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -63.75 -21.0 66.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.633 -0.712 . . . . 3.4199999999999999 110.588 176.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.58 -32.78 74.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.941 0.4 . . . . 0.65000000000000002 110.56 175.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.509 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . . . -94.61 -63.61 1.16 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.96 -0.564 . . . . 0.40999999999999998 110.952 -177.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -162.25 142.05 7.67 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.69 -0.767 . . . . 0.60999999999999999 112.277 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.2 m -84.38 141.18 31.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.786 0.327 . . . . 0.87 110.215 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.476 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 6.9 p -100.17 129.35 46.18 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.215 -0.448 . . . . 1.4199999999999999 110.068 177.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -128.31 111.48 13.42 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.399 -0.593 . . . . 1.9199999999999999 109.399 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.45 ' HG3' ' HB3' ' A' ' 13' ' ' ALA . 2.9 mp0 -68.33 119.71 13.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.127 0.489 . . . . 1.6599999999999999 110.93 -178.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 60.7 p -102.66 -175.69 2.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.581 -0.736 . . . . 0.62 110.403 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -64.78 -44.84 88.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.693 0.283 . . . . 2.4300000000000002 110.258 175.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.5 m -62.75 -41.09 99.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.091 0.472 . . . . 1.4399999999999999 110.667 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 172.64 -82.19 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.81 -0.709 . . . . 0.37 111.657 177.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.59 ' CD1' ' HB1' ' A' ' 13' ' ' ALA . 42.4 p90 -155.5 156.01 34.45 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.91 0.385 . . . . 0.56999999999999995 110.886 176.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 46.3 pt -125.06 159.69 31.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.716 -0.675 . . . . 0.64000000000000001 109.485 172.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.532 ' SG ' ' HB2' ' A' ' 18' ' ' PRO . 36.4 m -123.57 121.1 34.75 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.108 0.48 . . . . 0.28999999999999998 110.539 178.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -101.92 100.18 10.45 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.048 -0.723 . . . . 4.4299999999999997 109.048 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 75.1 m -80.72 136.63 36.2 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.967 -0.56 . . . . 0.27000000000000002 111.108 -175.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -71.83 155.07 40.83 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.254 -0.885 . . . . 0.70999999999999996 109.327 175.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -60.49 121.2 11.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.154 0.502 . . . . 2.8999999999999999 110.105 -178.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.48 -10.42 11.53 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.721 -0.952 . . . . 0.47999999999999998 110.721 -170.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.509 ' CE2' ' HA ' ' A' ' 24' ' ' ALA . 92.9 m-85 -123.91 162.62 22.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.96 -0.62 . . . . 0.54000000000000004 110.099 176.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.476 ' HG3' HG13 ' A' ' 55' ' ' ILE . 31.6 ptt180 -139.04 156.51 47.14 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.906 0.384 . . . . 3.0499999999999998 110.665 -177.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.437 HD13 ' HA ' ' A' ' 44' ' ' ILE . 14.1 mm -83.08 130.31 35.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.949 -0.569 . . . . 0.34000000000000002 110.705 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 44.1 t -132.21 155.99 47.25 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.579 -0.737 . . . . 0.48999999999999999 109.809 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 84.3 mt -105.34 136.84 44.14 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.331 -0.618 . . . . 0.94999999999999996 109.331 175.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -59.22 -28.13 66.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.059 -0.973 . . . . 2.52 111.832 -176.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 137.07 -34.69 2.17 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.804 -0.918 . . . . 1.4199999999999999 110.804 -174.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 56.2 p -87.26 -29.72 21.44 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.368 0.604 . . . . 1.27 109.398 175.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 127.78 14.73 2.5 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.314 -0.857 . . . . 0.79000000000000004 112.333 176.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -82.02 142.34 32.44 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.845 0.355 . . . . 1.5 110.248 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.3 t -79.21 111.64 16.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.898 -0.592 . . . . 0.5 111.163 -172.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.9 p -120.64 169.95 9.89 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.983 -0.553 . . . . 1.05 110.263 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.416 ' HB2' ' HB3' ' A' ' 19' ' ' CYS . 17.3 t -125.0 131.85 53.35 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 110.04 -0.356 . . . . 0.28999999999999998 110.04 -178.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.476 HG13 ' HG3' ' A' ' 43' ' ' ARG . 29.0 pt -133.02 169.99 20.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.053 -0.521 . . . . 0.46999999999999997 110.204 -179.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.407 HG21 ' HA ' ' A' ' 59' ' ' GLU . 11.0 p -72.85 140.74 17.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.995 0.426 . . . . 0.73999999999999999 110.801 -177.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -76.75 -37.79 55.32 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.82 -0.627 . . . . 4.7000000000000002 110.409 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -150.44 -65.45 0.2 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.155 -0.683 . . . . 3.3199999999999998 109.155 172.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.407 ' HA ' HG21 ' A' ' 56' ' ' VAL . 9.8 tp10 -174.96 100.56 0.08 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.306 -0.861 . . . . 5.9900000000000002 109.378 177.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.9 t 52.59 38.87 27.01 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 121.546 0.689 . . . . 4.6600000000000001 109.813 -174.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.948 0 CA-C-O 117.761 -1.577 . . . . 4.7400000000000002 110.132 -173.429 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.9 m . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 120.892 0.377 . . . . 2.7999999999999998 110.557 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.579 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 7.6 tt0 -93.84 94.42 8.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.879 0.371 . . . . 6.6900000000000004 110.092 -177.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.0 mt -85.74 99.71 11.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.959 -0.564 . . . . 2.8199999999999998 111.595 -175.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.7 m 72.11 -62.52 0.46 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.513 -0.767 . . . . 3.77 112.368 173.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -132.44 -63.95 0.78 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.888 0.375 . . . . 4.5899999999999999 110.484 -176.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.485 ' C ' ' H ' ' A' ' 12' ' ' ALA . 14.7 p -90.26 142.18 28.24 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.92 -0.582 . . . . 2.4199999999999999 110.868 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.579 ' HA ' ' HA ' ' A' ' 6' ' ' GLN . 11.4 Cg_exo -72.47 29.04 0.27 Allowed 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 123.009 2.473 . . . . 1.6899999999999999 112.144 171.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.518 ' HB3' ' OE2' ' A' ' 29' ' ' GLU . . . 43.63 -96.01 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.633 1.346 . . . . 1.4199999999999999 114.633 175.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.707 ' HB3' ' HG2' ' A' ' 29' ' ' GLU . . . -86.23 -18.09 33.04 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.261 0.553 . . . . 0.64000000000000001 110.802 -174.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 41.9 t -104.15 11.81 34.63 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.773 -0.825 . . . . 1.47 108.773 175.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 39.3 t -65.94 -28.53 68.99 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.073 -0.967 . . . . 1.3600000000000001 111.151 -174.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.1 m -101.45 13.21 35.69 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.968 0.413 . . . . 1.6399999999999999 111.472 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.6 m120 55.79 84.54 0.21 Allowed Pre-proline 0 N--CA 1.469 0.509 0 CA-C-N 115.389 -0.823 . . . . 1.6899999999999999 112.103 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.441 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 2.9 Cg_exo -73.13 -58.26 0.07 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.998 2.465 . . . . 0.54000000000000004 112.36 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.463 ' HB3' ' HB2' ' A' ' 54' ' ' CYS . 0.0 OUTLIER -86.39 17.52 3.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.069 -0.514 . . . . 0.55000000000000004 111.796 -175.048 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.477 ' HA3' ' HD3' ' A' ' 21' ' ' PRO . . . 76.01 -124.82 7.54 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.036 -0.602 . . . . 0.68999999999999995 112.938 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.477 ' HD3' ' HA3' ' A' ' 20' ' ' GLY . 9.2 Cg_endo -90.52 160.73 4.4 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.725 2.95 . . . . 0.82999999999999996 112.362 -178.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -64.31 -21.31 66.56 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.642 -0.708 . . . . 3.4199999999999999 111.325 -178.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.69 -31.96 67.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.324 -0.398 . . . . 0.65000000000000002 110.78 177.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.448 ' HB3' ' HD2' ' A' ' 21' ' ' PRO . . . -76.92 -50.16 13.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.812 -0.631 . . . . 0.40999999999999998 110.59 -177.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -172.82 166.6 39.26 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.23 -0.986 . . . . 0.60999999999999999 112.866 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.5 m -93.41 139.37 30.77 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.997 -0.372 . . . . 0.87 109.997 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.45 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 6.0 p -100.52 115.63 30.56 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.258 0.551 . . . . 1.4199999999999999 110.39 177.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -114.6 119.78 37.94 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.911 -0.586 . . . . 1.9199999999999999 109.696 -176.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.707 ' HG2' ' HB3' ' A' ' 13' ' ' ALA . 31.6 mt-10 -79.8 130.14 35.07 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.01 -0.541 . . . . 1.6599999999999999 110.568 -175.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.3 p -121.54 -174.86 2.95 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.854 -0.612 . . . . 0.62 111.43 -173.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -68.67 -29.3 67.74 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.961 0.41 . . . . 2.4300000000000002 110.904 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.6 t -85.85 -4.76 59.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.178 0.513 . . . . 1.4399999999999999 110.165 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 133.08 -83.12 0.3 Allowed Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 111.144 -0.782 . . . . 0.37 111.144 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.441 ' CE1' ' HB3' ' A' ' 18' ' ' PRO . 46.3 p90 -156.62 153.48 28.63 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.072 0.463 . . . . 0.56999999999999995 110.593 178.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 47.6 pt -125.7 165.19 23.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 108.764 -0.828 . . . . 0.64000000000000001 108.764 169.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.417 ' O ' HD11 ' A' ' 44' ' ' ILE . 62.6 m -121.38 131.25 54.07 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.225 0.536 . . . . 0.28999999999999998 110.443 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -107.73 98.07 7.71 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.302 -0.863 . . . . 4.4299999999999997 108.775 177.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 90.6 m -79.85 133.25 36.25 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.192 0.52 . . . . 0.27000000000000002 110.865 -176.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -64.9 143.99 57.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.17 -0.923 . . . . 0.70999999999999996 109.439 177.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.46 ' H ' ' CD ' ' A' ' 40' ' ' GLN . 2.7 pm0 -44.69 111.13 0.28 Allowed 'General case' 0 C--O 1.234 0.271 0 O-C-N 123.864 0.728 . . . . 2.8999999999999999 111.268 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.684 ' HA3' ' HA ' ' A' ' 60' ' ' SER . . . 125.96 -20.49 6.35 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.375 -0.829 . . . . 0.47999999999999998 111.124 -174.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -112.91 162.43 15.84 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.126 -0.537 . . . . 0.54000000000000004 109.682 174.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.428 ' HG3' HG13 ' A' ' 55' ' ' ILE . 30.3 ptt180 -140.72 157.25 45.69 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.976 0.417 . . . . 3.0499999999999998 110.882 -176.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.449 HD13 ' HA ' ' A' ' 44' ' ' ILE . 21.1 mm -82.11 128.12 39.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.463 -0.789 . . . . 0.34000000000000002 111.223 -178.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.406 ' HB2' HG12 ' A' ' 55' ' ' ILE . 33.4 t -129.59 150.47 50.9 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.633 -0.712 . . . . 0.48999999999999999 109.083 176.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 52' ' ' VAL . 64.5 mt -115.53 124.17 50.37 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.033 -0.729 . . . . 0.94999999999999996 109.033 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.43 56.61 1.41 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.023 -0.535 . . . . 2.52 112.228 -175.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.75 -56.88 4.24 Favored Glycine 0 N--CA 1.453 -0.195 0 CA-C-N 116.225 -0.443 . . . . 1.4199999999999999 113.298 174.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.1 p -78.92 7.56 7.0 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.161 0.43 . . . . 1.27 112.161 -176.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.85 10.75 84.69 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.983 -0.627 . . . . 0.79000000000000004 112.552 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.427 ' O ' ' HA ' ' A' ' 46' ' ' LEU . 12.9 m120 -72.41 128.08 34.53 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.122 -0.696 . . . . 1.5 109.122 176.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.468 ' HA ' HD23 ' A' ' 46' ' ' LEU . 31.5 t -79.69 111.49 16.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.024 -0.534 . . . . 0.5 110.631 -174.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.9 p -122.34 177.79 5.23 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.593 -0.521 . . . . 1.05 109.593 177.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.463 ' HB2' ' HB3' ' A' ' 19' ' ' CYS . 25.4 t -129.19 129.85 45.58 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.928 0.394 . . . . 0.28999999999999998 110.051 -176.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.428 HG13 ' HG3' ' A' ' 43' ' ' ARG . 26.3 pt -131.59 164.94 33.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.081 -0.509 . . . . 0.46999999999999997 110.35 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.8 p -69.35 138.44 22.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.271 0.558 . . . . 0.73999999999999999 110.911 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.2 ttp180 -85.02 -53.81 5.05 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.076 -0.712 . . . . 4.7000000000000002 109.076 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -177.74 89.59 0.03 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.433 -0.803 . . . . 3.3199999999999998 110.33 173.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 60.13 23.7 12.98 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.216 0.821 . . . . 5.9900000000000002 113.216 173.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.684 ' HA ' ' HA3' ' A' ' 41' ' ' GLY . 23.1 t 68.53 161.09 0.19 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.256 0.551 . . . . 4.6600000000000001 111.515 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.928 0 CA-C-O 118.752 -1.027 . . . . 4.7400000000000002 111.772 -178.842 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.526 ' HA ' ' HB3' ' A' ' 11' ' ' PRO . 47.5 t . . . . . 0 N--CA 1.479 1.018 0 CA-C-O 120.747 0.308 . . . . 2.7999999999999998 110.404 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.661 ' NE2' ' HB2' ' A' ' 29' ' ' GLU . 44.0 mt-30 -139.44 179.14 6.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.273 -0.422 . . . . 6.6900000000000004 110.166 177.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.1 mt 69.53 167.26 0.28 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.838 0.827 . . . . 2.8199999999999998 112.195 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.0 m -109.9 30.21 6.91 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.079 -0.964 . . . . 3.77 110.836 -176.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -142.12 -76.42 0.28 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.953 -0.758 . . . . 4.5899999999999999 108.953 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.424 ' C ' ' H ' ' A' ' 12' ' ' ALA . 8.9 p -137.65 146.94 55.26 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 108.546 -0.909 . . . . 2.4199999999999999 108.546 173.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.758 ' HB2' ' HB3' ' A' ' 14' ' ' CYS . 44.4 Cg_endo -71.5 20.39 0.25 Allowed 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 122.558 2.172 . . . . 1.6899999999999999 113.32 -177.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.424 ' H ' ' C ' ' A' ' 10' ' ' THR . . . 48.73 -94.52 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.877 0.871 . . . . 1.4199999999999999 112.879 175.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.536 ' HB1' ' CD1' ' A' ' 34' ' ' TYR . . . -65.33 -27.46 68.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.272 -0.422 . . . . 0.64000000000000001 111.309 -177.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.758 ' HB3' ' HB2' ' A' ' 11' ' ' PRO . 33.4 t -95.87 -2.86 46.5 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.063 -0.517 . . . . 1.47 110.559 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.42 ' HA ' ' HG2' ' A' ' 11' ' ' PRO . 9.7 t -70.72 -9.6 57.61 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.89 0.376 . . . . 1.3600000000000001 111.504 -174.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.5 m -90.45 4.85 49.84 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.034 0.445 . . . . 1.6399999999999999 111.275 177.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.436 ' N ' ' HD3' ' A' ' 18' ' ' PRO . 4.1 m-20 54.14 59.94 11.4 Favored Pre-proline 0 N--CA 1.467 0.423 0 CA-C-N 115.219 -0.9 . . . . 1.6899999999999999 110.984 -174.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.436 ' HD3' ' N ' ' A' ' 17' ' ' ASN . 11.5 Cg_exo -70.22 -52.62 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.952 2.434 . . . . 0.54000000000000004 112.131 -174.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.542 ' SG ' ' HB3' ' A' ' 27' ' ' CYS . 1.8 m -82.3 -7.3 59.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.757 -0.656 . . . . 0.55000000000000004 110.754 -177.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.34 -144.83 17.42 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.779 -0.724 . . . . 0.68999999999999995 112.389 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.452 ' HD2' ' CB ' ' A' ' 24' ' ' ALA . 9.6 Cg_endo -88.64 175.04 3.89 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.377 2.718 . . . . 0.82999999999999996 112.761 -177.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -53.04 -46.02 68.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.401 -0.363 . . . . 3.4199999999999999 111.193 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.1 -24.09 66.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.476 0.547 . . . . 0.65000000000000002 112.476 -176.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.452 ' CB ' ' HD2' ' A' ' 21' ' ' PRO . . . -85.96 -65.85 0.97 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.751 0.31 . . . . 0.40999999999999998 110.853 -177.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -168.56 155.97 27.0 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 119.971 -1.109 . . . . 0.60999999999999999 112.901 -177.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.2 m -90.29 142.58 27.58 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.772 0.32 . . . . 0.87 110.526 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.542 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 14.9 p -100.55 129.08 46.44 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.079 0.466 . . . . 1.4199999999999999 110.5 178.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.443 ' HB3' HG13 ' A' ' 35' ' ' ILE . 29.4 tptp -117.43 106.56 13.33 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.638 -0.71 . . . . 1.9199999999999999 110.046 -178.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.661 ' HB2' ' NE2' ' A' ' 6' ' ' GLN . 57.4 mp0 -67.4 119.48 12.31 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.315 -0.624 . . . . 1.6599999999999999 109.315 176.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 48.1 p -102.13 -173.42 2.34 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.849 -0.614 . . . . 0.62 111.037 -174.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -71.41 -37.99 71.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.18 0.514 . . . . 2.4300000000000002 110.164 177.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.7 m -83.3 -28.17 29.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.76 -0.654 . . . . 1.4399999999999999 111.277 -177.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 174.3 -94.56 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.878 -0.677 . . . . 0.37 111.658 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.564 ' OH ' ' HB2' ' A' ' 51' ' ' ASN . 38.1 p90 -156.1 154.21 30.57 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.628 0.252 . . . . 0.56999999999999995 110.556 177.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.443 HG13 ' HB3' ' A' ' 28' ' ' LYS . 40.1 pt -129.38 165.99 28.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.876 -0.602 . . . . 0.64000000000000001 109.412 171.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.45 ' O ' HD11 ' A' ' 44' ' ' ILE . 55.9 m -121.49 131.45 54.16 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.261 -0.427 . . . . 0.28999999999999998 110.404 -179.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 -114.86 101.56 9.16 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.05 -0.523 . . . . 4.4299999999999997 109.811 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.507 ' HB3' ' HB2' ' A' ' 42' ' ' TYR . 85.0 m -81.58 151.12 27.84 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.686 -0.688 . . . . 0.27000000000000002 111.375 -174.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -84.73 159.71 20.45 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.431 -0.804 . . . . 0.70999999999999996 109.325 175.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -51.19 122.68 8.07 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 120.991 0.424 . . . . 2.8999999999999999 111.276 -178.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 112.45 -16.22 24.39 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.601 -0.727 . . . . 0.47999999999999998 111.421 -175.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.507 ' HB2' ' HB3' ' A' ' 38' ' ' CYS . 89.6 m-85 -114.74 162.62 16.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.937 0.398 . . . . 0.54000000000000004 110.597 179.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.554 ' HG3' HG13 ' A' ' 55' ' ' ILE . 21.9 ptt180 -140.86 158.16 44.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.141 -0.481 . . . . 3.0499999999999998 111.181 -174.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.45 HD11 ' O ' ' A' ' 36' ' ' CYS . 16.0 mm -84.41 132.39 31.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.785 -0.643 . . . . 0.34000000000000002 110.708 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.491 ' HB2' HG12 ' A' ' 55' ' ' ILE . 33.8 t -133.02 164.37 27.16 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.753 -0.658 . . . . 0.48999999999999999 109.545 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.404 ' HA ' ' O ' ' A' ' 51' ' ' ASN . 77.5 mt -124.1 121.8 36.15 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.295 -0.631 . . . . 0.94999999999999996 109.295 178.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.98 69.31 10.52 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.361 -0.382 . . . . 2.52 111.96 -176.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.44 -72.32 2.83 Favored Glycine 0 CA--C 1.517 0.216 0 CA-C-N 115.957 -0.565 . . . . 1.4199999999999999 113.472 173.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.8 p -73.42 -0.41 14.77 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.397 0.517 . . . . 1.27 112.397 -173.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.35 20.3 52.52 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.32 -0.943 . . . . 0.79000000000000004 111.657 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.564 ' HB2' ' OH ' ' A' ' 34' ' ' TYR . 9.5 p30 -81.76 135.91 35.45 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.116 -0.698 . . . . 1.5 109.116 175.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.402 ' HA ' HD23 ' A' ' 46' ' ' LEU . 39.4 t -79.98 118.57 27.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.061 -0.518 . . . . 0.5 111.271 -172.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 81.1 p -128.01 172.44 10.93 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.082 -0.508 . . . . 1.05 110.619 177.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 19' ' ' CYS . 40.0 t -122.79 131.64 53.86 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.961 -0.563 . . . . 0.28999999999999998 109.551 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.554 HG13 ' HG3' ' A' ' 43' ' ' ARG . 23.9 pt -134.59 164.56 33.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.974 -0.557 . . . . 0.46999999999999997 109.835 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.3 p -71.75 136.22 26.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.418 0.628 . . . . 0.73999999999999999 110.952 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -87.93 -65.14 1.05 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.13 -1.063 . . . . 4.7000000000000002 108.13 171.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 172.53 127.82 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.461 -1.245 . . . . 3.3199999999999998 108.383 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 65.66 -175.43 0.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 O-C-N 123.503 0.502 . . . . 5.9900000000000002 110.323 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 42.1 m -141.08 130.16 23.33 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.929 0.395 . . . . 4.6600000000000001 110.641 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.91 0 CA-C-O 118.713 -1.048 . . . . 4.7400000000000002 111.992 -179.323 . . . . . . . . 0 0 . 1 stop_ save_